{"meta":{"query_hash":"039e52dae703","filters":{"venue":"Drug Safety"},"cohort_total":204,"direct_labels_cover":0,"predictions_cover":204,"exported":204,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/039e52dae703","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drug+Safety"},"results":[{"id":"W1239449858","doi":"10.2165/11599720-000000000-00000","title":"Impact of Regulatory Guidances and Drug Regulation on Risk Minimization Interventions in Drug Safety","year":2012,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Patient Safety Institute; Golden Key International Honour Society","keywords":"Medicine; Psychological intervention; Drug; Agency (philosophy); MEDLINE; Pharmacovigilance; Population; Adverse effect; Regulatory science; Intensive care medicine; Pharmacology; Environmental health; Psychiatry","score_opus":0.13580833739695367,"score_gpt":0.4777817785596545,"score_spread":0.3419734411627008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1239449858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041185235,0.9965978,0.00034304667,0.0010176226,0.00011653562,0.0000131192755,0.000024338924,0.0000083215855,0.0014673099],"genre_scores_gemma":[0.0061751883,0.9908573,0.0012393747,0.0011837729,0.00018967164,0.000017779801,0.000035688106,0.0000030016522,0.00029819456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969132,0.001075847,0.00043092933,0.00032618886,0.001130441,0.0001234223],"domain_scores_gemma":[0.9881464,0.009066525,0.0015286847,0.00017015118,0.00096302934,0.00012525191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073553384,0.0010848633,0.0027303838,0.002866431,0.00023596025,0.0016063688,0.0014950664,0.0023820105,0.003674153],"category_scores_gemma":[0.01028468,0.00044170493,0.0020341421,0.0022303998,0.00075041945,0.0014677325,0.0008276346,0.0023749808,0.00044637325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017228285,0.0001441293,0.00040129092,0.029533083,0.00052769855,0.00009860902,0.00006569278,0.0009303043,0.00042235496,0.005836366,0.0057418197,0.95612633],"study_design_scores_gemma":[0.0005491856,0.0009759054,0.012080512,0.12014287,0.0060747205,0.0016736584,0.00028120982,0.0014883223,0.002756921,0.013211111,0.840626,0.00013959529],"about_ca_topic_score_codex":0.0034393312,"about_ca_topic_score_gemma":0.00527762,"teacher_disagreement_score":0.0073553384,"about_ca_system_score_codex":0.0016598089,"about_ca_system_score_gemma":0.004255583,"threshold_uncertainty_score":0.038899183},"labels":[],"label_agreement":null},{"id":"W147912069","doi":"10.2165/00002018-200427110-00001","title":"Quantifying Adverse Drug Events","year":2004,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Health Sciences Centre; Sunnybrook Health Science Centre; Toronto Public Health; Children's & Women's Health Centre of British Columbia; Public Health Ontario; University of British Columbia; University of Toronto; Royal Victoria Hospital","funders":"","keywords":"Medicine; Systematic review; Terminology; Clinical trial; MEDLINE; Psychological intervention; Alternative medicine; Adverse effect; Intensive care medicine; Pharmacology; Pathology","score_opus":0.22090137391587814,"score_gpt":0.5039366087313554,"score_spread":0.2830352348154772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W147912069","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054150578,0.9512601,0.0253188,0.0012099682,0.00076899986,0.00047909672,0.0023333179,0.0004285132,0.012786143],"genre_scores_gemma":[0.05307437,0.8858298,0.044056423,0.0017927705,0.0010881218,0.00040578484,0.003388502,0.000058479225,0.010305741],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99540085,0.0011182474,0.00075859553,0.00048108664,0.002157615,0.00008359394],"domain_scores_gemma":[0.9928469,0.0028373264,0.0022357116,0.000248124,0.0017137364,0.000118263146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046672025,0.0024082311,0.003372201,0.0066241035,0.00022734057,0.0019893954,0.0017046187,0.0008259266,0.004936006],"category_scores_gemma":[0.009122521,0.00035914176,0.0023426674,0.004113573,0.00046783546,0.0014175491,0.0009447041,0.0011543873,0.0016382484],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001040272,0.00006534125,0.004163128,0.0074566,0.00048394097,0.000075734315,0.000032656997,0.00062275934,0.0009773709,0.0012038933,0.006925042,0.9778895],"study_design_scores_gemma":[0.00038366247,0.0024129276,0.092614725,0.028772347,0.008142272,0.010753834,0.0004892468,0.0077222628,0.018101074,0.021126084,0.8091501,0.00033151833],"about_ca_topic_score_codex":0.0017618388,"about_ca_topic_score_gemma":0.0026871457,"teacher_disagreement_score":0.0066241035,"about_ca_system_score_codex":0.00091987837,"about_ca_system_score_gemma":0.0015864357,"threshold_uncertainty_score":0.02468282},"labels":[],"label_agreement":null},{"id":"W1502985427","doi":"10.1007/s40264-015-0305-9","title":"Electronic Health Data for Postmarket Surveillance: A Vision Not Realized","year":2015,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Ottawa","keywords":"Medicine; Observational study; Terminology; Clinical trial; Adverse effect; MEDLINE; Medical emergency; Risk analysis (engineering); Pharmacology; Pathology","score_opus":0.2873736372829309,"score_gpt":0.5676336977194099,"score_spread":0.28026006043647894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1502985427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021071141,0.98352724,0.0015355385,0.011429991,0.0011273747,0.000021705675,0.00023549728,0.000058061807,0.0018539255],"genre_scores_gemma":[0.0035038888,0.9786592,0.004238683,0.009217803,0.0027072805,0.000038702747,0.00046266115,0.00002275994,0.0011489285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963075,0.0016163654,0.0004120743,0.00043043942,0.0010725245,0.00016110121],"domain_scores_gemma":[0.9615223,0.028266124,0.0029277462,0.0013919377,0.0046903593,0.0012014494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010966304,0.0014388381,0.0034560154,0.0044653732,0.00043955454,0.0044005495,0.0037279108,0.0046514506,0.008023895],"category_scores_gemma":[0.017109687,0.00052829174,0.0022492807,0.004761611,0.0022209794,0.009888105,0.002940498,0.007807089,0.0026533913],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007912943,0.000078173834,0.0007018402,0.01377259,0.0002968929,0.000098903954,0.00012473977,0.00023294392,0.00033746933,0.014923824,0.06665219,0.90270126],"study_design_scores_gemma":[0.00005658984,0.00010459701,0.0017220267,0.02749957,0.0004776857,0.00078859046,0.00033403677,0.00039181765,0.0004406547,0.014694845,0.953421,0.00006860673],"about_ca_topic_score_codex":0.0020938064,"about_ca_topic_score_gemma":0.0033841997,"teacher_disagreement_score":0.010966304,"about_ca_system_score_codex":0.0018087347,"about_ca_system_score_gemma":0.004670546,"threshold_uncertainty_score":0.057996035},"labels":[],"label_agreement":null},{"id":"W1525650584","doi":"10.1007/bf03261978","title":"Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders","year":2012,"lang":"en","type":"article","venue":"Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institut universitaire en santé mentale de Montréal","funders":"","keywords":"Olanzapine; Medicine; Akathisia; Extrapyramidal symptoms; Adverse effect; Tolerability; Psychiatry; Bipolar disorder; Randomized controlled trial; Mania; Internal medicine; Schizophrenia (object-oriented programming); Tardive dyskinesia; Antipsychotic; Mood","score_opus":0.015842044160158997,"score_gpt":0.28273057378372557,"score_spread":0.2668885296235666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1525650584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748933,0.0015914359,0.00012510804,0.00008489285,0.000036169688,0.000039225368,0.00017106472,0.000007331084,0.0004553767],"genre_scores_gemma":[0.9989188,0.00045930472,0.000097755765,0.00006955071,0.000054267235,0.00001907535,0.00020543404,0.0000031787401,0.00017268656],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9981036,0.001162511,0.0002494815,0.00009355448,0.0002451994,0.00014557289],"domain_scores_gemma":[0.9972324,0.0012298529,0.0008449879,0.00011397984,0.000249818,0.0003290463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025846642,0.0004042074,0.00063464907,0.00045776277,0.000192896,0.00057851896,0.00024226353,0.00044604868,0.0016123519],"category_scores_gemma":[0.0045104437,0.00017253536,0.0014297843,0.00032348212,0.00037736387,0.0007573113,0.00031256097,0.0007256939,0.00017364445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83231145,0.00210488,0.064013086,0.0006489912,0.004090812,0.0002670459,0.00033009436,0.0011829444,0.018637165,0.00022836876,0.0005018156,0.07568339],"study_design_scores_gemma":[0.060938023,0.4598952,0.45202374,0.00015597657,0.006576755,0.00092990993,0.001009664,0.0033732753,0.0117385825,0.0008581928,0.0023771129,0.00012353563],"about_ca_topic_score_codex":0.001847353,"about_ca_topic_score_gemma":0.0035190047,"teacher_disagreement_score":0.0025846642,"about_ca_system_score_codex":0.0012455359,"about_ca_system_score_gemma":0.0007241599,"threshold_uncertainty_score":0.013669193},"labels":[],"label_agreement":null},{"id":"W157430424","doi":"10.2165/00002018-200225110-00003","title":"Long-Term Tolerability of the Bisphosphonates in Postmenopausal Osteoporosis","year":2002,"lang":"en","type":"review","venue":"Drug Safety","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Discontinuation; Tolerability; Adverse effect; Placebo; Osteoporosis; Etidronic acid; Osteomalacia; Internal medicine; Clinical trial; Alendronic acid; Bisphosphonate; Surgery; Pathology; Alternative medicine","score_opus":0.04019643272622605,"score_gpt":0.35420974062932414,"score_spread":0.3140133079030981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W157430424","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047278192,0.99895704,0.00009300208,0.0000863193,0.000043971686,0.000003775557,0.000017763949,0.000003356782,0.00032191907],"genre_scores_gemma":[0.0031977426,0.9959758,0.00020618582,0.0001497578,0.00009290501,0.00000558758,0.00003694544,0.0000010354837,0.00033409448],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999613,0.000077310266,0.00008364081,0.000047800568,0.00016358563,0.000014667392],"domain_scores_gemma":[0.99922705,0.00041003438,0.00020081311,0.00001502244,0.00012074341,0.000026281656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011563903,0.00063035515,0.0023764726,0.0012553086,0.00015623317,0.00065189943,0.0008591265,0.0008328116,0.0019859986],"category_scores_gemma":[0.0012682878,0.00022451674,0.00082560006,0.0015375577,0.00025043782,0.0005929622,0.00027125183,0.00084576104,0.0005150639],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038371363,0.00009456149,0.00070965267,0.021715714,0.0004876939,0.00030236397,0.000046331577,0.0002693832,0.0017735058,0.00042162192,0.006217216,0.96757823],"study_design_scores_gemma":[0.00083071855,0.0024966875,0.024622347,0.022491412,0.0066117663,0.012130372,0.00034274577,0.0007488123,0.0044515734,0.0025908796,0.9225781,0.000104608494],"about_ca_topic_score_codex":0.0009859398,"about_ca_topic_score_gemma":0.0028784384,"teacher_disagreement_score":0.0023764726,"about_ca_system_score_codex":0.0003504329,"about_ca_system_score_gemma":0.00057859556,"threshold_uncertainty_score":0.0066438317},"labels":[],"label_agreement":null},{"id":"W158498742","doi":"10.2165/00002018-200022020-00004","title":"Corticosteroid-Induced Adverse Psychiatric Effects","year":2000,"lang":"en","type":"review","venue":"Drug Safety","topic":"Stress Responses and Cortisol","field":"Neuroscience","cited_by":172,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Calgary","funders":"","keywords":"Medicine; Adverse effect; Psychiatry; Corticosteroid; Psychosis; Delirium; Intensive care medicine; Pharmacology; Surgery","score_opus":0.03429765987612213,"score_gpt":0.31898409180058335,"score_spread":0.2846864319244612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W158498742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016091473,0.99829763,0.00013883032,0.00015934107,0.00014786192,0.000005793712,0.000021901551,0.000008976078,0.0010588218],"genre_scores_gemma":[0.0010433054,0.9977042,0.00016291879,0.00018143593,0.00026066447,0.00000489117,0.000028957356,0.0000011453337,0.00061258196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975854,0.00004340845,0.000041813237,0.000042323994,0.00009723417,0.000016681304],"domain_scores_gemma":[0.99929845,0.00034554937,0.00014385805,0.00002460748,0.00014117814,0.000046259614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006175802,0.0011307697,0.002061305,0.0019198478,0.00027799438,0.0009112392,0.0010096037,0.0011426209,0.003664506],"category_scores_gemma":[0.0011213425,0.00022409158,0.00053440675,0.0020453678,0.00048562937,0.0007489446,0.0004453311,0.0014161654,0.0016995838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009228424,0.00007083585,0.00035525905,0.008557923,0.00011197149,0.00040515367,0.000022508568,0.00030129662,0.0009062696,0.00048540634,0.01903617,0.9696548],"study_design_scores_gemma":[0.00011729745,0.00034747872,0.0066630966,0.0071017877,0.0007257763,0.007412006,0.00013003842,0.00036813086,0.001162016,0.0020974514,0.97382045,0.000054456224],"about_ca_topic_score_codex":0.0021738592,"about_ca_topic_score_gemma":0.00596646,"teacher_disagreement_score":0.003664506,"about_ca_system_score_codex":0.00056360604,"about_ca_system_score_gemma":0.0010359762,"threshold_uncertainty_score":0.012258947},"labels":[],"label_agreement":null},{"id":"W176098340","doi":"10.2165/00002018-200124030-00005","title":"Saquinavir Soft Gelatin Capsule","year":2001,"lang":"en","type":"review","venue":"Drug Safety","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Saquinavir; Pharmacology; Medicine; Indinavir; Ritonavir; Protease inhibitor (pharmacology); Nelfinavir; Virology; Virus","score_opus":0.03345830669221781,"score_gpt":0.3288295794363439,"score_spread":0.29537127274412606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W176098340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018265931,0.99121726,0.0008919044,0.0002340252,0.00024088079,0.000053089938,0.000075601376,0.000048124177,0.005412553],"genre_scores_gemma":[0.008316463,0.9827405,0.0012957008,0.00031536078,0.0001434873,0.000037167738,0.00016384498,0.000005969054,0.0069814944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989617,0.000025090832,0.000017193901,0.000013135884,0.000041145646,0.000007318294],"domain_scores_gemma":[0.9998785,0.000048115347,0.000042419833,0.0000045006004,0.000017473189,0.000008890443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002911618,0.00083343644,0.0009561304,0.001505828,0.00013260712,0.00037751175,0.00043344634,0.0004299126,0.0051444266],"category_scores_gemma":[0.00032734455,0.00016631102,0.0003578794,0.0009749319,0.00021594221,0.00048392703,0.0004004805,0.0004914997,0.0017122722],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010344303,0.000048359198,0.00007774214,0.008677851,0.000045220015,0.00019872912,0.000016018259,0.00010172533,0.004765377,0.00036034576,0.0077752294,0.9778299],"study_design_scores_gemma":[0.00014190398,0.0007588119,0.002108044,0.0024775544,0.00030750953,0.0036888986,0.000047980477,0.00017527246,0.006784648,0.0003527376,0.9831315,0.000025149457],"about_ca_topic_score_codex":0.00062151864,"about_ca_topic_score_gemma":0.0011584057,"teacher_disagreement_score":0.0051444266,"about_ca_system_score_codex":0.00018613275,"about_ca_system_score_gemma":0.00035885532,"threshold_uncertainty_score":0.017209768},"labels":[],"label_agreement":null},{"id":"W176241361","doi":"10.2165/00002018-200225050-00005","title":"Interaction Between Aspirin and ACE Inhibitors","year":2002,"lang":"en","type":"review","venue":"Drug Safety","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Baycrest Hospital; University of Toronto","funders":"","keywords":"Medicine; Aspirin; Confidence interval; Drug; Logistic regression; Drug interaction; Pharmacology; Internal medicine; Meta-analysis; Coronary artery disease","score_opus":0.027696829803634224,"score_gpt":0.320877671552314,"score_spread":0.29318084174867975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W176241361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046883014,0.99819726,0.00012397848,0.0001773921,0.00014469515,0.0000062768363,0.000026610427,0.0000051531833,0.0008498543],"genre_scores_gemma":[0.0027904639,0.99554354,0.00025319523,0.00031516128,0.00031728402,0.000009317202,0.000052017607,0.0000013001469,0.00071764586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954885,0.00009221561,0.00012238939,0.000056723064,0.00016049456,0.000019337187],"domain_scores_gemma":[0.99897695,0.00058025523,0.00031375003,0.000018912437,0.00008302353,0.000027088385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058815174,0.00090628554,0.0023440432,0.001807919,0.0002013769,0.0007671706,0.00073614967,0.0011724656,0.0030691568],"category_scores_gemma":[0.0016706159,0.00028159772,0.00086608087,0.0020068954,0.00024130021,0.00073620223,0.00036042664,0.0009498427,0.00089693884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056176115,0.000121782745,0.00082413765,0.029169675,0.0008193806,0.0010720796,0.00003949411,0.00036873537,0.0015477979,0.00057929277,0.012400836,0.9524951],"study_design_scores_gemma":[0.0006123194,0.0015654475,0.015275691,0.011294561,0.0071624033,0.012296149,0.00012304969,0.0005345463,0.0022885005,0.0015204771,0.9472505,0.00007625334],"about_ca_topic_score_codex":0.001068146,"about_ca_topic_score_gemma":0.003272631,"teacher_disagreement_score":0.0030691568,"about_ca_system_score_codex":0.00040457887,"about_ca_system_score_gemma":0.000836031,"threshold_uncertainty_score":0.010267377},"labels":[],"label_agreement":null},{"id":"W17705998","doi":"10.2165/00002018-200528080-00005","title":"Fetal Safety of Drugs Used in the Treatment of Allergic Rhinitis","year":2005,"lang":"en","type":"review","venue":"Drug Safety","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Loratadine; Desloratadine; Decongestant; Antihistamine; Pregnancy; Terfenadine; Azelastine; Drug; Pharmacology","score_opus":0.03658178240198973,"score_gpt":0.31620733290389713,"score_spread":0.2796255505019074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W17705998","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001524566,0.9990238,0.00007667242,0.000091950664,0.000049507868,0.0000021399017,0.0000125301385,0.0000022519118,0.00058871694],"genre_scores_gemma":[0.0011694124,0.99822706,0.00013253345,0.00007361488,0.000080478574,0.0000022617724,0.000019440351,6.098122e-7,0.00029459293],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996531,0.000089523994,0.000064895605,0.000043055916,0.00013204053,0.000017327153],"domain_scores_gemma":[0.99888307,0.0006508008,0.00023605087,0.00002170174,0.00017425677,0.000034216013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088881596,0.0007292552,0.0013535958,0.00240521,0.0002077866,0.0006685083,0.0006322351,0.0009371784,0.0024650288],"category_scores_gemma":[0.00158428,0.00024636224,0.00045879785,0.0020488678,0.00037440227,0.00077049655,0.0005098301,0.0009033435,0.0008049641],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009278226,0.00004877937,0.0005485259,0.01749302,0.000128359,0.0004043408,0.00006193955,0.00026824893,0.0012072129,0.0012716597,0.008240822,0.9702344],"study_design_scores_gemma":[0.00004015256,0.0002461628,0.0048714033,0.011703984,0.0005053154,0.005264719,0.00014251756,0.0001491957,0.0016453,0.0015094918,0.97388965,0.000032099604],"about_ca_topic_score_codex":0.0020063538,"about_ca_topic_score_gemma":0.0031874673,"teacher_disagreement_score":0.0024650288,"about_ca_system_score_codex":0.0005219469,"about_ca_system_score_gemma":0.0010273948,"threshold_uncertainty_score":0.008246362},"labels":[],"label_agreement":null},{"id":"W177097020","doi":"10.2165/00002018-200427070-00004","title":"Evaluation of the Extent of Under-Reporting of Serious Adverse Drug Reactions","year":2004,"lang":"en","type":"article","venue":"Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Health Canada","keywords":"Medicine; Drug reaction; Drug; Intensive care medicine; Adverse effect; Adverse drug reaction; Pharmacovigilance; Pharmacology; Traditional medicine","score_opus":0.042390662388530155,"score_gpt":0.3305245273732291,"score_spread":0.28813386498469895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W177097020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745695,0.0038431196,0.005978556,0.0006718608,0.000103753046,0.0008127489,0.0022753885,0.00010412317,0.011640842],"genre_scores_gemma":[0.9937239,0.00054649694,0.0040903734,0.00018244635,0.00005692517,0.00015296639,0.0007595526,0.0000096907115,0.0004774953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95336705,0.02223921,0.010598579,0.0018311051,0.01121713,0.0007468878],"domain_scores_gemma":[0.77054036,0.090128854,0.085144706,0.011056369,0.040396955,0.0027327],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.057560176,0.0003333382,0.0010641924,0.0028103765,0.00036565118,0.00076123874,0.0006665715,0.00055344554,0.0010132027],"category_scores_gemma":[0.07615658,0.00012883022,0.0012886071,0.0019620284,0.00079295423,0.001128832,0.0009805145,0.0009823912,0.00015798725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021219116,0.00018925812,0.94029105,0.0006108215,0.0007501162,0.00019731995,0.0008086284,0.00041151827,0.0019935747,0.00036712375,0.00046913815,0.051789664],"study_design_scores_gemma":[0.00007098849,0.003375396,0.9828708,0.00016033443,0.0006983646,0.0010817663,0.0009356587,0.00178401,0.0045106513,0.0004554584,0.0040186225,0.000037851787],"about_ca_topic_score_codex":0.00069387484,"about_ca_topic_score_gemma":0.0012609649,"teacher_disagreement_score":0.9424398,"about_ca_system_score_codex":0.0007515577,"about_ca_system_score_gemma":0.0009414025,"threshold_uncertainty_score":0.30441093},"labels":[],"label_agreement":null},{"id":"W1808463404","doi":"10.1007/s40264-015-0306-8","title":"DNA Barcoding and Pharmacovigilance of Herbal Medicines","year":2015,"lang":"en","type":"review","venue":"Drug Safety","topic":"Identification and Quantification in Food","field":"Biochemistry, Genetics and Molecular Biology","cited_by":158,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Pharmacovigilance; Medicine; DNA barcoding; Traditional medicine; Identification (biology); Pharmacology; Biotechnology; Adverse effect; Biology; Botany","score_opus":0.048929263907772115,"score_gpt":0.3647490413050003,"score_spread":0.31581977739722816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1808463404","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003174917,0.9974509,0.0006495994,0.00055939716,0.0001611282,0.000005186541,0.000037948677,0.000009974463,0.00080834125],"genre_scores_gemma":[0.0034958976,0.9936138,0.0011949801,0.00056639017,0.00031018475,0.000007696352,0.0000885672,0.000002492521,0.00071995426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995192,0.000090386384,0.000066357854,0.000094094234,0.00019451609,0.000035395075],"domain_scores_gemma":[0.9986506,0.00082535954,0.00023328964,0.000031915315,0.0002218766,0.00003690559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013057304,0.0007308038,0.0010028554,0.0023583162,0.00021422023,0.0010927905,0.0008864445,0.0014695359,0.0017785709],"category_scores_gemma":[0.0021098836,0.0002787561,0.0006824928,0.0018470815,0.00074586656,0.0010466888,0.00080067775,0.0012477434,0.00068405695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052294756,0.00003439843,0.00071013166,0.0067967153,0.0000951234,0.00017778682,0.000046964462,0.0002171677,0.002025163,0.0025591527,0.0073704855,0.9799146],"study_design_scores_gemma":[0.000026590806,0.00016283686,0.0052493825,0.0086386185,0.00049111084,0.002891568,0.00017851652,0.00057371735,0.0054961615,0.00779579,0.9684142,0.00008159733],"about_ca_topic_score_codex":0.0020788694,"about_ca_topic_score_gemma":0.0027366725,"teacher_disagreement_score":0.0023583162,"about_ca_system_score_codex":0.00054361345,"about_ca_system_score_gemma":0.0012497564,"threshold_uncertainty_score":0.0069054365},"labels":[],"label_agreement":null},{"id":"W1932082260","doi":"10.1007/s40264-015-0318-4","title":"Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries","year":2015,"lang":"en","type":"article","venue":"Drug Safety","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"National Health and Medical Research Council; Medical Research Council; Australian Government","keywords":"Medicine; Ethnic group; Health care; Retrospective cohort study; Variation (astronomy); Family medicine; Database; Internal medicine; Economic growth; Law","score_opus":0.01714628738415355,"score_gpt":0.31568623082870256,"score_spread":0.29853994344454904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1932082260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599624,0.0007254247,0.0002937841,0.00003424004,0.0000062979325,0.00003075179,0.0026302887,0.0000073527563,0.00027563426],"genre_scores_gemma":[0.9970233,0.00025972526,0.00025936883,0.000043395714,0.000005121671,0.00004217046,0.0023225474,0.0000052558994,0.000039201732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916101,0.003575912,0.0017311666,0.001670537,0.0010251523,0.0003871303],"domain_scores_gemma":[0.9838734,0.004233528,0.007729178,0.0021187663,0.0014693744,0.00057574816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005747826,0.0004276414,0.0011392744,0.002417858,0.00055721897,0.0014673112,0.00092354394,0.0006787019,0.00073003396],"category_scores_gemma":[0.010501412,0.000693735,0.0015287669,0.005586303,0.0006400357,0.00067441957,0.0013926021,0.0005089401,0.00018837758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012269898,0.00001274286,0.99828005,0.000048191047,0.00057222636,0.00004318549,0.00012762289,0.00007251083,0.00010257986,0.000014700018,0.00008465192,0.00051905756],"study_design_scores_gemma":[0.000010672282,0.000028442242,0.99921465,0.000017475146,0.00015951617,0.00010806032,0.00018158431,0.00013379092,0.0000379071,0.000008972789,0.000093974995,0.0000049806254],"about_ca_topic_score_codex":0.021306254,"about_ca_topic_score_gemma":0.01778837,"teacher_disagreement_score":0.021306254,"about_ca_system_score_codex":0.00079040544,"about_ca_system_score_gemma":0.000740734,"threshold_uncertainty_score":0.042364478},"labels":[],"label_agreement":null},{"id":"W1965661149","doi":"10.2165/00002018-200124060-00004","title":"Treating Hypertension in Women of Child-Bearing Age and during Pregnancy","year":2001,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Medicine; Pregnancy; Concomitant; Blood pressure; Disease; Diabetes mellitus; Obstetrics; Internal medicine; Endocrinology","score_opus":0.02718214980784474,"score_gpt":0.2783600050014794,"score_spread":0.25117785519363467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965661149","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048176554,0.9988263,0.000048170168,0.00010352239,0.000052088744,0.000012510398,0.000036128058,0.0000035134276,0.0004359919],"genre_scores_gemma":[0.002600804,0.9968291,0.00018546949,0.00016329723,0.000043027823,0.000013831965,0.000023343076,7.3870126e-7,0.00014053706],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99941313,0.00019137237,0.0001751041,0.0000616726,0.00013662076,0.000022013792],"domain_scores_gemma":[0.9975116,0.0017257599,0.0005110072,0.000031663007,0.00015761782,0.000062412786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011870464,0.00080850493,0.003011308,0.0028364637,0.00022189232,0.0006473051,0.0007365443,0.00087390665,0.0032211244],"category_scores_gemma":[0.0034462218,0.00032715517,0.0010989974,0.0028665955,0.00028378243,0.0006883154,0.00038372303,0.00083994004,0.00028957136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009245776,0.0001695261,0.00059426937,0.131745,0.0018714403,0.0003464631,0.00010877113,0.00021967261,0.0013009475,0.00037478097,0.0064638904,0.8558807],"study_design_scores_gemma":[0.0038039503,0.0054781423,0.022636678,0.14927684,0.03631087,0.0068285484,0.0007858048,0.00047061336,0.004266795,0.0014770405,0.7685075,0.00015733566],"about_ca_topic_score_codex":0.0020220734,"about_ca_topic_score_gemma":0.00860789,"teacher_disagreement_score":0.0032211244,"about_ca_system_score_codex":0.0004723359,"about_ca_system_score_gemma":0.0011094068,"threshold_uncertainty_score":0.010775745},"labels":[],"label_agreement":null},{"id":"W1966053262","doi":"10.1007/s40264-014-0255-7","title":"Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project","year":2015,"lang":"en","type":"review","venue":"Drug Safety","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Clair College","funders":"National Cancer Institute","keywords":"Rasburicase; Medicine; Anaphylaxis; Urate oxidase; Incidence (geometry); Uric acid; Adverse effect; Allergy; Internal medicine; Hyperuricemia; Immunology","score_opus":0.0710957407791591,"score_gpt":0.4028550479284119,"score_spread":0.33175930714925284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966053262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007403643,0.9979505,0.000097044904,0.00040060547,0.000119320386,0.000027326814,0.00010600901,0.0000072145267,0.00055167085],"genre_scores_gemma":[0.004784218,0.99390984,0.0003281014,0.00037338407,0.00018101069,0.00002864994,0.000111051544,0.0000018573085,0.0002818378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987301,0.00033640562,0.00032170812,0.00012744479,0.00044070237,0.000043538545],"domain_scores_gemma":[0.9944194,0.0029306456,0.0015956172,0.000083117426,0.0008398406,0.00013130416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032048952,0.00071417505,0.0017887156,0.003061303,0.00020807347,0.0011722188,0.00083726225,0.0011710614,0.0040428094],"category_scores_gemma":[0.0049240664,0.00027987003,0.0025278137,0.0022763882,0.00029853536,0.0010324188,0.00074887206,0.0011429297,0.00045118312],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053608406,0.00013810753,0.0028074174,0.048977327,0.0019308147,0.00017972602,0.00007389755,0.00019784216,0.00040175047,0.00085465005,0.014124365,0.92977816],"study_design_scores_gemma":[0.0015439524,0.0021804129,0.044260424,0.1361425,0.026093282,0.0052194586,0.00062825385,0.0005759875,0.0016787061,0.0027217562,0.7787689,0.00018639355],"about_ca_topic_score_codex":0.0014713871,"about_ca_topic_score_gemma":0.0024851144,"teacher_disagreement_score":0.0040428094,"about_ca_system_score_codex":0.0006508463,"about_ca_system_score_gemma":0.0018804104,"threshold_uncertainty_score":0.016949296},"labels":[],"label_agreement":null},{"id":"W1968682431","doi":"10.1007/s40264-014-0185-4","title":"Causality Assessment for Suspected DILI During Clinical Phases of Drug Development","year":2014,"lang":"en","type":"review","venue":"Drug Safety","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Innovative Medicines Initiative","keywords":"Medicine; Clinical trial; Causality (physics); Drug; Expert opinion; Drug development; Intensive care medicine; Pathology; Pharmacology","score_opus":0.2678899825798018,"score_gpt":0.5536385489352086,"score_spread":0.2857485663554068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968682431","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02799225,0.13636012,0.5537655,0.17073973,0.022592274,0.033996902,0.0035975487,0.0018708619,0.049084764],"genre_scores_gemma":[0.31197274,0.061263323,0.5435172,0.03845788,0.012512486,0.016974643,0.003679136,0.00032370051,0.011298922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7153981,0.20682439,0.039303686,0.0049464507,0.031180141,0.0023472963],"domain_scores_gemma":[0.48346844,0.33558398,0.06894798,0.024594605,0.08251002,0.004894921],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.30603898,0.0011886938,0.0030379116,0.0047560437,0.0020762477,0.00555182,0.0030029765,0.0045206486,0.0063718883],"category_scores_gemma":[0.30993497,0.00079040736,0.004180729,0.003081468,0.002468063,0.0041515986,0.0049974523,0.0072008073,0.001633803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005069085,0.00037166392,0.031631287,0.02152145,0.001356743,0.0026334533,0.005458362,0.001683243,0.0038177783,0.032371685,0.1134011,0.7806841],"study_design_scores_gemma":[0.0020283463,0.004125159,0.036271203,0.031683475,0.0030689244,0.006231567,0.0036279713,0.012176997,0.013989878,0.0932193,0.79284865,0.00072847656],"about_ca_topic_score_codex":0.0009198407,"about_ca_topic_score_gemma":0.0026422045,"teacher_disagreement_score":0.30603898,"about_ca_system_score_codex":0.0034320494,"about_ca_system_score_gemma":0.01156138,"threshold_uncertainty_score":0.8557775},"labels":[],"label_agreement":null},{"id":"W1969431665","doi":"10.2165/11587290-000000000-00000","title":"A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery","year":2011,"lang":"en","type":"review","venue":"Drug Safety","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Bayer HealthCare; American Association of Orthopaedic Surgeons","keywords":"Dabigatran; Medicine; Direct thrombin inhibitor; Warfarin; Regimen; Anticoagulant; Adverse effect; Rivaroxaban; Atrial fibrillation; Anesthesia; Intensive care medicine; Surgery; Internal medicine","score_opus":0.04673206360759131,"score_gpt":0.34531253649471394,"score_spread":0.29858047288712264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969431665","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016032078,0.9992267,0.00010033191,0.00019896207,0.000057143636,0.000005864888,0.000014920291,0.000002113114,0.00023368638],"genre_scores_gemma":[0.0027546259,0.9961797,0.00044441738,0.00028935084,0.00014450202,0.000007781331,0.000029707982,0.0000010362678,0.00014886225],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991037,0.00024921136,0.00021446211,0.00007274131,0.0003324351,0.000027405893],"domain_scores_gemma":[0.9963798,0.0027262361,0.0005024713,0.000033837383,0.00030682897,0.000050898874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020940646,0.00083376595,0.0031954055,0.0027009654,0.0002003049,0.0010267949,0.0011811283,0.0013437977,0.0025849112],"category_scores_gemma":[0.0042756703,0.0003885373,0.001614282,0.0021760168,0.00042791892,0.0010767812,0.000492489,0.0018122507,0.00052260124],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033118075,0.00008622863,0.00070523855,0.06920294,0.0015387763,0.00027999186,0.0000561489,0.0005011002,0.00057268544,0.0017168812,0.011251284,0.9137575],"study_design_scores_gemma":[0.0011813443,0.001407683,0.014667163,0.11383715,0.019047217,0.007734128,0.00039392908,0.0016370768,0.0018064918,0.010322989,0.8277995,0.00016532122],"about_ca_topic_score_codex":0.0015295387,"about_ca_topic_score_gemma":0.003736183,"teacher_disagreement_score":0.0031954055,"about_ca_system_score_codex":0.0007066931,"about_ca_system_score_gemma":0.001225624,"threshold_uncertainty_score":0.011074603},"labels":[],"label_agreement":null},{"id":"W1975891969","doi":"10.1007/s40264-015-0284-x","title":"Organ-On-A-Chip: Development and Clinical Prospects Toward Toxicity Assessment with an Emphasis on Bone Marrow","year":2015,"lang":"en","type":"review","venue":"Drug Safety","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Bone marrow; Medicine; Toxicity; Haematopoiesis; Organ-on-a-chip; Immune system; Stem cell; Pharmacology; Immunology; Biology; Internal medicine; Nanotechnology; Cell biology","score_opus":0.07570553997331483,"score_gpt":0.39374042916713775,"score_spread":0.31803488919382294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975891969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013271209,0.9899629,0.0041165096,0.00037288349,0.0004715557,0.000026422918,0.00007929049,0.0000442949,0.0035989685],"genre_scores_gemma":[0.009354076,0.9806631,0.0040396918,0.0007143165,0.00028370143,0.000044839995,0.00014453713,0.000013026255,0.0047426308],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963987,0.000049104114,0.000028955159,0.000066633045,0.00017982896,0.00003558015],"domain_scores_gemma":[0.9996246,0.00018127497,0.00006173774,0.000015271791,0.00009328335,0.000023769056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008053911,0.00096584513,0.0012203738,0.0014744567,0.0001749262,0.0010613403,0.00081575883,0.0010562923,0.0022247445],"category_scores_gemma":[0.0007036069,0.00032269696,0.0006820172,0.001022191,0.0004470533,0.00091546855,0.0007045131,0.0012177101,0.0013528507],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008245255,0.00011087439,0.00023814334,0.0077183954,0.000073132556,0.00019119905,0.000040308903,0.00081774197,0.021876868,0.003917118,0.011048891,0.9538849],"study_design_scores_gemma":[0.000025140584,0.0005107089,0.0012627088,0.0015103344,0.00026895324,0.0019532796,0.0001016904,0.0009899193,0.031515673,0.0031170384,0.95868087,0.00006373395],"about_ca_topic_score_codex":0.0005228292,"about_ca_topic_score_gemma":0.001181987,"teacher_disagreement_score":0.0022247445,"about_ca_system_score_codex":0.00041685716,"about_ca_system_score_gemma":0.0007654064,"threshold_uncertainty_score":0.007442534},"labels":[],"label_agreement":null},{"id":"W1976017085","doi":"10.2165/00002018-200225090-00006","title":"Adverse Effects of Observational Studies When Examining Adverse Outcomes of Drugs","year":2002,"lang":"en","type":"article","venue":"Drug Safety","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Observational study; Adverse effect; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.2316084619514706,"score_gpt":0.3963446661703264,"score_spread":0.16473620421885576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976017085","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03366365,0.02414142,0.92551386,0.0074415966,0.0014862291,0.0010953762,0.001818312,0.0003839672,0.004455566],"genre_scores_gemma":[0.7316641,0.007958211,0.24936926,0.0027000948,0.0027232098,0.002012147,0.00080180855,0.0001152298,0.0026560011],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.5694576,0.37472084,0.025968213,0.012320478,0.01637599,0.0011568691],"domain_scores_gemma":[0.050815113,0.9185866,0.0134693645,0.014737337,0.0018104744,0.00058106467],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.28295252,0.0018331854,0.0054646884,0.007605305,0.0013660861,0.0042682425,0.005010365,0.0041827783,0.008485484],"category_scores_gemma":[0.72519684,0.0019065058,0.010130914,0.0053717988,0.0062342095,0.0083303405,0.0047428715,0.008806271,0.00040319088],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006482761,0.0005383025,0.17999516,0.012571883,0.045089092,0.0062438445,0.0028508469,0.043999624,0.0012960553,0.33223605,0.009897452,0.35879895],"study_design_scores_gemma":[0.0011380283,0.0012197373,0.02447192,0.0029429724,0.022996522,0.003913607,0.0006080683,0.13020946,0.0030185967,0.79618156,0.013115394,0.00018415666],"about_ca_topic_score_codex":0.0033329702,"about_ca_topic_score_gemma":0.003673048,"teacher_disagreement_score":0.71704745,"about_ca_system_score_codex":0.001754055,"about_ca_system_score_gemma":0.0037076015,"threshold_uncertainty_score":0.8842472},"labels":[],"label_agreement":null},{"id":"W1981214055","doi":"10.1007/s40264-014-0211-6","title":"Adverse Gastrointestinal Events with Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Nested Case–Control Study","year":2014,"lang":"en","type":"article","venue":"Drug Safety","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre; Kingston General Hospital; Queen's University; McMaster University; University of Toronto; Institute for Clinical Evaluative Sciences; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Nested case-control study; Adverse effect; Vascular endothelial growth factor; Pharmacology; Case-control study; Internal medicine; VEGF receptors","score_opus":0.005395916585612967,"score_gpt":0.23134036587720538,"score_spread":0.2259444492915924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981214055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705195,0.0011129346,0.00095923716,0.000028390294,0.000024857143,0.0001799207,0.00020358291,0.000011120969,0.00042804235],"genre_scores_gemma":[0.9989405,0.00012922735,0.00030123672,0.00005702135,0.000025415091,0.000082337516,0.0002700088,0.000005702828,0.00018858034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931486,0.0024683375,0.0006871939,0.002288755,0.00086668937,0.00054046826],"domain_scores_gemma":[0.99344045,0.0022088042,0.0019472016,0.0013686478,0.0006105813,0.00042433193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038465885,0.00088928605,0.0014193571,0.00072162534,0.0008226948,0.0011070815,0.00089775154,0.001441358,0.0021234713],"category_scores_gemma":[0.0072593093,0.0011338114,0.0026352936,0.0006373768,0.0012514299,0.0008666959,0.0008333903,0.001346136,0.0003078182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05123996,0.004080735,0.9204669,0.0005040979,0.008476992,0.0010026809,0.00067400065,0.0003389673,0.005206389,0.00034394625,0.00048880937,0.007176568],"study_design_scores_gemma":[0.004819835,0.012230595,0.9709524,0.000067211906,0.0049531125,0.0019676576,0.00039601984,0.0019241647,0.0010955497,0.00027462485,0.0012138408,0.00010515471],"about_ca_topic_score_codex":0.0043353573,"about_ca_topic_score_gemma":0.003544098,"teacher_disagreement_score":0.0043353573,"about_ca_system_score_codex":0.001039627,"about_ca_system_score_gemma":0.00070493954,"threshold_uncertainty_score":0.020342946},"labels":[],"label_agreement":null},{"id":"W1982809494","doi":"10.2165/00002018-200326060-00005","title":"Comparison of the Risk of Adverse Events with Pramipexole and Ropinirole in Patients with Parkinson???s Disease","year":2003,"lang":"en","type":"review","venue":"Drug Safety","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto","funders":"","keywords":"Ropinirole; Pramipexole; Medicine; Adverse effect; Placebo; Nausea; Levodopa; Parkinson's disease; Anesthesia; Internal medicine; Disease","score_opus":0.013331681376489674,"score_gpt":0.28334091463195005,"score_spread":0.2700092332554604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982809494","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030583018,0.99618787,0.00011312803,0.00012081031,0.00004851735,0.000011270466,0.000053059724,0.0000033945869,0.0004035884],"genre_scores_gemma":[0.02950113,0.96922934,0.00043904415,0.00019812139,0.00016531574,0.000022729322,0.000109090855,0.0000016163164,0.00033353543],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99935216,0.00021646012,0.00012806406,0.00006859706,0.00021287205,0.000021846834],"domain_scores_gemma":[0.998489,0.00089788093,0.0003993003,0.000016419326,0.00015589445,0.000041437495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014853864,0.0006201463,0.0027118719,0.0009982835,0.000119994635,0.00044345384,0.00060972903,0.00061772706,0.0014415181],"category_scores_gemma":[0.0022281979,0.00017650331,0.0017129765,0.0011171603,0.00012896271,0.0003699684,0.00021382718,0.00070883636,0.00015409307],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010195676,0.00016122911,0.005262267,0.04541146,0.006658898,0.0005633385,0.00007903283,0.0005967814,0.0016343055,0.0003490411,0.00411286,0.92497504],"study_design_scores_gemma":[0.021232069,0.03639743,0.2100464,0.05004231,0.10539148,0.02402886,0.00085335266,0.0030312114,0.009985536,0.004269916,0.53440505,0.00031636187],"about_ca_topic_score_codex":0.0009916391,"about_ca_topic_score_gemma":0.0024367638,"teacher_disagreement_score":0.0027118719,"about_ca_system_score_codex":0.00045362936,"about_ca_system_score_gemma":0.0006142128,"threshold_uncertainty_score":0.007855594},"labels":[],"label_agreement":null},{"id":"W1983048187","doi":"10.2165/00002018-200629120-00005","title":"Tolerability of Different Dosing Regimens of Bisphosphonates for the Treatment of Osteoporosis and Malignant Bone Disease","year":2006,"lang":"en","type":"review","venue":"Drug Safety","topic":"Bone health and treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Tolerability; Medicine; Dosing; Adverse effect; Osteoporosis; Bone disease; Context (archaeology); Toxicity; Internal medicine; Pharmacology; Intensive care medicine","score_opus":0.033163416466188936,"score_gpt":0.32719313146298706,"score_spread":0.29402971499679814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983048187","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015496452,0.99750334,0.00022438342,0.00010829147,0.000049060607,0.000011083758,0.000047288697,0.0000069310067,0.0004999726],"genre_scores_gemma":[0.010928935,0.9876485,0.0005881165,0.00023422232,0.000119838245,0.000017470242,0.00011061843,0.00000340339,0.00034895862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993112,0.0001868822,0.00014809606,0.0000870347,0.00024120227,0.00002553226],"domain_scores_gemma":[0.9989712,0.00054996385,0.00030226816,0.000020606913,0.00012942597,0.000026536673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015970629,0.0007788208,0.0031040763,0.0012597734,0.0001436415,0.0006838419,0.0011118567,0.0008754389,0.0018174343],"category_scores_gemma":[0.0018342076,0.00025290233,0.0013328893,0.001498172,0.0002954147,0.000628391,0.00026997417,0.00088316156,0.00037525684],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010676188,0.00014993206,0.0007351143,0.028396714,0.0008312637,0.00020903419,0.00005328925,0.0005284605,0.0028742396,0.0005505821,0.00404857,0.9605552],"study_design_scores_gemma":[0.003188022,0.009307744,0.051601518,0.04073675,0.01634971,0.017076716,0.0007025428,0.0024249193,0.016921293,0.005565617,0.83581614,0.00030906443],"about_ca_topic_score_codex":0.0008674262,"about_ca_topic_score_gemma":0.0016978064,"teacher_disagreement_score":0.0031040763,"about_ca_system_score_codex":0.0003994849,"about_ca_system_score_gemma":0.0005109437,"threshold_uncertainty_score":0.008446157},"labels":[],"label_agreement":null},{"id":"W1986040212","doi":"10.2165/11319000-000000000-00000","title":"Prospective Data Mining of Six Products in the US FDA Adverse Event Reporting System","year":2010,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Adverse Event Reporting System; Adverse effect; Event (particle physics); MEDLINE; Intensive care medicine; Pharmacology","score_opus":0.10990941038024392,"score_gpt":0.4324854646658608,"score_spread":0.32257605428561686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986040212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9495579,0.0020008143,0.002983588,0.00034543237,0.000029370483,0.00017759336,0.043660134,0.00018428682,0.0010609931],"genre_scores_gemma":[0.9227735,0.00068038213,0.007518069,0.00014444372,0.000031026873,0.0001505614,0.06828819,0.00002599274,0.00038782132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946903,0.0008929679,0.0015039676,0.0009818212,0.0016490537,0.00028186553],"domain_scores_gemma":[0.9680944,0.014705527,0.0107253045,0.0022448765,0.003467707,0.0007620586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041429666,0.00054897246,0.0009256609,0.0062934943,0.00046810092,0.0018649003,0.0008608872,0.0011031344,0.0008806478],"category_scores_gemma":[0.016628377,0.00034780905,0.0011168725,0.0067091268,0.00030870162,0.0010342273,0.00071681343,0.00080874143,0.0005223585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011086753,0.00039972152,0.95605576,0.00039024718,0.0005229171,0.0007911351,0.00013355033,0.0030532277,0.002743502,0.00030039373,0.0026262873,0.031874493],"study_design_scores_gemma":[0.00013677683,0.00060452917,0.9474039,0.0001800825,0.00087685266,0.002295255,0.0003511507,0.029141862,0.010021724,0.00051458844,0.00840479,0.00006854712],"about_ca_topic_score_codex":0.00778364,"about_ca_topic_score_gemma":0.0064892746,"teacher_disagreement_score":0.00778364,"about_ca_system_score_codex":0.0007191964,"about_ca_system_score_gemma":0.001593655,"threshold_uncertainty_score":0.02191037},"labels":[],"label_agreement":null},{"id":"W1991982980","doi":"10.2165/00002018-200528080-00006","title":"Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis","year":2005,"lang":"en","type":"review","venue":"Drug Safety","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Raloxifene; Medicine; Selective estrogen receptor modulator; Osteoporosis; Endometrial hyperplasia; Bone density; Internal medicine; Endocrinology; Tamoxifen; Estrogen; Hormone replacement therapy (female-to-male); Breast cancer; Cancer; Hyperplasia","score_opus":0.03527083153688363,"score_gpt":0.4078907233701266,"score_spread":0.37261989183324296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991982980","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020470675,0.99895704,0.00017268823,0.00016373496,0.00006744971,0.000011576962,0.000034375087,0.000005712279,0.0003826885],"genre_scores_gemma":[0.004120823,0.9942074,0.0006553281,0.00042499823,0.00015706275,0.00001741652,0.00005460456,0.000001999839,0.0003602894],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9990709,0.00029351693,0.00017537514,0.000074181924,0.00036115423,0.000024882025],"domain_scores_gemma":[0.99727386,0.002075888,0.0003963264,0.000025443782,0.0001891495,0.00003930661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019324953,0.00087053,0.004551419,0.002561385,0.00016523394,0.0008538288,0.0011683756,0.0013024098,0.0036014854],"category_scores_gemma":[0.0041086357,0.00041960127,0.0018592178,0.0018883924,0.0003651205,0.00077875884,0.0004371454,0.0014872242,0.00050273264],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009573243,0.000094689996,0.0004581043,0.09221937,0.0030402818,0.00032591887,0.00005124947,0.00078506494,0.0008226319,0.001502016,0.013400434,0.886343],"study_design_scores_gemma":[0.0026294026,0.0018123097,0.010947422,0.0902595,0.033989135,0.005453814,0.0002645837,0.0017940274,0.0019837555,0.009842255,0.84088516,0.00013858285],"about_ca_topic_score_codex":0.0018926761,"about_ca_topic_score_gemma":0.004906588,"teacher_disagreement_score":0.004551419,"about_ca_system_score_codex":0.0007036914,"about_ca_system_score_gemma":0.00084255676,"threshold_uncertainty_score":0.012048185},"labels":[],"label_agreement":null},{"id":"W1999551976","doi":"10.1007/s40264-013-0088-9","title":"Clinical Hypotension with Co-prescription of Macrolide Antibiotics and Calcium-Channel Blockers in Haemodialysis Patients: A Retrospective Chart Review","year":2013,"lang":"en","type":"article","venue":"Drug Safety","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Dihydropyridine; Medical prescription; Blood pressure; Calcium channel blocker; Macrolide Antibiotics; Calcium channel; Antibiotics; Internal medicine; Pharmacology; Calcium; Erythromycin","score_opus":0.013942953776152898,"score_gpt":0.28493802487640857,"score_spread":0.27099507110025567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999551976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926944,0.0040122555,0.00032294902,0.000085507876,0.000020874742,0.000075572134,0.0015320603,0.000016286378,0.0012401787],"genre_scores_gemma":[0.996573,0.0016139237,0.0003050935,0.00011890106,0.000029237108,0.000029834093,0.001191212,0.000005343676,0.0001334829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984547,0.00020891603,0.00055407913,0.0002888498,0.00035486862,0.0001386431],"domain_scores_gemma":[0.9929361,0.0016601934,0.0037936992,0.00032216622,0.0008379715,0.0004499796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007779114,0.0001890316,0.00046516076,0.0025377208,0.00056687783,0.000916319,0.00039432105,0.00050360983,0.0013357404],"category_scores_gemma":[0.0028962893,0.0003221274,0.0006144957,0.0028078665,0.00036839044,0.00070343324,0.00055273384,0.00046226612,0.00021774945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055468823,0.000023663582,0.9963588,0.00007284505,0.000039643106,0.0013383365,0.00015200219,0.00001518536,0.00016770003,0.000021880498,0.0001472191,0.0016072042],"study_design_scores_gemma":[0.0000059386543,0.0001293119,0.9903047,0.00007114593,0.00008341379,0.0074111484,0.0006957145,0.00008269468,0.0002668923,0.000015186275,0.000920336,0.00001342191],"about_ca_topic_score_codex":0.0043684524,"about_ca_topic_score_gemma":0.003612536,"teacher_disagreement_score":0.0043684524,"about_ca_system_score_codex":0.00063668314,"about_ca_system_score_gemma":0.0012447158,"threshold_uncertainty_score":0.008686066},"labels":[],"label_agreement":null},{"id":"W1999859711","doi":"10.2165/00002018-200427080-00009","title":"Current Requirements and Emerging Trends for Labelling as a Tool for Communicating Pharmacovigilance Findings","year":2004,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pharmacovigilance; Labelling; Medicine; CLARITY; Risk analysis (engineering); Medical prescription; Confusion; Product (mathematics); Patient safety; Health care; Pharmacology; Drug","score_opus":0.2112922528361526,"score_gpt":0.5332601897570727,"score_spread":0.3219679369209201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999859711","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036962726,0.98366284,0.004317745,0.005430703,0.00077639444,0.00003193247,0.000108790606,0.000087037384,0.005214913],"genre_scores_gemma":[0.0037438949,0.977749,0.0119584445,0.0031816368,0.0006873636,0.00006065043,0.0002583297,0.000031283587,0.0023295016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99268323,0.00233194,0.0012608452,0.0008082371,0.002666195,0.00024947483],"domain_scores_gemma":[0.96449715,0.023770597,0.0036846492,0.0007259055,0.006665691,0.0006560108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020612577,0.0015319064,0.0037160215,0.005358282,0.0007849419,0.0060197967,0.004123369,0.0049041654,0.0058558593],"category_scores_gemma":[0.020688735,0.00078600965,0.0014475894,0.0073823035,0.0025948356,0.0064726854,0.0016572878,0.0052062008,0.0037997335],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009269478,0.00007593183,0.0005149123,0.019106189,0.00006685232,0.00029641794,0.00024394678,0.0003709901,0.00115525,0.011647455,0.024758361,0.941671],"study_design_scores_gemma":[0.000048327573,0.0001580073,0.0018465854,0.022875039,0.0003275074,0.0024574937,0.00046129778,0.0005538338,0.0014681281,0.008178676,0.96154886,0.000076263925],"about_ca_topic_score_codex":0.0067590605,"about_ca_topic_score_gemma":0.007389512,"teacher_disagreement_score":0.020612577,"about_ca_system_score_codex":0.004074133,"about_ca_system_score_gemma":0.008437975,"threshold_uncertainty_score":0.109011054},"labels":[],"label_agreement":null},{"id":"W2001336525","doi":"10.2165/00002018-200629020-00007","title":"The Effect of Detection Approaches on the Reported Incidence of Tenfold Errors","year":2006,"lang":"en","type":"article","venue":"Drug Safety","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Incidence (geometry); Intensive care medicine","score_opus":0.04719435890675205,"score_gpt":0.33761302912668534,"score_spread":0.2904186702199333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001336525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97374314,0.005050096,0.014229923,0.0011025333,0.00036704857,0.0002817436,0.00058309274,0.00017023354,0.004472258],"genre_scores_gemma":[0.98826593,0.00073397387,0.0091423085,0.00047394657,0.00007233245,0.00012879266,0.00019824714,0.00003295754,0.0009514583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.92920107,0.04848576,0.005315225,0.0061253766,0.0094451355,0.0014274791],"domain_scores_gemma":[0.38962245,0.56236285,0.027208298,0.008924501,0.009948227,0.001933726],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0572469,0.0008411466,0.000974734,0.0016863934,0.00065077125,0.0015990067,0.0013868872,0.0018613746,0.001444859],"category_scores_gemma":[0.2872699,0.00048488655,0.0021890763,0.0012966371,0.0009589398,0.002440209,0.0019873362,0.0021406584,0.00029878796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018343639,0.0018841677,0.78287196,0.0011865972,0.0031378083,0.00022159619,0.0022904116,0.0033519818,0.0037424278,0.0009112856,0.0010730941,0.18098511],"study_design_scores_gemma":[0.00024890256,0.012532054,0.95961696,0.0003695627,0.0023747934,0.0009753362,0.0011156391,0.01074229,0.008364402,0.0011065734,0.0024161579,0.00013734736],"about_ca_topic_score_codex":0.0030028808,"about_ca_topic_score_gemma":0.0035012683,"teacher_disagreement_score":0.9427531,"about_ca_system_score_codex":0.0010667498,"about_ca_system_score_gemma":0.0017631163,"threshold_uncertainty_score":0.30275422},"labels":[],"label_agreement":null},{"id":"W2001939357","doi":"10.2165/11589350-000000000-00000","title":"Strategies for Quantifying the Relationship between Medications and Suicidal Behaviour","year":2011,"lang":"en","type":"review","venue":"Drug Safety","topic":"Mental Health Research Topics","field":"Psychology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Institute of Mental Health; GlaxoSmithKline; U.S. Department of Justice","keywords":"Medicine; Pharmacoepidemiology; Observational study; Psychiatry; Context (archaeology); Poison control; Medical prescription; Pharmacology; Medical emergency; Internal medicine","score_opus":0.536022993164736,"score_gpt":0.5569885795591598,"score_spread":0.020965586394423807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001939357","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019621033,0.99769115,0.00086326286,0.00046942328,0.00015256031,0.00003298568,0.00011585079,0.000010322862,0.00046831102],"genre_scores_gemma":[0.0016528687,0.9943968,0.0031000157,0.00026549023,0.00017341957,0.0000583312,0.00013600646,0.000003313947,0.00021378136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978908,0.0007969702,0.0004311611,0.00024903988,0.00059078675,0.000041328032],"domain_scores_gemma":[0.9879995,0.009131115,0.0013127316,0.00024241595,0.0011988798,0.00011532093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006709165,0.0022159372,0.0046049515,0.007690292,0.0003717044,0.0021475581,0.0024605843,0.0018067686,0.0041382574],"category_scores_gemma":[0.013774594,0.00077400054,0.0030998457,0.0052989307,0.0009533686,0.002211175,0.0012283917,0.0025509123,0.0012349443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006491963,0.0000702698,0.0026216547,0.037262056,0.001400992,0.000044468863,0.00007046314,0.00025001774,0.00020299779,0.0021296875,0.0064284992,0.94945395],"study_design_scores_gemma":[0.0002327691,0.0008318494,0.05695581,0.20341952,0.017688751,0.0027163734,0.0010042319,0.0016366953,0.0016901713,0.02425941,0.6892057,0.00035863995],"about_ca_topic_score_codex":0.0057305675,"about_ca_topic_score_gemma":0.013232476,"teacher_disagreement_score":0.007690292,"about_ca_system_score_codex":0.0014186511,"about_ca_system_score_gemma":0.0034076273,"threshold_uncertainty_score":0.03548187},"labels":[],"label_agreement":null},{"id":"W2004582721","doi":"10.2165/00002018-200730020-00006","title":"Psychotropic Medications and the Risk of Fracture","year":2007,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Queen's University","funders":"","keywords":"Medicine; Intensive care medicine; Psychiatry","score_opus":0.031805500990452054,"score_gpt":0.3951480545193872,"score_spread":0.3633425535289352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004582721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000119165175,0.99956423,0.000024244253,0.00005338497,0.000032347678,0.0000024409774,0.000014810339,0.0000011354414,0.0001881972],"genre_scores_gemma":[0.0011060843,0.9985287,0.000097405435,0.00007181206,0.000050837367,0.000003083899,0.0000173008,3.5746623e-7,0.0001244101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956256,0.000078982725,0.000112924106,0.00006113979,0.00016735433,0.00001705535],"domain_scores_gemma":[0.9986733,0.0007993809,0.00035285123,0.000022220256,0.00013062583,0.000021618014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009825128,0.0007654743,0.0020426696,0.0033525021,0.00019987983,0.0007506111,0.0008613413,0.0009993094,0.004101197],"category_scores_gemma":[0.002020946,0.00041522647,0.00138625,0.0032898542,0.0003960368,0.0005689383,0.00047964224,0.0008630151,0.00050535274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034122722,0.00009164163,0.0014092675,0.07486789,0.0017489112,0.00031086933,0.00005116595,0.00033513556,0.00048076257,0.0009875696,0.009085137,0.9102905],"study_design_scores_gemma":[0.0004934119,0.00081816386,0.021933312,0.095883116,0.015123069,0.008036061,0.0004014055,0.0005023424,0.0013462998,0.0051660305,0.85017157,0.00012515519],"about_ca_topic_score_codex":0.0030066047,"about_ca_topic_score_gemma":0.006332716,"teacher_disagreement_score":0.004101197,"about_ca_system_score_codex":0.00046137645,"about_ca_system_score_gemma":0.0010761833,"threshold_uncertainty_score":0.013719857},"labels":[],"label_agreement":null},{"id":"W2005769804","doi":"10.2165/00002018-200427130-00004","title":"Treatment Costs to Prevent or Treat Upper Gastrointestinal Adverse Events Associated with NSAIDs","year":2004,"lang":"en","type":"review","venue":"Drug Safety","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Adverse effect; Reimbursement; Indirect costs; Health care; MEDLINE; Intensive care medicine; Emergency medicine; Internal medicine","score_opus":0.018448110612911697,"score_gpt":0.3043677989203357,"score_spread":0.28591968830742404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005769804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058125594,0.99734515,0.00020408157,0.00036671344,0.0001607589,0.000012872497,0.000055605236,0.000006395898,0.0012672341],"genre_scores_gemma":[0.0064824163,0.99148023,0.0007103648,0.00028992168,0.00021396841,0.00002632864,0.00008878184,0.0000024741337,0.00070540153],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989023,0.0002478189,0.00019196367,0.000060782433,0.0005478329,0.000049195616],"domain_scores_gemma":[0.9983265,0.00087566563,0.00048212893,0.000021026357,0.0002477578,0.000046915633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012791168,0.0006923441,0.0019417069,0.002397886,0.00018324127,0.0008454988,0.0006839285,0.000796722,0.0043520452],"category_scores_gemma":[0.0032144054,0.00026674045,0.0014213367,0.0024011517,0.00021831573,0.0007438028,0.00037528007,0.0011803366,0.0005275732],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002750527,0.00008934885,0.0011999164,0.036146145,0.0011654932,0.00016511892,0.000037817026,0.0005343844,0.00045968877,0.0016448247,0.013860612,0.9444215],"study_design_scores_gemma":[0.0006571531,0.0008423324,0.03150816,0.06408347,0.009064338,0.0064615807,0.00028016933,0.0013373514,0.0017735987,0.003667671,0.88025635,0.00006791183],"about_ca_topic_score_codex":0.003059336,"about_ca_topic_score_gemma":0.0057066567,"teacher_disagreement_score":0.0043520452,"about_ca_system_score_codex":0.0011430972,"about_ca_system_score_gemma":0.0018085823,"threshold_uncertainty_score":0.0145590305},"labels":[],"label_agreement":null},{"id":"W2008807002","doi":"10.2165/00002018-200831080-00008","title":"Safety of Efalizumab Therapy in Patients with Moderate to Severe Psoriasis","year":2008,"lang":"en","type":"article","venue":"Drug Safety","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Genentech; Abbott Laboratories","keywords":"Efalizumab; Medicine; Psoriasis; Placebo; Internal medicine; Dermatology; Plaque psoriasis; Surgery; Pathology","score_opus":0.010667903469793037,"score_gpt":0.20868609147315725,"score_spread":0.1980181880033642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008807002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838308,0.009627456,0.0006626809,0.00092239934,0.00005159485,0.000035555404,0.00045865716,0.000029849534,0.0043809037],"genre_scores_gemma":[0.9985275,0.0006806433,0.000101142075,0.00021857314,0.00008121345,0.0000063583757,0.00018267035,0.000002863038,0.00019904046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984883,0.00061187975,0.00025620134,0.00011770048,0.0004066613,0.00011936829],"domain_scores_gemma":[0.9946308,0.0026106187,0.0015597683,0.00025464242,0.0006431535,0.00030098984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019551534,0.00019360967,0.0010242868,0.0004120354,0.00037257554,0.00070027116,0.0001666221,0.0005251522,0.0009802263],"category_scores_gemma":[0.006109896,0.0000840111,0.00060174614,0.00058939133,0.0002261584,0.00046885852,0.00018153767,0.0008585655,0.00019758043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029577684,0.0006717144,0.7114412,0.0006738131,0.0010713593,0.0013338733,0.00046571624,0.00075308915,0.012737252,0.0004840102,0.0017913905,0.23899892],"study_design_scores_gemma":[0.0012632648,0.013684583,0.9612509,0.0001411125,0.0012167658,0.006590514,0.00036153768,0.0016824685,0.0052129515,0.0007871667,0.0077663334,0.00004234542],"about_ca_topic_score_codex":0.00043645606,"about_ca_topic_score_gemma":0.0004759759,"teacher_disagreement_score":0.0019551534,"about_ca_system_score_codex":0.00037221803,"about_ca_system_score_gemma":0.0003922943,"threshold_uncertainty_score":0.010339975},"labels":[],"label_agreement":null},{"id":"W2009830490","doi":"10.2165/00002018-200124020-00001","title":"What Will Be the Role of Pharmacogenetics in Evaluating Drug Safety and Minimising Adverse Effects?","year":2001,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Canada Research Chairs; University of Toronto","funders":"","keywords":"Pharmacogenetics; Medicine; Drug; Drug development; Pharmacology; Precision medicine; Bioinformatics; Computational biology; Intensive care medicine; Genetics; Gene; Biology; Genotype","score_opus":0.09356849628257248,"score_gpt":0.4601029387777244,"score_spread":0.36653444249515194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009830490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012729524,0.9929964,0.0009792267,0.0044439235,0.0005818332,0.0000070958217,0.000014892521,0.000011919005,0.0008373869],"genre_scores_gemma":[0.0011177426,0.99289614,0.0018328024,0.0026400022,0.001009847,0.000012054893,0.000015824853,0.000004009912,0.0004716503],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980469,0.0007711402,0.00018841522,0.00024111752,0.0006604029,0.00009198857],"domain_scores_gemma":[0.98978746,0.0066282754,0.0007541058,0.00025380682,0.0022309977,0.00034535374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009300078,0.0016394655,0.005290721,0.002350995,0.00044616053,0.0035256995,0.002296386,0.0047070137,0.0026010964],"category_scores_gemma":[0.007698058,0.0005796338,0.0015303451,0.0030932173,0.0024158233,0.0059257494,0.00091319863,0.0050125523,0.0023230265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001454576,0.000103508195,0.00072187703,0.0065580606,0.00023493124,0.00020198793,0.00006667166,0.0004491494,0.00069773116,0.0066365898,0.016041037,0.9681429],"study_design_scores_gemma":[0.00015945813,0.0004883026,0.0040716166,0.015190917,0.0006611083,0.0027060474,0.00039153517,0.00094655383,0.0010202692,0.027735734,0.94648534,0.00014320601],"about_ca_topic_score_codex":0.003922153,"about_ca_topic_score_gemma":0.0058572115,"teacher_disagreement_score":0.009300078,"about_ca_system_score_codex":0.0016430841,"about_ca_system_score_gemma":0.0032808993,"threshold_uncertainty_score":0.049184144},"labels":[],"label_agreement":null},{"id":"W2010725925","doi":"10.1007/s40264-014-0194-3","title":"A Comparison of Active Adverse Event Surveillance Systems Worldwide","year":2014,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sun Yat-sen University; Johns Hopkins University","keywords":"Pharmacovigilance; Medicine; Postmarketing surveillance; Adverse Event Reporting System; Pharmacoepidemiology; General partnership; Medical emergency; Adverse effect; Pharmacology; Business; Medical prescription","score_opus":0.13697062891435727,"score_gpt":0.505399370736806,"score_spread":0.36842874182244867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010725925","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9022793,0.00964017,0.013811765,0.00455672,0.00040325048,0.00089918333,0.025862494,0.0009843323,0.04156269],"genre_scores_gemma":[0.9666372,0.0020455765,0.006063117,0.0004884336,0.00019017475,0.0003143733,0.02264136,0.0001411661,0.0014786824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97534776,0.006441704,0.005717349,0.004636585,0.0064615463,0.0013950493],"domain_scores_gemma":[0.8536531,0.04049335,0.027615665,0.011979375,0.06187347,0.004385111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027216787,0.00070686114,0.0008420368,0.015018852,0.0007115798,0.0041679796,0.0013590377,0.00089742534,0.0032138021],"category_scores_gemma":[0.07556843,0.000408127,0.0013195014,0.0136094885,0.00089277123,0.0065146275,0.003069421,0.00093960634,0.00075008697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061197265,0.0001669661,0.8266929,0.0010380521,0.0011258702,0.00023390916,0.003334908,0.0033036582,0.001005824,0.0076654833,0.00950152,0.14531891],"study_design_scores_gemma":[0.00012859251,0.0005794599,0.9456895,0.00082491495,0.00045258028,0.00071564637,0.006236802,0.007154502,0.0015004704,0.0020541472,0.03455411,0.00010925585],"about_ca_topic_score_codex":0.010131004,"about_ca_topic_score_gemma":0.0070031458,"teacher_disagreement_score":0.027216787,"about_ca_system_score_codex":0.0023098972,"about_ca_system_score_gemma":0.0021409222,"threshold_uncertainty_score":0.14393789},"labels":[],"label_agreement":null},{"id":"W2011508485","doi":"10.1007/s40264-013-0117-8","title":"Evaluating the Health Literacy Burden of Canada’s Public Advisories: A Comparative Effectiveness Study on Clarity and Readability","year":2013,"lang":"en","type":"article","venue":"Drug Safety","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Medicine; Readability; CLARITY; Health literacy; Public health; Literacy; Family medicine; Alternative medicine; Optometry; Medical education; Environmental health; Nursing; Health care; Economic growth","score_opus":0.12231480013376475,"score_gpt":0.503172113786225,"score_spread":0.3808573136524602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011508485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98956,0.0012520897,0.0006540943,0.0004987188,0.00005940607,0.0032665785,0.0006449726,0.000059181468,0.0040049073],"genre_scores_gemma":[0.99224794,0.0007976612,0.003674347,0.0002870589,0.000055101485,0.0017734851,0.00042353448,0.000011755347,0.00072915264],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.95858085,0.02015704,0.0028762727,0.0018883604,0.01535218,0.0011454184],"domain_scores_gemma":[0.90163195,0.061001547,0.017515574,0.0038369815,0.010923947,0.0050901067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03104409,0.00071127916,0.0010808979,0.0019570403,0.0013030525,0.0017576647,0.0013230754,0.0014261439,0.0025458848],"category_scores_gemma":[0.0822834,0.00043409737,0.0020126672,0.0015943462,0.0017231315,0.001767543,0.0013184443,0.0011897921,0.00022760214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060845602,0.050441932,0.23773171,0.0043465504,0.0025338193,0.00015586347,0.008078575,0.0019873823,0.0027134041,0.0005497857,0.0043532373,0.6262622],"study_design_scores_gemma":[0.015024993,0.15677632,0.80540204,0.0011345412,0.002245156,0.00013895435,0.0028576888,0.004651193,0.004881782,0.00027808102,0.0063457275,0.0002635369],"about_ca_topic_score_codex":0.13949682,"about_ca_topic_score_gemma":0.16274218,"teacher_disagreement_score":0.8605032,"about_ca_system_score_codex":0.01187514,"about_ca_system_score_gemma":0.01570777,"threshold_uncertainty_score":0.27736968},"labels":[],"label_agreement":null},{"id":"W2012693180","doi":"10.1007/s40264-014-0219-y","title":"The Safety of Olanzapine in Young Children: A Systematic Review and Meta-Analysis","year":2014,"lang":"en","type":"review","venue":"Drug Safety","topic":"Nausea and vomiting management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Olanzapine; Medicine; Adverse effect; Nausea; Extrapyramidal symptoms; Pediatrics; Meta-analysis; Internal medicine; Psychiatry; Antipsychotic; Schizophrenia (object-oriented programming)","score_opus":0.03361663763893994,"score_gpt":0.33235035912183214,"score_spread":0.2987337214828922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012693180","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057746274,0.9933751,0.00019894393,0.00008450747,0.00008354436,0.000110896784,0.0002179862,0.000009882802,0.00014450557],"genre_scores_gemma":[0.123782456,0.8731983,0.0012455521,0.0007552505,0.00013602484,0.00025496437,0.0003580619,0.00001287606,0.0002565684],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964045,0.0010435766,0.0015302012,0.00041109268,0.0004681703,0.00014242103],"domain_scores_gemma":[0.99144816,0.005652555,0.0019760074,0.00021304359,0.00056836876,0.00014185485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005917677,0.002035459,0.012412184,0.003282025,0.00046151894,0.0021259615,0.0014772408,0.0018015613,0.0029785412],"category_scores_gemma":[0.017571408,0.0011020204,0.020467838,0.003980502,0.0006368416,0.0015914093,0.0012431957,0.0016551008,0.00020272177],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044978024,0.000061484636,0.0052175666,0.54376256,0.4160793,0.00029813134,0.00014493003,0.00035807845,0.0004622144,0.000115767805,0.0007304382,0.028271701],"study_design_scores_gemma":[0.0012780734,0.00040302114,0.005334142,0.024272567,0.9655938,0.00024062484,0.0000927266,0.000093182076,0.00018056238,0.00014980829,0.0023214272,0.0000400383],"about_ca_topic_score_codex":0.00558984,"about_ca_topic_score_gemma":0.020073116,"teacher_disagreement_score":0.012412184,"about_ca_system_score_codex":0.0019547057,"about_ca_system_score_gemma":0.0026493312,"threshold_uncertainty_score":0.031296074},"labels":[],"label_agreement":null},{"id":"W2012976492","doi":"10.2165/00002018-200326090-00002","title":"Hydroxyurea in the Treatment of HIV Infection","year":2003,"lang":"en","type":"review","venue":"Drug Safety","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Didanosine; Hydroxycarbamide; Medicine; Nucleoside analogue; Adverse effect; Toxicity; Pharmacology; Stavudine; Internal medicine; Gastroenterology; Immunology; Nucleoside; Disease; Viral disease; Zidovudine; Virus; Biology","score_opus":0.03181441492354512,"score_gpt":0.3230180253122227,"score_spread":0.29120361038867754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012976492","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054541048,0.998982,0.00007785964,0.00013828493,0.00025732905,0.000002443712,0.000005142158,0.0000044800895,0.00047778717],"genre_scores_gemma":[0.0005084674,0.99827147,0.0001705049,0.0001769749,0.0003919362,0.000003361918,0.000012095929,9.742744e-7,0.00046424614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997787,0.000046453595,0.000034483015,0.00003134667,0.00009204499,0.000017060647],"domain_scores_gemma":[0.99955183,0.00022036541,0.00007425898,0.000012819444,0.00009916747,0.000041580257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064303045,0.0010052861,0.0017776028,0.002104879,0.0003041661,0.00086163636,0.0011875932,0.0011135023,0.0024321375],"category_scores_gemma":[0.0008858682,0.00024161211,0.0003776993,0.0022777293,0.0006278627,0.0010520187,0.0005189632,0.0021929115,0.0013360757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011232177,0.0000663475,0.00013179296,0.0070533263,0.00006606093,0.00029329082,0.000035121117,0.00029993977,0.00077490753,0.001710862,0.031746518,0.9577095],"study_design_scores_gemma":[0.00006416767,0.0001440763,0.0007429435,0.0031205197,0.00014348271,0.0021761896,0.000052021678,0.00012249398,0.00033615937,0.0014516768,0.99162924,0.000017056527],"about_ca_topic_score_codex":0.0021175807,"about_ca_topic_score_gemma":0.0047503347,"teacher_disagreement_score":0.0024321375,"about_ca_system_score_codex":0.0006795679,"about_ca_system_score_gemma":0.0010065425,"threshold_uncertainty_score":0.008136332},"labels":[],"label_agreement":null},{"id":"W2013574060","doi":"10.1007/s40264-014-0138-y","title":"Exposure to Oral Fluoroquinolones and the Risk of Retinal Detachment: Retrospective Analyses of Two Large Healthcare Databases","year":2014,"lang":"en","type":"article","venue":"Drug Safety","topic":"Ocular Infections and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Confounding; Odds ratio; Ciprofloxacin; Case-control study; Database; Internal medicine; Antibiotics","score_opus":0.021197604993124092,"score_gpt":0.34599315180046514,"score_spread":0.324795546807341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013574060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300295,0.0013911896,0.0005156342,0.000095925236,0.000008446489,0.00011933341,0.0044448897,0.0000133650965,0.00040828434],"genre_scores_gemma":[0.9942802,0.00049699546,0.00085461675,0.00009109463,0.000011056524,0.00008098733,0.0041200207,0.000006352559,0.00005867724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98978746,0.002937173,0.0017117108,0.0018374128,0.002954549,0.0007716875],"domain_scores_gemma":[0.9723518,0.005613218,0.010807035,0.0039825332,0.005868733,0.0013767107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006297414,0.0007604579,0.0009643307,0.0041082865,0.0011652845,0.0018041735,0.0017036069,0.00091770024,0.00061995594],"category_scores_gemma":[0.022143073,0.0009557237,0.001580393,0.0080919005,0.0008415896,0.0006971991,0.0015430262,0.0006730796,0.0001316771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026377896,0.000030280431,0.99729186,0.000056472865,0.00064228324,0.00007648988,0.00016549347,0.00007163048,0.0001278771,0.000022173483,0.00020681082,0.0010447112],"study_design_scores_gemma":[0.000048241596,0.00006610271,0.9979843,0.000030286288,0.0004971844,0.00030129036,0.00026166154,0.00029489453,0.0001320345,0.000010620015,0.00035539488,0.000018121993],"about_ca_topic_score_codex":0.45088175,"about_ca_topic_score_gemma":0.44514832,"teacher_disagreement_score":0.45088175,"about_ca_system_score_codex":0.005043923,"about_ca_system_score_gemma":0.0062157735,"threshold_uncertainty_score":0.89651465},"labels":[],"label_agreement":null},{"id":"W2020673378","doi":"10.2165/00002018-200932050-00003","title":"Patch Testing for the Diagnosis of Anticonvulsant Hypersensitivity Syndrome","year":2009,"lang":"en","type":"review","venue":"Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Children's Hospital of Western Ontario; Health Sciences Centre; Sunnybrook Health Science Centre; Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Rash; Anticonvulsant; Patch test; Drug; Dermatology; Patch testing; Hypersensitivity reaction; Predictive value; Eosinophilia; Intensive care medicine; Pharmacology; Epilepsy; Internal medicine; Allergy; Contact dermatitis; Immunology; Psychiatry","score_opus":0.09752480955862972,"score_gpt":0.35759587753067845,"score_spread":0.2600710679720487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020673378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024209631,0.9980982,0.00031196824,0.0001517218,0.000137794,0.000007103862,0.000020390511,0.0000137293255,0.0010169361],"genre_scores_gemma":[0.0032775763,0.99480903,0.0006082064,0.00029078108,0.00025739646,0.000006549747,0.0000590588,0.0000037430827,0.0006875892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958247,0.00007641424,0.000064365166,0.00007620363,0.000177792,0.000022776047],"domain_scores_gemma":[0.99873024,0.000732909,0.00019474626,0.000029037383,0.0002544739,0.000058614514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077399943,0.0011431685,0.002646314,0.0036752594,0.00018737567,0.00066609355,0.0013773718,0.0011086717,0.0032191866],"category_scores_gemma":[0.0013975118,0.00032560065,0.00087744487,0.0018541242,0.00056758994,0.0011455291,0.00044758266,0.0017271561,0.0018915838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000870331,0.00008452675,0.000580112,0.0098834885,0.00016012984,0.0008880776,0.000027873324,0.00020122377,0.0014738584,0.00046838677,0.013923492,0.97222185],"study_design_scores_gemma":[0.00023985164,0.00060326845,0.012803645,0.014911252,0.0013790968,0.04002351,0.00028031415,0.0008741896,0.0032129781,0.0034418697,0.9220969,0.00013299764],"about_ca_topic_score_codex":0.001740238,"about_ca_topic_score_gemma":0.0032540748,"teacher_disagreement_score":0.0036752594,"about_ca_system_score_codex":0.00039783708,"about_ca_system_score_gemma":0.00065911916,"threshold_uncertainty_score":0.010769248},"labels":[],"label_agreement":null},{"id":"W2020715522","doi":"10.2165/11534580-000000000-00000","title":"Enhancing Pharmacosurveillance with Systematic Collection of Treatment Indication in Electronic Prescribing","year":2010,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Electronic prescribing; Medical prescription; Electronic data; Medical record; Off-label use; Electronic medical record; Gold standard (test); MEDLINE; Clinical decision support system; Documentation; Intensive care medicine; Drug Utilization Review; Emergency medicine; Decision support system; Surgery; Internal medicine; Database; Data mining","score_opus":0.03130026216337235,"score_gpt":0.36825298916125243,"score_spread":0.3369527269978801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020715522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5844381,0.006413833,0.32298824,0.02020237,0.0010834823,0.014772954,0.007059012,0.007759177,0.035282787],"genre_scores_gemma":[0.7116262,0.0023405696,0.2720466,0.0041899337,0.0013144038,0.0028989862,0.0033967998,0.00023275733,0.0019538053],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.90593934,0.06371825,0.016549349,0.00304178,0.009959108,0.00079216424],"domain_scores_gemma":[0.5787111,0.274308,0.055412427,0.035667296,0.05240306,0.0034981929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06499743,0.0011785581,0.002310095,0.008533399,0.000990648,0.003927628,0.0015628397,0.0015557277,0.0020629202],"category_scores_gemma":[0.2740506,0.0010221092,0.0011444417,0.006404431,0.00055887876,0.0053789294,0.0039463853,0.0015491503,0.0012664727],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019385263,0.0016846241,0.38570818,0.0024738708,0.0009857063,0.00030321136,0.0030597472,0.0051189424,0.0042186594,0.001196846,0.013294254,0.5800174],"study_design_scores_gemma":[0.0014442785,0.0051349676,0.7213547,0.004498736,0.0036966407,0.0021208334,0.0051716077,0.14311495,0.041031737,0.011715566,0.06001448,0.0007015992],"about_ca_topic_score_codex":0.0061283056,"about_ca_topic_score_gemma":0.008619019,"teacher_disagreement_score":0.06499743,"about_ca_system_score_codex":0.0016357765,"about_ca_system_score_gemma":0.0067523825,"threshold_uncertainty_score":0.34374338},"labels":[],"label_agreement":null},{"id":"W2022144328","doi":"10.1007/s40264-015-0265-0","title":"Pediatric Drug Safety Signal Detection: A New Drug–Event Reference Set for Performance Testing of Data-Mining Methods and Systems","year":2015,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université de Montréal","funders":"ZonMw; Pfizer; Eli Lilly and Company","keywords":"Medicine; Adverse Event Reporting System; Drug; Data mining; Event (particle physics); Data set; Pharmacology; Artificial intelligence; Computer science","score_opus":0.29306572323039615,"score_gpt":0.4570619595480828,"score_spread":0.16399623631768667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022144328","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19009992,0.0037431335,0.687422,0.0013487521,0.00042328663,0.003984146,0.083116405,0.022262076,0.007600335],"genre_scores_gemma":[0.22804943,0.00086855236,0.6419846,0.00033287585,0.000101900805,0.0041278605,0.12293509,0.000498076,0.0011017207],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98054457,0.005979278,0.00432329,0.0028681431,0.0058998666,0.00038484455],"domain_scores_gemma":[0.9355984,0.033789627,0.006068455,0.009915546,0.013892753,0.00073523296],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.025143122,0.0017540909,0.0016659667,0.011525123,0.00088016666,0.0030630745,0.002939356,0.0016854857,0.0035250112],"category_scores_gemma":[0.073939666,0.00058033643,0.0023254359,0.006110983,0.00054570846,0.0029546223,0.0028116233,0.0016765576,0.0014868099],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022872163,0.002131052,0.15862013,0.003754846,0.0021630595,0.001386692,0.00069267926,0.0728164,0.015989352,0.008068065,0.044262376,0.6878282],"study_design_scores_gemma":[0.0009540209,0.004468635,0.102274865,0.0013938693,0.0016926511,0.0028092256,0.0009570084,0.6983756,0.045560822,0.014317191,0.12680624,0.00038990704],"about_ca_topic_score_codex":0.0042926995,"about_ca_topic_score_gemma":0.0037765705,"teacher_disagreement_score":0.97485685,"about_ca_system_score_codex":0.0015241811,"about_ca_system_score_gemma":0.003623353,"threshold_uncertainty_score":0.13297111},"labels":[],"label_agreement":null},{"id":"W2025227155","doi":"10.2165/00002018-200831050-00001","title":"Chemotherapy-Associated Osteonecrosis in Cancer Patients with Solid Tumours","year":2008,"lang":"en","type":"review","venue":"Drug Safety","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Chemotherapy; Complication; Cancer; Breast cancer; Lung cancer; Surgery; Osteosarcoma; Internal medicine; Oncology; Pathology","score_opus":0.017940990627278018,"score_gpt":0.3081367119240935,"score_spread":0.2901957212968155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025227155","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014570568,0.99919885,0.00006359275,0.000096599186,0.000078695775,0.0000027568533,0.000014129343,0.0000035027888,0.00039624324],"genre_scores_gemma":[0.0013559151,0.99797934,0.00013937776,0.00016988555,0.00010597043,0.0000029300277,0.000023422604,8.4331947e-7,0.0002222756],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996427,0.00006308539,0.00008675831,0.00005755484,0.00013236835,0.000017470282],"domain_scores_gemma":[0.9989967,0.0005078151,0.00031370655,0.000016339522,0.0001343092,0.000031138836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006075204,0.000726138,0.0018659196,0.002326279,0.00018042118,0.0007672156,0.00061704445,0.000885785,0.002450368],"category_scores_gemma":[0.001314598,0.00028750545,0.00069804676,0.0026819755,0.00039356132,0.0007448466,0.00048324847,0.0009324743,0.0005573478],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086351974,0.0000514471,0.0008194058,0.030605813,0.0002557656,0.00023979774,0.000041945594,0.00027340226,0.00068433105,0.0004795571,0.013006283,0.9534559],"study_design_scores_gemma":[0.00015809949,0.00050029275,0.013773354,0.03205034,0.002237244,0.009195674,0.00021847733,0.0003834863,0.00094894,0.0014336371,0.9390342,0.00006611776],"about_ca_topic_score_codex":0.0015899045,"about_ca_topic_score_gemma":0.0046176678,"teacher_disagreement_score":0.002450368,"about_ca_system_score_codex":0.0004227875,"about_ca_system_score_gemma":0.0009000894,"threshold_uncertainty_score":0.008197308},"labels":[],"label_agreement":null},{"id":"W2026568528","doi":"10.2165/11597860-000000000-00000","title":"Embedding ‘Speaking Up’ into Systems for Safe Healthcare Product Development and Marketing Surveillance","year":2012,"lang":"en","type":"article","venue":"Drug Safety","topic":"Ethics in Business and Education","field":"Decision Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Transparency (behavior); Patient safety; Health care; Medicine; Process management; Public relations; Best practice; Accountability; Product (mathematics); Business; Risk analysis (engineering); Computer security; Computer science","score_opus":0.14309581358658305,"score_gpt":0.41837764921251863,"score_spread":0.27528183562593556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026568528","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057109524,0.0005231872,0.7524178,0.05526882,0.00093557104,0.00085872714,0.00006413766,0.0019283792,0.1308939],"genre_scores_gemma":[0.7707462,0.00021292774,0.20783646,0.007294379,0.00039746804,0.0005258601,0.00009474734,0.00035717088,0.012534878],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9053388,0.07559981,0.0034327325,0.0042518876,0.008527595,0.002849174],"domain_scores_gemma":[0.88220084,0.0683698,0.009833455,0.022176461,0.011740563,0.005678817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.047134105,0.0010608864,0.0008304224,0.0016513625,0.0039594597,0.01193097,0.0025271885,0.0064267144,0.010384932],"category_scores_gemma":[0.09058021,0.0011728717,0.0010600459,0.0008479822,0.013497642,0.014094962,0.012843411,0.007806051,0.003813615],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029750474,0.0007849561,0.010063492,0.0007466597,0.0001479372,0.0007377793,0.032470215,0.00958768,0.011412585,0.6455058,0.01402724,0.27421808],"study_design_scores_gemma":[0.0001135146,0.0006799898,0.004010242,0.00082775357,0.00013322814,0.00053030817,0.009182918,0.04369279,0.014864254,0.78415114,0.1415812,0.00023273853],"about_ca_topic_score_codex":0.0010869349,"about_ca_topic_score_gemma":0.0010886602,"teacher_disagreement_score":0.047134105,"about_ca_system_score_codex":0.0034003737,"about_ca_system_score_gemma":0.009433584,"threshold_uncertainty_score":0.24927193},"labels":[],"label_agreement":null},{"id":"W2028232434","doi":"10.2165/00002018-200831110-00005","title":"Detection of Adverse Drug Events and Other Treatment Outcomes Using an Electronic Prescribing System","year":2008,"lang":"en","type":"article","venue":"Drug Safety","topic":"Electronic Health Records Systems","field":"Health Professions","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Discontinuation; Medicine; Medical prescription; Drug; Adverse effect; Electronic prescribing; Medical record; Intensive care medicine; Gold standard (test); Emergency medicine; Internal medicine; Pharmacology","score_opus":0.06250692843296986,"score_gpt":0.37788225003560594,"score_spread":0.3153753216026361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028232434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604014,0.001531368,0.0056654196,0.0013665651,0.00022379884,0.0009789797,0.013257089,0.00060212106,0.015973262],"genre_scores_gemma":[0.97653514,0.0012199361,0.012564418,0.0007778057,0.0003458345,0.00033520834,0.005008578,0.000023879766,0.0031891537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99212354,0.0026742523,0.0019077857,0.0009778739,0.0020996432,0.00021690351],"domain_scores_gemma":[0.95345914,0.020823125,0.016000282,0.0025642256,0.005978028,0.0011751626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044405875,0.00047430376,0.00065980764,0.0055051553,0.0006127919,0.0012201297,0.0006951659,0.000760659,0.0025656107],"category_scores_gemma":[0.023298929,0.00032669047,0.00057798263,0.004171504,0.00022605623,0.0012247167,0.0007179959,0.00072859804,0.0008546591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004178659,0.0005355714,0.9392624,0.00021112611,0.0001072752,0.00014543056,0.0001464393,0.00032082948,0.0011555927,0.00016171984,0.0015363568,0.05599941],"study_design_scores_gemma":[0.00013197056,0.001231859,0.9807287,0.00015020513,0.0002551708,0.00076047634,0.00028516082,0.0069708475,0.0050971704,0.00029924695,0.0040438934,0.00004532687],"about_ca_topic_score_codex":0.0047011133,"about_ca_topic_score_gemma":0.0052835215,"teacher_disagreement_score":0.0055051553,"about_ca_system_score_codex":0.0009695524,"about_ca_system_score_gemma":0.0016070221,"threshold_uncertainty_score":0.02348435},"labels":[],"label_agreement":null},{"id":"W2029833913","doi":"10.2165/00002018-200124060-00002","title":"Complications of Regional Anaesthesia","year":2001,"lang":"en","type":"article","venue":"Drug Safety","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Anesthesia; Regional anaesthesia; General anaesthesia; Complication; Incidence (geometry); Surgery; Perforation; Brachial plexus","score_opus":0.024666242244185642,"score_gpt":0.27174587353789026,"score_spread":0.2470796312937046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029833913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6396573,0.14915447,0.010794334,0.0047473945,0.0016229107,0.0006801259,0.0017505226,0.00038445482,0.19120845],"genre_scores_gemma":[0.9646287,0.01930225,0.0020577416,0.0025165256,0.0009460674,0.00013918815,0.0007344318,0.00006973688,0.009605425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973767,0.0006569427,0.00038458395,0.00015845703,0.0008910994,0.0005321551],"domain_scores_gemma":[0.99110186,0.0023294757,0.0036748871,0.0006684551,0.0012420695,0.0009831863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011669847,0.00044700384,0.0006551719,0.001238811,0.0010704701,0.0011849824,0.00069838075,0.0006762952,0.008349818],"category_scores_gemma":[0.008886075,0.00015092446,0.0016128018,0.00162392,0.0004992352,0.0004520967,0.0008724083,0.0022676976,0.001466707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046643033,0.0007432046,0.26563364,0.0029683965,0.0011778325,0.04091893,0.00094284397,0.0009829763,0.006787467,0.008411262,0.014562382,0.6522068],"study_design_scores_gemma":[0.0003001833,0.0052761994,0.58893144,0.00172065,0.0012501627,0.27985767,0.0012393554,0.00120299,0.008663031,0.0036077932,0.107847825,0.00010276073],"about_ca_topic_score_codex":0.0016662508,"about_ca_topic_score_gemma":0.002009029,"teacher_disagreement_score":0.008349818,"about_ca_system_score_codex":0.0013327479,"about_ca_system_score_gemma":0.0015019394,"threshold_uncertainty_score":0.027932882},"labels":[],"label_agreement":null},{"id":"W2030289873","doi":"10.1007/s40264-014-0216-1","title":"Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum","year":2014,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacovigilance; Medicine; Curriculum; The Internet; Multidisciplinary approach; Public relations; Alternative medicine; Health care; Globalization; Medical education; Pharmacology; Adverse effect; Law; Political science","score_opus":0.07154550662978594,"score_gpt":0.42545354338143304,"score_spread":0.3539080367516471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030289873","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11693062,0.007726382,0.2954329,0.2156076,0.009572152,0.0075516016,0.0016579885,0.009193688,0.3363271],"genre_scores_gemma":[0.25008565,0.009582955,0.59691536,0.04025234,0.0037588961,0.004103315,0.0019508441,0.00092591846,0.09242464],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99655235,0.00088013674,0.00027458568,0.00028774273,0.0013735621,0.000631713],"domain_scores_gemma":[0.98197097,0.0023847094,0.0011887724,0.0009600045,0.003212595,0.01028295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007538364,0.0009536385,0.00070997246,0.0017687996,0.0013138677,0.0032850385,0.002430344,0.0020134316,0.016024228],"category_scores_gemma":[0.014012268,0.00056667934,0.00093435385,0.00096674514,0.0009285719,0.0020650516,0.007666093,0.0039134254,0.0060794204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108168075,0.0032669727,0.010053856,0.0009246544,0.000033646826,0.000510583,0.002078313,0.0030427715,0.003531476,0.014552458,0.21281652,0.7490806],"study_design_scores_gemma":[0.00025988068,0.0013483597,0.06493002,0.005215295,0.00011328579,0.0035059212,0.0039478308,0.008630992,0.008276645,0.09257683,0.8110345,0.00016037238],"about_ca_topic_score_codex":0.0030191492,"about_ca_topic_score_gemma":0.00997923,"teacher_disagreement_score":0.016024228,"about_ca_system_score_codex":0.0041748905,"about_ca_system_score_gemma":0.03219493,"threshold_uncertainty_score":0.05360639},"labels":[],"label_agreement":null},{"id":"W2030342857","doi":"10.2165/00002018-200730100-00176","title":"Evaluation of an Adverse Reaction (AR) Reporting Educational Program (Curriculum) Developed for Undergraduate/Graduate Students Studying a Health Profession","year":2007,"lang":"en","type":"article","venue":"Drug Safety","topic":"Chemical Safety and Risk Management","field":"Chemical Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Medicine; Curriculum; Medical education; Health professions; Educational program; Adverse drug reaction; Family medicine; Health professionals; MEDLINE; Pharmacology; Health care; Pedagogy; Drug","score_opus":0.07739610183345241,"score_gpt":0.4189339967639572,"score_spread":0.3415378949305048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030342857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880701,0.00008947537,0.003101785,0.00019518331,0.000054926437,0.0048369053,0.00035809178,0.00016053443,0.0031331787],"genre_scores_gemma":[0.9682235,0.00028108075,0.023294251,0.00037266852,0.000062711915,0.0020224983,0.0012014082,0.00002204534,0.0045198766],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9956383,0.0024587195,0.00030390063,0.00034912673,0.0009588222,0.00029130167],"domain_scores_gemma":[0.9887567,0.002931467,0.0013194161,0.0005381449,0.0045143375,0.0019398988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008249753,0.0005701929,0.00048031416,0.0009750331,0.0006276135,0.0004045883,0.000929284,0.0007521313,0.0022473757],"category_scores_gemma":[0.012243258,0.00022144869,0.0006623164,0.0003651642,0.00019855832,0.00031192513,0.0007444797,0.00054587855,0.00059911597],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015367484,0.19487809,0.12941709,0.0010508425,0.0002457481,0.00050214905,0.0011886611,0.0034136141,0.034614865,0.00040078783,0.0036391972,0.6152815],"study_design_scores_gemma":[0.0072660665,0.49902055,0.4187676,0.00023648444,0.0006403173,0.0006922068,0.0013542594,0.008876836,0.051992778,0.00018040906,0.010871911,0.00010065562],"about_ca_topic_score_codex":0.003429793,"about_ca_topic_score_gemma":0.0045084036,"teacher_disagreement_score":0.008249753,"about_ca_system_score_codex":0.0010480724,"about_ca_system_score_gemma":0.0035499968,"threshold_uncertainty_score":0.043629408},"labels":[],"label_agreement":null},{"id":"W2039265908","doi":"10.2165/00002018-200124070-00003","title":"Management of Paracetamol Overdose","year":2001,"lang":"en","type":"review","venue":"Drug Safety","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Acetaminophen; Regimen; Ingestion; Acetylcysteine; Toxicity; Pharmacokinetics; Pharmacology; Intensive care medicine; Drug; Anesthesia; Internal medicine","score_opus":0.19929945640177288,"score_gpt":0.4813305071893962,"score_spread":0.2820310507876233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039265908","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009325402,0.9955552,0.0009100227,0.0004418783,0.0001574412,0.00001273234,0.000016468906,0.000023470362,0.0019502369],"genre_scores_gemma":[0.00667024,0.9898415,0.0016612355,0.00042323626,0.00039966402,0.000017668888,0.000058132915,0.0000035791788,0.0009247191],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998087,0.000043097258,0.000027184442,0.000025297784,0.00008117974,0.000014533337],"domain_scores_gemma":[0.9997981,0.00007100265,0.000058837617,0.0000064122705,0.00004383601,0.000021769607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031485493,0.0007802775,0.0013428854,0.0014521491,0.00023432073,0.0005962339,0.0009001772,0.00085542497,0.0015133821],"category_scores_gemma":[0.00070449995,0.00013414511,0.00044115304,0.00081161223,0.00027403294,0.00061222364,0.00040726183,0.0013685941,0.0010694762],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008203485,0.00008493583,0.00034611294,0.003873844,0.00007010813,0.0012151945,0.000037055397,0.00019105479,0.0013699004,0.00037002517,0.0063440404,0.98601574],"study_design_scores_gemma":[0.00027559575,0.0011325091,0.013493882,0.008589429,0.00052235276,0.04185322,0.00033680105,0.00079174375,0.003705446,0.0030720264,0.9261558,0.00007118425],"about_ca_topic_score_codex":0.0006828412,"about_ca_topic_score_gemma":0.001551355,"teacher_disagreement_score":0.0015133821,"about_ca_system_score_codex":0.00026638363,"about_ca_system_score_gemma":0.00050802185,"threshold_uncertainty_score":0.0050628185},"labels":[],"label_agreement":null},{"id":"W2040225343","doi":"10.2165/11317640-000000000-00000","title":"Long-Term Developmental Outcome of Children of Women with Epilepsy, Unexposed or Exposed Prenatally to Antiepileptic Drugs","year":2009,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Carbamazepine; Pediatrics; Valproic Acid; Intelligence quotient; Wechsler Adult Intelligence Scale; Phenobarbital; Phenytoin; Bayley Scales of Infant Development; Epilepsy; In utero; Cohort study; Psychomotor learning; Pregnancy; Psychiatry; Cognition; Internal medicine; Fetus","score_opus":0.035460349624673794,"score_gpt":0.335869591103718,"score_spread":0.3004092414790442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040225343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062456005,0.9933316,0.00001825164,0.00003718122,0.00002193079,0.000004163485,0.00011049806,8.751275e-7,0.00022995604],"genre_scores_gemma":[0.012763871,0.9869178,0.00007274555,0.000029739911,0.000012736675,0.000006013339,0.00009409486,3.21589e-7,0.00010257945],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997553,0.000047320573,0.00007595624,0.00003738064,0.0000680289,0.000016064247],"domain_scores_gemma":[0.99948263,0.00029016958,0.0001414844,0.00000621629,0.000064477055,0.00001508374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058774994,0.00055871473,0.0014528871,0.0012482652,0.000120919045,0.00034125973,0.00049454125,0.00044577962,0.0010358656],"category_scores_gemma":[0.001432909,0.00017526529,0.0011155981,0.0016488134,0.00015817115,0.00029322715,0.00028279042,0.00025943562,0.00010779486],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013423556,0.00018681167,0.035323124,0.13623746,0.006598585,0.0016851248,0.00047482355,0.00036977974,0.0024706894,0.00053209625,0.004976395,0.80980283],"study_design_scores_gemma":[0.00075772544,0.0034214372,0.47118297,0.14467642,0.06308287,0.024483353,0.002797271,0.00027325648,0.005395139,0.0012085754,0.28253207,0.00018889115],"about_ca_topic_score_codex":0.005551612,"about_ca_topic_score_gemma":0.011842492,"teacher_disagreement_score":0.005551612,"about_ca_system_score_codex":0.00032750936,"about_ca_system_score_gemma":0.00090657827,"threshold_uncertainty_score":0.011038601},"labels":[],"label_agreement":null},{"id":"W2041187947","doi":"10.2165/11539300-000000000-00000","title":"Case Series in Drug Safety","year":2010,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pharmacovigilance; Drug reaction; Drug; Adverse effect; Adverse drug reaction; Pediatrics; Pharmacology","score_opus":0.1231651913550462,"score_gpt":0.4639343263772994,"score_spread":0.34076913502225326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041187947","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12801714,0.64059144,0.021281023,0.018947478,0.008673459,0.00032393524,0.0009435387,0.0011805138,0.18004146],"genre_scores_gemma":[0.6719537,0.26241964,0.008133066,0.010685525,0.014006678,0.00012424422,0.0008232173,0.00018748888,0.031666454],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.999067,0.00016849682,0.00015582694,0.00018383958,0.00023408687,0.00019088],"domain_scores_gemma":[0.9973525,0.00086863566,0.0009001708,0.00021747436,0.00023369807,0.00042755032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005507512,0.0023953686,0.0010609521,0.0052894186,0.0012798852,0.0018266687,0.0015568971,0.004684803,0.013021777],"category_scores_gemma":[0.005201691,0.00061764405,0.0012429726,0.0029461798,0.0014028029,0.0023776258,0.0020712318,0.0034063514,0.0042092255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028900107,0.00007486251,0.0053479327,0.0004882294,0.00005201181,0.9309287,0.00022406137,0.00019852971,0.0004737631,0.0011381488,0.010595878,0.050448984],"study_design_scores_gemma":[0.0000067830997,0.000010329064,0.0007372787,0.00024056331,0.000029605415,0.98639107,0.00008740798,0.00007594498,0.00019779765,0.0005422737,0.011671909,0.000008997861],"about_ca_topic_score_codex":0.0008353219,"about_ca_topic_score_gemma":0.0012667672,"teacher_disagreement_score":0.013021777,"about_ca_system_score_codex":0.00073098036,"about_ca_system_score_gemma":0.00095072004,"threshold_uncertainty_score":0.043562174},"labels":[],"label_agreement":null},{"id":"W2041278952","doi":"10.2165/00002018-200629100-00176","title":"Temporal Trends in Adverse Events Reported Following Immunization Over A Six Year Period In Canada","year":2006,"lang":"en","type":"article","venue":"Drug Safety","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Medicine; Period (music); Adverse effect; Immunization; Pediatrics; Pharmacology; Immunology; Antibody","score_opus":0.008014197542691356,"score_gpt":0.25645306491921227,"score_spread":0.2484388673765209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041278952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821437,0.0017103709,0.00010482517,0.00063286227,0.000026300962,0.00003939715,0.011848105,0.00003436035,0.003460066],"genre_scores_gemma":[0.99389124,0.0011603105,0.00010691099,0.00014111887,0.000015363143,0.000012816534,0.0033309378,0.0000047065155,0.0013365429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991549,0.00004623815,0.00011358092,0.00009213621,0.00032698468,0.00026609286],"domain_scores_gemma":[0.9946784,0.00030265536,0.0015276711,0.000053026335,0.0026073123,0.0008309223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051128835,0.00020038475,0.0003225564,0.0022212511,0.0009529913,0.0009672757,0.00080065907,0.00056361814,0.0020749064],"category_scores_gemma":[0.003244307,0.00022323984,0.0007641598,0.003542002,0.00040805907,0.00038836146,0.0005318872,0.0009441665,0.00019368315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002510405,0.000033674864,0.9947114,0.0000487392,0.000094549934,0.00012893946,0.0002311657,0.0002578456,0.00016363879,0.000052474363,0.0009604973,0.0030661754],"study_design_scores_gemma":[0.0000031667582,0.000027941016,0.99893314,0.000009684266,0.000017327227,0.000048231082,0.00024986797,0.00016194809,0.00005644375,0.0000050634244,0.0004815371,0.0000056497465],"about_ca_topic_score_codex":0.97936475,"about_ca_topic_score_gemma":0.9766922,"teacher_disagreement_score":0.020635247,"about_ca_system_score_codex":0.014221509,"about_ca_system_score_gemma":0.013793503,"threshold_uncertainty_score":0.10318476},"labels":[],"label_agreement":null},{"id":"W2044045388","doi":"10.2165/00002018-200932080-00003","title":"Serenoa repens (Saw Palmetto)","year":2009,"lang":"en","type":"review","venue":"Drug Safety","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Park","funders":"Korea Institute of Oriental Medicine","keywords":"Medicine; Adverse effect; Randomized controlled trial; Placebo; Nausea; Clinical trial; Surgery; Internal medicine; Alternative medicine; Pathology","score_opus":0.06812897605361037,"score_gpt":0.40530514764569486,"score_spread":0.33717617159208446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044045388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010987332,0.969271,0.0014015436,0.00066356314,0.00064152834,0.000101691716,0.0005111721,0.00019070473,0.016231552],"genre_scores_gemma":[0.06505578,0.9136286,0.002326767,0.0015981237,0.00062730064,0.000055182165,0.00073244935,0.000026394202,0.015949318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990344,0.000013033929,0.000017054172,0.000023897463,0.000034385772,0.000008251003],"domain_scores_gemma":[0.9998548,0.00004413507,0.00005977195,0.0000059921226,0.00002233681,0.00001301737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017092656,0.001378249,0.0010464021,0.0025571624,0.00025364707,0.0004656381,0.00047474884,0.00047261672,0.0070437468],"category_scores_gemma":[0.00025539036,0.00021796009,0.0005267072,0.0012398438,0.00021001641,0.00062368275,0.00046865563,0.000651501,0.0017683947],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020689113,0.00025340056,0.00041274197,0.01627934,0.00015422217,0.00041051832,0.00005838337,0.0003766129,0.017494343,0.00072234205,0.011224161,0.95240706],"study_design_scores_gemma":[0.00031745218,0.0016579132,0.010956341,0.0058820494,0.0014290464,0.005203738,0.00019072604,0.0006361186,0.012120054,0.0015894724,0.959935,0.0000820891],"about_ca_topic_score_codex":0.0012098985,"about_ca_topic_score_gemma":0.0047428925,"teacher_disagreement_score":0.0070437468,"about_ca_system_score_codex":0.00013985527,"about_ca_system_score_gemma":0.00026772468,"threshold_uncertainty_score":0.023563683},"labels":[],"label_agreement":null},{"id":"W2045953536","doi":"10.2165/00002018-200629100-00002","title":"Atypical Antipsychotics for Neuropsychiatric Symptoms of Dementia","year":2006,"lang":"en","type":"review","venue":"Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Dementia; Adverse effect; Olanzapine; QT interval; Atypical antipsychotic; Extrapyramidal symptoms; Psychiatry; Pediatrics; Internal medicine; Schizophrenia (object-oriented programming); Antipsychotic; Disease","score_opus":0.03200213024990545,"score_gpt":0.3552677723647584,"score_spread":0.323265642114853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045953536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018248717,0.998458,0.00010206287,0.000113760914,0.00013105145,0.000009232513,0.000023464052,0.000007754103,0.00097206084],"genre_scores_gemma":[0.0012504619,0.9976036,0.00033123328,0.0001744124,0.00009169377,0.0000065304644,0.00003328094,0.0000010405456,0.00050780317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981016,0.000033745084,0.00004534579,0.0000219298,0.00007544961,0.000013416417],"domain_scores_gemma":[0.9995815,0.00020233466,0.00010606649,0.000010452803,0.00007380621,0.000025869605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005867883,0.0010179514,0.0016873128,0.002193258,0.00021977456,0.0005936892,0.0008752955,0.00069274136,0.0032007652],"category_scores_gemma":[0.0009522313,0.00024364414,0.00070500036,0.0019620536,0.00032345747,0.0006996089,0.00047301626,0.0010986577,0.0008456353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014721937,0.00006960746,0.0002161056,0.020952506,0.00023105505,0.0003036414,0.000037873764,0.00021917617,0.00072469993,0.0009322546,0.018809445,0.9573566],"study_design_scores_gemma":[0.000232417,0.0002550594,0.0034081475,0.013094615,0.0014053282,0.0036464282,0.00014133485,0.0001833034,0.00059664674,0.0020916343,0.9749062,0.00003873495],"about_ca_topic_score_codex":0.0024326826,"about_ca_topic_score_gemma":0.008788966,"teacher_disagreement_score":0.0032007652,"about_ca_system_score_codex":0.0005159862,"about_ca_system_score_gemma":0.0009910285,"threshold_uncertainty_score":0.010707617},"labels":[],"label_agreement":null},{"id":"W2048732558","doi":"10.1007/s40264-015-0275-y","title":"Comparative Safety and Tolerability of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension","year":2015,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"Actelion Pharmaceuticals; University Health Network Foundation; University Health Network; GlaxoSmithKline","keywords":"Ambrisentan; Medicine; Bosentan; Tolerability; Peripheral edema; Adverse effect; Endothelin receptor antagonist; Pharmacology; Intensive care medicine; Population; Endothelin receptor; Internal medicine; Receptor","score_opus":0.07548638903000758,"score_gpt":0.3591478479243453,"score_spread":0.2836614588943377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048732558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076590705,0.9987656,0.00007244695,0.00007192842,0.000040483326,0.000008077237,0.000034078123,0.0000021631697,0.00023931732],"genre_scores_gemma":[0.005585954,0.993719,0.00021166888,0.000191086,0.00008087727,0.000009381957,0.000052225354,0.0000013277215,0.00014853505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944574,0.00012962025,0.00017954626,0.00006160824,0.00015986485,0.000023609655],"domain_scores_gemma":[0.9981337,0.0012829727,0.00034705803,0.00002355347,0.00017857624,0.000034069293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001701125,0.0005647471,0.002995586,0.0013642872,0.00012292681,0.00078783487,0.00087335735,0.0007320773,0.0030384779],"category_scores_gemma":[0.0024564387,0.00023826348,0.0018276081,0.0013356908,0.0002754637,0.0007920216,0.00036915773,0.0011077104,0.00032441947],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019834551,0.00017730531,0.0006400794,0.12271597,0.0034329975,0.00019629071,0.000087025015,0.00042729764,0.00285101,0.00081189646,0.005038762,0.86163783],"study_design_scores_gemma":[0.0061486936,0.009620843,0.032015324,0.106347024,0.060582846,0.0062896744,0.0007724758,0.0014646898,0.009053462,0.005593067,0.7617799,0.0003321265],"about_ca_topic_score_codex":0.0006328892,"about_ca_topic_score_gemma":0.001690829,"teacher_disagreement_score":0.0030384779,"about_ca_system_score_codex":0.00032438018,"about_ca_system_score_gemma":0.0006809105,"threshold_uncertainty_score":0.010164678},"labels":[],"label_agreement":null},{"id":"W2049029282","doi":"10.1007/s40264-014-0165-8","title":"The 8th International Congress on Cutaneous Adverse Drug Reactions, Taiwan, 2013: Focus on Severe Cutaneous Adverse Reactions","year":2014,"lang":"en","type":"article","venue":"Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Drug reaction; Dermatology; Adverse effect; Skin reaction; Adverse drug reaction; Drug; Pharmacology","score_opus":0.009414399362942926,"score_gpt":0.25885428869683536,"score_spread":0.24943988933389244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049029282","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034341842,0.3879133,0.006355809,0.21808971,0.12565753,0.0021539477,0.0038954963,0.0010851561,0.22050719],"genre_scores_gemma":[0.12917523,0.29919618,0.010206507,0.09311499,0.07105716,0.0018396196,0.008123314,0.000412091,0.3868748],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997959,0.0004503817,0.00028682683,0.00017883725,0.00074805884,0.0003768438],"domain_scores_gemma":[0.99535275,0.00047188342,0.0008364896,0.000239083,0.0019931442,0.0011066236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049489085,0.0011626839,0.0011336359,0.002842384,0.0011047339,0.002523015,0.0010879702,0.004367364,0.012312982],"category_scores_gemma":[0.0031209562,0.0002870902,0.0009967653,0.0014906859,0.0009629265,0.0010247359,0.0024954244,0.0039860774,0.003785526],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003546819,0.0004245161,0.005815382,0.0023920112,0.00009871673,0.0008371228,0.00020544766,0.0005881657,0.0065404736,0.0025847866,0.7045488,0.27560982],"study_design_scores_gemma":[0.000048158698,0.00023610619,0.014672532,0.0014648539,0.000072866445,0.0007741683,0.00017125583,0.00019103127,0.0013566981,0.00055132114,0.98042715,0.000033910706],"about_ca_topic_score_codex":0.004467555,"about_ca_topic_score_gemma":0.012801234,"teacher_disagreement_score":0.012312982,"about_ca_system_score_codex":0.002108621,"about_ca_system_score_gemma":0.0070443572,"threshold_uncertainty_score":0.04119104},"labels":[],"label_agreement":null},{"id":"W2052024407","doi":"10.2165/11592020-000000000-00000","title":"Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children","year":2011,"lang":"en","type":"review","venue":"Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Ziprasidone; Quetiapine; Olanzapine; Risperidone; Adverse effect; Aripiprazole; Antipsychotic; Population; Randomized controlled trial; Pediatrics; MEDLINE; Psychiatry; Schizophrenia (object-oriented programming); Internal medicine","score_opus":0.09021524539864947,"score_gpt":0.3437373671077288,"score_spread":0.2535221217090793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052024407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031976445,0.9991536,0.00004067928,0.00006594585,0.00004189072,0.0000024600804,0.000028141083,0.0000029266964,0.0003445671],"genre_scores_gemma":[0.0012678788,0.99834275,0.00010634419,0.00006643314,0.000051254057,0.0000028577701,0.000028970198,6.0915517e-7,0.00013287432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979204,0.000031539366,0.000065199805,0.000028914725,0.00006665012,0.000015712134],"domain_scores_gemma":[0.99923396,0.00032302545,0.00031926876,0.000011435263,0.000079518155,0.000032759817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046563742,0.00081735814,0.0016231996,0.002148301,0.00015020117,0.00058933126,0.00048076123,0.0006177441,0.0021260919],"category_scores_gemma":[0.00091008644,0.00025613437,0.0009134906,0.0023980218,0.00023648437,0.0004847795,0.00044220607,0.00080279395,0.00034647202],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020547396,0.00007153347,0.002067879,0.037932467,0.0007107715,0.0005854262,0.000058142767,0.00027329006,0.00084186974,0.00047848382,0.00982014,0.9469546],"study_design_scores_gemma":[0.00031979947,0.00065690785,0.040202815,0.047585547,0.007329542,0.016749145,0.00042163458,0.00040403623,0.0019841744,0.001582243,0.8826416,0.0001225064],"about_ca_topic_score_codex":0.0040362906,"about_ca_topic_score_gemma":0.011784738,"teacher_disagreement_score":0.0040362906,"about_ca_system_score_codex":0.00050860085,"about_ca_system_score_gemma":0.0013137489,"threshold_uncertainty_score":0.008025587},"labels":[],"label_agreement":null},{"id":"W2052084025","doi":"10.1007/bf03261973","title":"Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments","year":2012,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; St. Michael's Hospital; Toronto Rehabilitation Institute; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Polypharmacy; Incidence (geometry); Emergency department; Emergency medicine; Pharmacy; Population; Retrospective cohort study; Logistic regression; Diagnosis code; Health care; Pediatrics; Family medicine; Environmental health; Internal medicine","score_opus":0.03744386741267191,"score_gpt":0.3582969599565819,"score_spread":0.32085309254391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052084025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99380857,0.00091680523,0.000042999556,0.0006306764,0.000010915844,0.000035561774,0.0023276585,0.0000050353647,0.002221759],"genre_scores_gemma":[0.9977041,0.00087711704,0.0000880285,0.00008609058,0.000018298442,0.000012720238,0.0009553454,0.0000013544452,0.00025689648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900717,0.00011578122,0.00009370162,0.000083880404,0.0004778231,0.00022165691],"domain_scores_gemma":[0.99694973,0.00016605979,0.0017163947,0.000057605157,0.00059728447,0.0005129848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042288,0.00020391168,0.0002366075,0.0010872496,0.00076906354,0.0007549101,0.00049213733,0.00025838034,0.0017874873],"category_scores_gemma":[0.0031532373,0.00023969325,0.00045326154,0.0017779929,0.00038223213,0.00028803744,0.00075722585,0.00039760466,0.00011156294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033778757,0.000015188761,0.9966551,0.000026224336,0.00003712791,0.00012957428,0.00010206656,0.000076954144,0.000048832015,0.000034441106,0.00059147755,0.002249186],"study_design_scores_gemma":[0.0000031599986,0.000010374803,0.99939466,0.0000135094,0.000008058572,0.000073705836,0.00012236479,0.00010161613,0.0000049860237,0.000008107785,0.00025756695,0.000001833257],"about_ca_topic_score_codex":0.7715653,"about_ca_topic_score_gemma":0.83815724,"teacher_disagreement_score":0.22843468,"about_ca_system_score_codex":0.010934569,"about_ca_system_score_gemma":0.007308027,"threshold_uncertainty_score":0.45955992},"labels":[],"label_agreement":null},{"id":"W2053681261","doi":"10.2165/00002018-200124120-00004","title":"A Comparison of Liposomal Formulations of Doxorubicin with Drug Administered in Free Form","year":2001,"lang":"en","type":"review","venue":"Drug Safety","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":244,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Doxorubicin; Medicine; Anthracycline; Pharmacology; Liposome; Toxicity; Drug; Cardiotoxicity; Pharmacokinetics; Cumulative dose; Chemotherapy; Internal medicine; Cancer; Chemistry","score_opus":0.043275833021310516,"score_gpt":0.3335715452609478,"score_spread":0.2902957122396373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053681261","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050831884,0.9398846,0.0047190976,0.00017713942,0.0001705339,0.000079399615,0.00010546001,0.00003359606,0.003998232],"genre_scores_gemma":[0.2133192,0.7722582,0.0068919784,0.00025612762,0.00012361875,0.00007882829,0.000269063,0.00002315217,0.006779827],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998098,0.00004546052,0.000021632093,0.00003592867,0.000072761635,0.000014599588],"domain_scores_gemma":[0.99985766,0.00006934567,0.00003197041,0.000007496578,0.000028087368,0.00000542461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006158539,0.0004580803,0.00072337734,0.0006970343,0.0001234884,0.0003566538,0.00039356283,0.00036881285,0.00088082574],"category_scores_gemma":[0.0004344263,0.00011192427,0.00029120455,0.0004796864,0.00019177055,0.0004278759,0.00015829685,0.00026929527,0.00024795264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020884871,0.0002481673,0.00059819757,0.007610576,0.000099095385,0.00046255573,0.00011399262,0.00053982687,0.26161844,0.0016977312,0.0013497802,0.72357315],"study_design_scores_gemma":[0.00020978237,0.009780352,0.010121998,0.0010962624,0.00071557995,0.006024314,0.00015268268,0.001162969,0.70377225,0.0008920254,0.26600504,0.00006680398],"about_ca_topic_score_codex":0.0005265637,"about_ca_topic_score_gemma":0.0007085655,"teacher_disagreement_score":0.00088082574,"about_ca_system_score_codex":0.0004873656,"about_ca_system_score_gemma":0.00033935066,"threshold_uncertainty_score":0.0035361648},"labels":[],"label_agreement":null},{"id":"W2055764278","doi":"10.2165/00002018-200427100-00005","title":"Haematological Effects of Interferon-??-1a (Rebif??) Therapy in Multiple Sclerosis","year":2004,"lang":"en","type":"article","venue":"Drug Safety","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Cytopenia; Asymptomatic; Internal medicine; Placebo; Multiple sclerosis; Postmarketing surveillance; Interferon; Clinical trial; Interferon beta-1a; Gastroenterology; Immunology; Adverse effect; Pathology; Bone marrow","score_opus":0.061836752263614576,"score_gpt":0.2998670617595056,"score_spread":0.23803030949589105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055764278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96338487,0.032580573,0.00017543744,0.0006047226,0.00014694108,0.00010806552,0.0002437167,0.000016008644,0.002739689],"genre_scores_gemma":[0.9941136,0.0037614394,0.00018628502,0.0003526802,0.0002997866,0.000040329094,0.00017910739,0.0000056271824,0.0010611059],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9969683,0.002501034,0.00015157794,0.00006678433,0.00018625088,0.00012612621],"domain_scores_gemma":[0.9960372,0.0020269868,0.0010815618,0.00026502914,0.00028604415,0.00030320237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00438802,0.00027561764,0.0007879445,0.0007023668,0.00037516918,0.00047981335,0.0003687209,0.0007090474,0.001822228],"category_scores_gemma":[0.006211471,0.00017780294,0.0005453715,0.00064373435,0.0006102761,0.00042311606,0.00028462106,0.0011651248,0.00030874164],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5328698,0.008408067,0.082358964,0.002700996,0.0024098419,0.0014179827,0.00063688174,0.0007986268,0.038385425,0.00066051644,0.0019889995,0.32736388],"study_design_scores_gemma":[0.037713196,0.29517406,0.60567105,0.00046652244,0.0041836514,0.0031098605,0.00048422057,0.0008255736,0.033309005,0.0011314532,0.017834349,0.000097002536],"about_ca_topic_score_codex":0.00071566127,"about_ca_topic_score_gemma":0.0008202263,"teacher_disagreement_score":0.00438802,"about_ca_system_score_codex":0.0004801068,"about_ca_system_score_gemma":0.00040344655,"threshold_uncertainty_score":0.023206353},"labels":[],"label_agreement":null},{"id":"W2056359850","doi":"10.2165/00002018-200124130-00008","title":"Lipid Abnormalities Induced by Novel Antipsychotic Drugs","year":2001,"lang":"en","type":"letter","venue":"Drug Safety","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Medicine; Antipsychotic; Pharmacology; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.01615402993544175,"score_gpt":0.25292363784840977,"score_spread":0.23676960791296803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056359850","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013004595,0.003426586,0.00047662467,0.95417535,0.012157017,0.000046550616,0.00016071308,0.00010807211,0.016444491],"genre_scores_gemma":[0.08858732,0.0046503553,0.0010946846,0.8168302,0.076565675,0.00009159202,0.0001635466,0.000053615986,0.011962987],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99838376,0.0005878552,0.00028064282,0.00013726923,0.00040665173,0.00020384298],"domain_scores_gemma":[0.99473,0.0034127315,0.0006036515,0.00019924491,0.00052695477,0.0005273466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018664189,0.0008613405,0.0016116711,0.00075960613,0.0022490271,0.0020474119,0.0011184791,0.034620877,0.0036984077],"category_scores_gemma":[0.018578215,0.00059031614,0.0015077256,0.0007885645,0.0015636941,0.0018206042,0.00086980575,0.018886847,0.001980447],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016814023,0.00029830265,0.016221661,0.00043393698,0.00031247828,0.16550596,0.00064299034,0.0005134562,0.00207745,0.0071148016,0.7475302,0.05766727],"study_design_scores_gemma":[0.002152697,0.0015358876,0.030340737,0.001317404,0.0007265352,0.16261014,0.0012791429,0.004415906,0.0029360587,0.02179067,0.7706702,0.00022464733],"about_ca_topic_score_codex":0.0030849457,"about_ca_topic_score_gemma":0.006868467,"teacher_disagreement_score":0.034620877,"about_ca_system_score_codex":0.0031282443,"about_ca_system_score_gemma":0.0016024704,"threshold_uncertainty_score":0.022697091},"labels":[],"label_agreement":null},{"id":"W2058332964","doi":"10.2165/00002018-200326040-00005","title":"Evaluation of the Safety of Palivizumab in the Second Season of Exposure in Young Children at Risk for Severe Respiratory Syncytial Virus Infection","year":2003,"lang":"en","type":"article","venue":"Drug Safety","topic":"Respiratory viral infections research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"Abbott Laboratories","keywords":"Palivizumab; Medicine; Adverse effect; Pediatrics; Bronchopulmonary dysplasia; Respiratory system; Gestational age; Internal medicine; Biology","score_opus":0.03137107805167842,"score_gpt":0.33223800250262764,"score_spread":0.3008669244509492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058332964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993381,0.00024402227,0.00005666288,0.000041754218,0.000008454391,0.00003968898,0.000069761365,0.0000020497944,0.0001995751],"genre_scores_gemma":[0.9995833,0.000089956084,0.00008744282,0.00004262212,0.000010811158,0.000026900283,0.00007895222,0.0000010641947,0.00007899642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979742,0.001021537,0.00016299504,0.00016280366,0.00042958139,0.00024881904],"domain_scores_gemma":[0.9953892,0.0015709269,0.0011233853,0.00020163463,0.0008795925,0.00083525915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035750074,0.00040478545,0.00082882907,0.00033420563,0.00036428208,0.000611153,0.00045909232,0.000806643,0.00051994727],"category_scores_gemma":[0.0062261056,0.00026123316,0.0009341327,0.0002348329,0.00032890678,0.0005315428,0.00031095807,0.0010265685,0.00012004235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054748394,0.0025932363,0.8859312,0.00029217565,0.0003862004,0.0006476608,0.001031925,0.00089847133,0.010676951,0.00008115607,0.00024714446,0.04246549],"study_design_scores_gemma":[0.0025046417,0.16298069,0.8218218,0.00007147059,0.0003421515,0.0011333522,0.00087661063,0.0013948928,0.007692391,0.000048049482,0.0011158087,0.000018138311],"about_ca_topic_score_codex":0.0037204677,"about_ca_topic_score_gemma":0.0033573809,"teacher_disagreement_score":0.0037204677,"about_ca_system_score_codex":0.0012415514,"about_ca_system_score_gemma":0.001624005,"threshold_uncertainty_score":0.018906713},"labels":[],"label_agreement":null},{"id":"W2064016725","doi":"10.2165/00002018-200225130-00002","title":"Benefits and Risks to Mother and Infant of Drug Treatment for Postnatal Depression","year":2002,"lang":"en","type":"review","venue":"Drug Safety","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Sertraline; Breastfeeding; Fluoxetine; Antidepressant; Fluvoxamine; Psychiatry; Postpartum depression; Depression (economics); Paroxetine; Breast feeding; Adverse effect; Serotonin reuptake inhibitor; Dyad; Intensive care medicine; Pediatrics; Pharmacology; Pregnancy; Psychology; Anxiety; Internal medicine; Serotonin","score_opus":0.06686863101929572,"score_gpt":0.3682466836238525,"score_spread":0.30137805260455675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064016725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063666824,0.997971,0.000067797286,0.00017627509,0.00005095022,0.0000051401885,0.000023929744,0.000003143063,0.0010650912],"genre_scores_gemma":[0.0038277875,0.99541867,0.00016151028,0.000116041294,0.00006345199,0.0000061256133,0.000014138867,6.23053e-7,0.00039169652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980134,0.000053615626,0.000036600006,0.000022592865,0.000076043594,0.000009878039],"domain_scores_gemma":[0.99919826,0.00055473374,0.00015041122,0.000013822869,0.000060466795,0.000022253338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048648837,0.00050522195,0.0011795346,0.0012927603,0.0001920203,0.00042115393,0.00043281462,0.00068352546,0.002599977],"category_scores_gemma":[0.001365558,0.00020303729,0.0005226526,0.0011805361,0.00024019634,0.00050424365,0.0002637654,0.0007329604,0.0003214114],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023537359,0.00007730069,0.0007706858,0.022856321,0.00037718128,0.00034094864,0.00007404177,0.00017846389,0.0009323724,0.0008458493,0.006050333,0.96726114],"study_design_scores_gemma":[0.0003509668,0.0011646211,0.027359225,0.033210672,0.0050654663,0.009821896,0.00054303487,0.00036424815,0.0027488663,0.0033802253,0.9159238,0.00006700843],"about_ca_topic_score_codex":0.002075569,"about_ca_topic_score_gemma":0.008080599,"teacher_disagreement_score":0.002599977,"about_ca_system_score_codex":0.0004042995,"about_ca_system_score_gemma":0.0007640117,"threshold_uncertainty_score":0.008697808},"labels":[],"label_agreement":null},{"id":"W2064115956","doi":"10.2165/00002018-200831020-00006","title":"A Surveillance Method for the Early Identification of Idiosyncratic Adverse Drug Reactions","year":2008,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Western University","funders":"","keywords":"Medicine; Adverse Event Reporting System; Adverse effect; Drug; Incidence (geometry); Exact test; Adverse drug reaction; Drug reaction; Pharmacology; Internal medicine","score_opus":0.07724585836498933,"score_gpt":0.4216054189303475,"score_spread":0.34435956056535816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064115956","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4032075,0.0055164276,0.5587427,0.0013398357,0.00053891324,0.0016236225,0.005478854,0.007741299,0.015810871],"genre_scores_gemma":[0.6670055,0.0010573342,0.32318836,0.000627227,0.0002058204,0.0008335345,0.0018940056,0.00010264325,0.005085539],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99770314,0.0006280326,0.00031047026,0.00040188874,0.00087347085,0.000083106555],"domain_scores_gemma":[0.98656195,0.0060137915,0.0019223964,0.0012076804,0.003910928,0.00038322748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037380687,0.0005631885,0.00075886055,0.0041182074,0.0003691412,0.0009913845,0.00072329736,0.00079414743,0.0024000714],"category_scores_gemma":[0.011696758,0.00026411645,0.00046033814,0.0013970694,0.0001498064,0.00082809257,0.0006379788,0.0006575283,0.0011146638],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011519593,0.00045598167,0.18258002,0.00028795065,0.00015529567,0.00046274954,0.00026740236,0.00082917215,0.039548814,0.0012026103,0.0072251717,0.76583296],"study_design_scores_gemma":[0.0006977736,0.0053896504,0.53241223,0.0005816172,0.0015550165,0.026363593,0.00072345126,0.1779261,0.2006823,0.004538354,0.04869832,0.00043163422],"about_ca_topic_score_codex":0.0012701015,"about_ca_topic_score_gemma":0.0015024644,"teacher_disagreement_score":0.0041182074,"about_ca_system_score_codex":0.0002858039,"about_ca_system_score_gemma":0.00095112546,"threshold_uncertainty_score":0.019769073},"labels":[],"label_agreement":null},{"id":"W2069170088","doi":"10.2165/00002018-200831050-00005","title":"Inhaled Corticosteroids and the Risk of Fractures in Older Adults","year":2008,"lang":"en","type":"review","venue":"Drug Safety","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; Vancouver General Hospital; Vancouver Coastal Health","funders":"","keywords":"Medicine; Funnel plot; Meta-analysis; Relative risk; Cochrane Library; MEDLINE; Publication bias; Asthma; Internal medicine; Randomized controlled trial; Confidence interval","score_opus":0.015600954101286549,"score_gpt":0.3443646075294708,"score_spread":0.32876365342818425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069170088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000093959665,0.9996302,0.00002124567,0.00006626865,0.000055564084,0.0000017340087,0.000013507043,0.0000014405025,0.00011605027],"genre_scores_gemma":[0.0008953411,0.99866486,0.000069925445,0.00011307463,0.00011737546,0.0000026525533,0.000018435001,3.5826108e-7,0.00011800049],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996082,0.00005642364,0.00008573502,0.000055271765,0.0001744064,0.000019996622],"domain_scores_gemma":[0.9990551,0.00050119666,0.00028884993,0.000014297914,0.00010951688,0.000031021198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074849004,0.0007853583,0.0024442784,0.0022297385,0.00017171589,0.00073620194,0.0008579563,0.0014143041,0.002564598],"category_scores_gemma":[0.0015385587,0.00038541676,0.001287831,0.0024459532,0.00033032527,0.0005190119,0.00043554086,0.001309491,0.00054204185],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027783017,0.00008036887,0.0017920119,0.051806025,0.0012793127,0.0002967211,0.000042125597,0.00029156115,0.0006411089,0.00055417325,0.014485352,0.9284535],"study_design_scores_gemma":[0.00072405447,0.0008275328,0.03669349,0.071952105,0.013676317,0.007971343,0.00034918715,0.0006774924,0.0011783359,0.0036903697,0.8621241,0.00013561807],"about_ca_topic_score_codex":0.0049457774,"about_ca_topic_score_gemma":0.0103545105,"teacher_disagreement_score":0.0049457774,"about_ca_system_score_codex":0.00043895913,"about_ca_system_score_gemma":0.0009932333,"threshold_uncertainty_score":0.0098339915},"labels":[],"label_agreement":null},{"id":"W2069867585","doi":"10.2165/00002018-200326030-00004","title":"Safety of Celecoxib in Individuals Allergic to Sulfonamide","year":2003,"lang":"en","type":"article","venue":"Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Celecoxib; Sulfonamide; Sulfamethoxazole; Trimethoprim; Antimicrobial; Allergy; Internal medicine; Dermatology; Antibiotics; Immunology; Microbiology","score_opus":0.014067532295573015,"score_gpt":0.2720527182811136,"score_spread":0.2579851859855406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069867585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943693,0.0026838789,0.00019653953,0.00015644786,0.000018008815,0.00001760967,0.00008486881,0.000011017264,0.0024622858],"genre_scores_gemma":[0.9986628,0.0006659764,0.00010126281,0.00009378355,0.00003360868,0.0000037192285,0.00007090904,0.0000022220859,0.00036577668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995053,0.00016301424,0.00006930543,0.0000334484,0.00018504959,0.000043886947],"domain_scores_gemma":[0.9985045,0.00051461306,0.0005610588,0.000068544956,0.00024693852,0.00010421391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073662435,0.00019499953,0.00043176176,0.00041485124,0.00031172624,0.00036244388,0.00010083748,0.0003841701,0.0013404519],"category_scores_gemma":[0.0025258076,0.000089917914,0.00048685115,0.0002986413,0.0001235388,0.00017399798,0.00011725553,0.00041030938,0.00022448914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018815486,0.0006820551,0.7528923,0.00071906694,0.0006971789,0.006407372,0.0011805857,0.0003837096,0.049068157,0.00025969243,0.0010596173,0.16783476],"study_design_scores_gemma":[0.00054795155,0.018553343,0.9284585,0.00016370308,0.0013262574,0.019205414,0.00080779445,0.0015370498,0.022594871,0.00020893422,0.006566199,0.000029905603],"about_ca_topic_score_codex":0.001073655,"about_ca_topic_score_gemma":0.001250559,"teacher_disagreement_score":0.0013404519,"about_ca_system_score_codex":0.0003061453,"about_ca_system_score_gemma":0.00019824013,"threshold_uncertainty_score":0.0044842362},"labels":[],"label_agreement":null},{"id":"W2075535167","doi":"10.2165/00002018-200932070-00007","title":"Drug-Induced Changes in the T-Wave Morphology","year":2009,"lang":"en","type":"letter","venue":"Drug Safety","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint Paul University","funders":"","keywords":"Medicine; Morphology (biology); Zoology","score_opus":0.017068435529602067,"score_gpt":0.25184705992423567,"score_spread":0.2347786243946336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075535167","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06705589,0.0051933923,0.00481796,0.83233875,0.030006485,0.00016032488,0.0005168524,0.00045109654,0.05945921],"genre_scores_gemma":[0.36755747,0.0054367576,0.004455453,0.50759065,0.09809184,0.00014494218,0.00022223906,0.00012454882,0.01637615],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991429,0.0002982565,0.00014985826,0.00012695922,0.00019515307,0.00008689349],"domain_scores_gemma":[0.99635845,0.0024026872,0.00039808708,0.00023683815,0.00038307765,0.00022078038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088012055,0.0004915571,0.0010326358,0.00045408905,0.00069960713,0.0012916883,0.0007418462,0.012621021,0.0022701814],"category_scores_gemma":[0.011750148,0.0002497175,0.00079640426,0.00046411043,0.00088198174,0.0012206569,0.00033015746,0.008509541,0.0018535242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018305938,0.00046567494,0.023371853,0.00044083057,0.00028911023,0.45265403,0.00079812645,0.0009574097,0.01018934,0.009359292,0.38139734,0.11824646],"study_design_scores_gemma":[0.001116847,0.0020984486,0.04859153,0.00069026434,0.0004551144,0.4905122,0.0010687915,0.009635438,0.008576731,0.028027333,0.40896416,0.00026322322],"about_ca_topic_score_codex":0.0008077422,"about_ca_topic_score_gemma":0.0014601008,"teacher_disagreement_score":0.012621021,"about_ca_system_score_codex":0.0010380198,"about_ca_system_score_gemma":0.0003664112,"threshold_uncertainty_score":0.007594526},"labels":[],"label_agreement":null},{"id":"W2078645381","doi":"10.2165/00002018-200932090-00001","title":"Overview of Seizure-Inducing Potential of Doripenem","year":2009,"lang":"en","type":"review","venue":"Drug Safety","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"","keywords":"Medicine; Doripenem; Pharmacology; Epilepsy; Intensive care medicine; Antibiotics; Meropenem; Microbiology; Psychiatry","score_opus":0.06074115006699437,"score_gpt":0.386552952569537,"score_spread":0.3258118025025426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078645381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025611377,0.9985916,0.00016648325,0.000106997926,0.00007431099,0.00000663888,0.000032702592,0.000008180326,0.0007568716],"genre_scores_gemma":[0.0012515895,0.9977677,0.00034905405,0.00013797413,0.00011265771,0.000006592875,0.0000448327,0.0000015214455,0.00032813085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999767,0.000038874547,0.000078794525,0.000036046255,0.00006483519,0.000014511625],"domain_scores_gemma":[0.9994592,0.00029943063,0.000121409954,0.0000127054955,0.000087845096,0.00001948948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006232374,0.0010189211,0.0020558096,0.0028199179,0.00016809197,0.0008137019,0.00078475644,0.0007558171,0.002965075],"category_scores_gemma":[0.0008813395,0.0003480419,0.0009808855,0.0021087204,0.0002810254,0.0011645522,0.00043347903,0.0011003274,0.00091740343],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019998635,0.00010419528,0.00026639973,0.037787773,0.00026926302,0.00039578063,0.000040378567,0.00036038947,0.0026729743,0.0010772565,0.010929844,0.94589573],"study_design_scores_gemma":[0.00016855124,0.00075328135,0.004127338,0.014918778,0.0020567433,0.006524484,0.000099493045,0.0005061162,0.00369856,0.0017863656,0.9652915,0.000068697125],"about_ca_topic_score_codex":0.0010478507,"about_ca_topic_score_gemma":0.0025888178,"teacher_disagreement_score":0.002965075,"about_ca_system_score_codex":0.00046370534,"about_ca_system_score_gemma":0.00089848234,"threshold_uncertainty_score":0.009919107},"labels":[],"label_agreement":null},{"id":"W2082686341","doi":"10.2165/00002018-200629010-00004","title":"Fulfilling an Unmet Need in Psoriasis","year":2006,"lang":"en","type":"review","venue":"Drug Safety","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Psoriasis; Medicine; Efalizumab; Etanercept; Adalimumab; Infliximab; Rheumatoid arthritis; Methotrexate; Dermatology; Psoriatic arthritis; Acitretin; Immunology; Ciclosporin; Population; Tumor necrosis factor alpha; Transplantation; Internal medicine","score_opus":0.031329017145245386,"score_gpt":0.29074359468332905,"score_spread":0.25941457753808367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082686341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000070802416,0.9939085,0.00026769502,0.002989766,0.001709214,0.0000035336213,0.000008737126,0.000015299895,0.0010263276],"genre_scores_gemma":[0.000897177,0.9911889,0.00060610403,0.0023808207,0.0032509312,0.0000074930986,0.000029975397,0.00000429337,0.0016342789],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917835,0.00020100911,0.00016945288,0.00009219761,0.0002848721,0.00007395741],"domain_scores_gemma":[0.9981217,0.00074486283,0.00038620812,0.00006586531,0.00045095154,0.00023034766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024640337,0.0013693104,0.0029254549,0.002302499,0.00055570685,0.0022741542,0.0010320983,0.0034163843,0.005545997],"category_scores_gemma":[0.0026693856,0.00046961804,0.00058450026,0.002956764,0.0011231198,0.0036176506,0.0014190213,0.00398895,0.0039087515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012544502,0.00007905745,0.00016460793,0.00846915,0.00005831243,0.00029441583,0.00004624442,0.0002256499,0.00087462144,0.002922201,0.09908653,0.8876539],"study_design_scores_gemma":[0.000053968386,0.00012061416,0.00055467803,0.0028308835,0.00008922661,0.0018747944,0.000066502325,0.00012360238,0.00017194993,0.001981674,0.99211687,0.00001521167],"about_ca_topic_score_codex":0.00071411685,"about_ca_topic_score_gemma":0.0018536883,"teacher_disagreement_score":0.005545997,"about_ca_system_score_codex":0.0009969396,"about_ca_system_score_gemma":0.002146129,"threshold_uncertainty_score":0.018553257},"labels":[],"label_agreement":null},{"id":"W2083238585","doi":"10.2165/00002018-200225130-00006","title":"Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children","year":2002,"lang":"en","type":"article","venue":"Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Wilson Centre; SickKids Foundation; University of Toronto; Sunnybrook Hospital; Hospital for Sick Children; Sunnybrook Health Science Centre","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Erythema multiforme; Etiology; Dermatology; Epidemiology; Population; Pediatrics; Retrospective cohort study; Surgery; Internal medicine","score_opus":0.011426641618773237,"score_gpt":0.23234796562855262,"score_spread":0.22092132400977937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083238585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97608256,0.013653818,0.0003999957,0.00096076494,0.00005862996,0.00006722695,0.00046069155,0.000053239863,0.008263062],"genre_scores_gemma":[0.99401665,0.004660819,0.0003503011,0.00020991414,0.00004423179,0.0000248593,0.00017157465,0.000005744535,0.0005158864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936384,0.00018143174,0.00011963783,0.000049967013,0.00015418086,0.00013097483],"domain_scores_gemma":[0.99841964,0.0004586363,0.0007218421,0.0000391988,0.00011568313,0.0002449479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007498083,0.0005146806,0.0006221101,0.001231227,0.0005610679,0.00059161335,0.00024550193,0.0009347461,0.00126842],"category_scores_gemma":[0.0037324682,0.00027579057,0.0004608268,0.001058329,0.0007415596,0.00063706737,0.00047240572,0.0011979116,0.00020248262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041378787,0.0002437238,0.8875359,0.00040117514,0.00010509215,0.085209645,0.00045896063,0.00047609708,0.001429421,0.0010309729,0.0025992792,0.020095875],"study_design_scores_gemma":[0.00005710558,0.0005346026,0.71047103,0.00018096837,0.0001160547,0.2820134,0.00073843263,0.00035413343,0.0008691533,0.00041903774,0.004229874,0.000016204976],"about_ca_topic_score_codex":0.0055913115,"about_ca_topic_score_gemma":0.005810675,"teacher_disagreement_score":0.0055913115,"about_ca_system_score_codex":0.00077134726,"about_ca_system_score_gemma":0.0011533085,"threshold_uncertainty_score":0.011117518},"labels":[],"label_agreement":null},{"id":"W2083499423","doi":"10.2165/00002018-200730090-00001","title":"Is There Still a Role for Aprotinin in Cardiac Surgery?","year":2007,"lang":"en","type":"review","venue":"Drug Safety","topic":"Blood transfusion and management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Aprotinin; Medicine; Tranexamic acid; Coagulopathy; Antifibrinolytic; Cardiac surgery; Thrombelastography; Intensive care medicine; Anesthesia; Hemostatics; Surgery; Hemostasis; Internal medicine; Blood loss; Coagulation","score_opus":0.05347987259038035,"score_gpt":0.3426449656972879,"score_spread":0.2891650931069076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083499423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000075868,0.99835026,0.00008103009,0.0006995414,0.00021763172,0.0000020267657,0.000007359571,0.0000056646913,0.00056069216],"genre_scores_gemma":[0.00071873097,0.9976528,0.00021436726,0.0007173556,0.0003214304,0.000003903529,0.000013083859,0.000001088288,0.00035720077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99955803,0.00010432009,0.00010289079,0.00005976014,0.00014598954,0.000029125293],"domain_scores_gemma":[0.9981382,0.001069879,0.0004136145,0.000032922002,0.00026479684,0.00008061304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014556408,0.00081895874,0.002457901,0.0017959884,0.00029551613,0.0012882187,0.0008410067,0.0015605823,0.00332975],"category_scores_gemma":[0.0027712015,0.00029456452,0.0006869579,0.0020840603,0.0006644996,0.0017440667,0.00053956395,0.0021998493,0.0014122933],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013978509,0.000051841715,0.00030837164,0.0154268425,0.00018431529,0.00023991674,0.000032597523,0.00019128615,0.0005322978,0.0013836242,0.02756445,0.95394456],"study_design_scores_gemma":[0.00013824104,0.00033557945,0.002217087,0.01269956,0.00090960995,0.0028028153,0.00012850972,0.00018856967,0.0005138336,0.002298509,0.9777309,0.000036766025],"about_ca_topic_score_codex":0.0012786685,"about_ca_topic_score_gemma":0.0036709479,"teacher_disagreement_score":0.00332975,"about_ca_system_score_codex":0.0007172959,"about_ca_system_score_gemma":0.0018684062,"threshold_uncertainty_score":0.011139154},"labels":[],"label_agreement":null},{"id":"W2084380298","doi":"10.2165/00002018-200427030-00004","title":"Malformation Rates in Children of Women with Untreated Epilepsy","year":2004,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Epilepsy; Offspring; Odds ratio; Pediatrics; Cohort study; Pregnancy; Case-control study; Internal medicine; Psychiatry","score_opus":0.015145552277940467,"score_gpt":0.31579390680233493,"score_spread":0.3006483545243945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084380298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020322732,0.9974999,0.00005390897,0.000051426272,0.000016979622,0.0000031062732,0.000091798676,0.000002283576,0.00024827945],"genre_scores_gemma":[0.0067119217,0.99292326,0.00012724035,0.000043618693,0.00001500623,0.000003771427,0.000052276187,6.460266e-7,0.00012222088],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958247,0.000087880144,0.00013334533,0.000064664,0.000119042066,0.0000126573905],"domain_scores_gemma":[0.9986927,0.00077593216,0.00041040644,0.000014988539,0.00009005344,0.000016064108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006295344,0.0005064906,0.0014544803,0.002473816,0.00009499032,0.00037706253,0.00040311422,0.00037837052,0.0018976361],"category_scores_gemma":[0.0019262341,0.00020585662,0.0010188014,0.0029776166,0.00025102374,0.000375063,0.00027685385,0.0003270591,0.00015242829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079203525,0.000043965105,0.016917748,0.07448742,0.0028616022,0.0012295421,0.00022669692,0.00035568612,0.0021926954,0.0004934294,0.0040538455,0.8963453],"study_design_scores_gemma":[0.0007224831,0.002030777,0.23865335,0.08170961,0.045235183,0.05658556,0.0013145981,0.00034353344,0.0108304145,0.0014597434,0.56095386,0.00016094517],"about_ca_topic_score_codex":0.0032922989,"about_ca_topic_score_gemma":0.0067237983,"teacher_disagreement_score":0.0032922989,"about_ca_system_score_codex":0.0003769592,"about_ca_system_score_gemma":0.00066435675,"threshold_uncertainty_score":0.006546259},"labels":[],"label_agreement":null},{"id":"W2084696188","doi":"10.2165/00002018-200022010-00004","title":"A Risk-Benefit Assessment of the Newer Oral Antifungal Agents Used to Treat Onychomycosis","year":2000,"lang":"en","type":"review","venue":"Drug Safety","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Terbinafine; Itraconazole; Griseofulvin; Fluconazole; Medicine; Ketoconazole; Dermatophyte; Regimen; Dermatology; Pharmacology; Candida parapsilosis; Mycosis; Candida albicans; Antifungal drug; Antifungal; Internal medicine; Surgery; Microbiology; Biology","score_opus":0.04709609411921183,"score_gpt":0.38273973541843165,"score_spread":0.3356436412992198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084696188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060152815,0.9983006,0.00023362861,0.00023699719,0.000063564315,0.000009752887,0.000024840847,0.0000036294007,0.00052549975],"genre_scores_gemma":[0.0072698207,0.99063045,0.0008777599,0.00048757368,0.00021022023,0.000019577055,0.00004800308,0.0000013606287,0.00045528656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99945825,0.00015411692,0.00007972692,0.00004952633,0.00023990092,0.00001848776],"domain_scores_gemma":[0.9983543,0.0011793477,0.000266277,0.000017834464,0.00015654185,0.000025747915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012699745,0.00068647886,0.0020139818,0.0014630689,0.00014487896,0.0006568819,0.00071181083,0.0011711903,0.002126899],"category_scores_gemma":[0.0022307616,0.0002077428,0.0013020918,0.0010958867,0.00024044266,0.0005952011,0.00024879875,0.0011617462,0.00035023235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008077543,0.00010351582,0.0005744008,0.031635266,0.0009266068,0.00047589082,0.000041018113,0.0007518694,0.0019558098,0.0015953244,0.006772012,0.9543605],"study_design_scores_gemma":[0.001577565,0.0037198414,0.020852631,0.047095764,0.015597807,0.012877375,0.00031774538,0.002256648,0.005239535,0.010653125,0.8796796,0.00013243008],"about_ca_topic_score_codex":0.0007512735,"about_ca_topic_score_gemma":0.0017392335,"teacher_disagreement_score":0.002126899,"about_ca_system_score_codex":0.0005213204,"about_ca_system_score_gemma":0.0006577649,"threshold_uncertainty_score":0.0071151853},"labels":[],"label_agreement":null},{"id":"W2085402348","doi":"10.1007/s40264-013-0045-7","title":"Idiopathic Acute Liver Injury in Paediatric Outpatients: Incidence and Signal Detection in Two European Countries","year":2013,"lang":"en","type":"article","venue":"Drug Safety","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"Erasmus+; Vereniging Trustfonds Erasmus Universiteit Rotterdam","keywords":"Medicine; Incidence (geometry); Autoimmune hepatitis; Population; Cohort; Liver injury; Retrospective cohort study; Pediatrics; Internal medicine; Hepatitis; Environmental health","score_opus":0.02924156566193085,"score_gpt":0.3422572911791497,"score_spread":0.31301572551721885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085402348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994099,0.0001351946,0.0000418549,0.000014827413,0.0000018004959,0.0000041950384,0.000119602155,0.0000022864415,0.00027034598],"genre_scores_gemma":[0.99949825,0.00015562207,0.000086651264,0.000016487307,0.0000034853551,0.0000044341687,0.0001698126,0.0000015479908,0.000063708394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900204,0.00029906543,0.00017909928,0.00016510638,0.00016704369,0.00018766492],"domain_scores_gemma":[0.99720156,0.00057135936,0.0012735906,0.00009428877,0.00041090586,0.00044821005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007862246,0.00036637855,0.00044213375,0.0023456528,0.00052252185,0.000974015,0.00045404557,0.0006266733,0.0009827815],"category_scores_gemma":[0.0024248508,0.0003500351,0.00045367045,0.0024143471,0.00072882615,0.0005742594,0.0010564141,0.0004075063,0.00015096966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088688605,0.00003907123,0.99727756,0.0000153318,0.000019230129,0.0005649993,0.00037698873,0.000027925611,0.00017763986,0.000023012026,0.000050052702,0.0013394811],"study_design_scores_gemma":[0.000008413935,0.000106520514,0.99682367,0.000009434671,0.00001514231,0.0015151144,0.001218968,0.0000473794,0.00009114102,0.000007618761,0.00015204077,0.000004623833],"about_ca_topic_score_codex":0.010825753,"about_ca_topic_score_gemma":0.009358516,"teacher_disagreement_score":0.010825753,"about_ca_system_score_codex":0.00070804777,"about_ca_system_score_gemma":0.0007340057,"threshold_uncertainty_score":0.021525502},"labels":[],"label_agreement":null},{"id":"W2086681374","doi":"10.2165/11316640-000000000-00000","title":"Cisplatin Overdose","year":2009,"lang":"en","type":"review","venue":"Drug Safety","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Cisplatin; Amifostine; Nephrotoxicity; Ototoxicity; Vomiting; Drug overdose; Hyponatremia; Carboplatin; Pharmacology; Internal medicine; Chemotherapy; Toxicity","score_opus":0.032486031291598966,"score_gpt":0.34780345136589347,"score_spread":0.31531742007429453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086681374","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043967302,0.9945064,0.0003352626,0.00024274891,0.00017810673,0.000018603076,0.000050991654,0.000019150413,0.004209045],"genre_scores_gemma":[0.0042571938,0.99311876,0.00044137653,0.00038105904,0.00012944582,0.000016160471,0.00008008888,0.000002996405,0.0015728081],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981385,0.000041624928,0.000032237233,0.00003706359,0.00006317827,0.000012087499],"domain_scores_gemma":[0.99972564,0.00010957805,0.00009128205,0.000012118356,0.00004717345,0.000014136402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031535872,0.00070408545,0.0012453893,0.0012613594,0.00020138957,0.00056580314,0.00055189786,0.0005544337,0.004434403],"category_scores_gemma":[0.0008177302,0.00021927453,0.0004544747,0.0012999282,0.0002905373,0.0006384471,0.0005879998,0.0009464627,0.0012553193],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009485384,0.000053267384,0.00030376163,0.0142317,0.00015696012,0.00024386482,0.000020125102,0.0002856604,0.001272104,0.0009007132,0.017025897,0.9654111],"study_design_scores_gemma":[0.00009678785,0.00024981145,0.0021308104,0.005966826,0.0005994468,0.004443772,0.000040943876,0.00020779438,0.0019542333,0.0014637887,0.9828262,0.000019651869],"about_ca_topic_score_codex":0.0009951768,"about_ca_topic_score_gemma":0.002274179,"teacher_disagreement_score":0.004434403,"about_ca_system_score_codex":0.00041393892,"about_ca_system_score_gemma":0.00087942014,"threshold_uncertainty_score":0.014834583},"labels":[],"label_agreement":null},{"id":"W2086926322","doi":"10.2165/00002018-200730100-00081","title":"Retailers and Herbal Product-Related Adverse Drug Reactions: Whose Responsibility is It?","year":2007,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Traditional medicine; Adverse effect; Drug; Drug reaction; Product (mathematics); Pharmacovigilance; Adverse drug reaction; Pharmacology","score_opus":0.03620774693516004,"score_gpt":0.35490252207657463,"score_spread":0.3186947751414146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086926322","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.095508315,0.1426381,0.00228769,0.7053801,0.0033255727,0.000048841513,0.00018672062,0.0000870284,0.050537676],"genre_scores_gemma":[0.8333555,0.07832841,0.0019546514,0.066438526,0.011831204,0.000035241083,0.00011209477,0.00005469193,0.007889712],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.988194,0.00630863,0.00081189413,0.00071476906,0.0032797782,0.0006909644],"domain_scores_gemma":[0.8827273,0.06152791,0.030076565,0.004123647,0.015983986,0.005560552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014001461,0.00034543412,0.0013344581,0.0012946455,0.0018912122,0.005911139,0.0010503202,0.009348018,0.017627627],"category_scores_gemma":[0.06274695,0.00048609969,0.0012050695,0.0013909752,0.004730142,0.008744669,0.0018285842,0.004950961,0.0018013298],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016720839,0.0015567851,0.44705406,0.0016232936,0.0008841431,0.0044552837,0.0058962046,0.0004374612,0.0005910905,0.03810875,0.099977285,0.39774355],"study_design_scores_gemma":[0.0006574395,0.0010084811,0.505913,0.006728031,0.0016797907,0.025097694,0.044731647,0.002917967,0.001060268,0.11032096,0.299395,0.0004897118],"about_ca_topic_score_codex":0.005911954,"about_ca_topic_score_gemma":0.009984225,"teacher_disagreement_score":0.017627627,"about_ca_system_score_codex":0.001967299,"about_ca_system_score_gemma":0.0056265234,"threshold_uncertainty_score":0.074047685},"labels":[],"label_agreement":null},{"id":"W2087395980","doi":"10.2165/00002018-200225080-00006","title":"Approaches Toward Repeated Supratherapeutic Doses of Paracetamol in Children","year":2002,"lang":"en","type":"article","venue":"Drug Safety","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pharmacology; Intensive care medicine; Anesthesia","score_opus":0.23808226176066574,"score_gpt":0.37502647954484997,"score_spread":0.13694421778418422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087395980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.794845,0.036632054,0.13104524,0.014420741,0.0005148004,0.0005326693,0.00022217967,0.0008325633,0.020954778],"genre_scores_gemma":[0.93351406,0.012579137,0.04937416,0.0013790055,0.00030447682,0.00020179118,0.00007384702,0.00006369667,0.0025099262],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994704,0.00023447636,0.00005336031,0.000057595593,0.00012464874,0.000059523245],"domain_scores_gemma":[0.9992681,0.00023867765,0.00020723506,0.00011993926,0.000100083584,0.00006594737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010379347,0.00036512275,0.00047765533,0.00037309088,0.00040673048,0.0004907673,0.00073429575,0.0004309626,0.0009461102],"category_scores_gemma":[0.0016812587,0.00013828112,0.00038552465,0.00021461253,0.00081066735,0.00039406703,0.00054610363,0.0013163534,0.00026745093],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002873617,0.0011421557,0.038174383,0.00090551213,0.00018637748,0.004106903,0.0012699547,0.003001667,0.16071181,0.01316711,0.0029562144,0.7715043],"study_design_scores_gemma":[0.0013571172,0.027690008,0.17530471,0.0010019067,0.001194912,0.06664375,0.00424637,0.007478962,0.5264266,0.011784054,0.17670621,0.00016546091],"about_ca_topic_score_codex":0.0022311672,"about_ca_topic_score_gemma":0.004099604,"teacher_disagreement_score":0.0022311672,"about_ca_system_score_codex":0.00095212914,"about_ca_system_score_gemma":0.0020071263,"threshold_uncertainty_score":0.0069081783},"labels":[],"label_agreement":null},{"id":"W2092849802","doi":"10.2165/00002018-200023020-00003","title":"A Risk-Benefit Assessment of Injections of Hyaluronan and its Derivatives in the Treatment of Osteoarthritis of the Knee","year":2000,"lang":"en","type":"review","venue":"Drug Safety","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Arthritis Research Centre of Canada; University of Calgary","funders":"","keywords":"Medicine; Osteoarthritis; Risk assessment; Physical therapy; Intensive care medicine; Pharmacology; Alternative medicine; Pathology","score_opus":0.021634162369255666,"score_gpt":0.3130389121815917,"score_spread":0.291404749812336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092849802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047536672,0.99862766,0.00021282243,0.0002018041,0.00005628149,0.000010465271,0.000020706579,0.0000032807716,0.0003916177],"genre_scores_gemma":[0.0069504604,0.9913743,0.0006489721,0.0003631494,0.00017802868,0.000020899339,0.000040374067,0.0000012892954,0.00042245636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937314,0.00022245127,0.000078142795,0.000049912895,0.00025490305,0.000021441081],"domain_scores_gemma":[0.99814117,0.0013952925,0.00028168107,0.000019853347,0.000131848,0.00003018723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016677578,0.00081951224,0.0025883277,0.0017060027,0.00015285605,0.0006240241,0.0008780943,0.0014313175,0.0025561263],"category_scores_gemma":[0.002559193,0.00025029315,0.0012565264,0.0012960827,0.00028417393,0.0006211095,0.0002694571,0.0009794865,0.00039458935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015976172,0.00014008199,0.0003907663,0.034910195,0.0011078708,0.00043003465,0.000039641738,0.0010483731,0.0018216203,0.0018719631,0.0072806566,0.9493613],"study_design_scores_gemma":[0.0034770754,0.006063838,0.01863606,0.053216074,0.016808186,0.010279436,0.000360748,0.003096339,0.0060182754,0.015440815,0.86643636,0.0001668167],"about_ca_topic_score_codex":0.00093209813,"about_ca_topic_score_gemma":0.0018604128,"teacher_disagreement_score":0.0025883277,"about_ca_system_score_codex":0.0006281539,"about_ca_system_score_gemma":0.0007216797,"threshold_uncertainty_score":0.008819997},"labels":[],"label_agreement":null},{"id":"W2092946324","doi":"10.2165/00002018-200528040-00003","title":"Benefit-Risk Assessment of Zaleplon in the Treatment of Insomnia","year":2005,"lang":"en","type":"review","venue":"Drug Safety","topic":"Sleep and related disorders","field":"Psychology","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Zolpidem; Zopiclone; Medicine; Insomnia; Hypnotic; Lorazepam; Triazolam; Benzodiazepine; Adverse effect; Physical dependence; Pharmacodynamics; Anesthesia; Psychiatry; Pharmacology; Internal medicine; Pharmacokinetics; Receptor","score_opus":0.02905679373870748,"score_gpt":0.3816588745044812,"score_spread":0.3526020807657737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092946324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009941858,0.9974886,0.0003160961,0.0002649657,0.00006593643,0.000017666644,0.00003668946,0.0000114036475,0.00080444885],"genre_scores_gemma":[0.010098075,0.98777336,0.00096415787,0.00037830562,0.00015829613,0.000024642783,0.000060964026,0.0000034496993,0.00053880824],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99969685,0.00010637342,0.00004675744,0.000029767358,0.00010722367,0.000013047464],"domain_scores_gemma":[0.99886036,0.00081272423,0.00019459859,0.000014797356,0.0000858952,0.000031738182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012589656,0.00069449906,0.0025370086,0.0012272653,0.00015522137,0.0005740161,0.0011669947,0.0008843182,0.0034841327],"category_scores_gemma":[0.001564461,0.00025390863,0.0010911636,0.0008749365,0.00029121817,0.000645764,0.00031939233,0.0014427849,0.00047824846],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009769921,0.00018267347,0.00041886652,0.020336213,0.0008699236,0.0002676638,0.000035490597,0.00064256403,0.0008704855,0.0009453983,0.006842375,0.96761125],"study_design_scores_gemma":[0.005604411,0.006470344,0.023797495,0.031746764,0.013261745,0.0086194035,0.00036281568,0.004085333,0.0044095814,0.010538419,0.8908811,0.00022266703],"about_ca_topic_score_codex":0.0011007037,"about_ca_topic_score_gemma":0.0043531717,"teacher_disagreement_score":0.0034841327,"about_ca_system_score_codex":0.00046363904,"about_ca_system_score_gemma":0.0005579771,"threshold_uncertainty_score":0.011655569},"labels":[],"label_agreement":null},{"id":"W2105458393","doi":"10.1007/s40264-013-0089-8","title":"Tendon Injury and Fluoroquinolone Use: A Systematic Review","year":2013,"lang":"en","type":"review","venue":"Drug Safety","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Institute of Health Services and Policy Research; Institute for Work & Health; St. Michael's Hospital; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Tendinopathy; Observational study; Achilles tendon; Tendon; Odds ratio; MEDLINE; Physical therapy; Cochrane Library; Systematic review; Tendinitis; Surgery; Internal medicine; Randomized controlled trial","score_opus":0.040020524831272865,"score_gpt":0.3532091409783153,"score_spread":0.3131886161470424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105458393","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008615672,0.99865013,0.000046329435,0.00008512312,0.000040745534,0.000058280075,0.00015947304,0.0000037746454,0.00009451241],"genre_scores_gemma":[0.011634309,0.9875479,0.0002415196,0.00031728265,0.000041717136,0.000060341332,0.00007364871,0.0000019607821,0.000081198596],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975139,0.0005688184,0.0011477552,0.00024599177,0.00041018892,0.0001133894],"domain_scores_gemma":[0.9913959,0.004632773,0.0031480195,0.0000935306,0.0005809644,0.00014875049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028516555,0.0014313605,0.0070368797,0.0060129305,0.00038441573,0.001956976,0.0012805192,0.0018623503,0.0052967775],"category_scores_gemma":[0.011315238,0.0010237572,0.0067097144,0.007015588,0.00069942017,0.0018145589,0.0014073229,0.0012441735,0.00026051162],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004983243,0.000039961997,0.001282975,0.93875486,0.022117235,0.00020160367,0.00013780073,0.00013011672,0.0002463489,0.00011265551,0.0015802534,0.034897983],"study_design_scores_gemma":[0.0013104313,0.00064694474,0.012527502,0.5766047,0.3726987,0.0012340689,0.000516201,0.00017893434,0.00038299774,0.0003573085,0.0334287,0.00011355497],"about_ca_topic_score_codex":0.0071496945,"about_ca_topic_score_gemma":0.028249942,"teacher_disagreement_score":0.0071496945,"about_ca_system_score_codex":0.0018367157,"about_ca_system_score_gemma":0.0052492986,"threshold_uncertainty_score":0.017719448},"labels":[],"label_agreement":null},{"id":"W2120242446","doi":"10.1007/s40264-015-0297-5","title":"A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance","year":2015,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Humana; Pfizer","keywords":"Observational study; Medicine; Analytics; Usability; Computer science; Data mining; Outcome (game theory); Data science; Internal medicine","score_opus":0.4922250256428415,"score_gpt":0.5517772702141691,"score_spread":0.05955224457132763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120242446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9199868,0.0024298348,0.053884283,0.005194788,0.0003989125,0.0015800174,0.009423659,0.00038177834,0.006719997],"genre_scores_gemma":[0.9754742,0.00037682278,0.018082941,0.0005425482,0.00008689542,0.0005661121,0.0043057012,0.00008924159,0.0004755069],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.82984024,0.14400741,0.006302822,0.0070345625,0.0109784035,0.001836593],"domain_scores_gemma":[0.418806,0.5046348,0.024319315,0.025258804,0.022080513,0.0049006077],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.23568685,0.0010052397,0.0014826913,0.0027729825,0.00076044776,0.0047845836,0.0039072484,0.0016718579,0.0033243848],"category_scores_gemma":[0.39278364,0.00061762135,0.0042474275,0.0031166375,0.0016357765,0.009581945,0.0055931597,0.002326049,0.00050494325],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024323303,0.0026116318,0.84944826,0.0014467008,0.009038793,0.00009898509,0.0025886637,0.018273924,0.00049574126,0.017773764,0.004797639,0.0691027],"study_design_scores_gemma":[0.0029295755,0.023861669,0.684107,0.0014461462,0.008244203,0.00067656476,0.010009975,0.2301504,0.002110072,0.024059301,0.012071952,0.0003331574],"about_ca_topic_score_codex":0.010905881,"about_ca_topic_score_gemma":0.0090370765,"teacher_disagreement_score":0.76431316,"about_ca_system_score_codex":0.0030749985,"about_ca_system_score_gemma":0.005472598,"threshold_uncertainty_score":0.9425342},"labels":[],"label_agreement":null},{"id":"W2126118326","doi":"10.2165/00002018-200831090-00006","title":"Risk of Hypospadias in Offspring of Women Using Loratadine during Pregnancy","year":2008,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Loratadine; Medicine; Hypospadias; Offspring; Incidence (geometry); Pregnancy; Meta-analysis; Cohort; Cohort study; Obstetrics; Gynecology; Pediatrics; Internal medicine; Surgery; Pharmacology","score_opus":0.03672914759717614,"score_gpt":0.32341562842332416,"score_spread":0.286686480826148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126118326","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056706127,0.99346656,0.000099447396,0.00014317952,0.000040470462,0.0000037278676,0.000048980473,0.0000028351412,0.00052429544],"genre_scores_gemma":[0.01971969,0.9796652,0.00016654527,0.00007001631,0.00005387097,0.0000041942485,0.000051747407,5.123054e-7,0.00026815277],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99982786,0.00004415417,0.000027749387,0.000024825002,0.00006475548,0.000010642597],"domain_scores_gemma":[0.9994066,0.0003357793,0.00017942832,0.000007343816,0.00005444649,0.000016440687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032752028,0.00035709405,0.0009919466,0.0007850713,0.00010929713,0.00034688454,0.0003688798,0.00048259296,0.0012860819],"category_scores_gemma":[0.0011468175,0.00016103996,0.00072386727,0.0009810985,0.00010130676,0.00022468358,0.00019054154,0.00048638426,0.00013421611],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008314945,0.00011298004,0.038169187,0.029419405,0.0033017623,0.0021612234,0.00018675497,0.0004836718,0.002795351,0.0005744986,0.0049862135,0.91697747],"study_design_scores_gemma":[0.00079011876,0.0031610194,0.41306454,0.03811744,0.03345698,0.06442919,0.0013648762,0.0013751363,0.0067908424,0.0027249756,0.43451735,0.00020747063],"about_ca_topic_score_codex":0.0020272695,"about_ca_topic_score_gemma":0.0029791046,"teacher_disagreement_score":0.0020272695,"about_ca_system_score_codex":0.00020597834,"about_ca_system_score_gemma":0.00040163723,"threshold_uncertainty_score":0.0043023825},"labels":[],"label_agreement":null},{"id":"W2127801848","doi":"10.2165/00002018-200528020-00001","title":"Thiomersal in Vaccines","year":2005,"lang":"en","type":"review","venue":"Drug Safety","topic":"Mercury impact and mitigation studies","field":"Environmental Science","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Canadian Blood Services; University of British Columbia","funders":"","keywords":"Thiomersal; Medicine; Environmental health; MERCURY EXPOSURE; Developing country; Toxicology; Immunology; Economic growth","score_opus":0.03169563105924495,"score_gpt":0.33003977206621493,"score_spread":0.29834414100697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127801848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002973808,0.9975528,0.00029945007,0.0001238095,0.00025631476,0.000013316553,0.000021317124,0.000013558365,0.0014220955],"genre_scores_gemma":[0.0022527815,0.9942901,0.0005615159,0.00026458877,0.00023962307,0.000022439204,0.000055417833,0.000003609811,0.002309907],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984825,0.000033718414,0.00002034071,0.000026010634,0.00005425467,0.00001742068],"domain_scores_gemma":[0.99982184,0.00007677722,0.000047130998,0.000010310582,0.00003057032,0.000013501184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053328683,0.001096402,0.0015301497,0.0023206596,0.00023307052,0.00062381977,0.00070752366,0.00095788005,0.0048219194],"category_scores_gemma":[0.0005348901,0.0003210084,0.0005503511,0.0016221537,0.0005085313,0.00094422273,0.0006801906,0.00166348,0.0020866592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013986108,0.00008829681,0.00007177234,0.010559962,0.000074945325,0.00023535891,0.000035534053,0.00045884273,0.0036038843,0.002917621,0.015981795,0.96583205],"study_design_scores_gemma":[0.00012792111,0.00039025073,0.0003924576,0.0034913926,0.0002515209,0.0016718257,0.000036014084,0.00014429326,0.0037780146,0.0020480626,0.98765,0.000018293691],"about_ca_topic_score_codex":0.00097027596,"about_ca_topic_score_gemma":0.0017066906,"teacher_disagreement_score":0.0048219194,"about_ca_system_score_codex":0.00042951092,"about_ca_system_score_gemma":0.0008093821,"threshold_uncertainty_score":0.016130924},"labels":[],"label_agreement":null},{"id":"W2130075738","doi":"10.2165/00002018-200730050-00001","title":"Guidelines for Submitting Adverse Event Reports for Publication","year":2007,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pharmacovigilance; Alternative medicine; Pharmacy; Adverse effect; Warrant; Credence; Medical education; Family medicine; Pharmacology; Pathology","score_opus":0.18196448700324783,"score_gpt":0.5093983329817617,"score_spread":0.3274338459785139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130075738","genre_codex":"protocol","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006378707,0.01751729,0.17773631,0.12046046,0.06392987,0.28648683,0.087273255,0.020838369,0.21937895],"genre_scores_gemma":[0.015503328,0.01565591,0.3758985,0.03924894,0.020372747,0.27568382,0.07787892,0.0039407476,0.17581716],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.770004,0.092869855,0.09929188,0.0036190269,0.030384546,0.0038306543],"domain_scores_gemma":[0.3673778,0.16090733,0.07130591,0.05229955,0.33727673,0.010832748],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14017133,0.0032946044,0.0061946716,0.027500248,0.004818802,0.012897136,0.009493866,0.020718966,0.12902254],"category_scores_gemma":[0.3836766,0.005767348,0.0105917,0.011489846,0.0028698316,0.006689504,0.0061269957,0.01406487,0.13229518],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009369759,0.0007278604,0.0016046095,0.006512147,0.00023494019,0.00090940786,0.0006880038,0.000560147,0.0017428512,0.0024147797,0.8555262,0.12814201],"study_design_scores_gemma":[0.0018240759,0.0006339393,0.0082697505,0.015080204,0.00041696968,0.0018704508,0.00071490865,0.0017950248,0.0021455267,0.006067452,0.96088934,0.0002924297],"about_ca_topic_score_codex":0.0036448748,"about_ca_topic_score_gemma":0.009727901,"teacher_disagreement_score":0.85982865,"about_ca_system_score_codex":0.002418132,"about_ca_system_score_gemma":0.02585275,"threshold_uncertainty_score":0.7413057},"labels":[],"label_agreement":null},{"id":"W2143346814","doi":"10.2165/00002018-200932070-00004","title":"Risk Perception and Reasons for Noncompliance in Pharmacovigilance","year":2009,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Pharmacovigilance; Medicine; Patient safety; Adverse effect; Health care; Postmarketing surveillance; Perception; Health professionals; Adverse drug reaction; Scope (computer science); Under-reporting; Family medicine; Pharmacology; Drug; Psychology","score_opus":0.06591350728348887,"score_gpt":0.43933007991107614,"score_spread":0.37341657262758726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143346814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466634,0.0008186342,0.0005366753,0.0018811498,0.000026799684,0.000074180716,0.0001361125,0.00002310599,0.0018370334],"genre_scores_gemma":[0.99894446,0.00008775322,0.0004887152,0.00023570184,0.000018517632,0.000011804529,0.00006412637,0.000004715851,0.00014419602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9812991,0.00756786,0.0035316858,0.0008220685,0.005912211,0.000867087],"domain_scores_gemma":[0.8667995,0.06864607,0.04825399,0.0034959656,0.008649739,0.0041547823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019015897,0.0002568984,0.0006328609,0.0018937702,0.00088102295,0.001796415,0.00059407693,0.0015723058,0.002311446],"category_scores_gemma":[0.112870395,0.0003843771,0.0019305595,0.0012973023,0.0005191052,0.0015946606,0.0009408618,0.0025781363,0.00021993493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036388825,0.00035021867,0.9896771,0.00003681336,0.00014047952,0.00018352097,0.0010535512,0.00011958531,0.00013902201,0.00010747104,0.00027682472,0.0075516594],"study_design_scores_gemma":[0.000056904308,0.00072255323,0.9907013,0.00010631977,0.00018539684,0.0016199456,0.0023813022,0.0024756286,0.00030864825,0.00037072913,0.0010137699,0.000057450136],"about_ca_topic_score_codex":0.0059486832,"about_ca_topic_score_gemma":0.004031507,"teacher_disagreement_score":0.019015897,"about_ca_system_score_codex":0.0014444436,"about_ca_system_score_gemma":0.0020559682,"threshold_uncertainty_score":0.100566864},"labels":[],"label_agreement":null},{"id":"W2159311047","doi":"10.2165/00002018-200124110-00007","title":"Increased Risk of Somnolence with the New Dopamine Agonists in Patients with Parkinson??s Disease","year":2001,"lang":"en","type":"review","venue":"Drug Safety","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Baycrest Hospital","funders":"","keywords":"Ropinirole; Pramipexole; Somnolence; Medicine; Levodopa; Placebo; Relative risk; Parkinson's disease; Internal medicine; Confidence interval; Adverse effect; Disease","score_opus":0.009755393399975288,"score_gpt":0.2510826202410317,"score_spread":0.2413272268410564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159311047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010553501,0.9975836,0.00010292795,0.00031440824,0.000080833466,0.000002722147,0.000024551247,0.000004173077,0.00083136314],"genre_scores_gemma":[0.009342186,0.9892771,0.0001982561,0.00034995415,0.0002542308,0.0000057476987,0.000049422943,0.0000011744426,0.0005219299],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996985,0.00008458702,0.00004683115,0.00003922678,0.000112694484,0.000018084485],"domain_scores_gemma":[0.9992887,0.00038314535,0.00019589446,0.000013299662,0.00008916399,0.000029913424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006320667,0.00048749358,0.0018911896,0.000903285,0.0001682496,0.0005299382,0.00039748297,0.0009280633,0.0021334735],"category_scores_gemma":[0.0011264097,0.00015911387,0.0008824525,0.0010526794,0.00017672492,0.00042005815,0.00028270818,0.0009458182,0.00046854684],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086814316,0.000082788494,0.0066320645,0.012525124,0.0011336908,0.0015124285,0.000059867234,0.00030331564,0.0012713511,0.000670637,0.011051781,0.96388876],"study_design_scores_gemma":[0.001063171,0.0029173144,0.10513415,0.01441207,0.007597318,0.04672592,0.00030185666,0.00076259696,0.003188149,0.0036283704,0.8141435,0.0001256231],"about_ca_topic_score_codex":0.00080304453,"about_ca_topic_score_gemma":0.0020718726,"teacher_disagreement_score":0.0021334735,"about_ca_system_score_codex":0.00032071784,"about_ca_system_score_gemma":0.0005484366,"threshold_uncertainty_score":0.00713712},"labels":[],"label_agreement":null},{"id":"W2179845226","doi":"10.2165/00002018-200124040-00001","title":"Should Celecoxib Be Contraindicated in Patients Who Are Allergic to Sulfonamides?","year":2001,"lang":"en","type":"review","venue":"Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Sulfonamide; Medicine; Antimicrobial; Chemistry; Stereochemistry; Organic chemistry","score_opus":0.06721411891045735,"score_gpt":0.3467344293542841,"score_spread":0.27952031044382675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2179845226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004240189,0.9840307,0.0006489451,0.005398065,0.0008763496,0.00001558283,0.00006473056,0.000027025353,0.0046984013],"genre_scores_gemma":[0.028006338,0.96016675,0.0014002421,0.00549828,0.0022218076,0.000026718835,0.00014578762,0.000007081819,0.0025271133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996278,0.000100553654,0.00010098139,0.000033461114,0.00011658789,0.00002062449],"domain_scores_gemma":[0.9985954,0.00067690166,0.00046831727,0.000033887405,0.00016642848,0.00005900439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010111232,0.00045928705,0.0018871947,0.0007640499,0.00020960331,0.0005890999,0.000527583,0.0017503776,0.0038492645],"category_scores_gemma":[0.0036002232,0.00022735725,0.0007292281,0.0008212568,0.00033871277,0.0009055548,0.00019508749,0.0012472277,0.0011481943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009042536,0.00007830172,0.003599187,0.010277531,0.00028090735,0.0021610637,0.00006596408,0.00016611892,0.0019066208,0.00062179717,0.02091476,0.9590235],"study_design_scores_gemma":[0.0018486694,0.0019407645,0.047752142,0.019539243,0.0033770732,0.047119673,0.00070400094,0.0008055012,0.0033737768,0.0046361685,0.86879855,0.0001044161],"about_ca_topic_score_codex":0.0010068527,"about_ca_topic_score_gemma":0.0038794666,"teacher_disagreement_score":0.0038492645,"about_ca_system_score_codex":0.0003407893,"about_ca_system_score_gemma":0.0008103757,"threshold_uncertainty_score":0.012877107},"labels":[],"label_agreement":null},{"id":"W2182436270","doi":"10.1007/s40264-015-0360-2","title":"Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase®","year":2015,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Circulatory and Respiratory Health; World Health Organization","keywords":"Medicine; Montelukast; Anxiety; Psychiatry; Depression (economics); Population; Pharmacovigilance; Pediatrics; Internal medicine; Drug; Asthma","score_opus":0.04465659511420584,"score_gpt":0.39752481724631095,"score_spread":0.3528682221321051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182436270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997538,0.0011722042,0.00011706313,0.00006979241,0.0000074450486,0.000014740592,0.000753027,0.000005223859,0.0003224575],"genre_scores_gemma":[0.9987067,0.000505532,0.00013484023,0.000046764613,0.000011401839,0.000009190881,0.00050471956,0.00000542004,0.00007540221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978542,0.0004961659,0.00030435977,0.000442374,0.0006340442,0.00026879282],"domain_scores_gemma":[0.9965834,0.0008761502,0.0019171953,0.00016271761,0.00022381931,0.00023665634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010471237,0.0003426131,0.000764747,0.0017145207,0.00030884793,0.0007047266,0.00034962202,0.00039506247,0.0011619023],"category_scores_gemma":[0.004097718,0.00027010782,0.0018170538,0.0018401606,0.000353286,0.0004405823,0.0011147908,0.0007262027,0.00013546407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071950664,0.000024663981,0.9932613,0.000079668556,0.0008612082,0.0003912707,0.00009690334,0.00003865703,0.00041707745,0.0000546347,0.0001754959,0.0038797858],"study_design_scores_gemma":[0.00004390207,0.0002429668,0.99576074,0.000044076085,0.0008015921,0.001895059,0.00028016773,0.00017839142,0.00026370626,0.000024861485,0.00045326722,0.000011385371],"about_ca_topic_score_codex":0.007212792,"about_ca_topic_score_gemma":0.0072788266,"teacher_disagreement_score":0.007212792,"about_ca_system_score_codex":0.00085540983,"about_ca_system_score_gemma":0.00073077524,"threshold_uncertainty_score":0.014341593},"labels":[],"label_agreement":null},{"id":"W22265382","doi":"10.2165/00002018-200629070-00006","title":"Increase in Nonfatal Digestive Perforations and Haemorrhages Following Introduction of Selective NSAIDs","year":2006,"lang":"en","type":"article","venue":"Drug Safety","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Montréal","keywords":"Medicine; Pharmacology","score_opus":0.002726505569962231,"score_gpt":0.21915902887076488,"score_spread":0.21643252330080265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W22265382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955308,0.0024000972,0.00032799464,0.000093845934,0.000022721462,0.000011137591,0.00021331196,0.000027903348,0.0013722576],"genre_scores_gemma":[0.99837863,0.00056440965,0.00019802216,0.000051573978,0.000049256792,0.000004555528,0.00020587629,0.0000036394588,0.0005440214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933964,0.00017262674,0.00009630362,0.000083344705,0.0002158392,0.000092286566],"domain_scores_gemma":[0.9910625,0.002664825,0.0037080972,0.00066129985,0.0010800022,0.00082327804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076530944,0.00020224955,0.0005719946,0.0007957053,0.0003078936,0.00047202894,0.0002254675,0.0007083555,0.0028301792],"category_scores_gemma":[0.005660743,0.0001824595,0.0006300945,0.00070335885,0.00021675807,0.00048228118,0.00028298458,0.0010509123,0.00040760534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011069631,0.00030283965,0.9513275,0.00020558079,0.0002944084,0.0019002354,0.00016913662,0.00008128811,0.008352438,0.00006357375,0.00021810891,0.026015328],"study_design_scores_gemma":[0.0000192567,0.0018366481,0.9929784,0.0000092568935,0.00015552068,0.0024178876,0.000094928364,0.00010746765,0.0018752856,0.000041543688,0.00045770005,0.0000060477046],"about_ca_topic_score_codex":0.00071496464,"about_ca_topic_score_gemma":0.0007380244,"teacher_disagreement_score":0.0028301792,"about_ca_system_score_codex":0.0002876447,"about_ca_system_score_gemma":0.00031607298,"threshold_uncertainty_score":0.0094679},"labels":[],"label_agreement":null},{"id":"W2261045102","doi":"10.1007/s40264-015-0390-9","title":"The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015","year":2016,"lang":"en","type":"review","venue":"Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Teijin Pharma; National Yang-Ming University; Chang Gung Medical Foundation; National Science Council","keywords":"Medicine; Drug reaction; Dermatology; Drug; Pharmacology","score_opus":0.021452367362099063,"score_gpt":0.33544581053356504,"score_spread":0.313993443171466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2261045102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075010577,0.95301896,0.0005446856,0.0067587113,0.014712516,0.00021077972,0.00037221017,0.00008754579,0.023544464],"genre_scores_gemma":[0.004651634,0.9210658,0.001228682,0.006047785,0.006362642,0.00013874623,0.0011117301,0.000026031583,0.05936694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988575,0.0001672095,0.00013879086,0.00008372615,0.00057973753,0.00017290865],"domain_scores_gemma":[0.99825054,0.00017937721,0.00024669923,0.000040420677,0.00090845756,0.00037453047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002128893,0.0011979464,0.0017480147,0.0036722438,0.0008707651,0.0022652368,0.0013136193,0.00225313,0.02100558],"category_scores_gemma":[0.0017938919,0.00036937653,0.0008588887,0.0019703084,0.00067327294,0.0011746454,0.0021665762,0.0030117806,0.0069795023],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013788366,0.00015042757,0.0003493109,0.00588086,0.00005075689,0.0001401321,0.000052434105,0.00016858678,0.0012954782,0.001095984,0.40314138,0.5875367],"study_design_scores_gemma":[0.000039182953,0.000110293535,0.0017476036,0.0035732365,0.00006661286,0.00035258016,0.00005149196,0.000059111426,0.00030589447,0.0004805915,0.9931946,0.000018867328],"about_ca_topic_score_codex":0.0091357585,"about_ca_topic_score_gemma":0.04240571,"teacher_disagreement_score":0.02100558,"about_ca_system_score_codex":0.0021485905,"about_ca_system_score_gemma":0.0053332727,"threshold_uncertainty_score":0.07027066},"labels":[],"label_agreement":null},{"id":"W2281383011","doi":"10.1007/s40264-016-0398-9","title":"The Safety of Prochlorperazine in Children: A Systematic Review and Meta-Analysis","year":2016,"lang":"en","type":"review","venue":"Drug Safety","topic":"Nausea and vomiting management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Pediatric Oncology Group; University of Toronto","funders":"Pediatric Oncology Group of Ontario","keywords":"Medicine; Meta-analysis; Prochlorperazine; MEDLINE; Systematic review; Anesthesia; Internal medicine; Nausea","score_opus":0.03309541578035267,"score_gpt":0.3321817724619434,"score_spread":0.2990863566815907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281383011","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051259743,0.99411654,0.00020008601,0.00008060079,0.00007682419,0.000094243376,0.00016381503,0.0000076628785,0.00013419642],"genre_scores_gemma":[0.12404115,0.8729165,0.0012769484,0.0008361935,0.00016600845,0.00021771553,0.0002974027,0.000012102375,0.00023598698],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99579453,0.0012907734,0.0017259055,0.00046607692,0.00056624506,0.00015650275],"domain_scores_gemma":[0.9887206,0.007710329,0.0024787483,0.00029565068,0.0006501726,0.00014456597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006448441,0.0018093118,0.012336338,0.0029858353,0.0003973521,0.0020524042,0.0013586436,0.001830554,0.002838975],"category_scores_gemma":[0.019940121,0.0011322282,0.021130443,0.0038068644,0.00067502115,0.0016065285,0.0012133815,0.001772562,0.00019245215],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034717026,0.000062149054,0.0050897673,0.50327927,0.46013275,0.00022204533,0.00013038889,0.0003703827,0.0004136107,0.00012355902,0.0006063152,0.026098074],"study_design_scores_gemma":[0.0010891699,0.0004437284,0.0054639843,0.023775684,0.9661256,0.0002089322,0.000072544484,0.00010511403,0.00017855245,0.0001445245,0.0023583046,0.000033829492],"about_ca_topic_score_codex":0.0039723357,"about_ca_topic_score_gemma":0.012417854,"teacher_disagreement_score":0.012336338,"about_ca_system_score_codex":0.001484316,"about_ca_system_score_gemma":0.0022651055,"threshold_uncertainty_score":0.034103036},"labels":[],"label_agreement":null},{"id":"W2311333448","doi":"10.1007/s40264-016-0418-9","title":"The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis","year":2016,"lang":"en","type":"review","venue":"Drug Safety","topic":"Nausea and vomiting management","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Pediatric Oncology Group; University of Toronto","funders":"Pediatric Oncology Group of Ontario","keywords":"Metoclopramide; Medicine; Adverse effect; Nausea; Vomiting; Sedation; Prospective cohort study; Antiemetic; Respiratory distress; Tardive dyskinesia; Anesthesia; Pediatrics; Internal medicine; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.038060485857638576,"score_gpt":0.3402356136317886,"score_spread":0.30217512777415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2311333448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056000114,0.99362284,0.00021001998,0.000084156614,0.000079028345,0.00009646138,0.00017110136,0.000008129555,0.00012836634],"genre_scores_gemma":[0.1313773,0.8654317,0.0014480174,0.0007972474,0.00018433439,0.0002319348,0.0002927865,0.000013155486,0.0002235845],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99539316,0.0014614532,0.0018889123,0.00051490887,0.000582433,0.00015913176],"domain_scores_gemma":[0.9892952,0.0071104085,0.002523938,0.00027374687,0.00064879394,0.0001479902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065252064,0.0019349644,0.012736593,0.0031135415,0.0004332844,0.0020431518,0.0015170657,0.0019664818,0.0028320772],"category_scores_gemma":[0.020945184,0.0011961694,0.020964397,0.0040960447,0.00066141627,0.0017016117,0.0012710036,0.0017801074,0.00019206572],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038330446,0.00006371507,0.005090173,0.5103594,0.45471892,0.00022352855,0.00014500787,0.00036330186,0.00040249914,0.00011511121,0.00059804687,0.024087278],"study_design_scores_gemma":[0.0010924819,0.0004270502,0.0053940206,0.023983864,0.9663323,0.00019344722,0.000080963444,0.00011188598,0.00016341377,0.00013663984,0.002048893,0.000035086086],"about_ca_topic_score_codex":0.0048122522,"about_ca_topic_score_gemma":0.015598124,"teacher_disagreement_score":0.012736593,"about_ca_system_score_codex":0.0016267528,"about_ca_system_score_gemma":0.0023519516,"threshold_uncertainty_score":0.034509003},"labels":[],"label_agreement":null},{"id":"W2316126040","doi":"10.2165/11641680-000000000-00000","title":"The Authorsʼ Reply","year":2012,"lang":"en","type":"article","venue":"Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine","score_opus":0.018875409388820145,"score_gpt":0.30654524364197866,"score_spread":0.2876698342531585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316126040","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029503327,0.0011107203,0.000071582945,0.9618505,0.03583956,0.0000080951095,0.00003904005,0.00002157033,0.000763826],"genre_scores_gemma":[0.002267536,0.000423268,0.00010611573,0.97466666,0.01987766,0.000020100992,0.000010392585,0.000015402973,0.002612798],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938013,0.0014151682,0.0007871873,0.0013913598,0.0017616168,0.00084333995],"domain_scores_gemma":[0.96985584,0.014396288,0.002807354,0.0013444191,0.008387201,0.003208794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065104566,0.00077324454,0.0022701954,0.0011886322,0.0048408085,0.005896016,0.0035536622,0.07011015,0.0091924425],"category_scores_gemma":[0.06700749,0.0013197723,0.0020609293,0.00088320486,0.0045704697,0.004424331,0.003776658,0.07811274,0.0068546114],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051352537,0.000017855646,0.0005914396,0.000059254842,0.000046557278,0.0008787193,0.00032626768,0.000036439273,0.00016882001,0.0024362768,0.9922867,0.0031003854],"study_design_scores_gemma":[0.00009424004,0.0000532727,0.001437852,0.00031705017,0.000089912464,0.0014288411,0.0010795837,0.00020069082,0.00049783755,0.006084505,0.9885678,0.00014835162],"about_ca_topic_score_codex":0.0062856358,"about_ca_topic_score_gemma":0.007502247,"teacher_disagreement_score":0.07011015,"about_ca_system_score_codex":0.0039619557,"about_ca_system_score_gemma":0.006981608,"threshold_uncertainty_score":0.03443098},"labels":[],"label_agreement":null},{"id":"W236522014","doi":"10.2165/00002018-200124080-00005","title":"Corticosteroid-Induced Osteoporosis","year":2001,"lang":"en","type":"review","venue":"Drug Safety","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Osteoporosis; Osteoblast; Calcitonin; Osteocyte; Corticosteroid; Intensive care medicine; Internal medicine","score_opus":0.07762810963410435,"score_gpt":0.39528485687716947,"score_spread":0.31765674724306514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W236522014","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009335083,0.9979674,0.00008798903,0.0001860906,0.00028106535,0.000013197053,0.000036956353,0.000008038565,0.0013258399],"genre_scores_gemma":[0.0008073611,0.99693763,0.00016222158,0.00044826497,0.0003393988,0.000012195614,0.000055367775,0.0000012425072,0.0012362619],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951696,0.00008385304,0.00010987976,0.00006431505,0.0001894206,0.000035620993],"domain_scores_gemma":[0.9992435,0.0003068215,0.00023291846,0.000027424658,0.00014369453,0.000045688084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064751453,0.0013896875,0.0029085958,0.004516884,0.00037201404,0.0011066003,0.0009583667,0.0014022313,0.008466273],"category_scores_gemma":[0.001446071,0.0004047849,0.00079800334,0.003863182,0.0005759123,0.001147166,0.0007466161,0.0016720709,0.0032220448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013802537,0.00009550613,0.00020375379,0.024474889,0.00016215492,0.00029132658,0.000029617218,0.0001259018,0.00074752595,0.0006450677,0.040316887,0.9327694],"study_design_scores_gemma":[0.00016957836,0.00031968186,0.002485742,0.010887562,0.00092530146,0.0039015485,0.000060714763,0.0001097209,0.0005930279,0.0010153556,0.9795051,0.00002679391],"about_ca_topic_score_codex":0.0025564753,"about_ca_topic_score_gemma":0.008865559,"teacher_disagreement_score":0.008466273,"about_ca_system_score_codex":0.0006874213,"about_ca_system_score_gemma":0.0015737587,"threshold_uncertainty_score":0.028322518},"labels":[],"label_agreement":null},{"id":"W2413974287","doi":"10.1007/s40264-016-0434-9","title":"Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale","year":2016,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Ontario HIV Treatment Network","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; Australian Government; National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute on Alcohol Abuse and Alcoholism; National Eye Institute; National Cancer Institute; Canadian Institutes of Health Research; National Institute on Minority Health and Health Disparities; U.S. President’s Emergency Plan for AIDS Relief; Centers for Disease Control and Prevention; Ministerie van Buitenlandse Zaken; National Center for Advancing Translational Sciences; Health Resources and Services Administration; Government of Alberta; Agency for Healthcare Research and Quality; National Institute of Mental Health; Mbarara University of Science and Technology; Vanderbilt University; United States Agency for International Development; National Institutes of Health; National Institute on Drug Abuse; Aids Fonds","keywords":"Pharmacovigilance; Medicine; Staffing; Documentation; Outreach; Medical emergency; Family medicine; Adverse effect; Environmental health; Nursing; Pharmacology; Economic growth","score_opus":0.2686755808106513,"score_gpt":0.491746583398983,"score_spread":0.22307100258833168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413974287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77011836,0.0032206613,0.15213917,0.004294203,0.00016921341,0.029922124,0.016449915,0.0010993945,0.022587033],"genre_scores_gemma":[0.83995277,0.001088346,0.1388533,0.00057694886,0.00007436842,0.013688528,0.0053241025,0.000057127367,0.0003844747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.747909,0.16951968,0.052129906,0.0060474067,0.021723647,0.0026703982],"domain_scores_gemma":[0.45926604,0.25125873,0.19830838,0.035020884,0.051043745,0.0051022326],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.20728838,0.0007077621,0.0007385398,0.0076836217,0.0010071784,0.003540358,0.0029151042,0.0007752111,0.0015981498],"category_scores_gemma":[0.300068,0.00058588356,0.0017672309,0.0068254126,0.0014203436,0.004121306,0.006393259,0.00089963106,0.0003826164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078060734,0.00028745696,0.84201634,0.003784696,0.00077522645,0.00025959776,0.008744993,0.0016428268,0.00080063083,0.0019790402,0.005168958,0.13375968],"study_design_scores_gemma":[0.00035915506,0.0040414254,0.90800494,0.004436807,0.0012111383,0.0017438313,0.019505147,0.012453115,0.004630049,0.003821146,0.039519843,0.0002734591],"about_ca_topic_score_codex":0.00274964,"about_ca_topic_score_gemma":0.0032224949,"teacher_disagreement_score":0.20728838,"about_ca_system_score_codex":0.0023031149,"about_ca_system_score_gemma":0.008893171,"threshold_uncertainty_score":0.97755456},"labels":[],"label_agreement":null},{"id":"W2470322485","doi":"10.2165/00002018-200831100-00127","title":"Antipsychotic Use and Myocardial Infarction in Demented Patients Treated with Cholinesterase Inhibitors","year":2008,"lang":"en","type":"article","venue":"Drug Safety","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cholinesterase; Antipsychotic; Myocardial infarction; Donepezil; Pharmacology; Internal medicine; Dementia; Cardiology; Psychiatry; Schizophrenia (object-oriented programming); Disease","score_opus":0.017373830953664546,"score_gpt":0.2411950564938622,"score_spread":0.22382122554019765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470322485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773395,0.0011844902,0.000024638759,0.000107366825,0.000013109804,0.000005480428,0.00018665717,0.000002875363,0.00074134144],"genre_scores_gemma":[0.9986444,0.00067238824,0.000036999238,0.00009937761,0.00004626114,0.000005782474,0.00024766635,0.0000013432575,0.00024572422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972755,0.0000690423,0.000052115807,0.000031390988,0.00006881799,0.000051157196],"domain_scores_gemma":[0.9983631,0.00039418443,0.0007796646,0.0000661208,0.000104868275,0.00029215516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039533107,0.00032642393,0.000673212,0.0008847324,0.00054006616,0.0008952249,0.00024967728,0.0008333626,0.0015249671],"category_scores_gemma":[0.0028659264,0.00035575352,0.00071565073,0.0010490353,0.00024072203,0.00051679194,0.00033107403,0.0009369325,0.00015830997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024985683,0.00013496877,0.99382037,0.000033906963,0.000293441,0.0005663008,0.00010596407,0.00004806891,0.0004152441,0.000027768727,0.00010075873,0.001954732],"study_design_scores_gemma":[0.00007601641,0.00034838315,0.9982741,0.00001178416,0.0001586456,0.0005834904,0.00015178762,0.00014458406,0.000062939274,0.00005017425,0.00013021796,0.00000799845],"about_ca_topic_score_codex":0.0053569432,"about_ca_topic_score_gemma":0.008204934,"teacher_disagreement_score":0.0053569432,"about_ca_system_score_codex":0.00044907845,"about_ca_system_score_gemma":0.00046855136,"threshold_uncertainty_score":0.010651529},"labels":[],"label_agreement":null},{"id":"W2470469847","doi":"10.2165/00002018-200831100-00126","title":"Cholinesterase Inhibitors in Demented Patients: Impact of Treatment Non-Persistence on Institutionalization or Death","year":2008,"lang":"en","type":"article","venue":"Drug Safety","topic":"Suicide and Self-Harm Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cholinesterase; Institutionalisation; Persistence (discontinuity); Rivastigmine; Donepezil; Dementia; Pharmacology; Internal medicine; Psychiatry; Disease","score_opus":0.05179874813569446,"score_gpt":0.3306507138887706,"score_spread":0.27885196575307614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470469847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883276,0.0007289348,0.000009595876,0.00004393608,0.0000047169783,0.0000068911027,0.00003684416,6.2648445e-7,0.00033566222],"genre_scores_gemma":[0.99943525,0.00024728,0.000017102606,0.00005188706,0.000015485111,0.000004204918,0.00006353304,5.319239e-7,0.0001647023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897313,0.0005592815,0.00009281007,0.000085508065,0.00010388586,0.00018551051],"domain_scores_gemma":[0.99672973,0.0013697095,0.0008859049,0.00025242078,0.00015624212,0.00060598983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021042558,0.00027173146,0.00077636505,0.00060544297,0.00075193204,0.001094337,0.0004054526,0.000583435,0.0022280037],"category_scores_gemma":[0.0066525256,0.00019303712,0.00132872,0.000709549,0.00058673235,0.0010500207,0.000826273,0.0011427021,0.00012623517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037957884,0.0020665224,0.94102633,0.0001557739,0.0016518146,0.00020757248,0.00058194797,0.00009102186,0.00043547835,0.00015116319,0.0001683834,0.015506134],"study_design_scores_gemma":[0.0007962187,0.012618577,0.9834921,0.00004697016,0.0010162181,0.00019645756,0.0009985348,0.00015003585,0.00019913157,0.00016477553,0.00030060572,0.00002048996],"about_ca_topic_score_codex":0.0057803756,"about_ca_topic_score_gemma":0.009937774,"teacher_disagreement_score":0.0057803756,"about_ca_system_score_codex":0.0008744927,"about_ca_system_score_gemma":0.0012376651,"threshold_uncertainty_score":0.011493444},"labels":[],"label_agreement":null},{"id":"W2524719280","doi":"10.1007/s40264-016-0459-0","title":"Estimating Herbal Product Authentication and Adulteration in India Using a Vouchered, DNA-Based Biological Reference Material Library","year":2016,"lang":"en","type":"article","venue":"Drug Safety","topic":"Identification and Quantification in Food","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Medicine; Traditional medicine; Authentication (law); Product (mathematics); Computational biology; Computer security; Computer science","score_opus":0.023274745342271152,"score_gpt":0.2645399009370638,"score_spread":0.24126515559479267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524719280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963875,0.001130804,0.0253623,0.00023160598,0.000038639228,0.00011384331,0.0036421157,0.0008273771,0.004778248],"genre_scores_gemma":[0.9751521,0.000683289,0.017531496,0.00009789443,0.00000821955,0.00005058828,0.0035332248,0.00003922499,0.0029039204],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827266,0.00023827211,0.00012261736,0.0003346657,0.000892016,0.00013982283],"domain_scores_gemma":[0.99847835,0.00034037698,0.00036074317,0.00014836052,0.00062283414,0.000049272378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010493551,0.00039300194,0.00027806225,0.0028258723,0.00049828715,0.00093604595,0.0007230944,0.00055496447,0.00076667883],"category_scores_gemma":[0.0016810475,0.00029672022,0.00057058566,0.0019769329,0.0005287044,0.00042880155,0.00059112045,0.00042923447,0.0007462071],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010673734,0.00050709886,0.43662265,0.00078351016,0.00038139577,0.0004784327,0.000990605,0.010061348,0.31669557,0.0012765897,0.002075264,0.22906019],"study_design_scores_gemma":[0.000031228567,0.0007382418,0.5747293,0.00006392549,0.00049812463,0.0012661709,0.0010269756,0.019469697,0.39015573,0.00050121796,0.011419148,0.00010031239],"about_ca_topic_score_codex":0.023334177,"about_ca_topic_score_gemma":0.032545283,"teacher_disagreement_score":0.023334177,"about_ca_system_score_codex":0.001211895,"about_ca_system_score_gemma":0.0012743063,"threshold_uncertainty_score":0.046396732},"labels":[],"label_agreement":null},{"id":"W2541910387","doi":"10.1007/s40264-016-0457-2","title":"On Designs for Vaccine Surveillance","year":2016,"lang":"en","type":"letter","venue":"Drug Safety","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Postmarketing surveillance; Virology; Pharmacology; Adverse effect","score_opus":0.027064763381725126,"score_gpt":0.29807772043631503,"score_spread":0.2710129570545899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541910387","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006894929,0.000731832,0.0010928157,0.9750209,0.0044618826,0.000060116334,0.000057315992,0.000026421576,0.017859146],"genre_scores_gemma":[0.011149381,0.00043370342,0.0012746662,0.9691835,0.0064778375,0.00027816958,0.000023846203,0.00002082938,0.011158195],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9216166,0.046501882,0.003846554,0.0061593778,0.015389885,0.0064855264],"domain_scores_gemma":[0.81295586,0.15097363,0.0063030203,0.006978548,0.012332104,0.010456742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.079941586,0.0015474808,0.0018126242,0.002216319,0.009126086,0.013749787,0.004228864,0.1057485,0.021806905],"category_scores_gemma":[0.21234901,0.002007759,0.00229782,0.0010836145,0.021562897,0.0154635245,0.010850808,0.05654615,0.0066562574],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013117607,0.00013303687,0.0018038122,0.000121080746,0.000048979953,0.0004423563,0.000989738,0.00033752204,0.00028273134,0.1980392,0.77315336,0.024516974],"study_design_scores_gemma":[0.0006484035,0.00026830903,0.001984004,0.0011021881,0.00009454205,0.0004966331,0.001762514,0.0016766252,0.0006718657,0.34021977,0.6508989,0.00017626013],"about_ca_topic_score_codex":0.013837779,"about_ca_topic_score_gemma":0.027388098,"teacher_disagreement_score":0.1057485,"about_ca_system_score_codex":0.010742366,"about_ca_system_score_gemma":0.027202094,"threshold_uncertainty_score":0.42277658},"labels":[],"label_agreement":null},{"id":"W2553006099","doi":"10.1007/s40264-016-0479-9","title":"The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis","year":2016,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Meta-analysis; Pregnancy; Adverse effect; Outcome (game theory); Obstetrics; MEDLINE; Pharmacology; Internal medicine","score_opus":0.042258220417843724,"score_gpt":0.34492064373255543,"score_spread":0.3026624233147117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553006099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076490343,0.99139154,0.00024003515,0.00009046439,0.00010094362,0.00006931384,0.00027137104,0.000010257485,0.00017716308],"genre_scores_gemma":[0.19372997,0.8027875,0.0012889287,0.00085151277,0.00023521227,0.00022436235,0.00046681621,0.000016980159,0.00039883005],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99652916,0.0011279124,0.0012619413,0.00052974944,0.0003846975,0.00016661367],"domain_scores_gemma":[0.99043804,0.0068279007,0.0017759961,0.00030389536,0.00052709295,0.0001271335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049946886,0.0020570573,0.010028495,0.0030485494,0.00046333284,0.0021116934,0.0015505207,0.002444811,0.003429451],"category_scores_gemma":[0.01684651,0.0014050972,0.026221603,0.004016202,0.00054059766,0.0015267521,0.0013603767,0.0021047315,0.00026151774],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035098114,0.00005942767,0.0111053735,0.30870232,0.65827143,0.00031380565,0.00012546788,0.00039345634,0.00032160152,0.0001064638,0.0006193746,0.016471516],"study_design_scores_gemma":[0.00051232224,0.00021037096,0.0067394576,0.009890493,0.9808421,0.00016531712,0.000060442784,0.000111176814,0.000099031626,0.00012956464,0.0012100248,0.000029642271],"about_ca_topic_score_codex":0.005726165,"about_ca_topic_score_gemma":0.014920998,"teacher_disagreement_score":0.010028495,"about_ca_system_score_codex":0.0012546901,"about_ca_system_score_gemma":0.0018891374,"threshold_uncertainty_score":0.026414752},"labels":[],"label_agreement":null},{"id":"W2563313380","doi":"10.1007/s40264-016-0493-y","title":"Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases","year":2016,"lang":"en","type":"article","venue":"Drug Safety","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Medical prescription; Odds ratio; Confidence interval; Antibiotics; Database; Population; Logistic regression; Pharmacoepidemiology; Azithromycin; Internal medicine; Environmental health; Pharmacology","score_opus":0.07108173828415906,"score_gpt":0.3718132438122116,"score_spread":0.3007315055280525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563313380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982008,0.0004816542,0.00017485417,0.000040618284,0.0000034860795,0.000084220286,0.00085927953,0.000004216785,0.00015084904],"genre_scores_gemma":[0.9978294,0.00035928344,0.0005021907,0.000056961562,0.000016493703,0.00009536547,0.0010953347,0.000002850529,0.00004212152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99450004,0.0019064811,0.00087915047,0.0014195754,0.00094593014,0.00034876086],"domain_scores_gemma":[0.99034613,0.0029939404,0.0040750075,0.0011987204,0.00082238874,0.0005638289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032432447,0.0003398881,0.0011478034,0.0020324364,0.000981688,0.0014055416,0.00091278064,0.00090700336,0.0015501037],"category_scores_gemma":[0.011678846,0.00079745083,0.0009304636,0.004544621,0.00063604844,0.0008884616,0.00097458594,0.0009045286,0.00022935314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027093745,0.00012734105,0.9974195,0.00010452914,0.0002539282,0.00039948837,0.0002970724,0.000022074195,0.00014189929,0.000024383487,0.00017398916,0.00076490216],"study_design_scores_gemma":[0.000088791,0.00022424836,0.997134,0.000034826415,0.00022413055,0.0013076719,0.00038337856,0.00024154365,0.000062179126,0.000017675715,0.00027317103,0.000008447892],"about_ca_topic_score_codex":0.015772913,"about_ca_topic_score_gemma":0.01577694,"teacher_disagreement_score":0.015772913,"about_ca_system_score_codex":0.0009347844,"about_ca_system_score_gemma":0.00087015185,"threshold_uncertainty_score":0.031362176},"labels":[],"label_agreement":null},{"id":"W2595056566","doi":"10.1007/s40264-017-0521-6","title":"Medicines Save, Medicines Kill","year":2017,"lang":"en","type":"letter","venue":"Drug Safety","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Traditional medicine; Pharmacology","score_opus":0.35360715477038684,"score_gpt":0.5458071683789217,"score_spread":0.1922000136085349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595056566","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017281988,0.0009164479,0.00007157547,0.9828987,0.008450857,0.00000894757,0.000021882834,0.000026458441,0.0074322815],"genre_scores_gemma":[0.00083499355,0.0003105364,0.00006660515,0.9814031,0.0076266346,0.000011160332,0.000008093555,0.000011929386,0.009726913],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99382097,0.0011763847,0.00053055387,0.0008950339,0.0023452595,0.0012318252],"domain_scores_gemma":[0.99015534,0.0037746024,0.00076034927,0.0003790957,0.001601501,0.0033291045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004653884,0.001159163,0.0014182162,0.0009847522,0.010679934,0.010994277,0.0024432102,0.106959976,0.022307942],"category_scores_gemma":[0.02838132,0.001149358,0.0017384423,0.0007582707,0.008229401,0.009081874,0.005470958,0.094498016,0.015107757],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025081132,0.00004305881,0.0003817214,0.000030245888,0.000012361004,0.00051958853,0.00017349706,0.000038963844,0.00012389677,0.008814787,0.98353136,0.0063053663],"study_design_scores_gemma":[0.00005456431,0.00004656112,0.00053974026,0.00019890029,0.00001599835,0.00047210217,0.00058907486,0.00018293661,0.0001079393,0.0138016185,0.98393905,0.000051416173],"about_ca_topic_score_codex":0.020335522,"about_ca_topic_score_gemma":0.047726914,"teacher_disagreement_score":0.106959976,"about_ca_system_score_codex":0.007672225,"about_ca_system_score_gemma":0.014091464,"threshold_uncertainty_score":0.07462746},"labels":[],"label_agreement":null},{"id":"W2600910988","doi":"10.2165/00002018-200831100-00128","title":"Case Series in Drug Safety Surveillance: Are they Useful as a Risk Management Tool?","year":2008,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Drug; Series (stratigraphy); Intensive care medicine; Pharmacology","score_opus":0.05273912787287435,"score_gpt":0.36304461591476417,"score_spread":0.31030548804188984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600910988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7131932,0.044633042,0.03230467,0.05002614,0.010168575,0.0013532097,0.0012872372,0.0017757614,0.14525832],"genre_scores_gemma":[0.95856494,0.008683125,0.01252271,0.005625715,0.0114624845,0.0002908048,0.00043602634,0.00013082723,0.0022833957],"study_design_codex":"case_report","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99454826,0.0021452983,0.0011446152,0.000537563,0.0009746814,0.00064965343],"domain_scores_gemma":[0.9513332,0.028877089,0.00866244,0.0029605886,0.0034268084,0.0047398],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0040070494,0.0027314564,0.0013686422,0.007842995,0.0021933517,0.0036314395,0.002518399,0.011459626,0.006349298],"category_scores_gemma":[0.07381386,0.0013846087,0.0014424428,0.0029931078,0.0025068256,0.010390598,0.0023182959,0.0055238632,0.0036093537],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020610797,0.0002797463,0.1348193,0.00034521433,0.000049210466,0.8246621,0.0010295365,0.00063116965,0.0007153286,0.0021238434,0.009844778,0.025293613],"study_design_scores_gemma":[0.00003232423,0.00009763289,0.006798314,0.00034528473,0.00005126549,0.9840475,0.00098274,0.0014492588,0.0006377103,0.0014072141,0.0041044788,0.00004637161],"about_ca_topic_score_codex":0.0010127462,"about_ca_topic_score_gemma":0.0010601185,"teacher_disagreement_score":0.99599296,"about_ca_system_score_codex":0.0011465357,"about_ca_system_score_gemma":0.0012592534,"threshold_uncertainty_score":0.021240532},"labels":[],"label_agreement":null},{"id":"W2604260813","doi":"10.1007/s40264-017-0527-0","title":"Species Adulteration in the Herbal Trade: Causes, Consequences and Mitigation","year":2017,"lang":"en","type":"review","venue":"Drug Safety","topic":"Ethnobotanical and Medicinal Plants Studies","field":"Agricultural and Biological Sciences","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Medicine; Traditional medicine; Medicinal plants; International trade; Biotechnology; Business; Biology","score_opus":0.10831003451766838,"score_gpt":0.3276840447903514,"score_spread":0.21937401027268302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604260813","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006485616,0.99822444,0.00006940064,0.00022325144,0.0000637643,0.000004102919,0.00004174131,0.000003294688,0.0007214588],"genre_scores_gemma":[0.0038057433,0.9955087,0.00014276004,0.00011176653,0.00007304846,0.0000028471884,0.000027842812,7.4822407e-7,0.0003266457],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978155,0.00003376137,0.00003397098,0.000047631827,0.00008181585,0.00002133541],"domain_scores_gemma":[0.99964917,0.00016369986,0.00010118985,0.000008917501,0.000057374302,0.000019694882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004985328,0.0006730234,0.0009509166,0.002255497,0.00029795276,0.0010803214,0.0006580885,0.0008830546,0.0037987153],"category_scores_gemma":[0.0006741311,0.0001745302,0.00062697264,0.0019055116,0.00045198508,0.0008827107,0.00063585903,0.0007061249,0.00049083424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012484599,0.00011077261,0.0019257054,0.035282407,0.0003085892,0.00030932168,0.00014117065,0.00022774607,0.0015266087,0.002433753,0.00618082,0.9514283],"study_design_scores_gemma":[0.000038241607,0.00030136466,0.016713671,0.022942435,0.001435849,0.003922375,0.001017098,0.00023034813,0.0022673334,0.0038562003,0.9472043,0.00007074462],"about_ca_topic_score_codex":0.0021807638,"about_ca_topic_score_gemma":0.006360626,"teacher_disagreement_score":0.0037987153,"about_ca_system_score_codex":0.0003521226,"about_ca_system_score_gemma":0.0013059382,"threshold_uncertainty_score":0.012708008},"labels":[],"label_agreement":null},{"id":"W2604280648","doi":"10.1007/s40264-017-0525-2","title":"Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters","year":2017,"lang":"en","type":"article","venue":"Drug Safety","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Drospirenone; Medicine; Levonorgestrel; Hazard ratio; Cohort study; Pill; Proportional hazards model; Cohort; Pharmacoepidemiology; Population; Gynecology; Medical prescription; Obstetrics; Internal medicine; Confidence interval; Family planning; Environmental health; Pharmacology","score_opus":0.011834470120544859,"score_gpt":0.3160396488662389,"score_spread":0.3042051787456941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604280648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458474,0.0037189603,0.0001472707,0.000046464866,0.000007071191,0.000025469097,0.0002818644,0.0000046707287,0.0011835507],"genre_scores_gemma":[0.99830365,0.0009529922,0.00021672623,0.000022784596,0.000020074573,0.000008289367,0.00016342747,0.0000017418193,0.00031019736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991886,0.00030639995,0.000106636166,0.000060962426,0.00027248604,0.00006486693],"domain_scores_gemma":[0.99760014,0.0010878904,0.0007754238,0.00014381572,0.00017138157,0.00022136184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011325355,0.0004669974,0.0005667336,0.001826794,0.00036545674,0.0008597177,0.00032380671,0.00073196186,0.0016598112],"category_scores_gemma":[0.0036051872,0.00036523136,0.0014963262,0.0010956399,0.00032238394,0.00059782265,0.00048408157,0.00064289046,0.00020220134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021703767,0.00013689505,0.9895376,0.000056758166,0.0005326989,0.00011285578,0.00010968714,0.00009472211,0.00041517618,0.00007894978,0.00004044411,0.006713858],"study_design_scores_gemma":[0.000067843175,0.0013598042,0.9956168,0.00002955773,0.00052936916,0.00079195324,0.00021525117,0.00067131006,0.0002616502,0.00011798212,0.0003239504,0.000014601415],"about_ca_topic_score_codex":0.0019463226,"about_ca_topic_score_gemma":0.0030552591,"teacher_disagreement_score":0.0019463226,"about_ca_system_score_codex":0.0003168674,"about_ca_system_score_gemma":0.00025252695,"threshold_uncertainty_score":0.005989492},"labels":[],"label_agreement":null},{"id":"W2607175605","doi":"10.1007/s40264-017-0539-9","title":"Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study","year":2017,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Azithromycin; Digoxin; Erythromycin; Clarithromycin; Cefuroxime; Odds ratio; Internal medicine; Population; Sudden death; Macrolide Antibiotics; Relative risk; Confidence interval; Antibiotics; Heart failure","score_opus":0.013396318368599773,"score_gpt":0.29041003223629397,"score_spread":0.2770137138676942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607175605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897707,0.00031668463,0.000094902345,0.000026035375,0.0000083908635,0.000015101551,0.00024633924,0.0000033335577,0.0003122254],"genre_scores_gemma":[0.9991035,0.0001997655,0.000071944174,0.00005846868,0.000034137214,0.000018892424,0.00032035826,0.000003137054,0.0001897298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988778,0.00036568797,0.00011213912,0.0003171476,0.00018667399,0.0001404793],"domain_scores_gemma":[0.99817705,0.0003990328,0.00057214714,0.0002557134,0.00020313308,0.0003930083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012527525,0.00093535415,0.001016276,0.001301636,0.0009698221,0.0015162403,0.00064831297,0.0019602168,0.0024419553],"category_scores_gemma":[0.0025082235,0.0012431127,0.0022192819,0.0020961931,0.00092669204,0.0015355343,0.00076999963,0.0017051356,0.00050297636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035082386,0.00053310423,0.9919911,0.000036914356,0.0016116443,0.00023528875,0.0001765264,0.00009517619,0.00056241313,0.000031116713,0.00013104048,0.0010874975],"study_design_scores_gemma":[0.00038198644,0.0019712392,0.995063,0.000011075618,0.0009679102,0.0004900244,0.0003831585,0.00036026383,0.00006691784,0.000059622373,0.00021338463,0.00003140944],"about_ca_topic_score_codex":0.0055305446,"about_ca_topic_score_gemma":0.005724528,"teacher_disagreement_score":0.0055305446,"about_ca_system_score_codex":0.00063911744,"about_ca_system_score_gemma":0.0004827798,"threshold_uncertainty_score":0.010996699},"labels":[],"label_agreement":null},{"id":"W2621276102","doi":"10.1007/s40264-017-0549-7","title":"Using Simulated Data to Assess Case-Crossover Designs for Studying Less Transient Effects of Drugs","year":2017,"lang":"en","type":"letter","venue":"Drug Safety","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Transient (computer programming); Crossover study; Crossover; Pharmacology; Intensive care medicine; Artificial intelligence; Alternative medicine; Pathology","score_opus":0.8589573799309084,"score_gpt":0.6137502789181453,"score_spread":0.2452071010127631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621276102","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039520595,0.006615456,0.9029784,0.03703796,0.005053809,0.0036121595,0.00088577956,0.00075504783,0.0035408179],"genre_scores_gemma":[0.44825843,0.003427943,0.5015977,0.031052958,0.0044368496,0.008854159,0.00065609947,0.00022314157,0.0014926923],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.62824893,0.35309422,0.0071936063,0.0043125204,0.0067205015,0.00043019326],"domain_scores_gemma":[0.13845958,0.81802857,0.012911837,0.024403617,0.0054392624,0.0007571542],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.31007096,0.0012318856,0.0029622344,0.001994183,0.00065914175,0.0028761907,0.0038614685,0.008915904,0.006568822],"category_scores_gemma":[0.6733311,0.00097458315,0.0031231216,0.0018426051,0.0045931987,0.004697077,0.0020553255,0.008738074,0.00086598145],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05763676,0.003374152,0.021342611,0.009153319,0.013339619,0.002318565,0.0023561176,0.06336616,0.0034481958,0.26112205,0.04675825,0.5157842],"study_design_scores_gemma":[0.02789083,0.017621769,0.008715739,0.0019453444,0.0027865984,0.0025724869,0.00035970498,0.2496573,0.0027116516,0.6529223,0.032520574,0.00029572358],"about_ca_topic_score_codex":0.0005009305,"about_ca_topic_score_gemma":0.00055402983,"teacher_disagreement_score":0.689929,"about_ca_system_score_codex":0.0017621315,"about_ca_system_score_gemma":0.0027532764,"threshold_uncertainty_score":0.85080534},"labels":[],"label_agreement":null},{"id":"W2623772785","doi":"10.1007/s40264-017-0543-0","title":"Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies","year":2017,"lang":"en","type":"review","venue":"Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Medicine; Olanzapine; Population; Metabolic syndrome; Quetiapine; Clozapine; Type 2 Diabetes Mellitus; Antipsychotic; Dyslipidemia; Risperidone; Adverse effect; Internal medicine; Diabetes mellitus; Psychiatry; Obesity; Schizophrenia (object-oriented programming); Endocrinology; Environmental health","score_opus":0.09374888659150309,"score_gpt":0.4216693101882836,"score_spread":0.3279204235967805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623772785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014325746,0.9978867,0.00008367141,0.00006919545,0.000034151646,0.000074108626,0.00032847308,0.0000032431299,0.00008784793],"genre_scores_gemma":[0.01807005,0.98076713,0.0004201891,0.00030564916,0.000043367556,0.00010651364,0.0002280695,0.0000024982094,0.000056484012],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964217,0.00080327166,0.0016655638,0.00043671622,0.00055506325,0.00011775094],"domain_scores_gemma":[0.9886262,0.0076733097,0.0027515877,0.00015950039,0.00065752235,0.00013184892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004604545,0.0016113396,0.007817342,0.0054704263,0.00040560547,0.0019948161,0.0014727475,0.0015148744,0.0038104553],"category_scores_gemma":[0.016262403,0.0008470962,0.010430513,0.008048801,0.00057788566,0.0016009429,0.0013353849,0.0011215305,0.00018781229],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066258584,0.000029816432,0.0032085245,0.90378094,0.05563904,0.0001681594,0.00015859638,0.00016108163,0.0002165844,0.00013620274,0.0011736044,0.034664836],"study_design_scores_gemma":[0.00090219383,0.00035008317,0.023154926,0.36647424,0.58901453,0.0010294154,0.00045147332,0.00015156853,0.00027265714,0.00056414196,0.017530814,0.00010396548],"about_ca_topic_score_codex":0.0064376756,"about_ca_topic_score_gemma":0.024400977,"teacher_disagreement_score":0.007817342,"about_ca_system_score_codex":0.0015198216,"about_ca_system_score_gemma":0.00426806,"threshold_uncertainty_score":0.024351478},"labels":[],"label_agreement":null},{"id":"W2626971118","doi":"10.1007/s40264-017-0552-z","title":"Lipophilic Statins and the Risk of Intracranial Hemorrhage Following Ischemic Stroke: A Population-Based Study","year":2017,"lang":"en","type":"article","venue":"Drug Safety","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Hospital; Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pravastatin; Odds ratio; Statin; Rosuvastatin; Atorvastatin; Stroke (engine); Internal medicine; Intracerebral hemorrhage; Population; Confidence interval; Subarachnoid hemorrhage; Cholesterol","score_opus":0.007320156132173619,"score_gpt":0.2591175840512058,"score_spread":0.25179742791903215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626971118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99903786,0.00028654878,0.000093556984,0.000031994747,0.000008266179,0.000016515316,0.00018500997,0.000004042415,0.00033628262],"genre_scores_gemma":[0.9992003,0.000186911,0.00007737326,0.000054654192,0.000034348814,0.000016677412,0.00023271481,0.000002943348,0.0001941655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991755,0.00025442327,0.000099367135,0.0002090156,0.00014190747,0.00011979702],"domain_scores_gemma":[0.99857414,0.00026983104,0.00049865927,0.00020548895,0.00015546217,0.00029643535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011363936,0.00082768913,0.0010184048,0.0011115278,0.001043905,0.0015576688,0.000575331,0.0020649119,0.0018599275],"category_scores_gemma":[0.0020037014,0.0013097273,0.0019604613,0.0022443838,0.000836356,0.001402694,0.0006811909,0.0017900451,0.00054197287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003867236,0.0007450064,0.99135745,0.000033174558,0.0013890194,0.00024747502,0.00020172642,0.00008413532,0.00077072537,0.000040187337,0.000128657,0.0011350812],"study_design_scores_gemma":[0.0003500426,0.0014005469,0.9956493,0.000011123109,0.0008878631,0.00044014555,0.00042201436,0.00042174562,0.00009246951,0.0000843807,0.00020831652,0.000031987463],"about_ca_topic_score_codex":0.0060795415,"about_ca_topic_score_gemma":0.0059212176,"teacher_disagreement_score":0.0060795415,"about_ca_system_score_codex":0.00058095873,"about_ca_system_score_gemma":0.0005308725,"threshold_uncertainty_score":0.012088358},"labels":[],"label_agreement":null},{"id":"W264015876","doi":"10.2165/11316620-000000000-00000","title":"Public Perceptions of the Pharmaceutical Industry and Drug Safety","year":2009,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Medicine; Family medicine; Medical prescription; Pharmaceutical industry; Public health; Patient safety; Alternative medicine; Questionnaire; Health care; Pharmacology; Nursing","score_opus":0.06901833424340867,"score_gpt":0.3740612636135453,"score_spread":0.30504292937013666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W264015876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66785204,0.009647948,0.0009075404,0.23826003,0.00044727037,0.000028188535,0.00016006823,0.000017930595,0.08267893],"genre_scores_gemma":[0.9928012,0.0015064059,0.000076648095,0.004565199,0.0002950411,0.000003553733,0.00002211515,0.0000025585596,0.00072737224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9841824,0.00917134,0.0007274803,0.00042339042,0.004247521,0.0012478832],"domain_scores_gemma":[0.867089,0.086483784,0.026037915,0.0019779787,0.009872781,0.008538621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016460432,0.00016937764,0.00026916742,0.0027531544,0.0022930794,0.005527899,0.00037841868,0.0034217366,0.006460572],"category_scores_gemma":[0.04697779,0.000231504,0.00041291697,0.0013201998,0.0055306936,0.003770173,0.0032725486,0.0041255257,0.00028498544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013690253,0.0009431291,0.64176536,0.0010176746,0.0003179155,0.0022580184,0.07872022,0.0011191672,0.0034513006,0.108407654,0.033984024,0.12664653],"study_design_scores_gemma":[0.00020179011,0.0011303489,0.5854939,0.002003808,0.00024024975,0.002688456,0.18269576,0.0015958893,0.0029680526,0.05055913,0.17023204,0.00019050931],"about_ca_topic_score_codex":0.004213855,"about_ca_topic_score_gemma":0.0049115545,"teacher_disagreement_score":0.016460432,"about_ca_system_score_codex":0.0036013026,"about_ca_system_score_gemma":0.003548489,"threshold_uncertainty_score":0.08705211},"labels":[],"label_agreement":null},{"id":"W2724666143","doi":"10.1007/s40264-017-0555-9","title":"Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance","year":2017,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research; Pfizer Canada","keywords":"Pharmacovigilance; Medicine; Parametric statistics; Hazard; Postmarketing surveillance; Data mining; Parametric model; Computer science; Adverse effect; Statistics; Pharmacology","score_opus":0.12619630181361044,"score_gpt":0.43792640679558714,"score_spread":0.31173010498197673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724666143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74982584,0.00093475013,0.24128483,0.0023010985,0.00018892929,0.00019710149,0.0012441401,0.001751679,0.0022715633],"genre_scores_gemma":[0.9778511,0.0000956134,0.020874485,0.00016429764,0.00005137015,0.00004162605,0.0003855904,0.00003446908,0.0005015157],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99612314,0.0023325644,0.00027024283,0.00078370643,0.00026603256,0.0002242799],"domain_scores_gemma":[0.94818085,0.04460711,0.0033766292,0.0017511217,0.0013729043,0.0007114279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009399913,0.0014818043,0.0019349903,0.0011212272,0.0005511816,0.0022141743,0.0016087987,0.0020341228,0.0018139473],"category_scores_gemma":[0.03864748,0.0010766422,0.0015210499,0.00075685757,0.00043989118,0.0021187458,0.0010650129,0.0018983561,0.00025188996],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089418836,0.00027406335,0.021705432,0.00006693499,0.00028418697,0.000109369554,0.00006438831,0.9579095,0.00055012247,0.00073688384,0.0005591583,0.016845826],"study_design_scores_gemma":[0.000042459145,0.00010641389,0.0010403638,0.00000586641,0.000054191532,0.000031410258,0.000009296622,0.9979107,0.00022861685,0.00046893946,0.00009163526,0.000010058277],"about_ca_topic_score_codex":0.029426651,"about_ca_topic_score_gemma":0.017209591,"teacher_disagreement_score":0.029426651,"about_ca_system_score_codex":0.0015923247,"about_ca_system_score_gemma":0.003154807,"threshold_uncertainty_score":0.05851078},"labels":[],"label_agreement":null},{"id":"W2739188514","doi":"10.1007/s40264-017-0573-7","title":"The Fetal Safety of Enoxaparin Use During Pregnancy: A Population-Based Retrospective Cohort Study","year":2017,"lang":"en","type":"article","venue":"Drug Safety","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Clalit Health Services","keywords":"Medicine; Retrospective cohort study; Pregnancy; Obstetrics; Cohort study; Population; Surgery; Internal medicine; Environmental health","score_opus":0.019365162710496833,"score_gpt":0.27978036177992827,"score_spread":0.26041519906943145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739188514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986578,0.00036125872,0.00018771425,0.000029371151,0.000005514766,0.000010768553,0.00041819093,0.0000033132821,0.0003258998],"genre_scores_gemma":[0.9992161,0.00019893967,0.00010253983,0.000030112978,0.000007967374,0.000009982153,0.00030161423,0.0000031350564,0.00012961334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991412,0.00023610736,0.00010831991,0.0002794581,0.000124384,0.00011059377],"domain_scores_gemma":[0.9981133,0.00036194175,0.000755055,0.00039760035,0.00017255619,0.00019954353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089718425,0.00039881296,0.0005215473,0.0008714458,0.00060087873,0.0008773776,0.00041357425,0.0007550724,0.0013154799],"category_scores_gemma":[0.0026655002,0.0006468435,0.00096107146,0.0013920479,0.000397457,0.0007575488,0.0005330495,0.00094600563,0.00028325585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023575692,0.00004546317,0.9979352,0.000010824401,0.00022398721,0.00020047337,0.00011168712,0.000025855536,0.00034414558,0.000033402226,0.0000613992,0.0007718614],"study_design_scores_gemma":[0.000024189158,0.0003233604,0.99726796,0.000010491195,0.00021807272,0.0012173651,0.00030145567,0.00019408058,0.0001240391,0.000042892283,0.00026468057,0.000011489449],"about_ca_topic_score_codex":0.00500402,"about_ca_topic_score_gemma":0.0034935775,"teacher_disagreement_score":0.00500402,"about_ca_system_score_codex":0.00039963232,"about_ca_system_score_gemma":0.0004311964,"threshold_uncertainty_score":0.009949803},"labels":[],"label_agreement":null},{"id":"W2766998204","doi":"10.1007/s40264-017-0608-0","title":"Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis","year":2017,"lang":"en","type":"article","venue":"Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Alberta","funders":"Canadian Dermatology Foundation; Dermatology Foundation","keywords":"Toxic epidermal necrolysis; Medicine; Symblepharon; Dermatology; Scars; Retrospective cohort study; Mucous membrane; Physical examination; Medical record; Cohort; Surgery; Internal medicine; Pathology","score_opus":0.01765732438249887,"score_gpt":0.28377262158396477,"score_spread":0.2661152972014659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766998204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856013,0.0003806842,0.00006559985,0.000061988634,0.00000809482,0.000007775743,0.00005384428,0.0000028472134,0.0008590706],"genre_scores_gemma":[0.9996964,0.00011343262,0.000015112296,0.000030912073,0.000010935838,0.0000015216079,0.00004788167,4.8119205e-7,0.00008330198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995921,0.00012504007,0.00005885316,0.000036876885,0.00009957044,0.00008743159],"domain_scores_gemma":[0.9984479,0.00027715886,0.0007879247,0.00007509186,0.00012220143,0.00028968457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033326668,0.00016454702,0.00024418018,0.00048130087,0.00032454505,0.00041585753,0.00012563259,0.00027577454,0.0013140216],"category_scores_gemma":[0.0024519197,0.00010434449,0.00033924743,0.00044715512,0.0001979823,0.00034751554,0.0003572663,0.0005312106,0.00011435899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023527436,0.00007441212,0.99145,0.000018329556,0.00006437019,0.0010946153,0.000118371434,0.000044518674,0.00030960166,0.000023153898,0.00015742893,0.0064098556],"study_design_scores_gemma":[0.0000080317295,0.00021379956,0.9962651,0.000010905144,0.000040896495,0.0026906298,0.00034566052,0.000111139794,0.00007376521,0.00004840986,0.00018740224,0.000004280379],"about_ca_topic_score_codex":0.0014131333,"about_ca_topic_score_gemma":0.0019596834,"teacher_disagreement_score":0.0014131333,"about_ca_system_score_codex":0.00020671674,"about_ca_system_score_gemma":0.00025197738,"threshold_uncertainty_score":0.0043958426},"labels":[],"label_agreement":null},{"id":"W2771274175","doi":"10.1007/s40264-017-0623-1","title":"Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials","year":2017,"lang":"en","type":"article","venue":"Drug Safety","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada; Neurocrine Biosciences","keywords":"Medicine; Tardive dyskinesia; Placebo; Blood pressure; Internal medicine; Adverse effect; Population; QT interval; Anesthesia; Cardiology; Schizophrenia (object-oriented programming); Psychiatry; Pathology","score_opus":0.11531125068650619,"score_gpt":0.35405425774228155,"score_spread":0.23874300705577536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771274175","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38733584,0.57312864,0.012021736,0.001296925,0.0018424778,0.012857239,0.007040313,0.0005863529,0.00389048],"genre_scores_gemma":[0.8984688,0.0785466,0.0070302174,0.0013805828,0.0007165529,0.0095085995,0.0033735111,0.00010959935,0.00086551724],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9791381,0.012569467,0.0037576454,0.0020148964,0.002058786,0.00046117062],"domain_scores_gemma":[0.9791484,0.010785941,0.006908554,0.0012395435,0.0014148401,0.00050283433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027042842,0.0025249429,0.010939113,0.0020985345,0.00053057197,0.0024678833,0.0011147971,0.002139672,0.0033000046],"category_scores_gemma":[0.029683996,0.0011787837,0.017456505,0.002318555,0.001063411,0.0016436981,0.00087933516,0.0018511676,0.00031963663],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48560005,0.000767662,0.006171524,0.039599616,0.42606533,0.00012860376,0.00010768944,0.0014561123,0.0028338076,0.00015163666,0.001325803,0.03579215],"study_design_scores_gemma":[0.4649869,0.035136055,0.032169174,0.0034634594,0.4564851,0.0003121875,0.00010934472,0.0015910421,0.0012814238,0.00075985707,0.0035581803,0.00014725536],"about_ca_topic_score_codex":0.00071256247,"about_ca_topic_score_gemma":0.0015497693,"teacher_disagreement_score":0.027042842,"about_ca_system_score_codex":0.0011422705,"about_ca_system_score_gemma":0.0014541702,"threshold_uncertainty_score":0.14301789},"labels":[],"label_agreement":null},{"id":"W2772269827","doi":"10.1007/s40264-017-0619-x","title":"The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products","year":2017,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Public Health Ontario","funders":"","keywords":"Medicine; Checklist; Quality (philosophy); Statement (logic)","score_opus":0.4569020067255501,"score_gpt":0.5970565743537308,"score_spread":0.14015456762818074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772269827","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.092981614,0.024184404,0.45653555,0.038957644,0.0045611616,0.308663,0.0432854,0.006534644,0.024296595],"genre_scores_gemma":[0.080840066,0.0071310042,0.6653404,0.0044767587,0.0005977117,0.22952028,0.0102311475,0.00034939588,0.0015132825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.50180393,0.26436615,0.19599636,0.0040191216,0.031484734,0.002329692],"domain_scores_gemma":[0.25005227,0.4336001,0.121260315,0.025631288,0.16436979,0.005086208],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.39791846,0.0034755294,0.004395814,0.017455386,0.0027719527,0.004531623,0.005781011,0.0036628158,0.005062959],"category_scores_gemma":[0.49253246,0.0024422829,0.008615853,0.008257087,0.0035009524,0.0066385213,0.008534137,0.0046732486,0.0019829103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034521879,0.0013707591,0.07673243,0.11393256,0.0044850744,0.00062788755,0.018719615,0.006372102,0.0053026285,0.012986174,0.18936068,0.56665796],"study_design_scores_gemma":[0.006232925,0.0071584918,0.19368131,0.148456,0.0052952664,0.0021396484,0.021078577,0.021001177,0.017913928,0.03394402,0.5405792,0.0025194993],"about_ca_topic_score_codex":0.0030129664,"about_ca_topic_score_gemma":0.0051061343,"teacher_disagreement_score":0.60208154,"about_ca_system_score_codex":0.0074655283,"about_ca_system_score_gemma":0.035093628,"threshold_uncertainty_score":0.7424737},"labels":[],"label_agreement":null},{"id":"W27817818","doi":"10.2165/00002018-200831080-00004","title":"Association Between Use of Acid-Suppressive Drugs and Risk of Gastric Cancer","year":2008,"lang":"en","type":"article","venue":"Drug Safety","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal; Hotel Dieu Hospital","funders":"","keywords":"Medicine; Cancer; Internal medicine; Pharmacology; Traditional medicine","score_opus":0.017169673804712262,"score_gpt":0.25340405183656,"score_spread":0.23623437803184774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W27817818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920582,0.005829884,0.00016283199,0.00011041431,0.000028677461,0.000010578863,0.0003946757,0.0000086672335,0.0013962163],"genre_scores_gemma":[0.99826163,0.0010395529,0.000098156714,0.000050327315,0.000037845708,0.000004353757,0.0002546671,0.0000028564152,0.00025059172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990552,0.00045517733,0.00014002535,0.00013271374,0.00013387932,0.000082921775],"domain_scores_gemma":[0.9902227,0.005258706,0.0024861654,0.00085266714,0.00058291614,0.0005968945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016950745,0.0003517763,0.000527055,0.000997551,0.0003537612,0.000671274,0.0003254585,0.00069864374,0.0022782972],"category_scores_gemma":[0.0063579134,0.00036872597,0.0016678205,0.0010936357,0.00034966605,0.000475468,0.00038086833,0.0011232209,0.00013779856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002327558,0.000086538304,0.9932005,0.000065507695,0.0015794507,0.00009547762,0.000035161655,0.000059980783,0.0006493747,0.000031263884,0.00006457677,0.0018047598],"study_design_scores_gemma":[0.000062182466,0.00079192995,0.99743396,0.000012794234,0.00070635456,0.00028006846,0.000051180104,0.00016114807,0.0002025688,0.000038039198,0.00025415307,0.0000057124043],"about_ca_topic_score_codex":0.0027852552,"about_ca_topic_score_gemma":0.0020617514,"teacher_disagreement_score":0.0027852552,"about_ca_system_score_codex":0.00020042543,"about_ca_system_score_gemma":0.00030839627,"threshold_uncertainty_score":0.008964539},"labels":[],"label_agreement":null},{"id":"W2793980226","doi":"10.1007/s40264-018-0644-4","title":"The Risk for Lung Cancer Incidence with Calcium Channel Blockers: A Systematic Review and Meta-Analysis of Observational Studies","year":2018,"lang":"en","type":"review","venue":"Drug Safety","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Israel Cancer Association","keywords":"Medicine; Lung cancer; Meta-analysis; Internal medicine; Observational study; Relative risk; Confidence interval; Cohort study; Cancer; Subgroup analysis; Incidence (geometry); Oncology","score_opus":0.2627477557788937,"score_gpt":0.4297893718404371,"score_spread":0.16704161606154339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793980226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006392579,0.99232316,0.00043722504,0.00009947485,0.000085540974,0.000059433944,0.0004680315,0.000012964993,0.00012161349],"genre_scores_gemma":[0.1857254,0.8098647,0.0019463896,0.000827111,0.00026585985,0.00019254185,0.0009201677,0.000025551095,0.0002323074],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945716,0.0017818084,0.0020474428,0.0008721172,0.0005329264,0.00019404727],"domain_scores_gemma":[0.98575354,0.010766393,0.0020955799,0.0005649229,0.0006894832,0.00013011857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007128725,0.0020672479,0.01114487,0.003522163,0.00045664443,0.002098871,0.0016915922,0.0021203565,0.0026126476],"category_scores_gemma":[0.020873675,0.0014484223,0.028647887,0.0050855516,0.0005800151,0.0015485339,0.0013927912,0.002074087,0.00023394616],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024163844,0.00003410143,0.014701125,0.25240108,0.71104825,0.00019523776,0.00009569905,0.0004944309,0.00039253038,0.00013176676,0.000712176,0.017377233],"study_design_scores_gemma":[0.00040745048,0.00014354347,0.009284995,0.0079612555,0.9799819,0.00016659021,0.000052730702,0.00012808459,0.00011964442,0.00021647706,0.001508906,0.00002838914],"about_ca_topic_score_codex":0.005003018,"about_ca_topic_score_gemma":0.011358066,"teacher_disagreement_score":0.01114487,"about_ca_system_score_codex":0.0010138177,"about_ca_system_score_gemma":0.0018787931,"threshold_uncertainty_score":0.037700772},"labels":[],"label_agreement":null},{"id":"W2802686170","doi":"10.1007/s40264-018-0673-z","title":"Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial","year":2018,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority; Toronto East General Hospital; Fraser Institute; Canadian Institute for Health Information","funders":"","keywords":"Medicine; Health care; Data science; Database; Risk analysis (engineering); Computer science","score_opus":0.8280292550423739,"score_gpt":0.6473527646731293,"score_spread":0.1806764903692446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802686170","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009012161,0.9605697,0.0050015757,0.02030914,0.0014790144,0.0004463456,0.007127932,0.000099968805,0.0040650987],"genre_scores_gemma":[0.026282277,0.91325045,0.02315853,0.020687679,0.002434923,0.0015370441,0.011849588,0.00009191928,0.0007075965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8850282,0.05226915,0.031404532,0.005681876,0.024490101,0.0011260951],"domain_scores_gemma":[0.38145033,0.5010657,0.04082202,0.02843919,0.045464616,0.002758205],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1020136,0.0013420557,0.006782132,0.020415982,0.0013793607,0.008680872,0.007082291,0.0046446207,0.009485776],"category_scores_gemma":[0.35285598,0.0013432378,0.0044306405,0.019989219,0.0039249836,0.010178551,0.005571877,0.0060173324,0.0024093792],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000260527,0.00016139199,0.0074703842,0.20459826,0.0058515277,0.00019910348,0.0007083007,0.0005879586,0.0002014057,0.040003058,0.06699381,0.6729643],"study_design_scores_gemma":[0.00021054634,0.00011048365,0.009635484,0.32308748,0.0076689753,0.0005572757,0.0011530186,0.0006928256,0.0005058966,0.044260535,0.6119798,0.00013760249],"about_ca_topic_score_codex":0.006536245,"about_ca_topic_score_gemma":0.00794529,"teacher_disagreement_score":0.8979864,"about_ca_system_score_codex":0.00478277,"about_ca_system_score_gemma":0.03141088,"threshold_uncertainty_score":0.53950596},"labels":[],"label_agreement":null},{"id":"W2804988876","doi":"10.1007/s40264-018-0687-6","title":"Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit","year":2018,"lang":"en","type":"review","venue":"Drug Safety","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"Australian Government","keywords":"Medicine; Culprit; Medical prescription; Opioid; Medical emergency; Traditional medicine; Psychiatry; Pharmacology; Internal medicine","score_opus":0.08135583628018622,"score_gpt":0.34718305880423833,"score_spread":0.2658272225240521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804988876","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022339818,0.9981901,0.000035016677,0.00088564656,0.00010668342,0.0000045084953,0.000027766513,0.0000016535698,0.00052515574],"genre_scores_gemma":[0.0024248546,0.9964619,0.00013498747,0.00063609215,0.000114698276,0.0000045018664,0.000024361565,8.3567323e-7,0.00019778869],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994073,0.00016385232,0.00011724962,0.00008290845,0.0001772305,0.00005139691],"domain_scores_gemma":[0.9973769,0.0017378633,0.00043318034,0.000029845522,0.0003579221,0.00006431066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015075031,0.0005384214,0.0013150985,0.0022384652,0.00053119945,0.0015745005,0.0010692099,0.0020483346,0.0054224827],"category_scores_gemma":[0.0046342094,0.00030277704,0.0011541508,0.0019196696,0.00064901775,0.0015829568,0.00075973396,0.0016261161,0.0005722108],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014629068,0.00011335321,0.0033560428,0.093172625,0.00088499545,0.00041354875,0.00040491196,0.00026178808,0.00030402432,0.007420545,0.032232776,0.861289],"study_design_scores_gemma":[0.000092316244,0.00017405122,0.010848604,0.18336925,0.0032347336,0.0030656105,0.0021332006,0.00036802219,0.00040635772,0.0074045737,0.7888175,0.00008580892],"about_ca_topic_score_codex":0.0069366735,"about_ca_topic_score_gemma":0.024746228,"teacher_disagreement_score":0.0069366735,"about_ca_system_score_codex":0.0010614141,"about_ca_system_score_gemma":0.0038950096,"threshold_uncertainty_score":0.018139958},"labels":[],"label_agreement":null},{"id":"W2887322021","doi":"10.1007/s40264-018-0713-8","title":"The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database","year":2018,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Inro Consultants (Canada); Université de Montréal","funders":"","keywords":"Medicine; Vigilance (psychology); Seriousness; MedDRA; Pharmacovigilance; Database; Drug reaction; Social media; Descriptive statistics; Adverse drug reaction; Adverse effect; Family medicine; Drug; Pharmacology; Psychology","score_opus":0.05427527113949559,"score_gpt":0.4369644921105809,"score_spread":0.3826892209710853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887322021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90291536,0.0029592027,0.0004640587,0.0020369845,0.000029945615,0.00029690415,0.08645079,0.00005742021,0.004789471],"genre_scores_gemma":[0.9651742,0.0015515175,0.0005963042,0.0005114069,0.000026757833,0.000086576896,0.03121284,0.000022245136,0.0008181699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9892502,0.0017744921,0.00147762,0.0009062666,0.005780409,0.0008109819],"domain_scores_gemma":[0.9345995,0.017167484,0.02318408,0.0021163106,0.019800447,0.003132215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004694171,0.00036177092,0.0006029535,0.0059930137,0.001166943,0.0019839061,0.0019518343,0.0007425291,0.0013778375],"category_scores_gemma":[0.039046664,0.00037227658,0.00095998426,0.014609126,0.0005730696,0.00070039165,0.0013731597,0.0009393534,0.00018502415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015390644,0.000032718825,0.9907114,0.00010932591,0.00022835859,0.00011914799,0.00033939353,0.00030200765,0.0000591346,0.00018228259,0.0037750278,0.003987393],"study_design_scores_gemma":[0.000011845099,0.000021943046,0.9959638,0.000054764285,0.00009152349,0.000088773966,0.00040474033,0.0012755021,0.00005958161,0.00002531151,0.0019872643,0.000014957509],"about_ca_topic_score_codex":0.96155936,"about_ca_topic_score_gemma":0.95767057,"teacher_disagreement_score":0.038440645,"about_ca_system_score_codex":0.019936707,"about_ca_system_score_gemma":0.035321698,"threshold_uncertainty_score":0.14465165},"labels":[],"label_agreement":null},{"id":"W2911723829","doi":"10.1007/s40264-019-00797-3","title":"Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs","year":2019,"lang":"en","type":"article","venue":"Drug Safety","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Research and Development","keywords":"Medicine; Ustekinumab; Psoriatic arthritis; Psoriasis; Placebo; Internal medicine; Psoriasis Area and Severity Index; Methotrexate; Dermatology; Dosing; Gastroenterology; Adalimumab; Disease; Pathology","score_opus":0.018424278042091787,"score_gpt":0.31979427991632076,"score_spread":0.30137000187422897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911723829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960697,0.025189,0.0066220667,0.0004816151,0.000042146294,0.0018493235,0.0023732074,0.000119757606,0.002625903],"genre_scores_gemma":[0.98931926,0.0033107558,0.0030074394,0.0002780664,0.00007427989,0.0006369855,0.0030162372,0.00002970959,0.0003273119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9626808,0.02868964,0.0018299298,0.0013225428,0.004682049,0.0007949898],"domain_scores_gemma":[0.9461976,0.023984352,0.020819454,0.0036248288,0.0037992245,0.0015745042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.055133518,0.0006549041,0.0018533145,0.0018958965,0.00027262964,0.0019197911,0.00072772853,0.00057574763,0.0015234721],"category_scores_gemma":[0.03286437,0.0004075226,0.003827735,0.0024652798,0.00061944564,0.0010478721,0.0011036604,0.000878717,0.00019068384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10158577,0.0032151095,0.5137351,0.0023234102,0.02271726,0.00006341675,0.0003402302,0.009594641,0.005474181,0.0006577705,0.0018186333,0.33847442],"study_design_scores_gemma":[0.014178566,0.07241026,0.86064845,0.0007554196,0.022606552,0.00030024056,0.00022168094,0.0134281255,0.0062821764,0.0011420286,0.007940722,0.000085778694],"about_ca_topic_score_codex":0.00063936843,"about_ca_topic_score_gemma":0.0011166591,"teacher_disagreement_score":0.055133518,"about_ca_system_score_codex":0.0010333537,"about_ca_system_score_gemma":0.0028414894,"threshold_uncertainty_score":0.2915774},"labels":[],"label_agreement":null},{"id":"W2920183853","doi":"10.1007/s40264-018-00783-1","title":"Benefit–Risk Assessment of Vedolizumab in the Treatment of Crohn’s Disease and Ulcerative Colitis","year":2019,"lang":"en","type":"review","venue":"Drug Safety","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; Western University; University of Calgary; Robarts Clinical Trials","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Natalizumab; Adverse effect; Internal medicine; Maintenance therapy; Inflammatory bowel disease; Infliximab; Crohn's disease; Placebo; Gastroenterology; Immunology; Disease; Pathology; Chemotherapy","score_opus":0.01567007994426291,"score_gpt":0.3114790885300934,"score_spread":0.2958090085858305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920183853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009739113,0.9989506,0.00013913619,0.000329839,0.0001163924,0.0000045825896,0.000024209852,0.000004089416,0.00033383782],"genre_scores_gemma":[0.0026872044,0.995355,0.00040380613,0.00072970905,0.00039132105,0.000015404474,0.000054952936,0.0000027323185,0.00035986435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99919647,0.00027431306,0.00013893729,0.00008741907,0.00026295858,0.00003995552],"domain_scores_gemma":[0.997551,0.0018068266,0.00031490298,0.000029489289,0.00023491493,0.00006286419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025528993,0.0008837289,0.003423807,0.0015459792,0.00016925736,0.0012145905,0.00130632,0.0014804904,0.003160578],"category_scores_gemma":[0.0039852727,0.000304996,0.0014157406,0.0012001994,0.00049350597,0.0009524839,0.00057973963,0.0026666436,0.0007189353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063191465,0.00006267585,0.0002771611,0.025435992,0.0010153082,0.00015592217,0.000026447668,0.0007716496,0.00059176725,0.0035199837,0.018993298,0.9485178],"study_design_scores_gemma":[0.0009926831,0.0009259816,0.00507818,0.03094844,0.0054807686,0.0024165297,0.000100873556,0.0011267428,0.00087061373,0.016424613,0.9355305,0.0001040646],"about_ca_topic_score_codex":0.0011502901,"about_ca_topic_score_gemma":0.00222769,"teacher_disagreement_score":0.003423807,"about_ca_system_score_codex":0.0009586238,"about_ca_system_score_gemma":0.0010156309,"threshold_uncertainty_score":0.013501167},"labels":[],"label_agreement":null},{"id":"W2924627121","doi":"10.1007/s40264-019-00806-5","title":"Drug-Induced Photosensitivity—An Update: Culprit Drugs, Prevention and Management","year":2019,"lang":"en","type":"review","venue":"Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Dermatology; Photosensitivity; Drug; Phototoxicity; Culprit; Adverse effect; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.04186466193036711,"score_gpt":0.3494087729031313,"score_spread":0.30754411097276424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924627121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007062817,0.99912995,0.000057082438,0.00014330652,0.00019780638,0.000004222268,0.000026567555,0.0000068505883,0.0003636083],"genre_scores_gemma":[0.0004632788,0.99844176,0.00015227073,0.0003069269,0.00031874166,0.000004009087,0.00004129143,0.0000011826623,0.0002704689],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997025,0.000049519633,0.00007679998,0.000043578566,0.00010568572,0.000021868462],"domain_scores_gemma":[0.99920493,0.00038641677,0.00017748719,0.000016122332,0.00015967063,0.000055464436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063242257,0.0009340664,0.0017301356,0.0027542084,0.00018109888,0.0011812026,0.0008351205,0.0010197175,0.0055253017],"category_scores_gemma":[0.0011779992,0.00029934853,0.00085823465,0.0022376264,0.00027373838,0.0011484502,0.00061415345,0.0015843804,0.0013882555],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011189404,0.00009223255,0.0002940221,0.029697545,0.00020582759,0.00018010977,0.000024439565,0.00032937236,0.00071067835,0.0006738912,0.047725387,0.9199547],"study_design_scores_gemma":[0.00013777099,0.00030488826,0.0025294742,0.016577326,0.0011456324,0.0027109967,0.000083961335,0.00042107777,0.00034998506,0.0013403932,0.9743497,0.000048801525],"about_ca_topic_score_codex":0.001467048,"about_ca_topic_score_gemma":0.0046763704,"teacher_disagreement_score":0.0055253017,"about_ca_system_score_codex":0.00045898484,"about_ca_system_score_gemma":0.0011077098,"threshold_uncertainty_score":0.018483937},"labels":[],"label_agreement":null},{"id":"W2943329807","doi":"10.1007/s40264-019-00818-1","title":"The 10th International Congress on Cutaneous Adverse Drug Reactions, Shimane, Japan, 2018: Focus on New Discoveries","year":2019,"lang":"en","type":"editorial","venue":"Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto; University of Alberta","funders":"University of British Columbia; Vanderbilt University Medical Center; National Taiwan University Hospital; Shimane University; University of Pennsylvania","keywords":"Medicine; Drug reaction; Drug; Pharmacology","score_opus":0.008721719475899004,"score_gpt":0.2728918747818489,"score_spread":0.2641701553059499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943329807","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030393574,0.017715666,0.000084852785,0.027654974,0.9530064,0.000024937017,0.00005297312,0.000045281842,0.0013845974],"genre_scores_gemma":[0.0003141955,0.012903402,0.00012227068,0.021654883,0.95865357,0.000032751945,0.0000511311,0.00002550072,0.0062423022],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99388325,0.0013077565,0.00086566206,0.00058313337,0.0029665714,0.0003936796],"domain_scores_gemma":[0.9814813,0.0058728997,0.0019929893,0.00046574092,0.0075149746,0.0026719614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009417841,0.0049349545,0.005892532,0.0051268702,0.0028474268,0.00855757,0.0036493626,0.019029899,0.013538727],"category_scores_gemma":[0.020031715,0.0012701954,0.003686222,0.0021390794,0.0021455195,0.0047762785,0.0024254657,0.023764974,0.010193835],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006130357,0.000021679694,0.000034983965,0.0004346666,0.000024882742,0.000086297696,0.0000073519577,0.000018702902,0.000050926326,0.000121753925,0.9912281,0.007909371],"study_design_scores_gemma":[0.00017543988,0.000065131906,0.00038915445,0.00100027,0.00015153691,0.00025828183,0.000044954497,0.0001442481,0.00009621429,0.000583727,0.9970682,0.000022978646],"about_ca_topic_score_codex":0.0018311938,"about_ca_topic_score_gemma":0.0068520084,"teacher_disagreement_score":0.019029899,"about_ca_system_score_codex":0.0041225194,"about_ca_system_score_gemma":0.0042365068,"threshold_uncertainty_score":0.049806952},"labels":[],"label_agreement":null},{"id":"W2948648533","doi":"10.1007/s40264-019-00842-1","title":"Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational Studies","year":2019,"lang":"en","type":"review","venue":"Drug Safety","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Rivaroxaban; Dabigatran; Apixaban; Internal medicine; Atrial fibrillation; Meta-analysis; Stroke (engine); Observational study; Randomized controlled trial; Hazard ratio; Confidence interval; Relative risk; Warfarin","score_opus":0.2772551427506746,"score_gpt":0.43611349619470335,"score_spread":0.15885835344402877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948648533","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011544721,0.9868869,0.0006242464,0.00009779673,0.00012834117,0.0001520064,0.00039940563,0.000016805729,0.00014975556],"genre_scores_gemma":[0.2641392,0.73018074,0.002889528,0.0007697288,0.00030827138,0.00046369262,0.0009973653,0.000027104503,0.0002243429],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98706704,0.0052695856,0.004778723,0.001306675,0.0012887431,0.00028925258],"domain_scores_gemma":[0.97093964,0.022212233,0.0045550484,0.0009481813,0.0011010483,0.00024386612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015035332,0.0024531574,0.017706899,0.0042246412,0.0005311787,0.0030680017,0.0020940336,0.0023486442,0.0021496345],"category_scores_gemma":[0.03762443,0.0015104142,0.03498555,0.0051996335,0.000851648,0.0018766078,0.0017075455,0.0022331572,0.0001865711],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025040812,0.000030626245,0.0074179973,0.15594745,0.82536215,0.00007380126,0.00006414276,0.00029350302,0.00016985598,0.00008207639,0.00022281011,0.00783147],"study_design_scores_gemma":[0.0006858914,0.00016259577,0.005010459,0.0064812466,0.98663366,0.00007619417,0.000038748043,0.000121497425,0.000078942874,0.00014670908,0.0005437163,0.000020318086],"about_ca_topic_score_codex":0.004145153,"about_ca_topic_score_gemma":0.009191757,"teacher_disagreement_score":0.017706899,"about_ca_system_score_codex":0.0016703018,"about_ca_system_score_gemma":0.0023316336,"threshold_uncertainty_score":0.0795154},"labels":[],"label_agreement":null},{"id":"W2954339342","doi":"10.1007/s40264-019-00847-w","title":"Androgen Deprivation Therapy for Prostate Cancer and the Risk of Rheumatoid Arthritis: A Population-Based Cohort Study","year":2019,"lang":"en","type":"article","venue":"Drug Safety","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Hazard ratio; Internal medicine; Proportional hazards model; Cohort; Cumulative incidence; Rheumatoid arthritis; Population; Cohort study; Confidence interval; Oncology; Cancer","score_opus":0.005774240790760942,"score_gpt":0.25004341123668905,"score_spread":0.2442691704459281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954339342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842346,0.0004388965,0.00011588121,0.000054151686,0.000014596345,0.0000137412935,0.0006090331,0.000006040501,0.00032410424],"genre_scores_gemma":[0.99906,0.00018373434,0.00007511124,0.00004324409,0.000021604863,0.000011086846,0.0003097658,0.000003837483,0.0002916501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992417,0.00018103591,0.00006689194,0.00024995135,0.000114971306,0.0001454588],"domain_scores_gemma":[0.9987023,0.00016871374,0.0004067605,0.00030718098,0.00013796659,0.00027697525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083532586,0.00057658233,0.000695643,0.0008408088,0.0009416631,0.0013345801,0.00065355765,0.001091645,0.002078992],"category_scores_gemma":[0.0015107603,0.0010332714,0.0018673287,0.0018433796,0.0004314725,0.00076743204,0.00058091,0.0016400606,0.00035798692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012531611,0.00022654343,0.994863,0.000014372187,0.0012226469,0.00017460453,0.00010235614,0.00006352916,0.00092834444,0.00003126563,0.0001801883,0.0009399887],"study_design_scores_gemma":[0.00011566107,0.00037103923,0.99789137,0.000005268774,0.00054533273,0.00033004215,0.00017147559,0.00024394988,0.00007129145,0.00003197577,0.00020832696,0.000014380977],"about_ca_topic_score_codex":0.015838545,"about_ca_topic_score_gemma":0.013159188,"teacher_disagreement_score":0.015838545,"about_ca_system_score_codex":0.00050748826,"about_ca_system_score_gemma":0.0006443451,"threshold_uncertainty_score":0.03149271},"labels":[],"label_agreement":null},{"id":"W2975162082","doi":"10.1007/s40264-019-00861-y","title":"Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports","year":2019,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Context (archaeology); Credibility; Adverse effect; Odds; Odds ratio; MedDRA; Database; Geography; Pharmacology; Logistic regression; Pathology","score_opus":0.10533322493989772,"score_gpt":0.44578388009204156,"score_spread":0.34045065515214384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975162082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95672303,0.00071179663,0.006516585,0.0003358101,0.000030283265,0.0005848235,0.03398202,0.000311892,0.0008036911],"genre_scores_gemma":[0.9251846,0.00021316521,0.016684344,0.00013868466,0.000025495983,0.0009919511,0.056449067,0.00007717506,0.00023563174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98364073,0.007258235,0.0033722252,0.0029661153,0.0023143913,0.00044832964],"domain_scores_gemma":[0.92813486,0.038841326,0.016937485,0.008253848,0.0068745245,0.0009579782],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.023691664,0.00043990795,0.0007466467,0.0034833597,0.00040204483,0.0014630549,0.0008131488,0.0004259451,0.0014378902],"category_scores_gemma":[0.080786854,0.00033698222,0.00175794,0.0035489276,0.0005103433,0.0010586991,0.0019073281,0.00079192605,0.0004140141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025212232,0.00012477198,0.9584153,0.0007181485,0.001159197,0.0002366291,0.0010663895,0.0036132715,0.0010629793,0.00037910137,0.004465296,0.026237596],"study_design_scores_gemma":[0.00031155045,0.0005817099,0.95029676,0.00029273375,0.0014051996,0.00093435595,0.001360171,0.03212469,0.002868025,0.00084985927,0.008861548,0.00011344323],"about_ca_topic_score_codex":0.008653254,"about_ca_topic_score_gemma":0.0071638026,"teacher_disagreement_score":0.97630835,"about_ca_system_score_codex":0.0010625933,"about_ca_system_score_gemma":0.0019701715,"threshold_uncertainty_score":0.12529504},"labels":[],"label_agreement":null},{"id":"W2982160900","doi":"10.1007/s40264-019-00871-w","title":"Healthcare Database Networks for Drug Regulatory Policies: International Workshop on the Canadian, US and Spanish Experience and Future Steps for Italy","year":2019,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Health care; Drug; Database; Pharmacology; Economic growth","score_opus":0.03774148058192039,"score_gpt":0.28706842246698766,"score_spread":0.24932694188506727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982160900","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02120364,0.02936006,0.016098537,0.8421106,0.0032043222,0.0005981754,0.007908406,0.00079183374,0.078724414],"genre_scores_gemma":[0.44842982,0.11427648,0.13573213,0.1085834,0.008170926,0.0019371314,0.057977144,0.0014295519,0.1234635],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.976939,0.010659415,0.0014301448,0.0013139175,0.0059502763,0.0037072673],"domain_scores_gemma":[0.8792513,0.037836555,0.005267968,0.007787371,0.041638616,0.028218156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12528983,0.0008601541,0.0008131019,0.007090054,0.0041624,0.017283874,0.004767261,0.0051241983,0.015826462],"category_scores_gemma":[0.067154825,0.000747334,0.0011061254,0.012603201,0.003846315,0.013638357,0.008351343,0.0052227513,0.0023274447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051415205,0.0006030203,0.024588628,0.00071113126,0.000071005954,0.0002085248,0.003716722,0.00180739,0.00074132107,0.116243035,0.5717843,0.27901068],"study_design_scores_gemma":[0.000098200755,0.00005700719,0.016475776,0.0013763655,0.000033306587,0.000108987006,0.003560762,0.0017369,0.00038987672,0.006236995,0.969875,0.000050644914],"about_ca_topic_score_codex":0.4249703,"about_ca_topic_score_gemma":0.32017443,"teacher_disagreement_score":0.95744216,"about_ca_system_score_codex":0.042557813,"about_ca_system_score_gemma":0.12043536,"threshold_uncertainty_score":0.8449934},"labels":[],"label_agreement":null},{"id":"W2982673295","doi":"10.1007/s40264-019-00880-9","title":"New Discoveries and Updates on Cutaneous Adverse Drug Reactions Presented at the 24th World Congress of Dermatology, Milan, Italy, 2019","year":2019,"lang":"en","type":"article","venue":"Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Dermatology; Drug reaction; Adverse effect; Drug; Pharmacology","score_opus":0.0068084375564467,"score_gpt":0.25069663105859646,"score_spread":0.24388819350214977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982673295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003405604,0.82576644,0.0013549555,0.06636236,0.072088905,0.00006733046,0.0005106131,0.0002811111,0.030162754],"genre_scores_gemma":[0.020537939,0.66946393,0.0038157487,0.028822122,0.24420337,0.000057788377,0.001153783,0.00007568538,0.03186966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987153,0.00033752873,0.00019482024,0.00011693725,0.0005194993,0.00011608412],"domain_scores_gemma":[0.99390525,0.0017141764,0.0009478691,0.00017578193,0.0023315486,0.00092546595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027496808,0.00082633126,0.00096928875,0.00370633,0.000416226,0.0025617224,0.0006557338,0.002218691,0.011799012],"category_scores_gemma":[0.0050411955,0.00025532756,0.00068352063,0.0015933992,0.0005337714,0.0020191388,0.00089651,0.0027950066,0.0028817223],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002683907,0.0001366581,0.001329422,0.002642403,0.00007106314,0.0007241054,0.00007504259,0.00015783963,0.001828432,0.0015317153,0.41355073,0.5776842],"study_design_scores_gemma":[0.000036003137,0.00014195194,0.0029864907,0.0012681986,0.00009311407,0.0018305329,0.00007657405,0.0001207301,0.0004217254,0.0008204763,0.9921864,0.00001777176],"about_ca_topic_score_codex":0.0005693796,"about_ca_topic_score_gemma":0.0022971183,"teacher_disagreement_score":0.011799012,"about_ca_system_score_codex":0.00083482533,"about_ca_system_score_gemma":0.0010112957,"threshold_uncertainty_score":0.039471626},"labels":[],"label_agreement":null},{"id":"W2983419902","doi":"10.1007/s40264-019-00884-5","title":"Prenatal Exposure to Macrolides and Risk of Congenital Malformations: A Meta-Analysis","year":2019,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Pregnancy; Cohort study; Population; Obstetrics; Meta-analysis; Teratology; Fetus; Pediatrics; Cohort; Internal medicine; Environmental health; Genetics","score_opus":0.06881423842611953,"score_gpt":0.355838567842165,"score_spread":0.2870243294160455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983419902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026323343,0.9708331,0.0009655602,0.00021451134,0.00021709912,0.00006168248,0.000969117,0.000038128343,0.00037738713],"genre_scores_gemma":[0.38304582,0.6110002,0.0022350817,0.00089820486,0.00028316528,0.00017961973,0.00116897,0.000046891164,0.0011420096],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9982559,0.0006341806,0.00042058647,0.0003851455,0.0001710865,0.00013309866],"domain_scores_gemma":[0.99605775,0.0028105988,0.00054572505,0.00020422264,0.000275078,0.000106614825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026707277,0.0019725694,0.0065233647,0.0016178587,0.00037146494,0.0015137467,0.0013969883,0.0017351363,0.004697126],"category_scores_gemma":[0.007947328,0.0010080861,0.020163469,0.0029781673,0.0003162267,0.00085126783,0.0009993345,0.0016931656,0.0003692343],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054083737,0.00006527017,0.026081324,0.08355401,0.8645418,0.00037025567,0.00008937086,0.00070733204,0.00064999587,0.00016770257,0.0012921714,0.01707236],"study_design_scores_gemma":[0.0005382152,0.00019842609,0.012168601,0.0027128058,0.982363,0.0001323465,0.00004650117,0.00017950014,0.00012024436,0.00017810563,0.0013393346,0.000022920603],"about_ca_topic_score_codex":0.008304264,"about_ca_topic_score_gemma":0.014865785,"teacher_disagreement_score":0.008304264,"about_ca_system_score_codex":0.00071539264,"about_ca_system_score_gemma":0.0011934646,"threshold_uncertainty_score":0.016511858},"labels":[],"label_agreement":null},{"id":"W2986078640","doi":"10.1007/s40264-019-00882-7","title":"Effectiveness of Risk Minimization Measures for Fentanyl Buccal Tablet (FENTORA) in Canada: A Mixed-Methods Evaluation Using Surveys, Medical Chart Records and Web Surveillance","year":2019,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"Teva Canada Innovation","keywords":"Medicine; Medical prescription; Retrospective cohort study; Family medicine; Medical record; Oxycodone; Emergency medicine; Opioid; Medical emergency; Internal medicine; Pharmacology","score_opus":0.015589115102271971,"score_gpt":0.31499266021778594,"score_spread":0.299403545115514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986078640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941029,0.0009813575,0.0003913049,0.00025351794,0.000025917388,0.0018331943,0.0015507295,0.000027947475,0.00083311007],"genre_scores_gemma":[0.9928186,0.001033715,0.0028169975,0.00037526755,0.000037081263,0.0013549282,0.0009767747,0.00001060144,0.0005759667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9813797,0.00884795,0.0015651606,0.0013815741,0.0055966913,0.0012289181],"domain_scores_gemma":[0.9687393,0.014190875,0.008550679,0.0008602055,0.0054644416,0.0021945555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0118313255,0.001147349,0.0017885112,0.0018844411,0.002688227,0.0016073297,0.00236761,0.0015954403,0.001722272],"category_scores_gemma":[0.037270058,0.0010496251,0.0025140892,0.003042337,0.0015769672,0.0011808054,0.0013900482,0.0016086525,0.00016274433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03901785,0.021519322,0.8262817,0.002817448,0.006409816,0.00014532456,0.00490296,0.0040084478,0.00044323955,0.0004060988,0.0031368153,0.09091092],"study_design_scores_gemma":[0.009855181,0.031941246,0.93849003,0.00056204124,0.0031422882,0.000087464774,0.0030218633,0.010725488,0.00052930525,0.00017002512,0.0012583025,0.00021671577],"about_ca_topic_score_codex":0.90473336,"about_ca_topic_score_gemma":0.9027188,"teacher_disagreement_score":0.09526664,"about_ca_system_score_codex":0.040705875,"about_ca_system_score_gemma":0.041997235,"threshold_uncertainty_score":0.29534316},"labels":[],"label_agreement":null},{"id":"W2988672182","doi":"10.1007/s40264-019-00877-4","title":"Development and First Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit–Harm of Drugs Received During Clinical Studies","year":2019,"lang":"en","type":"article","venue":"Drug Safety","topic":"Diabetes Management and Education","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sanofi","keywords":"Medicine; Thematic analysis; Qualitative research; Clinical trial; Harm; Feeling; Adverse effect; Family medicine; Internal medicine","score_opus":0.10061690684734957,"score_gpt":0.3917832358589636,"score_spread":0.291166329011614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988672182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95579237,0.0005900128,0.019559592,0.0041455785,0.00016917271,0.010883527,0.00327915,0.00010787085,0.0054726354],"genre_scores_gemma":[0.94011444,0.0006111006,0.038366172,0.0012330617,0.000040176892,0.017648026,0.00091699447,0.000026636899,0.0010434713],"study_design_codex":"qualitative","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.982357,0.013670747,0.0013552667,0.0004381643,0.0014331692,0.0007456131],"domain_scores_gemma":[0.96019924,0.02359749,0.006808844,0.0014350098,0.0062821913,0.0016773029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030806692,0.0004259201,0.00062683603,0.001284915,0.0011802663,0.0014540387,0.00096471945,0.00074339466,0.002490432],"category_scores_gemma":[0.046009503,0.00037737557,0.0012087022,0.0010351978,0.0014112123,0.0015997117,0.0029457973,0.001723119,0.0003039974],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012491734,0.00087651727,0.20938408,0.0051138313,0.00024181024,0.0010215638,0.5445484,0.0014101083,0.0077533256,0.003321044,0.013637536,0.2114427],"study_design_scores_gemma":[0.0006526021,0.0037552582,0.3938681,0.0038696774,0.00018850579,0.0020601014,0.49378377,0.0057881703,0.006777668,0.006338516,0.08224018,0.00067749375],"about_ca_topic_score_codex":0.004423877,"about_ca_topic_score_gemma":0.0069787162,"teacher_disagreement_score":0.030806692,"about_ca_system_score_codex":0.004139995,"about_ca_system_score_gemma":0.004845168,"threshold_uncertainty_score":0.16292328},"labels":[],"label_agreement":null},{"id":"W2994680662","doi":"10.1007/s40264-019-00892-5","title":"The Use of Long-Acting Insulin Analogs and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based Cohort Study","year":2019,"lang":"en","type":"article","venue":"Drug Safety","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Insulin; Hazard ratio; Colorectal cancer; Population; Internal medicine; Insulin analog; Type 2 diabetes; Diabetes mellitus; Proportional hazards model; Cohort; Endocrinology; Cohort study; Cancer; Confidence interval; Oncology; Human insulin","score_opus":0.004571315314681759,"score_gpt":0.21093039962407883,"score_spread":0.2063590843093971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994680662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988223,0.00019157503,0.0001064455,0.00004067079,0.000013041857,0.000012899875,0.00048298843,0.0000045487286,0.00032556854],"genre_scores_gemma":[0.99908173,0.00013658234,0.000086720946,0.00004453237,0.000018709701,0.000011512848,0.00033070034,0.0000035761016,0.0002859913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994351,0.00013744552,0.000058382982,0.00017464883,0.000098367556,0.00009590943],"domain_scores_gemma":[0.9985991,0.00017990524,0.00044879285,0.00027975327,0.00015269915,0.00033967436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080282567,0.0006044357,0.00059086754,0.0009052511,0.000896947,0.0013522949,0.0004956316,0.0011887578,0.0016946445],"category_scores_gemma":[0.0014525302,0.0010263891,0.001499263,0.0015463914,0.00038021462,0.00091360987,0.0005280914,0.001672704,0.00036525505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006678232,0.00016177181,0.9973291,0.00000648254,0.0004080332,0.00009633138,0.000065049615,0.000042011685,0.00060073053,0.000014464592,0.00007302037,0.0005351634],"study_design_scores_gemma":[0.0000587205,0.00029388038,0.9986009,0.000003235099,0.00022065289,0.00021527502,0.00015974586,0.00023122174,0.00006738325,0.00001817902,0.000120143675,0.000010707329],"about_ca_topic_score_codex":0.013170202,"about_ca_topic_score_gemma":0.0104961265,"teacher_disagreement_score":0.013170202,"about_ca_system_score_codex":0.00042116758,"about_ca_system_score_gemma":0.0004933333,"threshold_uncertainty_score":0.026187122},"labels":[],"label_agreement":null},{"id":"W3018130893","doi":"10.1007/s40264-020-00924-5","title":"Oxycodone, Hydromorphone, and the Risk of Suicide: A Retrospective Population-Based Case–Control Study","year":2020,"lang":"en","type":"article","venue":"Drug Safety","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sunnybrook Hospital; Health Sciences Centre; West Park Healthcare Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Government of Ontario","keywords":"Hydromorphone; Oxycodone; Medicine; Hydrocodone; Odds ratio; Confidence interval; Opioid; Population; Anesthesia; Retrospective cohort study; Poison control; Internal medicine; Emergency medicine; Environmental health","score_opus":0.00819712624175507,"score_gpt":0.2453847744793225,"score_spread":0.23718764823756744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018130893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993319,0.00022880253,0.0000924982,0.000011992249,0.000007880414,0.000013633119,0.0001342664,0.0000023586388,0.0001765136],"genre_scores_gemma":[0.99941766,0.00014473092,0.00009229456,0.000022423665,0.000014528622,0.000012447295,0.00017231714,0.0000018351149,0.000121781544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921715,0.00023510293,0.00009296315,0.00023706372,0.00012888107,0.00008890839],"domain_scores_gemma":[0.99848527,0.00034182853,0.00051979,0.00026246885,0.00017095894,0.00021975796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008624685,0.0005811889,0.0006337038,0.0010779912,0.00078960485,0.00090042735,0.00050875143,0.0009639996,0.0015760814],"category_scores_gemma":[0.002000917,0.0010555862,0.0009953916,0.0012608543,0.00072486687,0.0006304976,0.0003927763,0.0009172047,0.00027367417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012459551,0.0003559718,0.99636745,0.000017373914,0.00038169007,0.00023968489,0.000115313305,0.000043016105,0.0005432103,0.000026834718,0.000067464396,0.00059598],"study_design_scores_gemma":[0.00014025853,0.0008694241,0.99691534,0.000007896238,0.00024688503,0.00091331836,0.00029553822,0.00031100388,0.000102566606,0.00003459592,0.00014793176,0.000015187207],"about_ca_topic_score_codex":0.0072217267,"about_ca_topic_score_gemma":0.005366454,"teacher_disagreement_score":0.0072217267,"about_ca_system_score_codex":0.00044196268,"about_ca_system_score_gemma":0.00039872836,"threshold_uncertainty_score":0.014359415},"labels":[],"label_agreement":null},{"id":"W3027985342","doi":"10.1007/s40264-020-00948-x","title":"Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety","year":2020,"lang":"en","type":"article","venue":"Drug Safety","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"EMD Serono; Merck KGaA","keywords":"Cladribine; Medicine; Placebo; Pregnancy; Multiple sclerosis; Cohort; Clinical trial; Cohort study; Internal medicine; Pediatrics; Obstetrics; Immunology; Pathology","score_opus":0.1441201449128646,"score_gpt":0.3744412569198225,"score_spread":0.2303211120069579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027985342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896034,0.006522176,0.0009679743,0.00011397021,0.000006039704,0.00031815082,0.0014873651,0.00001653028,0.00096444145],"genre_scores_gemma":[0.99618465,0.0009574463,0.0007053437,0.00006384872,0.000021067384,0.00021270872,0.0016255939,0.0000047183075,0.00022473997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98944455,0.005422489,0.0011631611,0.00088064413,0.0027182489,0.0003709003],"domain_scores_gemma":[0.96314657,0.01536058,0.017372245,0.0012097567,0.0019740309,0.00093683874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018106531,0.00036870476,0.00084119395,0.0015616912,0.00026933197,0.0006962479,0.00039390722,0.0003657626,0.0010785223],"category_scores_gemma":[0.01712432,0.00024169529,0.0016518475,0.0014754491,0.00037913435,0.00044789037,0.0010143883,0.0005418241,0.0001033079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020088239,0.00036257913,0.8844206,0.0008690351,0.003189373,0.00014720034,0.00029357764,0.0015133724,0.0022510453,0.00010693591,0.00040220443,0.086355746],"study_design_scores_gemma":[0.00070045184,0.011173644,0.98102164,0.00013228333,0.0016481652,0.00035705362,0.000071693976,0.0008371143,0.0023712097,0.00009324842,0.0015713649,0.000022109925],"about_ca_topic_score_codex":0.0007225974,"about_ca_topic_score_gemma":0.0010071171,"teacher_disagreement_score":0.018106531,"about_ca_system_score_codex":0.00086150423,"about_ca_system_score_gemma":0.0013137131,"threshold_uncertainty_score":0.09575766},"labels":[],"label_agreement":null},{"id":"W3034339356","doi":"10.1007/s40264-020-00953-0","title":"Does Ibuprofen Worsen COVID-19?","year":2020,"lang":"en","type":"article","venue":"Drug Safety","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Ibuprofen; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Betacoronavirus; Coronavirus Infections; Pharmacology; Intensive care medicine; Virology; Internal medicine; Infectious disease (medical specialty); Disease; Outbreak","score_opus":0.06200544371787952,"score_gpt":0.4290353611305098,"score_spread":0.36702991741263025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034339356","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21749285,0.56414324,0.0010567984,0.15244578,0.005602651,0.00075575116,0.005755514,0.0000779313,0.052669484],"genre_scores_gemma":[0.7762705,0.1557752,0.0028616441,0.04750633,0.00831234,0.0003286586,0.0036727916,0.000053035168,0.0052194367],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9906466,0.005710819,0.0013320502,0.0006050289,0.0008445719,0.00086086174],"domain_scores_gemma":[0.96606296,0.01532364,0.011189427,0.0015057336,0.003941378,0.0019769093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017895903,0.0006167737,0.0017840076,0.0007109928,0.000666472,0.0026480653,0.00084337336,0.0026667807,0.014043786],"category_scores_gemma":[0.041154977,0.0002569851,0.002779924,0.0011763109,0.0011552541,0.0023351447,0.00091861316,0.0025092904,0.0016070725],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.117648244,0.0039931997,0.18285418,0.018280147,0.025728928,0.000676889,0.0006526551,0.0005745047,0.0034483431,0.008964531,0.061756063,0.5754224],"study_design_scores_gemma":[0.033170238,0.044041492,0.48098403,0.031352356,0.036957826,0.0027167252,0.0038753557,0.001162478,0.006739961,0.014246254,0.34445888,0.00029431653],"about_ca_topic_score_codex":0.002761734,"about_ca_topic_score_gemma":0.0065118046,"teacher_disagreement_score":0.017895903,"about_ca_system_score_codex":0.0014702338,"about_ca_system_score_gemma":0.002854944,"threshold_uncertainty_score":0.09464371},"labels":[],"label_agreement":null},{"id":"W3036284444","doi":"10.1007/s40264-020-00956-x","title":"Association Between Intravitreal Aflibercept and Serious Non-ocular Haemorrhage Compared with Intravitreal Ranibizumab: A Multicentre Observational Cohort Study","year":2020,"lang":"en","type":"article","venue":"Drug Safety","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Agenzia Italiana del Farmaco, Ministero della Salute","keywords":"Ranibizumab; Aflibercept; Medicine; Hazard ratio; Dexamethasone; Incidence (geometry); Ophthalmology; Retrospective cohort study; Cohort study; Cohort; Bevacizumab; Internal medicine; Confidence interval; Chemotherapy","score_opus":0.015045567410910756,"score_gpt":0.2597051089564166,"score_spread":0.24465954154550582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036284444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986603,0.00064994063,0.00006194373,0.00004866612,0.000015093078,0.000011382298,0.00040540812,0.0000044264475,0.00014271599],"genre_scores_gemma":[0.99906164,0.00021618101,0.000089671346,0.00006313976,0.000029705325,0.000015207093,0.00036203352,0.000004823441,0.0001577064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882144,0.0002738607,0.00013677549,0.00042582327,0.00014223106,0.00019977978],"domain_scores_gemma":[0.99576354,0.0006829125,0.0022977728,0.0005380264,0.0002311795,0.00048648185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011005198,0.00054318376,0.00091982353,0.00061840774,0.0005215396,0.0013659995,0.0006559144,0.0013483333,0.0016363466],"category_scores_gemma":[0.003222438,0.00077616464,0.0020480675,0.0012375165,0.00040453818,0.00078439346,0.00048764466,0.0018475138,0.00025937503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010084946,0.00037356993,0.98297924,0.00008180679,0.002558272,0.00033091995,0.00013072713,0.00007065172,0.0015628147,0.00004652546,0.0002972722,0.0014832643],"study_design_scores_gemma":[0.00054240704,0.00089388626,0.99644476,0.000011966751,0.0008886593,0.0004268751,0.00012551247,0.00032258985,0.00010847542,0.00003162793,0.00018170425,0.000021441836],"about_ca_topic_score_codex":0.008400259,"about_ca_topic_score_gemma":0.0062138587,"teacher_disagreement_score":0.008400259,"about_ca_system_score_codex":0.0006824759,"about_ca_system_score_gemma":0.00057794683,"threshold_uncertainty_score":0.016702712},"labels":[],"label_agreement":null},{"id":"W3037918575","doi":"10.1007/s40264-020-00963-y","title":"Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand","year":2020,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Auckland","keywords":"Medicine; Pharmacovigilance; Pharmacy; Intensive care; Health care; Family medicine; Medical emergency; Adverse effect; Pharmacology; Intensive care medicine","score_opus":0.18115496397628034,"score_gpt":0.48468168332548767,"score_spread":0.30352671934920733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037918575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9206726,0.00073923555,0.05762638,0.0016836567,0.00015319149,0.0062860018,0.0022114122,0.0028288192,0.0077986447],"genre_scores_gemma":[0.8337768,0.00038038017,0.1581589,0.00077006937,0.000096056734,0.0018679362,0.0019617574,0.00021163208,0.0027765385],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9868547,0.0077541946,0.0012555016,0.00088581024,0.0030699908,0.00017988356],"domain_scores_gemma":[0.9405744,0.04157768,0.004249819,0.0034179694,0.009143158,0.0010369744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020556927,0.0005891577,0.0007466026,0.0011617932,0.00041018167,0.0018997471,0.0011923618,0.0011805248,0.0038478738],"category_scores_gemma":[0.054111622,0.00043790636,0.0006517277,0.00084372895,0.0004404698,0.0015763352,0.0010340072,0.0007915534,0.0008930639],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024850532,0.010284989,0.17174694,0.0026804204,0.0016693062,0.0005686687,0.003834378,0.0043418896,0.029095126,0.0008726104,0.007476775,0.74257827],"study_design_scores_gemma":[0.009430869,0.04484552,0.6816783,0.0010823149,0.0039303624,0.002946409,0.0033754916,0.15543804,0.05082846,0.0014646158,0.044341806,0.00063777587],"about_ca_topic_score_codex":0.012379947,"about_ca_topic_score_gemma":0.012475911,"teacher_disagreement_score":0.020556927,"about_ca_system_score_codex":0.0010219062,"about_ca_system_score_gemma":0.0022948496,"threshold_uncertainty_score":0.10871673},"labels":[],"label_agreement":null},{"id":"W3047471117","doi":"10.1007/s40264-020-00979-4","title":"Ipilimumab-Induced Enterocolitis: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Drug Safety","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"George & Fay Yee Centre for Healthcare Innovation; Winnipeg Regional Health Authority; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Meta-analysis; Ipilimumab; Enterocolitis; Intensive care medicine; Internal medicine; Necrotizing enterocolitis; Cancer","score_opus":0.07706174745811163,"score_gpt":0.35928694591775145,"score_spread":0.28222519845963984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047471117","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036045907,0.99543273,0.00022999456,0.000095482355,0.00008416891,0.00008610159,0.0003051772,0.000010714264,0.00015094706],"genre_scores_gemma":[0.13956046,0.8568196,0.0012516022,0.0009794413,0.00019283991,0.00030409975,0.0005302001,0.000019991601,0.0003417056],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960491,0.0015626078,0.0012481004,0.00050603074,0.00043592695,0.00019836173],"domain_scores_gemma":[0.9924306,0.0050372435,0.0017524423,0.0002346896,0.00042133708,0.00012367827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006171571,0.0021847966,0.012815609,0.0032555952,0.00042220793,0.0022091486,0.001595034,0.0019493335,0.0045249746],"category_scores_gemma":[0.013489167,0.0012525856,0.023089157,0.0047391164,0.00058337214,0.0015205098,0.001745173,0.0018709511,0.00035121752],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023178367,0.00003584472,0.004723744,0.4632057,0.5132944,0.00016288503,0.00007885166,0.00034540702,0.00024080517,0.00011523883,0.0008457282,0.014633579],"study_design_scores_gemma":[0.00087372237,0.00018615818,0.005166156,0.021665525,0.9693989,0.00013204571,0.000056216268,0.000118640986,0.000078998026,0.00014209085,0.0021552346,0.000026450403],"about_ca_topic_score_codex":0.0052951043,"about_ca_topic_score_gemma":0.016916554,"teacher_disagreement_score":0.012815609,"about_ca_system_score_codex":0.0017003646,"about_ca_system_score_gemma":0.0022408736,"threshold_uncertainty_score":0.03263879},"labels":[],"label_agreement":null},{"id":"W3058396309","doi":"10.1007/s40264-020-00991-8","title":"Real-World Data on Bleeding Risk and Anticoagulation in Patients with IPF Treated with Antifibrotics","year":2020,"lang":"en","type":"letter","venue":"Drug Safety","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Medicine; Intensive care medicine; Internal medicine","score_opus":0.016543860775424617,"score_gpt":0.24855260445682606,"score_spread":0.23200874368140145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3058396309","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0123985745,0.0023156418,0.0002347439,0.9727894,0.0030857048,0.000015979625,0.0014416971,0.00002597797,0.0076923184],"genre_scores_gemma":[0.14614403,0.0033169896,0.0012291891,0.8110677,0.032265417,0.0000932307,0.0014549339,0.000035525423,0.004392988],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99246573,0.003796396,0.0016358114,0.0003740942,0.0013325308,0.00039553223],"domain_scores_gemma":[0.93718857,0.045528565,0.007376635,0.0013199149,0.004853427,0.0037329297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005691444,0.0002563171,0.0007733827,0.0009909024,0.0011402793,0.002506939,0.0006949807,0.01238893,0.002810613],"category_scores_gemma":[0.047371645,0.00028964318,0.000633714,0.002049922,0.0011014317,0.0014028284,0.00067306863,0.0060547665,0.0017068726],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012887086,0.00021632404,0.13090739,0.00035224296,0.00025835988,0.013150871,0.0006258699,0.00048935163,0.00052630575,0.004406736,0.79541886,0.052359026],"study_design_scores_gemma":[0.0013283379,0.000695568,0.12592687,0.001726582,0.00037674143,0.019411676,0.0027190368,0.0037166348,0.0008084604,0.0217616,0.8212598,0.00026870758],"about_ca_topic_score_codex":0.0063218577,"about_ca_topic_score_gemma":0.011379376,"teacher_disagreement_score":0.01238893,"about_ca_system_score_codex":0.0025261417,"about_ca_system_score_gemma":0.0023167226,"threshold_uncertainty_score":0.03009957},"labels":[],"label_agreement":null},{"id":"W3081906735","doi":"10.1007/s40264-020-00989-2","title":"Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology","year":2020,"lang":"en","type":"article","venue":"Drug Safety","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Context (archaeology); Immunization; Safety monitoring; Immunology","score_opus":0.04061376038694249,"score_gpt":0.31348575356209096,"score_spread":0.2728719931751485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081906735","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07905876,0.011791273,0.6600219,0.0035072954,0.0011389822,0.20895164,0.017131781,0.0019901777,0.01640822],"genre_scores_gemma":[0.1614423,0.0072456235,0.65039295,0.002697888,0.0006510914,0.16191128,0.009827459,0.00040248988,0.005428874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8651556,0.067937724,0.026996033,0.009553247,0.028865512,0.00149192],"domain_scores_gemma":[0.8564504,0.031322304,0.036190897,0.017822204,0.056774765,0.001439521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12962414,0.0017921671,0.0011932509,0.007140355,0.0009541688,0.0029530637,0.0028862376,0.0012236784,0.0036314516],"category_scores_gemma":[0.13455331,0.0009423839,0.0019278538,0.00509172,0.0015125343,0.0019069187,0.0028667075,0.0012355773,0.002436851],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022484553,0.0011476771,0.10481903,0.021232272,0.0016218602,0.00049682264,0.0062584453,0.0027248661,0.015386578,0.009644316,0.030472022,0.8039476],"study_design_scores_gemma":[0.0013510147,0.016451284,0.2057821,0.015864836,0.004454029,0.0027163508,0.004685439,0.015121279,0.09736692,0.012509417,0.6228315,0.0008656891],"about_ca_topic_score_codex":0.0033416173,"about_ca_topic_score_gemma":0.005150905,"teacher_disagreement_score":0.12962414,"about_ca_system_score_codex":0.00292202,"about_ca_system_score_gemma":0.018993076,"threshold_uncertainty_score":0.6855262},"labels":[],"label_agreement":null},{"id":"W3094315798","doi":"10.1007/s40264-020-01015-1","title":"Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer","year":2020,"lang":"en","type":"article","venue":"Drug Safety","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Skin cancer; Hydrochlorothiazide; Dermatology; Melanoma; Cancer; Internal medicine; Cancer research","score_opus":0.020664551226225365,"score_gpt":0.25133787026001553,"score_spread":0.23067331903379015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094315798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98901063,0.008135755,0.00013957302,0.000058025707,0.00003457862,0.000024974212,0.00064718747,0.000008109702,0.0019412421],"genre_scores_gemma":[0.9971667,0.0014100958,0.00007127426,0.000046384663,0.000039377795,0.000009914366,0.00028873567,0.000002609049,0.000964838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923086,0.0003594859,0.00008099181,0.00012399447,0.00011188878,0.000092753835],"domain_scores_gemma":[0.9969894,0.0012985141,0.0009796706,0.0003140577,0.0001958236,0.00022250049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010305532,0.0003909615,0.0003889904,0.0008562082,0.0002856279,0.0007021935,0.00033053727,0.0006031607,0.0036886553],"category_scores_gemma":[0.0026834372,0.00036336418,0.002265847,0.0007158646,0.00020688926,0.00037797773,0.00033199158,0.00053395866,0.00019421057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012699047,0.0003494419,0.9708359,0.00044523468,0.0060145305,0.00024084255,0.00014527373,0.00013936026,0.0018297086,0.00012441073,0.0002770025,0.00689938],"study_design_scores_gemma":[0.0003840965,0.005003654,0.98881793,0.000060358,0.0023955647,0.00048802962,0.00021977458,0.00023929561,0.0008163537,0.00009751693,0.0014582454,0.000019178084],"about_ca_topic_score_codex":0.004218303,"about_ca_topic_score_gemma":0.004679994,"teacher_disagreement_score":0.004218303,"about_ca_system_score_codex":0.00023090486,"about_ca_system_score_gemma":0.0002819437,"threshold_uncertainty_score":0.01233983},"labels":[],"label_agreement":null},{"id":"W3112986797","doi":"10.1007/s40264-020-01008-0","title":"Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations","year":2020,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Pharmacovigilance; Legislation; Medicine; Scope (computer science); Benchmarking; European union; Obligation; Business; Marketing authorization; Risk analysis (engineering); Pharmacology; Marketing; International trade; Political science","score_opus":0.13453499215065462,"score_gpt":0.47553821532083984,"score_spread":0.3410032231701852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112986797","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011324857,0.11882791,0.07229249,0.75856346,0.010041696,0.0029843287,0.0019064525,0.0018406353,0.03241056],"genre_scores_gemma":[0.025528114,0.20111859,0.4351967,0.28874278,0.008011922,0.01049079,0.013078592,0.00095473917,0.016877761],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9149339,0.044358805,0.012388513,0.0037468933,0.019222971,0.0053488044],"domain_scores_gemma":[0.8409117,0.06442265,0.011152513,0.0073227836,0.06267325,0.013517076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1734497,0.0031888646,0.004083766,0.009538739,0.0026388038,0.014144692,0.01586989,0.029329704,0.016170956],"category_scores_gemma":[0.1722909,0.0018489426,0.009892668,0.006845651,0.004887796,0.012939881,0.0134297535,0.020329585,0.013370519],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025036125,0.000677577,0.0011490397,0.0117962025,0.00043787417,0.00063247985,0.0010526037,0.004728996,0.00074757787,0.07855177,0.410015,0.48996046],"study_design_scores_gemma":[0.00032006486,0.00026097696,0.0014206843,0.07081811,0.0005447922,0.0006287961,0.0006745811,0.0026370836,0.00080813165,0.0862838,0.83550197,0.0001010088],"about_ca_topic_score_codex":0.013835787,"about_ca_topic_score_gemma":0.007888345,"teacher_disagreement_score":0.1734497,"about_ca_system_score_codex":0.013683351,"about_ca_system_score_gemma":0.08325591,"threshold_uncertainty_score":0.91730064},"labels":[],"label_agreement":null},{"id":"W3116056305","doi":"10.1007/s40264-020-01029-9","title":"Correction to: DNA Barcoding and Pharmacovigilance of Herbal Medicines","year":2021,"lang":"en","type":"article","venue":"Drug Safety","topic":"Plant-based Medicinal Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Medicine; Pharmacovigilance; DNA barcoding; Traditional medicine; MEDLINE; Pharmacology; Drug","score_opus":0.0768053661766855,"score_gpt":0.44561610452053907,"score_spread":0.3688107383438536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116056305","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023642645,0.001094043,0.0010510101,0.07511835,0.918297,0.000029962514,0.002120769,0.00044832984,0.0016041574],"genre_scores_gemma":[0.025430126,0.010260275,0.011617477,0.21342818,0.56889874,0.00037990554,0.0064829458,0.0019659505,0.16153635],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99428326,0.0011254284,0.0012547622,0.0008505628,0.0018670751,0.0006189434],"domain_scores_gemma":[0.9512728,0.01663481,0.0030825215,0.0029027993,0.023782361,0.0023246403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043376843,0.0019311971,0.0019932569,0.0040338226,0.0022938128,0.003798995,0.0031876597,0.008929869,0.060078748],"category_scores_gemma":[0.07560178,0.001193646,0.0018964767,0.0024649187,0.0023393624,0.0018776486,0.0024327058,0.009684172,0.026103364],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058984955,0.00000737069,0.00014068605,0.00023745197,0.000029957759,0.00037313643,0.000051610154,0.000058309935,0.00008181545,0.0006094297,0.9918024,0.0065488266],"study_design_scores_gemma":[0.00010625553,0.00003133207,0.0012376029,0.0005995691,0.00008269051,0.0010563564,0.0001226761,0.00040073734,0.00046346377,0.0016916195,0.9941552,0.000052433126],"about_ca_topic_score_codex":0.016564436,"about_ca_topic_score_gemma":0.015684329,"teacher_disagreement_score":0.060078748,"about_ca_system_score_codex":0.0029536267,"about_ca_system_score_gemma":0.0065928786,"threshold_uncertainty_score":0.2009834},"labels":[],"label_agreement":null},{"id":"W3127870523","doi":"10.1007/s40264-020-01033-z","title":"Risk Management for the 21st Century: Current Status and Future Needs","year":2021,"lang":"en","type":"article","venue":"Drug Safety","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Health Canada","funders":"U.S. Food and Drug Administration","keywords":"Medicine; Risk management; Risk analysis (engineering); Harmonization; Guideline; Pharmacovigilance; Health care; Risk assessment; Management science; Engineering; Computer science; Business; Pharmacology; Drug; Political science","score_opus":0.10728181795879288,"score_gpt":0.36665768816723837,"score_spread":0.2593758702084455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127870523","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010088976,0.5359457,0.010328948,0.44529372,0.002681905,0.00003156809,0.0000700296,0.00010450422,0.004534617],"genre_scores_gemma":[0.03812715,0.86226517,0.026681924,0.056412812,0.0145389605,0.00019649696,0.00021135884,0.00010053192,0.0014655731],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9714154,0.015639655,0.0031261325,0.00219485,0.006261673,0.0013623305],"domain_scores_gemma":[0.75700957,0.19615723,0.010138894,0.005973487,0.02079486,0.009925941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09548734,0.0015329805,0.003614921,0.004283499,0.0034365538,0.01937108,0.0049198507,0.015724802,0.011526797],"category_scores_gemma":[0.10140887,0.00078907673,0.0021312302,0.0056458423,0.019908654,0.028233401,0.010447339,0.019898435,0.0021949145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001644069,0.00024107253,0.0017076671,0.007588252,0.00013668236,0.00016831211,0.0028933117,0.0027127478,0.0002704234,0.30905455,0.06046152,0.6146011],"study_design_scores_gemma":[0.00004678966,0.00021975146,0.0017851575,0.024431225,0.00007891348,0.0005715419,0.006544844,0.0019328808,0.00017878093,0.57197165,0.39207333,0.00016517338],"about_ca_topic_score_codex":0.004632712,"about_ca_topic_score_gemma":0.0040121716,"teacher_disagreement_score":0.09548734,"about_ca_system_score_codex":0.009459464,"about_ca_system_score_gemma":0.029972272,"threshold_uncertainty_score":0.50499135},"labels":[],"label_agreement":null},{"id":"W3128420623","doi":"10.1007/s40264-020-01041-z","title":"Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies","year":2021,"lang":"en","type":"article","venue":"Drug Safety","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia; Vancouver Coastal Health Research Institute; St. Joseph’s Healthcare Hamilton; Vancouver Coastal Health","funders":"AstraZeneca","keywords":"Budesonide; Formoterol; Budesonide/formoterol; Medicine; Terbutaline; Adverse effect; Asthma; Anesthesia; Internal medicine","score_opus":0.04238167780780312,"score_gpt":0.35568965340649716,"score_spread":0.31330797559869406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128420623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7766979,0.19756664,0.0033389318,0.0023834691,0.00042817736,0.00449694,0.01069856,0.00023602242,0.0041534267],"genre_scores_gemma":[0.94162804,0.041682657,0.0023932776,0.002240734,0.0005749168,0.002892118,0.007675839,0.000059575315,0.0008529064],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941737,0.0034102148,0.0008410905,0.00050871976,0.0008145041,0.00025167502],"domain_scores_gemma":[0.9808888,0.006394935,0.008584845,0.0013135977,0.0018253846,0.0009924459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012961488,0.0014128663,0.004290446,0.0007010548,0.0005377759,0.0018035965,0.0010146507,0.0020398225,0.0028518427],"category_scores_gemma":[0.011287525,0.00060364755,0.007279303,0.0009567992,0.00073317275,0.00090963824,0.00071115815,0.0018732767,0.0005261237],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59892994,0.0051764464,0.042557105,0.03134093,0.06881138,0.0004903051,0.0006483394,0.0017061298,0.04565215,0.0003166378,0.0058365967,0.19853401],"study_design_scores_gemma":[0.39618137,0.24968986,0.22896653,0.0054968353,0.07688831,0.0021391343,0.00027197818,0.0009884033,0.013089572,0.000761188,0.025287524,0.00023923103],"about_ca_topic_score_codex":0.00039816316,"about_ca_topic_score_gemma":0.0012164789,"teacher_disagreement_score":0.012961488,"about_ca_system_score_codex":0.0007070336,"about_ca_system_score_gemma":0.0017675818,"threshold_uncertainty_score":0.068547726},"labels":[],"label_agreement":null},{"id":"W3163866919","doi":"10.1007/s40264-021-01078-8","title":"Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities","year":2021,"lang":"en","type":"review","venue":"Drug Safety","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada","keywords":"Pharmacovigilance; Medicine; Excellence; Best practice; Presentation (obstetrics); Knowledge management; Engineering ethics; Pharmacology; Engineering; Management; Adverse effect; Computer science","score_opus":0.119996193234862,"score_gpt":0.4177286110289148,"score_spread":0.2977324177940528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163866919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051263818,0.9982938,0.00013268016,0.0010075709,0.0001514254,0.0000034685459,0.000010652222,0.000006732948,0.00034244964],"genre_scores_gemma":[0.00057181227,0.9979596,0.0003414403,0.0007101328,0.00023618939,0.00000550664,0.000018909996,0.0000018431708,0.00015453382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902105,0.00028624732,0.0001391306,0.00013088596,0.00034826016,0.00007446777],"domain_scores_gemma":[0.99441177,0.003569806,0.00064169546,0.00008117172,0.0010264367,0.00026912356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047905413,0.0010544298,0.0018618284,0.0025888903,0.00028034698,0.002462193,0.0015287086,0.0028640304,0.0036591857],"category_scores_gemma":[0.005880277,0.00028013485,0.0009651502,0.0029227354,0.00086066406,0.0025390862,0.0012515408,0.0032283957,0.0010777202],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006562907,0.00005630747,0.00019942388,0.01508526,0.00014017314,0.00007613541,0.000052878822,0.00020461465,0.0002893016,0.0028522627,0.019190202,0.96178776],"study_design_scores_gemma":[0.00008907156,0.00018587278,0.0016347574,0.03098877,0.0005877277,0.00096233934,0.00016227395,0.00024498758,0.000404382,0.0048492206,0.9598456,0.000045013054],"about_ca_topic_score_codex":0.0022632193,"about_ca_topic_score_gemma":0.0046930634,"teacher_disagreement_score":0.0047905413,"about_ca_system_score_codex":0.0014315955,"about_ca_system_score_gemma":0.0037995982,"threshold_uncertainty_score":0.025335133},"labels":[],"label_agreement":null},{"id":"W3165355211","doi":"10.1007/s40264-021-01065-z","title":"Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR","year":2021,"lang":"en","type":"review","venue":"Drug Safety","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University; Innovaderm (Canada)","funders":"Janssen Scientific Affairs; University of Pennsylvania","keywords":"Medicine; Term (time); Medical physics","score_opus":0.3266899675499887,"score_gpt":0.4281687764952196,"score_spread":0.10147880894523092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165355211","genre_codex":"methods","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03529104,0.029758072,0.88086176,0.040546887,0.0040068906,0.0042698667,0.0011116476,0.0005530898,0.0036007045],"genre_scores_gemma":[0.52826315,0.0071869744,0.41851008,0.02177275,0.0055742194,0.016260209,0.0009460402,0.00061381445,0.0008727674],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.13430728,0.7808239,0.045576166,0.013838563,0.0245757,0.00087842176],"domain_scores_gemma":[0.03706961,0.8571851,0.041251697,0.045166284,0.018532451,0.0007948157],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.76770097,0.0017896114,0.0033088494,0.004604357,0.0016301032,0.0085950205,0.0072153397,0.003945637,0.0021107863],"category_scores_gemma":[0.8833571,0.0016161812,0.0071816565,0.0047041243,0.009789865,0.0069094934,0.0056873444,0.007920526,0.00052226963],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057062125,0.00054787885,0.1671279,0.030615566,0.036208753,0.0012567802,0.012767848,0.025106084,0.002379847,0.14159921,0.026934909,0.5497491],"study_design_scores_gemma":[0.004894718,0.009810669,0.14488156,0.04121132,0.022694727,0.0037114185,0.00404509,0.13582009,0.014042549,0.48373336,0.13361995,0.0015344208],"about_ca_topic_score_codex":0.0020637538,"about_ca_topic_score_gemma":0.0014965357,"teacher_disagreement_score":0.23229903,"about_ca_system_score_codex":0.0042912774,"about_ca_system_score_gemma":0.0092663625,"threshold_uncertainty_score":0.28646612},"labels":[],"label_agreement":null},{"id":"W3184711658","doi":"10.1007/s40264-021-01092-w","title":"Study of Natural Products Adverse Reactions (SONAR) in Adults with Mental Health Conditions: A Cross-Sectional Study","year":2021,"lang":"en","type":"article","venue":"Drug Safety","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"START Clinic; University of Toronto; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates - Health Solutions","keywords":"Medicine; Cross-sectional study; Adverse effect; Mental health; Natural (archaeology); Environmental health; Psychiatry; Internal medicine; Pathology","score_opus":0.02720692673069639,"score_gpt":0.3602767952646766,"score_spread":0.3330698685339802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184711658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896395,0.00040515602,0.00007132541,0.000021396012,0.000007654877,0.00003977592,0.00021241486,0.0000014023225,0.00027693104],"genre_scores_gemma":[0.99889284,0.00031345832,0.00012801778,0.00010170138,0.000017801778,0.00004025954,0.000290372,0.0000012590365,0.00021432055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990914,0.00036928465,0.00016040365,0.0001496189,0.00013937042,0.00008996731],"domain_scores_gemma":[0.9975382,0.00049617153,0.0010961973,0.00020645867,0.00030589066,0.0003570894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013004713,0.00039268457,0.00048756402,0.0008360911,0.0006838741,0.0007537499,0.00030336215,0.000820663,0.0018214622],"category_scores_gemma":[0.0025542194,0.00059146475,0.0008808496,0.0010623154,0.00036367742,0.00074198085,0.0005593208,0.0008621953,0.00040036734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024746082,0.00027048422,0.99809366,0.000030411144,0.00014840634,0.00006545251,0.00019486244,0.0000072969756,0.00024197057,0.000010507314,0.000037761944,0.0006517076],"study_design_scores_gemma":[0.000026931366,0.00087187387,0.99792117,0.000010121141,0.00008289379,0.0002258545,0.0006269645,0.000031863063,0.000046843346,0.000007724078,0.00014308469,0.000004686017],"about_ca_topic_score_codex":0.0035534545,"about_ca_topic_score_gemma":0.0044323467,"teacher_disagreement_score":0.0035534545,"about_ca_system_score_codex":0.0002718416,"about_ca_system_score_gemma":0.00038926807,"threshold_uncertainty_score":0.0070655346},"labels":[],"label_agreement":null},{"id":"W3208329881","doi":"10.1007/s40264-021-01128-1","title":"Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Acute Pancreatitis: A Population-Based Cohort Study","year":2021,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Hazard ratio; Acute pancreatitis; Propensity score matching; Internal medicine; Cohort; Number needed to harm; Incidence (geometry); Population; Proportional hazards model; Defined daily dose; ACE inhibitor; Angiotensin-converting enzyme; Number needed to treat; Confidence interval; Relative risk; Pharmacology; Medical prescription; Blood pressure","score_opus":0.005743169677606608,"score_gpt":0.23934915470946494,"score_spread":0.23360598503185834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208329881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989484,0.00016032413,0.0001338585,0.00004496579,0.000012207562,0.00001598727,0.00041358327,0.0000054814554,0.00026523427],"genre_scores_gemma":[0.99898833,0.00012401014,0.000116487085,0.00005719062,0.000024523177,0.000019033829,0.00039915647,0.0000047446683,0.00026649033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900776,0.0002305082,0.00009567013,0.00034108578,0.00014988957,0.00017513843],"domain_scores_gemma":[0.99851996,0.00020717374,0.00043105928,0.00034771988,0.00016963993,0.00032455564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010223463,0.00071991363,0.0008030839,0.0009570631,0.0010323141,0.0014418234,0.00062627567,0.0012726124,0.002218067],"category_scores_gemma":[0.0018453388,0.0011603362,0.0021430005,0.0016874501,0.00056413544,0.0012197405,0.0008203733,0.0019006216,0.00048080427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010536856,0.00031813068,0.99573094,0.000012441228,0.0008427068,0.00020295517,0.00010804164,0.000051300034,0.00077040703,0.000031047046,0.00016843139,0.0007098547],"study_design_scores_gemma":[0.00014459013,0.00053893455,0.9973482,0.0000064182195,0.0004898832,0.0005025756,0.0002850489,0.00032795974,0.00008825545,0.00004711197,0.00020267311,0.000018206205],"about_ca_topic_score_codex":0.007617907,"about_ca_topic_score_gemma":0.0067979405,"teacher_disagreement_score":0.007617907,"about_ca_system_score_codex":0.0005049678,"about_ca_system_score_gemma":0.0006856171,"threshold_uncertainty_score":0.01514715},"labels":[],"label_agreement":null},{"id":"W32227235","doi":"10.2165/00002018-200831050-00003","title":"Improving Global Monitoring of Vaccine Safety","year":2008,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Ottawa","funders":"","keywords":"Medicine; Intensive care medicine; Vaccine safety; Immunology; Immunization","score_opus":0.07106683433441272,"score_gpt":0.4053396881695194,"score_spread":0.33427285383510663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W32227235","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5030327,0.069972,0.17662314,0.11085572,0.0026057544,0.0018004302,0.018739277,0.00644513,0.10992587],"genre_scores_gemma":[0.9106574,0.012361243,0.0538343,0.011084738,0.0015708274,0.00050247094,0.00651498,0.0002323693,0.0032417034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98418206,0.008993402,0.0017109565,0.0016063862,0.0028994726,0.00060775375],"domain_scores_gemma":[0.9144153,0.025714643,0.020316385,0.008211804,0.02806635,0.003275646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037677992,0.0010095676,0.0012330983,0.0048330002,0.00036444518,0.0021702358,0.0013669553,0.0012595088,0.002863039],"category_scores_gemma":[0.048817128,0.0003821436,0.0007881096,0.0032309487,0.000553267,0.0038074956,0.0021045853,0.0020745636,0.0008775532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003658654,0.00030538603,0.40006983,0.0009059298,0.0005385037,0.00007769602,0.0005520787,0.0031193264,0.004538929,0.0018911023,0.024694584,0.5629407],"study_design_scores_gemma":[0.00022275634,0.0020926073,0.8426255,0.0014537304,0.0011650069,0.00083511375,0.0011937403,0.008828234,0.010000323,0.005075036,0.1264211,0.00008682223],"about_ca_topic_score_codex":0.005018406,"about_ca_topic_score_gemma":0.005213931,"teacher_disagreement_score":0.037677992,"about_ca_system_score_codex":0.0016919031,"about_ca_system_score_gemma":0.0042740847,"threshold_uncertainty_score":0.19926262},"labels":[],"label_agreement":null},{"id":"W414070677","doi":"10.2165/00002018-200124150-00001","title":"Disclosure of Adverse Events and Errors in Healthcare","year":2001,"lang":"en","type":"article","venue":"Drug Safety","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Health care; Honesty; Patient safety; Adverse effect; Malpractice; Openness to experience; Medical emergency; Nursing; Family medicine; Psychology; Social psychology","score_opus":0.03627636029872138,"score_gpt":0.38544544017237753,"score_spread":0.34916907987365614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W414070677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5462908,0.029096507,0.011712588,0.23124978,0.0059344843,0.00050871767,0.009100527,0.00021930248,0.16588736],"genre_scores_gemma":[0.96582276,0.0086111855,0.0034405363,0.010200166,0.0031779741,0.00016500027,0.0018511475,0.000012737561,0.006718471],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9613211,0.02370708,0.007108754,0.0006821716,0.006201158,0.0009797625],"domain_scores_gemma":[0.6663391,0.19563772,0.096007854,0.013639281,0.02203611,0.0063400073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01977925,0.0002001848,0.00042658325,0.002547091,0.0011394281,0.0020225,0.0004311814,0.0034511678,0.0040767575],"category_scores_gemma":[0.16870606,0.00023788556,0.00042715517,0.0028060034,0.0008686988,0.0019190265,0.0019695312,0.0024168256,0.0006714288],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009984776,0.0004573158,0.61093956,0.0013445084,0.00021516289,0.0017982128,0.0068862243,0.0006559805,0.0006649696,0.024283372,0.08328208,0.26847413],"study_design_scores_gemma":[0.00018789475,0.0012068974,0.68912405,0.0044409167,0.00030698598,0.015398005,0.00835367,0.004744516,0.0031072819,0.027549513,0.24541831,0.0001618985],"about_ca_topic_score_codex":0.00081752025,"about_ca_topic_score_gemma":0.00084408204,"teacher_disagreement_score":0.01977925,"about_ca_system_score_codex":0.0008012196,"about_ca_system_score_gemma":0.0023647791,"threshold_uncertainty_score":0.104603946},"labels":[],"label_agreement":null},{"id":"W4220916416","doi":"10.1007/s40264-022-01166-3","title":"Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data","year":2022,"lang":"en","type":"letter","venue":"Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Drug; Rhabdomyolysis; Drug-drug interaction; Myopathy; Pharmacology; Drug interaction; Adverse effect; Transporter; Statin; Internal medicine","score_opus":0.027004083362397423,"score_gpt":0.2980044733781853,"score_spread":0.2710003900157879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220916416","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02471743,0.001605325,0.0011277114,0.9517041,0.00961418,0.00007775214,0.0017442298,0.000068287016,0.009341008],"genre_scores_gemma":[0.103922166,0.001765799,0.0019762248,0.85402036,0.030275764,0.000144417,0.0006218141,0.000064144886,0.0072093294],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9882613,0.005697788,0.0020194787,0.0007269471,0.002562853,0.0007316662],"domain_scores_gemma":[0.9262315,0.053959955,0.0069533866,0.0016177556,0.007916057,0.0033213603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012855454,0.00038635207,0.0009899357,0.0016379943,0.0014917062,0.0024462952,0.00084766955,0.009796574,0.0018070516],"category_scores_gemma":[0.054346085,0.0004846857,0.0015077112,0.0023522133,0.00093926536,0.001274614,0.0010113708,0.008629806,0.0013718284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010560675,0.00024814557,0.13065207,0.00017457988,0.00067205814,0.00700488,0.0005000865,0.0004228903,0.0007183357,0.0051428014,0.79688156,0.056526676],"study_design_scores_gemma":[0.0015378365,0.0013085828,0.2505742,0.0018636255,0.0019488643,0.015890237,0.003572506,0.013398277,0.0016019597,0.018055955,0.68973595,0.0005119465],"about_ca_topic_score_codex":0.015701078,"about_ca_topic_score_gemma":0.036414567,"teacher_disagreement_score":0.015701078,"about_ca_system_score_codex":0.0029142878,"about_ca_system_score_gemma":0.0035026132,"threshold_uncertainty_score":0.067986965},"labels":[],"label_agreement":null},{"id":"W4221065767","doi":"10.1007/s40264-022-01165-4","title":"Improving the Safety of Medicines via Digital Technology: An Assessment of the Scope and Quality of Risk Minimization Websites in the United States and United Kingdom","year":2022,"lang":"en","type":"article","venue":"Drug Safety","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Public Health Ontario","funders":"","keywords":"Medicine; eHealth; Usability; Scope (computer science); Quality (philosophy); Patient safety; Alliance; Health care; Computer science","score_opus":0.03615088166061262,"score_gpt":0.41981264564566706,"score_spread":0.3836617639850544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221065767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165994,0.0051793177,0.00036643626,0.00045473035,0.0000102168315,0.00013811834,0.00036625392,0.000013327166,0.0018117186],"genre_scores_gemma":[0.99612683,0.002211954,0.00092711224,0.00017623382,0.000009735966,0.00005118992,0.0003041341,0.000008168163,0.00018466187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96756583,0.008749931,0.009290952,0.0009735867,0.012736472,0.00068321585],"domain_scores_gemma":[0.8527499,0.058913544,0.0515809,0.0030240864,0.030512301,0.0032193505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019173209,0.00022973199,0.0005733633,0.0070077595,0.0006800593,0.0030993137,0.0005654088,0.000897121,0.0009241866],"category_scores_gemma":[0.07493863,0.00043378302,0.0007902944,0.004846511,0.0016939733,0.0025250101,0.0025069676,0.0005552767,0.00018708521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007515408,0.000152935,0.9187236,0.0015231763,0.0002376279,0.00041731866,0.009131222,0.0002478146,0.0018588207,0.00027455756,0.00064160506,0.066039845],"study_design_scores_gemma":[0.000021023632,0.0007109942,0.99119544,0.0005315501,0.00010104046,0.00059309613,0.003602178,0.0003130886,0.00073577097,0.00003811316,0.0021212506,0.000036399375],"about_ca_topic_score_codex":0.009504944,"about_ca_topic_score_gemma":0.0136798825,"teacher_disagreement_score":0.019173209,"about_ca_system_score_codex":0.0028752142,"about_ca_system_score_gemma":0.0021450121,"threshold_uncertainty_score":0.101398826},"labels":[],"label_agreement":null},{"id":"W4224232536","doi":"10.1007/s40264-022-01175-2","title":"Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study","year":2022,"lang":"en","type":"article","venue":"Drug Safety","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of British Columbia; Government of British Columbia; York University; Dalhousie University; University of Victoria","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research","keywords":"Medicine; Hydroxyzine; Cohort; Cohort study; Relative risk; Confidence interval; Internal medicine; Pediatrics; Anesthesia","score_opus":0.006660392849988586,"score_gpt":0.23235899690624004,"score_spread":0.22569860405625145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224232536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962798,0.0007288256,0.00008829056,0.00025221828,0.00001333512,0.0000365782,0.0018618909,0.0000059878503,0.0007331362],"genre_scores_gemma":[0.99806064,0.0003195926,0.000098511366,0.00016844881,0.000009426291,0.000017264216,0.0010066858,0.0000035748087,0.00031589877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983012,0.00019436987,0.0001476932,0.00039523788,0.00050861685,0.00045292274],"domain_scores_gemma":[0.9940404,0.0005018497,0.0024469087,0.00035049597,0.0017101207,0.00095018256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010647714,0.0002889608,0.00048163478,0.0008294746,0.0012247588,0.0012339613,0.00094609347,0.00066756346,0.0018608468],"category_scores_gemma":[0.005099654,0.00038048782,0.0009586799,0.0025145856,0.00058584637,0.0005494268,0.00080770714,0.000993982,0.0001942828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014279151,0.00001778628,0.99835455,0.00001428823,0.00009284606,0.000030748823,0.00015763687,0.000024935853,0.000045453526,0.000023749522,0.00026939609,0.00082573836],"study_design_scores_gemma":[0.000015789814,0.00004010001,0.9991947,0.000022609041,0.00006115256,0.000051267518,0.00021143045,0.00012634374,0.000023556635,0.000010281008,0.00023603467,0.0000066592916],"about_ca_topic_score_codex":0.8844079,"about_ca_topic_score_gemma":0.8869337,"teacher_disagreement_score":0.11559212,"about_ca_system_score_codex":0.006742527,"about_ca_system_score_gemma":0.008658209,"threshold_uncertainty_score":0.23254567},"labels":[],"label_agreement":null},{"id":"W4237684392","doi":"10.1007/s40264-020-01019-x","title":"Acknowledgement to Referees","year":2020,"lang":"en","type":"article","venue":"Drug Safety","topic":"Legal principles and applications","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Medicine; Acknowledgement; Family medicine","score_opus":0.0440305095228658,"score_gpt":0.3307043194318489,"score_spread":0.2866738099089831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237684392","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014070637,0.012409776,0.008767163,0.35958493,0.52935636,0.0011413674,0.023357268,0.003613127,0.0603629],"genre_scores_gemma":[0.028662268,0.0074101705,0.015075969,0.14949408,0.12352012,0.0028309363,0.014165944,0.0039859186,0.65485466],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9794098,0.0068838643,0.0023686574,0.0020152295,0.008426308,0.0008961887],"domain_scores_gemma":[0.70857054,0.04106942,0.007088276,0.01194676,0.22324039,0.008084553],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011223412,0.0015534799,0.002851189,0.012357777,0.004444515,0.0064580753,0.0036490022,0.0044885124,0.31087798],"category_scores_gemma":[0.20602666,0.0007652102,0.0022046347,0.0072295354,0.0015040918,0.0042197737,0.0060776602,0.0072771804,0.12045539],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025832815,0.00001089651,0.00009891394,0.0001679463,0.000009964368,0.00011449984,0.000210841,0.000056152752,0.0001741454,0.0015905129,0.99200106,0.005539272],"study_design_scores_gemma":[0.00002844378,0.000011011778,0.0008815953,0.0003871683,0.00004070072,0.000248103,0.0007724171,0.00030048334,0.00021815186,0.0032421825,0.99382293,0.000046825433],"about_ca_topic_score_codex":0.0368021,"about_ca_topic_score_gemma":0.0328613,"teacher_disagreement_score":0.31087798,"about_ca_system_score_codex":0.009546257,"about_ca_system_score_gemma":0.01032998,"threshold_uncertainty_score":0.9829489},"labels":[],"label_agreement":null},{"id":"W4241696871","doi":"10.2165/11641780-000000000-00000","title":"The Authorsʼ Reply","year":2012,"lang":"en","type":"article","venue":"Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine","score_opus":0.018875409388820145,"score_gpt":0.30654524364197866,"score_spread":0.2876698342531585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241696871","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029503327,0.0011107203,0.000071582945,0.9618505,0.03583956,0.0000080951095,0.00003904005,0.00002157033,0.000763826],"genre_scores_gemma":[0.002267536,0.000423268,0.00010611573,0.97466666,0.01987766,0.000020100992,0.000010392585,0.000015402973,0.002612798],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938013,0.0014151682,0.0007871873,0.0013913598,0.0017616168,0.00084333995],"domain_scores_gemma":[0.96985584,0.014396288,0.002807354,0.0013444191,0.008387201,0.003208794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065104566,0.00077324454,0.0022701954,0.0011886322,0.0048408085,0.005896016,0.0035536622,0.07011015,0.0091924425],"category_scores_gemma":[0.06700749,0.0013197723,0.0020609293,0.00088320486,0.0045704697,0.004424331,0.003776658,0.07811274,0.0068546114],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051352537,0.000017855646,0.0005914396,0.000059254842,0.000046557278,0.0008787193,0.00032626768,0.000036439273,0.00016882001,0.0024362768,0.9922867,0.0031003854],"study_design_scores_gemma":[0.00009424004,0.0000532727,0.001437852,0.00031705017,0.000089912464,0.0014288411,0.0010795837,0.00020069082,0.00049783755,0.006084505,0.9885678,0.00014835162],"about_ca_topic_score_codex":0.0062856358,"about_ca_topic_score_gemma":0.007502247,"teacher_disagreement_score":0.07011015,"about_ca_system_score_codex":0.0039619557,"about_ca_system_score_gemma":0.006981608,"threshold_uncertainty_score":0.03443098},"labels":[],"label_agreement":null},{"id":"W4242429010","doi":"10.1007/bf03262004","title":"The Authors’ Reply","year":2012,"lang":"en","type":"article","venue":"Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Medical physics","score_opus":0.01999188179189815,"score_gpt":0.30747105701676536,"score_spread":0.2874791752248672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242429010","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027150594,0.0010681842,0.000070632625,0.9504679,0.04714544,0.000009097089,0.000041465635,0.000021086233,0.0009047359],"genre_scores_gemma":[0.0020053799,0.00042185246,0.00009852824,0.97159594,0.022619171,0.00002257502,0.000012364664,0.000018022249,0.0032061117],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99211544,0.00189255,0.0010018413,0.0015680891,0.0023702064,0.0010518649],"domain_scores_gemma":[0.9642989,0.017035378,0.0030564165,0.0015764136,0.010555906,0.0034770088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007123193,0.0007715976,0.0022249455,0.0013696301,0.0047111553,0.0062190285,0.003554049,0.06704626,0.012304303],"category_scores_gemma":[0.07203018,0.0012185593,0.001970584,0.00086875097,0.0048704143,0.004726478,0.003950036,0.07267356,0.008235385],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004298086,0.000014840564,0.00039719406,0.00006226358,0.000040576855,0.00058597635,0.0002883295,0.000029714987,0.00013369009,0.0022381642,0.99354136,0.0026248568],"study_design_scores_gemma":[0.00010579668,0.000044556316,0.001144151,0.0003341144,0.000081235106,0.0010908364,0.0010558486,0.00015325185,0.00044127335,0.0051531885,0.99026525,0.00013060372],"about_ca_topic_score_codex":0.005161787,"about_ca_topic_score_gemma":0.0056267986,"teacher_disagreement_score":0.06704626,"about_ca_system_score_codex":0.004147315,"about_ca_system_score_gemma":0.0075406223,"threshold_uncertainty_score":0.041162014},"labels":[],"label_agreement":null},{"id":"W4242657250","doi":"10.1007/s40264-014-0217-0","title":"Erratum to: Adverse Gastrointestinal Events with Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Nested Case–Control Study","year":2014,"lang":"en","type":"erratum","venue":"Drug Safety","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre; University of Toronto; Mount Sinai Hospital; Institute for Clinical Evaluative Sciences; Kingston General Hospital; McMaster University; Queen's University","funders":"","keywords":"Medicine; Nested case-control study; Adverse effect; Vascular endothelial growth factor; Pharmacology; VEGF receptors; Case-control study; Internal medicine","score_opus":0.0073775185566138934,"score_gpt":0.23645588704906093,"score_spread":0.22907836849244703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242657250","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04529713,0.030267822,0.005973805,0.13561709,0.74376774,0.0009339115,0.02498632,0.0006296903,0.012526554],"genre_scores_gemma":[0.40964866,0.024508893,0.01719414,0.27867508,0.13820054,0.0013975532,0.019355956,0.00089352694,0.11012569],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99593323,0.00079717697,0.0017170107,0.00040987262,0.0009700408,0.00017266472],"domain_scores_gemma":[0.9765297,0.012654659,0.0038641372,0.0012655768,0.0053093806,0.00037642804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042126244,0.0010172917,0.0013451357,0.0017856514,0.00084091065,0.0008264974,0.00084967096,0.002877553,0.009247073],"category_scores_gemma":[0.041529164,0.0006653601,0.0015792662,0.0015215744,0.00048298645,0.0006239167,0.0003642765,0.0019187124,0.0021640873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001931187,0.00018087093,0.039062463,0.0021341387,0.0011717313,0.007937387,0.000120294964,0.0002195238,0.00030340833,0.000872609,0.9220198,0.024046667],"study_design_scores_gemma":[0.004358904,0.0009860254,0.24691778,0.006738097,0.006619161,0.028870525,0.0008711367,0.002779701,0.0025290733,0.002732453,0.6961592,0.00043802167],"about_ca_topic_score_codex":0.008476226,"about_ca_topic_score_gemma":0.009524487,"teacher_disagreement_score":0.009247073,"about_ca_system_score_codex":0.0013326692,"about_ca_system_score_gemma":0.0012844837,"threshold_uncertainty_score":0.030934513},"labels":[],"label_agreement":null},{"id":"W4243988069","doi":"10.1007/s40264-015-0322-8","title":"Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance","year":2015,"lang":"en","type":"erratum","venue":"Drug Safety","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Observational study; Drug; General partnership; Analytics; Data science; Intensive care medicine; Medical physics; Pharmacology; Internal medicine","score_opus":0.6190234269161506,"score_gpt":0.5237515137269193,"score_spread":0.09527191318923134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243988069","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010971056,0.0020055978,0.0027676483,0.18593602,0.7850781,0.00015237156,0.00924946,0.0004257946,0.013287948],"genre_scores_gemma":[0.038405053,0.010377343,0.027084937,0.34467697,0.18766418,0.0009618676,0.022519354,0.002772035,0.3655383],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98996747,0.002142958,0.0023961435,0.0006767373,0.0044571077,0.00035955952],"domain_scores_gemma":[0.86498207,0.053368036,0.0048930757,0.0054153195,0.06904365,0.002297903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0123190945,0.0012061617,0.001382781,0.0042353785,0.0025410736,0.0038212528,0.0021554602,0.0048583187,0.03664798],"category_scores_gemma":[0.21555696,0.000900155,0.0014673308,0.0037014575,0.001616375,0.0025711406,0.0015746969,0.0064025503,0.016396534],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028615694,0.000011741797,0.0002708542,0.0000663279,0.000008779217,0.00006210107,0.000019859013,0.000071787494,0.000011502748,0.0012546143,0.99367464,0.0045190565],"study_design_scores_gemma":[0.00013137904,0.00008193008,0.00591186,0.0016400494,0.00014456907,0.0005018089,0.0005345351,0.0015146035,0.0005093293,0.007853308,0.9810604,0.000116086434],"about_ca_topic_score_codex":0.04188407,"about_ca_topic_score_gemma":0.061089765,"teacher_disagreement_score":0.04188407,"about_ca_system_score_codex":0.0049030553,"about_ca_system_score_gemma":0.012175554,"threshold_uncertainty_score":0.12259972},"labels":[],"label_agreement":null},{"id":"W4246462925","doi":"10.2165/11631510-000000000-00000","title":"Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders","year":2012,"lang":"en","type":"article","venue":"Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institut universitaire en santé mentale de Montréal","funders":"","keywords":"Olanzapine; Medicine; Akathisia; Extrapyramidal symptoms; Adverse effect; Tolerability; Psychiatry; Bipolar disorder; Tardive dyskinesia; Randomized controlled trial; Mania; Schizophrenia (object-oriented programming); Internal medicine; Antipsychotic; Mood","score_opus":0.015842044160158997,"score_gpt":0.28273057378372557,"score_spread":0.2668885296235666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246462925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748933,0.0015914359,0.00012510804,0.00008489285,0.000036169688,0.000039225368,0.00017106472,0.000007331084,0.0004553767],"genre_scores_gemma":[0.9989188,0.00045930472,0.000097755765,0.00006955071,0.000054267235,0.00001907535,0.00020543404,0.0000031787401,0.00017268656],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9981036,0.001162511,0.0002494815,0.00009355448,0.0002451994,0.00014557289],"domain_scores_gemma":[0.9972324,0.0012298529,0.0008449879,0.00011397984,0.000249818,0.0003290463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025846642,0.0004042074,0.00063464907,0.00045776277,0.000192896,0.00057851896,0.00024226353,0.00044604868,0.0016123519],"category_scores_gemma":[0.0045104437,0.00017253536,0.0014297843,0.00032348212,0.00037736387,0.0007573113,0.00031256097,0.0007256939,0.00017364445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83231145,0.00210488,0.064013086,0.0006489912,0.004090812,0.0002670459,0.00033009436,0.0011829444,0.018637165,0.00022836876,0.0005018156,0.07568339],"study_design_scores_gemma":[0.060938023,0.4598952,0.45202374,0.00015597657,0.006576755,0.00092990993,0.001009664,0.0033732753,0.0117385825,0.0008581928,0.0023771129,0.00012353563],"about_ca_topic_score_codex":0.001847353,"about_ca_topic_score_gemma":0.0035190047,"teacher_disagreement_score":0.0025846642,"about_ca_system_score_codex":0.0012455359,"about_ca_system_score_gemma":0.0007241599,"threshold_uncertainty_score":0.013669193},"labels":[],"label_agreement":null},{"id":"W4249278919","doi":"10.1007/bf03262006","title":"The Authors’ Reply","year":2012,"lang":"en","type":"article","venue":"Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Traditional medicine; Pharmacology","score_opus":0.01999188179189815,"score_gpt":0.30747105701676536,"score_spread":0.2874791752248672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249278919","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027150594,0.0010681842,0.000070632625,0.9504679,0.04714544,0.000009097089,0.000041465635,0.000021086233,0.0009047359],"genre_scores_gemma":[0.0020053799,0.00042185246,0.00009852824,0.97159594,0.022619171,0.00002257502,0.000012364664,0.000018022249,0.0032061117],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99211544,0.00189255,0.0010018413,0.0015680891,0.0023702064,0.0010518649],"domain_scores_gemma":[0.9642989,0.017035378,0.0030564165,0.0015764136,0.010555906,0.0034770088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007123193,0.0007715976,0.0022249455,0.0013696301,0.0047111553,0.0062190285,0.003554049,0.06704626,0.012304303],"category_scores_gemma":[0.07203018,0.0012185593,0.001970584,0.00086875097,0.0048704143,0.004726478,0.003950036,0.07267356,0.008235385],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004298086,0.000014840564,0.00039719406,0.00006226358,0.000040576855,0.00058597635,0.0002883295,0.000029714987,0.00013369009,0.0022381642,0.99354136,0.0026248568],"study_design_scores_gemma":[0.00010579668,0.000044556316,0.001144151,0.0003341144,0.000081235106,0.0010908364,0.0010558486,0.00015325185,0.00044127335,0.0051531885,0.99026525,0.00013060372],"about_ca_topic_score_codex":0.005161787,"about_ca_topic_score_gemma":0.0056267986,"teacher_disagreement_score":0.06704626,"about_ca_system_score_codex":0.004147315,"about_ca_system_score_gemma":0.0075406223,"threshold_uncertainty_score":0.041162014},"labels":[],"label_agreement":null},{"id":"W4251796871","doi":"10.1007/s40264-019-00816-3","title":"Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs","year":2019,"lang":"en","type":"erratum","venue":"Drug Safety","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Ustekinumab; Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Crohn's disease; Crohn disease; Disease; Internal medicine; Adalimumab","score_opus":0.021662398114034052,"score_gpt":0.34313160117599306,"score_spread":0.32146920306195903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251796871","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018194113,0.0010480599,0.0006440139,0.05377114,0.9366824,0.00003313309,0.0029957686,0.00046623504,0.0041772677],"genre_scores_gemma":[0.0150656225,0.01220273,0.009091844,0.19416972,0.40343973,0.00032458972,0.010773931,0.0034716506,0.3514601],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99099606,0.001351003,0.0016135345,0.00087431853,0.004451625,0.00071357586],"domain_scores_gemma":[0.9308816,0.01930761,0.0039325776,0.003232525,0.03967721,0.0029685332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00635886,0.0019010123,0.0016662865,0.00475869,0.0029361297,0.0050745886,0.0024913917,0.0054642684,0.06059624],"category_scores_gemma":[0.0795556,0.0011128162,0.0016064002,0.004273655,0.001730415,0.0020746626,0.0016404814,0.010380954,0.039852887],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027145647,0.000007019158,0.00006318014,0.00007463192,0.0000066879297,0.00005560335,0.000012113395,0.000025609574,0.00002186304,0.00031338466,0.99432737,0.005065416],"study_design_scores_gemma":[0.00006334546,0.000032707267,0.00084447645,0.00045118987,0.000038103142,0.0002946752,0.000059764734,0.0001944837,0.00027134537,0.0007519992,0.99696344,0.00003430269],"about_ca_topic_score_codex":0.021180905,"about_ca_topic_score_gemma":0.030162103,"teacher_disagreement_score":0.06059624,"about_ca_system_score_codex":0.0047572716,"about_ca_system_score_gemma":0.010276839,"threshold_uncertainty_score":0.20271462},"labels":[],"label_agreement":null},{"id":"W4253160129","doi":"10.2165/11599540-000000000-00000","title":"Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments","year":2012,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; St. Michael's Hospital; Toronto Rehabilitation Institute; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Polypharmacy; Incidence (geometry); Emergency department; Emergency medicine; Pharmacy; Population; Retrospective cohort study; Logistic regression; Health care; Pediatrics; Family medicine; Environmental health; Internal medicine","score_opus":0.03465783627299796,"score_gpt":0.3250553486068341,"score_spread":0.29039751233383615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253160129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381036,0.0009148055,0.00004335387,0.0006302146,0.000011096701,0.00003582814,0.002320703,0.0000050088015,0.0022286144],"genre_scores_gemma":[0.9977005,0.0008775431,0.00008859659,0.00008681738,0.000018543742,0.000012801987,0.00095663115,0.0000013732595,0.00025725813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989943,0.00011759829,0.00009478838,0.000084600026,0.000483468,0.00022516867],"domain_scores_gemma":[0.99689806,0.00016823092,0.0017406489,0.00005911056,0.00060982455,0.0005242322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043075476,0.00020640928,0.00023882026,0.0011002403,0.0007807729,0.0007572742,0.0004996784,0.00025879554,0.0017922882],"category_scores_gemma":[0.0031697073,0.00024236544,0.00045711154,0.0017905674,0.00038626406,0.0002914223,0.0007631305,0.00040237303,0.000111611254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034157616,0.000015410425,0.9966487,0.000026263235,0.000037739257,0.0001291492,0.00010289555,0.00007758436,0.00004911258,0.000034869936,0.00059825234,0.0022458043],"study_design_scores_gemma":[0.0000031904467,0.0000104458495,0.99939,0.000013538717,0.000008124845,0.00007332837,0.00012302004,0.00010318398,0.0000050114186,0.000008211357,0.0002600351,0.0000018635498],"about_ca_topic_score_codex":0.7740017,"about_ca_topic_score_gemma":0.84072286,"teacher_disagreement_score":0.22599828,"about_ca_system_score_codex":0.011076259,"about_ca_system_score_gemma":0.007377888,"threshold_uncertainty_score":0.45465845},"labels":[],"label_agreement":null},{"id":"W4283077601","doi":"10.1007/s40264-022-01192-1","title":"Authors’ Reply to Noguchi’s comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.”","year":2022,"lang":"en","type":"letter","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Drug; Myopathy; Pharmacology; Transporter; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Adverse drug reaction; Drug-drug interaction; Drug reaction; Statin; Adverse effect; Internal medicine; Biochemistry","score_opus":0.11189344049358511,"score_gpt":0.43026414368380944,"score_spread":0.3183707031902243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283077601","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024735456,0.0005861653,0.00006761323,0.9796681,0.018127639,0.000011445348,0.000118893506,0.000028686829,0.0011440634],"genre_scores_gemma":[0.00072979846,0.00019461979,0.00007987241,0.9891479,0.007817908,0.000017117454,0.000019871104,0.000013693976,0.0019792165],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99249,0.0016558606,0.0012864472,0.0010457439,0.0024549942,0.0010668765],"domain_scores_gemma":[0.97995925,0.011020934,0.001285513,0.000466202,0.005077407,0.0021907652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009001132,0.0010195941,0.0019190921,0.0012990204,0.0051077697,0.004833952,0.0036694848,0.07408251,0.0079272315],"category_scores_gemma":[0.042830944,0.0013863425,0.0027104148,0.0014191524,0.0035990824,0.004367918,0.0021439274,0.05413541,0.009773649],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050689938,0.000020345213,0.0005929132,0.00003509325,0.000021004695,0.00070459116,0.00010844609,0.00003453488,0.00011355041,0.0008345308,0.99496764,0.0025166087],"study_design_scores_gemma":[0.00021870562,0.000099497905,0.0032647513,0.0005487575,0.00011240031,0.0017544194,0.0008165136,0.00042471776,0.00058719027,0.0062024416,0.9857611,0.00020963747],"about_ca_topic_score_codex":0.02147946,"about_ca_topic_score_gemma":0.034617897,"teacher_disagreement_score":0.07408251,"about_ca_system_score_codex":0.0051650326,"about_ca_system_score_gemma":0.010419803,"threshold_uncertainty_score":0.04760313},"labels":[],"label_agreement":null},{"id":"W4292266545","doi":"10.1007/s40264-022-01221-z","title":"Analytical Approaches to Reduce Selection Bias in As-Treated Analyses with Missing In-Hospital Drug Information","year":2022,"lang":"en","type":"article","venue":"Drug Safety","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Korea Health Industry Development Institute; Ministry of Food and Drug Safety","keywords":"Medicine; Inverse probability weighting; Discontinuation; Hazard ratio; Selection bias; Proportional hazards model; Censoring (clinical trials); Medical prescription; Missing data; Emergency medicine; Confidence interval; Information bias; Internal medicine; Statistics; Propensity score matching; Pharmacology","score_opus":0.22544401059947272,"score_gpt":0.39293869514155394,"score_spread":0.16749468454208122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292266545","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018305271,0.00040382493,0.99591464,0.00084803265,0.000111076646,0.000121002224,0.00011379927,0.00014537295,0.00051168056],"genre_scores_gemma":[0.13955921,0.0013113366,0.85076433,0.0016200516,0.0010659627,0.0013861827,0.00046676284,0.00025173413,0.0035743609],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9359689,0.05583774,0.0015331531,0.0026926002,0.0032868255,0.00068079797],"domain_scores_gemma":[0.7134031,0.25935748,0.007183869,0.01386696,0.0052246465,0.00096401665],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09318324,0.0020497367,0.0034691175,0.0052180216,0.0015792293,0.0032337492,0.0063273204,0.002703299,0.009930331],"category_scores_gemma":[0.27281144,0.0015490553,0.0049140323,0.005429093,0.0030979074,0.0039522583,0.003959328,0.0065651913,0.0010237006],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008727471,0.00069247687,0.010256433,0.001659959,0.0053558284,0.0010413777,0.0013232807,0.0704837,0.0012590111,0.6382352,0.014488138,0.25433186],"study_design_scores_gemma":[0.00031267919,0.00016195304,0.001220833,0.00015059003,0.000682622,0.00018729761,0.00013724735,0.208734,0.0005862025,0.7820896,0.0056975214,0.00003944138],"about_ca_topic_score_codex":0.0025654328,"about_ca_topic_score_gemma":0.0029533375,"teacher_disagreement_score":0.9068168,"about_ca_system_score_codex":0.0013057261,"about_ca_system_score_gemma":0.0054851035,"threshold_uncertainty_score":0.49280596},"labels":[],"label_agreement":null},{"id":"W4306875463","doi":"10.1007/s40264-022-01250-8","title":"Acknowledgement to Referees","year":2022,"lang":"en","type":"article","venue":"Drug Safety","topic":"Academic Publishing and Open Access","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University","keywords":"Medicine; Acknowledgement; Family medicine; Medical education","score_opus":0.07484939140585879,"score_gpt":0.3950007068293421,"score_spread":0.3201513154234833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306875463","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011022629,0.009707998,0.008497968,0.3701443,0.55878705,0.0009071275,0.017723065,0.0029481477,0.030182125],"genre_scores_gemma":[0.03766573,0.007872975,0.020105422,0.22101197,0.20565091,0.0031852482,0.015335916,0.004813037,0.4843589],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96404594,0.011607882,0.004105862,0.0031621363,0.015642345,0.0014359357],"domain_scores_gemma":[0.5244608,0.059101257,0.01156564,0.018095827,0.37507588,0.011700615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01727372,0.001743036,0.0032530478,0.011221538,0.003664464,0.007859929,0.0038658765,0.005387781,0.25763425],"category_scores_gemma":[0.30281523,0.0007584662,0.0025720163,0.0067849588,0.0018289741,0.0042863553,0.006678247,0.008487795,0.10429192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035908775,0.000011953823,0.00011138155,0.00018407269,0.000013835237,0.00014200181,0.0001912648,0.00006936063,0.00022834382,0.0014504724,0.99187344,0.0056879404],"study_design_scores_gemma":[0.000044282737,0.000015391406,0.000981945,0.0004939181,0.00005523804,0.00035651217,0.00077083154,0.00043034367,0.00035170434,0.004559345,0.99187183,0.00006873731],"about_ca_topic_score_codex":0.029653724,"about_ca_topic_score_gemma":0.026286528,"teacher_disagreement_score":0.25763425,"about_ca_system_score_codex":0.010165185,"about_ca_system_score_gemma":0.012654554,"threshold_uncertainty_score":0.86187243},"labels":[],"label_agreement":null},{"id":"W4307642528","doi":"10.1007/s40264-022-01248-2","title":"Characterization of Serous Retinopathy Associated with Cobimetinib: Integrated Safety Analysis of Four Studies","year":2022,"lang":"en","type":"article","venue":"Drug Safety","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche; Roche","keywords":"Medicine; Serous fluid; Retinopathy; Ophthalmology; Internal medicine; Endocrinology","score_opus":0.013423989524145823,"score_gpt":0.22816094373591547,"score_spread":0.21473695421176964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307642528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9092876,0.07103195,0.0052523636,0.00034463685,0.00003914408,0.0026761799,0.0057756915,0.00011626148,0.0054762186],"genre_scores_gemma":[0.9893182,0.0040520355,0.0028202257,0.0002238372,0.000047218768,0.00066938787,0.0026286442,0.000016601165,0.00022380176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98580325,0.0062655243,0.0033755805,0.0009982941,0.0031135005,0.00044393365],"domain_scores_gemma":[0.94462776,0.017805466,0.027106114,0.0028754699,0.0066108694,0.0009743563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028135184,0.0008108056,0.0016261247,0.0045277397,0.0004648859,0.0023165068,0.00075706746,0.00074727344,0.001402153],"category_scores_gemma":[0.017995967,0.0002793201,0.00446535,0.003918576,0.0005353515,0.00081696844,0.0011797374,0.0006764234,0.00016971034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03202992,0.0007897637,0.73048073,0.010279798,0.05479211,0.0003777172,0.00046244907,0.0015546586,0.017208181,0.00022456246,0.0009714546,0.15082859],"study_design_scores_gemma":[0.0037973006,0.021562533,0.88422537,0.0021760112,0.05878721,0.0019529484,0.00033110238,0.0015204356,0.013248885,0.00043401375,0.01186256,0.000101640515],"about_ca_topic_score_codex":0.0006237987,"about_ca_topic_score_gemma":0.0016166292,"teacher_disagreement_score":0.028135184,"about_ca_system_score_codex":0.0012552823,"about_ca_system_score_gemma":0.0016215707,"threshold_uncertainty_score":0.14879483},"labels":[],"label_agreement":null},{"id":"W4364353207","doi":"10.1007/s40264-023-01290-8","title":"Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities","year":2023,"lang":"en","type":"article","venue":"Drug Safety","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pandemic; Virology; Coronavirus Infections; Betacoronavirus; Engineering ethics; Infectious disease (medical specialty); Outbreak; Disease; Pathology; Engineering","score_opus":0.16460686972046257,"score_gpt":0.3998933305873278,"score_spread":0.23528646086686522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4364353207","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072339256,0.06609404,0.017886385,0.89116013,0.008207155,0.00014797391,0.00030097566,0.00032648843,0.008642919],"genre_scores_gemma":[0.25699857,0.18346472,0.082280435,0.4404921,0.022789817,0.0005177527,0.00093329785,0.00064706156,0.011876294],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.928649,0.037949476,0.006968235,0.005917024,0.01730185,0.0032144308],"domain_scores_gemma":[0.67214084,0.19263674,0.019358354,0.011776086,0.09099665,0.013091223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10107615,0.0008258361,0.0011287002,0.0032828178,0.0019101413,0.012387547,0.0037351258,0.009919105,0.0044231657],"category_scores_gemma":[0.13946924,0.00061718386,0.0018222608,0.0024570872,0.004590858,0.012544601,0.006470334,0.013406529,0.0020762624],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002843692,0.00028938943,0.02274736,0.0051041143,0.0003066936,0.0011979757,0.010534373,0.0024572988,0.0048589953,0.029968187,0.32154426,0.600707],"study_design_scores_gemma":[0.000066734836,0.00063328055,0.014403251,0.013004735,0.00028960768,0.0015170842,0.01753829,0.0042466098,0.004408725,0.04502318,0.89845246,0.00041613998],"about_ca_topic_score_codex":0.0054469313,"about_ca_topic_score_gemma":0.0069317087,"teacher_disagreement_score":0.10107615,"about_ca_system_score_codex":0.005455232,"about_ca_system_score_gemma":0.015123078,"threshold_uncertainty_score":0.53454816},"labels":[],"label_agreement":null},{"id":"W4365811063","doi":"10.1007/s40264-023-01293-5","title":"Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data”","year":2023,"lang":"en","type":"letter","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Drug; Drug-drug interaction; Pharmacology; Myopathy; Transporter; Adverse effect; Drug interaction; Drug reaction; Internal medicine; Biochemistry","score_opus":0.12853240761187057,"score_gpt":0.4418769651472665,"score_spread":0.3133445575353959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365811063","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025830863,0.0005303865,0.00008797389,0.9784546,0.019300146,0.000014309898,0.00014539009,0.000024791538,0.0011840416],"genre_scores_gemma":[0.00064888276,0.00015995788,0.00008493039,0.98778874,0.009667726,0.000023781287,0.000020585758,0.0000116552155,0.0015937896],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98746896,0.0027147029,0.0022806283,0.0018815805,0.0035844333,0.0020696605],"domain_scores_gemma":[0.9617347,0.022545407,0.0034005295,0.0009839842,0.0073307706,0.0040045357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011081735,0.0011781417,0.0029169037,0.001883523,0.0060603735,0.0073114247,0.0036674263,0.10294278,0.007554077],"category_scores_gemma":[0.060084242,0.001964208,0.0031506948,0.0023144356,0.0040190774,0.0045333398,0.0031924725,0.07038575,0.00878401],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073273455,0.000026900098,0.00085460785,0.000052890817,0.00004618783,0.0006861789,0.0001780101,0.000050067378,0.00011955708,0.0014123512,0.99377453,0.0027253137],"study_design_scores_gemma":[0.000313003,0.00012879583,0.0050434745,0.0009969095,0.00019545502,0.0011461797,0.0010913532,0.00061964995,0.00046877033,0.009269909,0.98043764,0.00028877484],"about_ca_topic_score_codex":0.023680037,"about_ca_topic_score_gemma":0.043362435,"teacher_disagreement_score":0.10294278,"about_ca_system_score_codex":0.006521717,"about_ca_system_score_gemma":0.012475792,"threshold_uncertainty_score":0.058606565},"labels":[],"label_agreement":null},{"id":"W4366351869","doi":"10.1007/s40264-023-01295-3","title":"Implications of Non-Specific Effects for Testing, Approving, and Regulating Vaccines","year":2023,"lang":"en","type":"article","venue":"Drug Safety","topic":"Immune responses and vaccinations","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Medicine; Vaccination; Immunology; Licensure; Immunity; Disease; Diphtheria; Clinical trial; Tetanus; Attenuated vaccine; Intensive care medicine; Immune system; Internal medicine; Biology","score_opus":0.016591016404333424,"score_gpt":0.26737680716810863,"score_spread":0.2507857907637752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366351869","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024253521,0.07176704,0.22176456,0.54444766,0.010671733,0.0013014396,0.0013711666,0.0004729027,0.123950034],"genre_scores_gemma":[0.5693068,0.020721652,0.115132034,0.27213427,0.008796416,0.001860758,0.00035794318,0.00031004267,0.011380112],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8823804,0.06713528,0.008334386,0.012380713,0.024169475,0.005599803],"domain_scores_gemma":[0.76820356,0.17956844,0.0131596625,0.015902892,0.01953146,0.003633955],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14086424,0.0013802982,0.0024011917,0.0017338927,0.002286317,0.008466389,0.0061837784,0.012547017,0.0061919396],"category_scores_gemma":[0.15121382,0.00075394096,0.004057811,0.00097101764,0.02199019,0.009761441,0.004800727,0.019405993,0.0008368161],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028725612,0.0001601562,0.004294021,0.00084520545,0.00027934666,0.00047204192,0.0013078008,0.004199677,0.00092985865,0.9117841,0.015249819,0.060190827],"study_design_scores_gemma":[0.00016921664,0.00070360303,0.0055487473,0.0017764372,0.00040229308,0.0006165662,0.0006834167,0.004229789,0.0021242038,0.82002205,0.16355117,0.00017250609],"about_ca_topic_score_codex":0.008247678,"about_ca_topic_score_gemma":0.0058300416,"teacher_disagreement_score":0.85913575,"about_ca_system_score_codex":0.007812657,"about_ca_system_score_gemma":0.014394791,"threshold_uncertainty_score":0.7449702},"labels":[],"label_agreement":null},{"id":"W4380985505","doi":"10.1007/s40264-023-01324-1","title":"Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance","year":2023,"lang":"en","type":"article","venue":"Drug Safety","topic":"Data-Driven Disease Surveillance","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Comparator; Medicine; Calibration; Type I and type II errors; Sensitivity (control systems); Clinical study design; SIGNAL (programming language); Statistics; Computer science; Clinical trial; Internal medicine; Electronic engineering; Mathematics","score_opus":0.022609838332286584,"score_gpt":0.28569730298624707,"score_spread":0.2630874646539605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380985505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54893297,0.006101171,0.4310706,0.0016922915,0.00048151758,0.0026009378,0.0011408058,0.0010031038,0.00697653],"genre_scores_gemma":[0.8180981,0.00061319966,0.17816009,0.00071304105,0.0001716249,0.0009590635,0.0005981472,0.00006491244,0.00062173745],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.704862,0.26214227,0.008478646,0.011328185,0.012224752,0.0009640836],"domain_scores_gemma":[0.4964023,0.35507768,0.06424575,0.06643741,0.016121458,0.0017153615],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2558762,0.0017865449,0.0019213258,0.0023946543,0.00068544695,0.002421204,0.0028407248,0.0021182105,0.002403197],"category_scores_gemma":[0.36513183,0.0011132191,0.003149338,0.0021228874,0.0019936715,0.0027880764,0.00259289,0.0016008271,0.0006304147],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011178877,0.0013988062,0.50967854,0.0020879265,0.008633553,0.00021797263,0.0014794656,0.026899388,0.005164443,0.007775961,0.0019715214,0.4235135],"study_design_scores_gemma":[0.0039863004,0.07172164,0.565639,0.0023184856,0.0122773405,0.0019729026,0.0006588172,0.22199762,0.051102195,0.04592458,0.021848446,0.00055277545],"about_ca_topic_score_codex":0.0008376709,"about_ca_topic_score_gemma":0.001093344,"teacher_disagreement_score":0.7441238,"about_ca_system_score_codex":0.0012641709,"about_ca_system_score_gemma":0.0024757711,"threshold_uncertainty_score":0.9176371},"labels":[],"label_agreement":null},{"id":"W4382344417","doi":"10.1007/s40264-023-01326-z","title":"Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study","year":2023,"lang":"en","type":"article","venue":"Drug Safety","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Russian Academy of Sciences; Szegedi Tudományegyetem; Universitätsmedizin Göttingen; Uniwersytet Medyczny w Lublinie; Octapharma","keywords":"Medicine; Adverse effect; Discontinuation; Tolerability; Nausea; Vomiting; Chronic inflammatory demyelinating polyneuropathy; Anesthesia; Incidence (geometry); Internal medicine; Antibody; Immunology","score_opus":0.008724957721747825,"score_gpt":0.24875458696459118,"score_spread":0.24002962924284335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382344417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864994,0.010066002,0.00042832777,0.00025521553,0.00007393218,0.00034737727,0.0009775079,0.000029811425,0.00132237],"genre_scores_gemma":[0.9944776,0.0023847062,0.00062727934,0.00039529445,0.00015402208,0.00025819248,0.001216188,0.000010731223,0.0004759282],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99876946,0.000771795,0.00009703159,0.00011698508,0.00017095788,0.00007366345],"domain_scores_gemma":[0.9979202,0.00063750707,0.0008124635,0.00017858147,0.00016541354,0.0002858842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037548963,0.00056312006,0.0010304983,0.00016078359,0.00017770616,0.0008165588,0.0003865652,0.00069272355,0.00116797],"category_scores_gemma":[0.0019633772,0.00021629459,0.0012925836,0.00025579514,0.00042534963,0.00040841184,0.00028095357,0.0014139668,0.0002585755],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7071977,0.006946955,0.10273736,0.003577983,0.0075454516,0.00046549464,0.00031501806,0.0016730397,0.012423476,0.00023769529,0.0028192364,0.15406068],"study_design_scores_gemma":[0.3113473,0.39256674,0.27044395,0.00038548643,0.007148741,0.0015718264,0.00015762848,0.001884975,0.0055083106,0.00027410104,0.008643045,0.00006794416],"about_ca_topic_score_codex":0.0002093814,"about_ca_topic_score_gemma":0.00038801727,"teacher_disagreement_score":0.0037548963,"about_ca_system_score_codex":0.00040043544,"about_ca_system_score_gemma":0.00045077427,"threshold_uncertainty_score":0.019858062},"labels":[],"label_agreement":null},{"id":"W4385331466","doi":"10.1007/s40264-023-01335-y","title":"The QTc-Bazett Interval in Former Very Preterm Infants in Adolescence and Young Adulthood is Not Different from Term-Born Controls","year":2023,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; QT interval; Pediatrics; Confidence interval; Young adult; Birth weight; Internal medicine; Pregnancy","score_opus":0.02660799816679061,"score_gpt":0.32701465709049515,"score_spread":0.30040665892370455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385331466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95762485,0.018491559,0.0025840718,0.00028214496,0.00009333152,0.000089456946,0.017633125,0.00006002351,0.0031414444],"genre_scores_gemma":[0.98946804,0.0023082637,0.0004634724,0.0001544259,0.0000649204,0.00010271053,0.007110217,0.00002352697,0.0003044458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966528,0.0006422305,0.00080184353,0.0012910743,0.00040556357,0.00020643324],"domain_scores_gemma":[0.99486744,0.0019656017,0.0018751799,0.0008330148,0.00033133378,0.00012741692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025768138,0.00026316807,0.0011157884,0.00084217114,0.0002845174,0.001028565,0.00046709666,0.0004814996,0.0021926507],"category_scores_gemma":[0.011257684,0.0002664451,0.001406124,0.0013988967,0.00027237475,0.00047603645,0.0005159166,0.00054972357,0.00029871648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062562977,0.000028632272,0.9614977,0.0013895368,0.004432607,0.0008830155,0.00040492063,0.00026721822,0.00286213,0.00050453853,0.0023085142,0.019164784],"study_design_scores_gemma":[0.00017025236,0.00021704224,0.98967826,0.00023998923,0.0028033084,0.001782074,0.00012780762,0.00025135357,0.0005049678,0.00038495418,0.0038231653,0.000016864436],"about_ca_topic_score_codex":0.003350325,"about_ca_topic_score_gemma":0.0021098997,"teacher_disagreement_score":0.003350325,"about_ca_system_score_codex":0.00029067587,"about_ca_system_score_gemma":0.00027430948,"threshold_uncertainty_score":0.013627648},"labels":[],"label_agreement":null},{"id":"W4387245287","doi":"10.1007/s40264-023-01348-7","title":"Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes","year":2023,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Vancouver General Hospital; University Health Network; University of British Columbia","funders":"Canadian Institutes of Health Research; Ministry of Health, British Columbia; Michael Smith Health Research BC","keywords":"Medicine; Adverse drug event; Drug; Medical emergency; Adverse effect; Family medicine; Intensive care medicine; Pharmacology","score_opus":0.09766998988305825,"score_gpt":0.4680446856590733,"score_spread":0.37037469577601506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387245287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612075,0.00041505322,0.0005852524,0.00020884152,0.000012137882,0.00024519674,0.0017510952,0.000016250075,0.00064533437],"genre_scores_gemma":[0.9971379,0.0002142331,0.0005709471,0.000078684294,0.000019460149,0.0002489878,0.0015538344,0.0000076075685,0.00016832582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9689196,0.012655526,0.0048990957,0.0025342852,0.008395361,0.0025962687],"domain_scores_gemma":[0.80396736,0.066051826,0.101125315,0.00558591,0.017793482,0.0054762415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02412643,0.0005462028,0.00062003126,0.0048184837,0.00081544643,0.002696992,0.0013389776,0.0007506369,0.0014468954],"category_scores_gemma":[0.086466655,0.00043445753,0.0015195531,0.007247892,0.00072432554,0.0019933784,0.003998656,0.0015949665,0.00027638205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015711309,0.0000829098,0.99550337,0.00005524311,0.00012059335,0.00002785807,0.0005029187,0.00006638871,0.00001924853,0.000029139821,0.0001659915,0.0032692244],"study_design_scores_gemma":[0.000022416047,0.0002293167,0.99654406,0.00006375521,0.00008465805,0.00007439174,0.0016880123,0.0007885958,0.00006210874,0.00004274326,0.00038704742,0.000012958907],"about_ca_topic_score_codex":0.029645935,"about_ca_topic_score_gemma":0.01985245,"teacher_disagreement_score":0.029645935,"about_ca_system_score_codex":0.0030710644,"about_ca_system_score_gemma":0.004640399,"threshold_uncertainty_score":0.12759423},"labels":[],"label_agreement":null},{"id":"W4388042291","doi":"10.1007/s40264-023-01361-w","title":"Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis","year":2023,"lang":"en","type":"article","venue":"Drug Safety","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Janssen Pharmaceuticals; National Institute for Health and Care Research; Janssen Research and Development; Janssen Scientific Affairs","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Placebo; Population; Adverse effect; Internal medicine; Psoriasis Area and Severity Index; Incidence (geometry); Concomitant; Body surface area; Dermatology; Pathology","score_opus":0.02649699749345453,"score_gpt":0.3186145722983213,"score_spread":0.2921175748048668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388042291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518547,0.03969651,0.003629914,0.00011845184,0.000025853504,0.00086586707,0.0029404897,0.000060105922,0.0008081116],"genre_scores_gemma":[0.9885704,0.004492764,0.0021369657,0.0001231629,0.000047100173,0.00049242616,0.0039900844,0.00002384145,0.00012316102],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9791272,0.011322385,0.004105166,0.0018352541,0.003107761,0.00050211995],"domain_scores_gemma":[0.9669281,0.015799131,0.011760181,0.0022521028,0.0024029156,0.00085751346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034639705,0.0008215264,0.0036556846,0.0027964981,0.00046767943,0.0020317102,0.000532205,0.0005603138,0.0009331711],"category_scores_gemma":[0.0164358,0.00042663308,0.005812824,0.0040833587,0.00048656258,0.00082198874,0.0012262604,0.0007782061,0.00012849113],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055390216,0.00076026574,0.71918875,0.0046406593,0.114428766,0.00025321209,0.00035514406,0.0035035014,0.0103329895,0.00012561762,0.0006705784,0.090350315],"study_design_scores_gemma":[0.004296236,0.014770412,0.9114762,0.0003269282,0.0610933,0.00070730696,0.00016530784,0.0018734244,0.0021835293,0.00020103435,0.002838113,0.000068178044],"about_ca_topic_score_codex":0.00035694154,"about_ca_topic_score_gemma":0.00085612375,"teacher_disagreement_score":0.034639705,"about_ca_system_score_codex":0.00068230386,"about_ca_system_score_gemma":0.0011629028,"threshold_uncertainty_score":0.18319446},"labels":[],"label_agreement":null},{"id":"W4388228914","doi":"10.1007/s40264-023-01362-9","title":"Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023","year":2023,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Ambulatory; Drug; Pharmacology; Internal medicine","score_opus":0.0354338696316949,"score_gpt":0.3293064325159505,"score_spread":0.29387256288425556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388228914","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016234051,0.08702232,0.0048757647,0.26876646,0.24392648,0.0005134325,0.0084459325,0.0007349252,0.3694806],"genre_scores_gemma":[0.030021504,0.031966113,0.0020710705,0.015754838,0.04776913,0.00019960065,0.005219861,0.00017248381,0.86682534],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993437,0.0001258228,0.000029728704,0.00007178662,0.00029947513,0.00012939991],"domain_scores_gemma":[0.99884653,0.00013712033,0.00007417185,0.000030313668,0.00045559203,0.00045628732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001931882,0.0011229947,0.0005794123,0.0008211992,0.00093316217,0.0028735513,0.0006904711,0.002975478,0.08103864],"category_scores_gemma":[0.0016506362,0.0002577291,0.0005437005,0.0005566825,0.00033647113,0.0008714027,0.0011735834,0.0023216512,0.0230851],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031466858,0.00011109844,0.0007307959,0.00010997712,0.000018140921,0.00010565066,0.000035594298,0.0000872376,0.0005370346,0.0003307287,0.95640147,0.041217577],"study_design_scores_gemma":[0.00009085419,0.00013756331,0.010921845,0.000267127,0.000046491223,0.0001266011,0.0002237582,0.00028592345,0.0005115886,0.0005044804,0.986868,0.000015790352],"about_ca_topic_score_codex":0.0057111797,"about_ca_topic_score_gemma":0.026635684,"teacher_disagreement_score":0.08103864,"about_ca_system_score_codex":0.0010955203,"about_ca_system_score_gemma":0.0022018221,"threshold_uncertainty_score":0.27110124},"labels":[],"label_agreement":null},{"id":"W4388947117","doi":"10.1007/s40264-023-01379-0","title":"A Descriptive Analysis of Adverse Event Reports from the Quebec Cannabis Registry","year":2023,"lang":"en","type":"article","venue":"Drug Safety","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Inro Consultants (Canada); Université de Montréal; Ontario Ministry of Labour; McGill University Health Centre","funders":"","keywords":"Medicine; Discontinuation; MedDRA; Nausea; Somnolence; Adverse effect; Vomiting; Cannabidiol; Pediatrics; Tolerability; Cannabis; Dysgeusia; Internal medicine; Pharmacovigilance; Psychiatry","score_opus":0.014126977134268944,"score_gpt":0.28756504017585494,"score_spread":0.27343806304158597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388947117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81788725,0.0037807375,0.0010997438,0.00032874176,0.000034309818,0.0017718844,0.16693069,0.00013791562,0.008028805],"genre_scores_gemma":[0.9410801,0.001942634,0.0007532995,0.00035226674,0.000031847176,0.00091588363,0.051472053,0.000045102548,0.00340684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99434483,0.0006123646,0.0012016853,0.0007902361,0.0021982093,0.0008526638],"domain_scores_gemma":[0.9772982,0.004292433,0.008047093,0.00086384744,0.00850619,0.0009921682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027772763,0.000407389,0.0007490355,0.0116744535,0.0014113104,0.0015738396,0.000856244,0.00053396536,0.004821002],"category_scores_gemma":[0.01314702,0.00033714788,0.00089864805,0.011555218,0.00046215556,0.0006197654,0.0008727724,0.0005282668,0.0006631716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031033476,0.000044363467,0.98847604,0.00017591094,0.00016941344,0.00037877428,0.0003811746,0.00015730257,0.00025728464,0.00009281568,0.003716416,0.005840106],"study_design_scores_gemma":[0.000013901182,0.00006362638,0.9948396,0.000076592616,0.00005673378,0.00031798935,0.00058707985,0.0002581931,0.00012885367,0.000016206252,0.0036242176,0.000016980657],"about_ca_topic_score_codex":0.7525206,"about_ca_topic_score_gemma":0.7502104,"teacher_disagreement_score":0.24747938,"about_ca_system_score_codex":0.012035759,"about_ca_system_score_gemma":0.0150446985,"threshold_uncertainty_score":0.49787366},"labels":[],"label_agreement":null},{"id":"W4389955199","doi":"10.1007/s40264-023-01384-3","title":"Improving Data Collection in Pregnancy Safety Studies: Towards Standardisation of Data Elements in Pregnancy Reports from Public and Private Partners, A Contribution from the ConcePTION Project","year":2023,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Innovative Medicines Initiative; Université de Lausanne","keywords":"Medicine; Pregnancy; Pharmacovigilance; Data collection; Family medicine; Drug; Psychiatry","score_opus":0.1166773171178641,"score_gpt":0.3973572955556053,"score_spread":0.2806799784377412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389955199","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059261307,0.014355305,0.7555151,0.09858092,0.0031570257,0.03219423,0.015934601,0.0032491225,0.01775241],"genre_scores_gemma":[0.14921539,0.005369324,0.80227023,0.0059282873,0.00095687015,0.016689941,0.016281364,0.0010462501,0.0022424678],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.479969,0.40585178,0.05498892,0.015788084,0.03932688,0.0040753274],"domain_scores_gemma":[0.27611837,0.29686478,0.0524059,0.19723596,0.16448084,0.012894137],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5647398,0.0012795915,0.0016680371,0.011552044,0.0024604953,0.013525519,0.0073154923,0.0030295828,0.0028284893],"category_scores_gemma":[0.51698285,0.0017903305,0.0022072995,0.012425722,0.0055994377,0.011050076,0.01935407,0.005455401,0.0021372754],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070033426,0.0006172282,0.12723343,0.0068651782,0.00046956964,0.00030912014,0.025286302,0.0027062974,0.0047237775,0.03824816,0.048830334,0.7440102],"study_design_scores_gemma":[0.00066920643,0.0016751873,0.19784519,0.023561386,0.00061032956,0.0012147076,0.019320838,0.0075157895,0.014174875,0.03329405,0.6996927,0.00042567376],"about_ca_topic_score_codex":0.014926866,"about_ca_topic_score_gemma":0.0051679737,"teacher_disagreement_score":0.43526018,"about_ca_system_score_codex":0.010202879,"about_ca_system_score_gemma":0.0733981,"threshold_uncertainty_score":0.5367533},"labels":[],"label_agreement":null},{"id":"W4392812418","doi":"10.1007/s40264-024-01416-6","title":"The Role of Pharmacogenomics in Rare Diseases","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Research (Canada); McMaster University; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Pharmacogenomics; Medicine; Rare disease; Harm; Disease; Context (archaeology); Orphan drug; Intensive care medicine; Drug development; Incentive; Drug; Bioinformatics; Psychiatry; Pharmacology; Pathology","score_opus":0.002397174975196518,"score_gpt":0.2225761377039006,"score_spread":0.2201789627287041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392812418","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09005938,0.48488423,0.09378944,0.2925442,0.0028935648,0.00007542626,0.0006587852,0.00039113747,0.034703802],"genre_scores_gemma":[0.7188094,0.21214114,0.028981045,0.026368951,0.010514668,0.0000656232,0.00020027971,0.00010357588,0.0028152948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99531376,0.0032726943,0.00018384648,0.00038737225,0.00070540246,0.00013699051],"domain_scores_gemma":[0.9655817,0.028214008,0.002249383,0.0013646627,0.0016364796,0.0009536985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0108023565,0.00072208693,0.001166849,0.002251843,0.0005135745,0.0033161037,0.000817225,0.0020808675,0.0019774034],"category_scores_gemma":[0.020120475,0.00031526943,0.00065157464,0.0013198076,0.005147119,0.0033543904,0.0013422014,0.0036004146,0.00032993467],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008301541,0.00046890872,0.082384914,0.0018807306,0.0010030894,0.0028738992,0.00084520126,0.0072513474,0.013756827,0.3546331,0.017112698,0.5169592],"study_design_scores_gemma":[0.00015507323,0.00068979786,0.06921509,0.0017471827,0.0005451128,0.006726345,0.00088056485,0.0124416575,0.009219286,0.7526709,0.14554527,0.00016370876],"about_ca_topic_score_codex":0.0012538813,"about_ca_topic_score_gemma":0.0011023444,"teacher_disagreement_score":0.0108023565,"about_ca_system_score_codex":0.0015897403,"about_ca_system_score_gemma":0.0021808925,"threshold_uncertainty_score":0.057129025},"labels":[],"label_agreement":null},{"id":"W4396644034","doi":"10.1007/s40264-024-01433-5","title":"Comparators in Pharmacovigilance: A Quasi-Quantification Bias Analysis","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; University of Ottawa","funders":"Charité – Universitätsmedizin Berlin; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Canagliflozin; Pharmacovigilance; Food and drug administration; Adverse Event Reporting System; Confidence interval; Odds ratio; Adverse effect; Pharmacology; Internal medicine; Endocrinology; Diabetes mellitus","score_opus":0.1663956603836436,"score_gpt":0.4818408762950039,"score_spread":0.3154452159113603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396644034","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06928549,0.01469501,0.865369,0.002518212,0.0012822534,0.040775348,0.0027134463,0.0005342613,0.002827054],"genre_scores_gemma":[0.5248557,0.00086365006,0.4252893,0.00214005,0.00032169733,0.04467427,0.0010314224,0.00010750794,0.00071643974],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.25078773,0.6669356,0.038939368,0.019238254,0.022454167,0.0016448606],"domain_scores_gemma":[0.26262787,0.5980247,0.07085891,0.049150757,0.018256757,0.0010808739],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.47181404,0.0025006463,0.005097813,0.003568757,0.0016897676,0.003565542,0.0047154813,0.0043040076,0.00822369],"category_scores_gemma":[0.6015263,0.0017901805,0.024180995,0.0034259735,0.0046155467,0.0046108915,0.0052601956,0.0033371544,0.0006167176],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056828342,0.002366067,0.19596124,0.062240794,0.26055896,0.00089421443,0.008805584,0.028140323,0.0032914057,0.117549516,0.010830736,0.25253287],"study_design_scores_gemma":[0.044131335,0.03297623,0.1257655,0.023598215,0.20570135,0.0024652844,0.0023441561,0.24992189,0.011776952,0.24604072,0.05364027,0.0016381337],"about_ca_topic_score_codex":0.0026609267,"about_ca_topic_score_gemma":0.0011783359,"teacher_disagreement_score":0.52818596,"about_ca_system_score_codex":0.004332401,"about_ca_system_score_gemma":0.0057762554,"threshold_uncertainty_score":0.6513474},"labels":[],"label_agreement":null},{"id":"W4396696102","doi":"10.1007/s40264-024-01423-7","title":"The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":273,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; Health Canada","funders":"","keywords":"Pharmacovigilance; Medicine; Context (archaeology); Transparency (behavior); Risk analysis (engineering); Drug; Pharmacology; Computer science; Computer security","score_opus":0.10175047514503634,"score_gpt":0.44984887507257826,"score_spread":0.34809839992754193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396696102","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011612496,0.0042453622,0.6897272,0.24652983,0.011959541,0.014853615,0.0041497382,0.0028063385,0.01411594],"genre_scores_gemma":[0.042259093,0.003837269,0.88126546,0.044676192,0.0039846664,0.015412694,0.0016479385,0.0004952437,0.0064215115],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.68245524,0.16868961,0.10552587,0.0053873546,0.034184255,0.0037576633],"domain_scores_gemma":[0.38376775,0.38391292,0.07007633,0.03220544,0.12759297,0.0024446172],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22196938,0.0017045602,0.0013363272,0.006276231,0.0025756508,0.0057277204,0.0032571398,0.010903757,0.004765239],"category_scores_gemma":[0.4263327,0.0019047754,0.0035071864,0.0039343177,0.0066619227,0.006267885,0.008174248,0.012185715,0.0036948414],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006319318,0.0003115512,0.012366775,0.013897838,0.00032937515,0.0016419115,0.026917346,0.0037633155,0.006446663,0.20816499,0.42458382,0.30094448],"study_design_scores_gemma":[0.0002842237,0.0005663055,0.008005102,0.022257864,0.00039704182,0.0024146207,0.00594017,0.008862535,0.011791334,0.099945515,0.8389948,0.0005405348],"about_ca_topic_score_codex":0.0034424493,"about_ca_topic_score_gemma":0.0036168601,"teacher_disagreement_score":0.77803063,"about_ca_system_score_codex":0.0046947524,"about_ca_system_score_gemma":0.016981775,"threshold_uncertainty_score":0.95945024},"labels":[],"label_agreement":null},{"id":"W4396696202","doi":"10.1007/s40264-024-01421-9","title":"The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Pharmacovigilance; Checklist; Medicine; Delphi method; Delphi; Guideline; Family medicine; Medical education; Adverse effect; Pharmacology; Psychology; Pathology; Computer science","score_opus":0.12570790955569228,"score_gpt":0.45566756990142127,"score_spread":0.329959660345729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396696202","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025242079,0.0136588365,0.5943993,0.15100667,0.010931949,0.16868693,0.007493154,0.004176485,0.024404781],"genre_scores_gemma":[0.040081006,0.005281365,0.84068245,0.01780856,0.0014882901,0.08860199,0.0035307186,0.00036711738,0.002158465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.27478543,0.38590193,0.25570253,0.01039042,0.0692384,0.0039813044],"domain_scores_gemma":[0.17305776,0.38733643,0.11445927,0.048953913,0.26792273,0.008269908],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.54007584,0.002896931,0.0030177354,0.016793204,0.004339348,0.009562389,0.009027674,0.009462869,0.0025682112],"category_scores_gemma":[0.6416456,0.0032348945,0.0074497727,0.0074059432,0.008608452,0.01025766,0.018080486,0.010669208,0.0033962347],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006237132,0.00065525365,0.029877242,0.060941182,0.0014155362,0.0009750037,0.028936418,0.0035020874,0.0049429,0.04334473,0.27036685,0.5544192],"study_design_scores_gemma":[0.0013080289,0.0023301276,0.03633376,0.15174446,0.002104644,0.0035348223,0.02040289,0.014354159,0.014536808,0.046927884,0.70494777,0.0014745676],"about_ca_topic_score_codex":0.004293737,"about_ca_topic_score_gemma":0.005416347,"teacher_disagreement_score":0.45992416,"about_ca_system_score_codex":0.0105179595,"about_ca_system_score_gemma":0.07104538,"threshold_uncertainty_score":0.5671684},"labels":[],"label_agreement":null},{"id":"W4396717974","doi":"10.1007/s40264-024-01434-4","title":"Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Gallbladder disease; Internal medicine; Type 2 diabetes; Population; Diabetes mellitus; Dipeptidyl peptidase-4; Cohort study; Bile duct; Gallbladder; Cohort; Gastroenterology; Endocrinology; Environmental health","score_opus":0.002864337265937815,"score_gpt":0.2028419557039618,"score_spread":0.19997761843802397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396717974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988341,0.0001988966,0.00009638846,0.00004484716,0.000017301832,0.000013437299,0.0004904053,0.0000050193753,0.0002997369],"genre_scores_gemma":[0.9987883,0.00016023636,0.000102753525,0.00006274474,0.000027710492,0.000017309423,0.000434572,0.00000451452,0.00040188085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927574,0.00016019888,0.00006840577,0.0002291985,0.00011977237,0.00014677155],"domain_scores_gemma":[0.99886984,0.00015229752,0.000323689,0.00024322294,0.0001264589,0.00028445869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010147048,0.00083370565,0.0008831178,0.0010395051,0.0011512744,0.0016939588,0.00068238936,0.0014747777,0.0019482799],"category_scores_gemma":[0.0014942894,0.0015129707,0.0020104665,0.0017968289,0.00048119447,0.0011524403,0.000764998,0.0022645118,0.00044731735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088306586,0.00026487364,0.99662685,0.000009210518,0.00060683227,0.00016831496,0.00008936089,0.00004770252,0.00057376275,0.000022317374,0.00012536423,0.00058235455],"study_design_scores_gemma":[0.00011038839,0.0003627292,0.9979632,0.000005387286,0.00036315928,0.00034907967,0.00028941475,0.0002909501,0.000068016234,0.000028364553,0.0001521516,0.000017218399],"about_ca_topic_score_codex":0.013976217,"about_ca_topic_score_gemma":0.011620204,"teacher_disagreement_score":0.013976217,"about_ca_system_score_codex":0.00056445785,"about_ca_system_score_gemma":0.00062471285,"threshold_uncertainty_score":0.027789712},"labels":[],"label_agreement":null},{"id":"W4396769640","doi":"10.1007/s40264-024-01429-1","title":"Risk of Mortality Associated with Potentially Inappropriate Medication Use Including Opioids in Older Adults","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; The Quebec Population Health Research Network; Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"","keywords":"Medicine; Intensive care medicine; Polypharmacy; MEDLINE; Emergency medicine","score_opus":0.012564736227843114,"score_gpt":0.2743755579181134,"score_spread":0.2618108216902703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396769640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99520075,0.0019222045,0.00018957641,0.00034332796,0.000041061732,0.000011480404,0.0006914791,0.000007588822,0.0015926352],"genre_scores_gemma":[0.9986708,0.00047733187,0.00010319138,0.0000634982,0.000085411295,0.000005002657,0.0003702883,0.000001527343,0.00022295395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962294,0.00010302649,0.000050252016,0.000058367783,0.000076216165,0.00008910437],"domain_scores_gemma":[0.998142,0.00037458332,0.0008825931,0.00012097101,0.00016391167,0.00031578835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041867592,0.00031570074,0.00038613813,0.00060464715,0.00039882417,0.0005786132,0.0002138062,0.0006522214,0.0016563328],"category_scores_gemma":[0.0034714725,0.00026052925,0.0010408494,0.0005284461,0.0001409746,0.00040436545,0.00051506166,0.0011811919,0.00014579625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017503672,0.000028715904,0.99764615,0.000014207311,0.00012666787,0.000090355454,0.000021535192,0.00004993644,0.000054986638,0.000029245184,0.00013925802,0.0016239672],"study_design_scores_gemma":[0.000008302533,0.00010735095,0.998662,0.000021617914,0.00008102857,0.00028046625,0.00010518247,0.00046360976,0.00002383979,0.000114967304,0.00012736915,0.0000041998137],"about_ca_topic_score_codex":0.004481006,"about_ca_topic_score_gemma":0.0063499897,"teacher_disagreement_score":0.004481006,"about_ca_system_score_codex":0.00029136645,"about_ca_system_score_gemma":0.0003872769,"threshold_uncertainty_score":0.008909881},"labels":[],"label_agreement":null},{"id":"W4399749747","doi":"10.1007/s40264-024-01444-2","title":"Proceedings of the Canadian Medication Appropriateness and Deprescribing Network’s 2023 National Meeting","year":2024,"lang":"en","type":"editorial","venue":"Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Université de Montréal; University of Calgary; Alberta Health Services; Alberta Health; St. Michael's Hospital; University of Manitoba; Trillium Health Centre; University of British Columbia; Institut Universitaire de Gériatrie de Montréal; Bruyère; McGill University; Assembly of First Nations; University of Ottawa; McGill University Health Centre; University of Waterloo; Dalhousie University; University of Toronto","funders":"Health Canada","keywords":"Medicine; Deprescribing; Beers Criteria; Family medicine; Polypharmacy; Intensive care medicine","score_opus":0.03746272109582585,"score_gpt":0.3282302275574091,"score_spread":0.2907675064615832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399749747","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012474194,0.009353411,0.00024172933,0.08185588,0.8929039,0.00012093839,0.000426363,0.0001289988,0.014844032],"genre_scores_gemma":[0.0014159105,0.01578272,0.00047539233,0.040108703,0.90208846,0.0000895607,0.00040547078,0.00007731866,0.039556436],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943962,0.00051564706,0.00040478274,0.00033845997,0.003994155,0.00035075686],"domain_scores_gemma":[0.9763498,0.004472389,0.0008800418,0.0004447585,0.0140072,0.0038458463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007022252,0.0024263577,0.0030422779,0.0030364434,0.0034314855,0.0062762694,0.0033305048,0.0122033665,0.030902075],"category_scores_gemma":[0.0236629,0.00086348894,0.0022813298,0.001690334,0.0016556816,0.002739803,0.0011004683,0.011451171,0.013268993],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002287732,0.000013509532,0.000036722788,0.0001017298,0.000009309961,0.00005442514,0.000005105234,0.000016167483,0.000018593526,0.00010846113,0.9932834,0.006329777],"study_design_scores_gemma":[0.000058724207,0.000012112994,0.00039491968,0.0004914759,0.00002461295,0.00008452835,0.000025734858,0.00009931626,0.00003387723,0.00024958438,0.99850875,0.000016248614],"about_ca_topic_score_codex":0.049735565,"about_ca_topic_score_gemma":0.1633351,"teacher_disagreement_score":0.9905376,"about_ca_system_score_codex":0.00946239,"about_ca_system_score_gemma":0.017449073,"threshold_uncertainty_score":0.10337776},"labels":[],"label_agreement":null},{"id":"W4400568462","doi":"10.1007/s40264-024-01453-1","title":"Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Quebec Population Health Research Network","funders":"Università di Bologna","keywords":"Polypharmacy; Medicine; Context (archaeology); Medical prescription; Geriatrics; Health care; Population ageing; Older people; Health professionals; Pharmacotherapy; MEDLINE; Population; Family medicine; Nursing; Intensive care medicine; Gerontology; Psychiatry","score_opus":0.2125169635568008,"score_gpt":0.5693373512255413,"score_spread":0.35682038766874047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400568462","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027268618,0.017667314,0.46415338,0.1856195,0.0076542217,0.105821945,0.019120118,0.023525212,0.1491697],"genre_scores_gemma":[0.0133337965,0.0077054338,0.9075897,0.010520761,0.0006014327,0.04049041,0.0038744467,0.0012367825,0.014647326],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96127844,0.022585588,0.0094675785,0.00084588816,0.0048475894,0.0009748071],"domain_scores_gemma":[0.9028103,0.058334075,0.008178962,0.003952441,0.023064807,0.0036595082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05307437,0.0022509014,0.00249581,0.006423996,0.0021542164,0.006522413,0.0034534466,0.0056569655,0.01775624],"category_scores_gemma":[0.09304366,0.002408073,0.0026502437,0.0055945446,0.0032708894,0.007802293,0.0056862007,0.0073209447,0.02543058],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023025843,0.0009347081,0.0046599843,0.002914478,0.000047608843,0.0009238686,0.008474529,0.0011420376,0.001469242,0.008276708,0.6151626,0.35576406],"study_design_scores_gemma":[0.00051408575,0.00072636607,0.012766413,0.008019432,0.00004375483,0.0033381432,0.013372325,0.004878328,0.0015571968,0.032468934,0.92189586,0.00041923852],"about_ca_topic_score_codex":0.0042014676,"about_ca_topic_score_gemma":0.010400061,"teacher_disagreement_score":0.05307437,"about_ca_system_score_codex":0.0038323868,"about_ca_system_score_gemma":0.021193346,"threshold_uncertainty_score":0.28068745},"labels":[],"label_agreement":null},{"id":"W4401252242","doi":"10.1007/s40264-024-01465-x","title":"The Methodological Quality of Observational Studies Examining the Risk of Pregnancy Drug Use on Congenital Malformations Needs Substantial Improvement: A Cross-Sectional Survey","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"National Science Fund for Distinguished Young Scholars; National Natural Science Foundation of China","keywords":"Medicine; Observational study; Cross-sectional study; Pregnancy; Drug; Quality (philosophy); Pediatrics; Obstetrics; Environmental health; Family medicine; Pharmacology; Internal medicine; Pathology","score_opus":0.41984621076371936,"score_gpt":0.4606043745548275,"score_spread":0.04075816379110814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401252242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5350787,0.112847425,0.2559421,0.037452817,0.0085393395,0.010868345,0.02638555,0.0008008712,0.012084822],"genre_scores_gemma":[0.88918126,0.011813537,0.06958719,0.012537538,0.001287036,0.0061809784,0.007888413,0.00022192554,0.0013021253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.6466923,0.23892002,0.08020534,0.01226169,0.019738225,0.0021823843],"domain_scores_gemma":[0.3038025,0.48616928,0.07677625,0.08709328,0.04278931,0.003369356],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.331263,0.0014812732,0.0048155054,0.004193535,0.0020070786,0.0060678143,0.004302467,0.002497159,0.0019309279],"category_scores_gemma":[0.5117943,0.0016744783,0.0044216765,0.008824891,0.0037090145,0.004686291,0.0028332262,0.0024422712,0.0004288424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009074226,0.00026119855,0.9392815,0.0067267404,0.010437714,0.00020185071,0.0022082545,0.0019098824,0.00052324595,0.003393838,0.00439494,0.029753312],"study_design_scores_gemma":[0.0005159897,0.0012249287,0.94310564,0.006314549,0.0077625806,0.0005787991,0.0035139841,0.0052559352,0.0011212083,0.007384494,0.022859566,0.00036228547],"about_ca_topic_score_codex":0.025239445,"about_ca_topic_score_gemma":0.032400038,"teacher_disagreement_score":0.668737,"about_ca_system_score_codex":0.0035989985,"about_ca_system_score_gemma":0.0074422727,"threshold_uncertainty_score":0.82467175},"labels":[],"label_agreement":null},{"id":"W4401344133","doi":"10.1007/s40264-024-01452-2","title":"Correction to: Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes","year":2024,"lang":"en","type":"erratum","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Vancouver General Hospital; University Health Network; University of British Columbia","funders":"","keywords":"Medicine; Adverse drug event; Drug; Adverse drug reaction; Adverse effect; Event (particle physics); Family medicine; Pharmacology; Medical emergency; Medical education","score_opus":0.06417309933637827,"score_gpt":0.4498013955058561,"score_spread":0.38562829616947786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401344133","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017109909,0.00091761356,0.005287738,0.117192164,0.81757635,0.00033740446,0.04783305,0.0023925274,0.006752174],"genre_scores_gemma":[0.091706246,0.0074413028,0.054651268,0.21959306,0.19334273,0.0032112154,0.08256567,0.015645253,0.33184332],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96770155,0.0066711023,0.009700354,0.0031654404,0.011042568,0.0017190583],"domain_scores_gemma":[0.68705463,0.124861725,0.023410091,0.020969987,0.13858736,0.005116223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021691727,0.0026112613,0.0019141556,0.006733626,0.0032814124,0.0048166825,0.0038770516,0.0048777135,0.09088858],"category_scores_gemma":[0.34143844,0.0016873579,0.0022779189,0.00924561,0.0022580363,0.0027861798,0.0027460142,0.008557258,0.048541065],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009453382,0.000020604033,0.00088278594,0.00039065888,0.00004517448,0.00018383765,0.000117415206,0.00010674872,0.000043680924,0.0007449136,0.9893607,0.00800889],"study_design_scores_gemma":[0.00031200214,0.000077927674,0.009126082,0.0029681192,0.00022840066,0.0009410021,0.000528635,0.0011393094,0.00093346235,0.003195222,0.9803617,0.00018813598],"about_ca_topic_score_codex":0.044833984,"about_ca_topic_score_gemma":0.0366305,"teacher_disagreement_score":0.09088858,"about_ca_system_score_codex":0.0070235454,"about_ca_system_score_gemma":0.013593437,"threshold_uncertainty_score":0.30405265},"labels":[],"label_agreement":null},{"id":"W4402600759","doi":"10.1007/s40264-024-01477-7","title":"23rd ISoP Annual Meeting “Global Perspectives on Pharmacovigilance in the Digital Age and Advanced Therapeutics” 1–5 October 2024 Montreal, Canada","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacovigilance; Family medicine; Pediatrics; Pharmacology; Adverse effect","score_opus":0.03077976993105358,"score_gpt":0.3800600807335554,"score_spread":0.3492803108025018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402600759","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030212863,0.040799778,0.0038491103,0.42203742,0.23248497,0.0006946924,0.01388615,0.0009763203,0.28225031],"genre_scores_gemma":[0.013424842,0.01746853,0.0027174135,0.05531832,0.024892222,0.00019815394,0.0067943013,0.00045999466,0.87872624],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99684674,0.00038200573,0.000085531356,0.00025719102,0.0015860522,0.00084245205],"domain_scores_gemma":[0.99190617,0.00032067703,0.00026087573,0.00013723187,0.0043162084,0.0030589737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054390407,0.0016574591,0.00096264214,0.0015727773,0.0029019779,0.005943264,0.0019308783,0.0060154987,0.13413623],"category_scores_gemma":[0.004988883,0.00054119516,0.0012936612,0.00095166976,0.0014191876,0.0012964674,0.0028346854,0.0049978057,0.032696184],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058252637,0.000017541175,0.00039417547,0.000053844986,0.000009231631,0.00005182767,0.00001724347,0.0000644828,0.00014904,0.00046395816,0.9882477,0.010472724],"study_design_scores_gemma":[0.000022101745,0.00001747812,0.0036583182,0.00016640156,0.000010811575,0.000030168016,0.000066396264,0.00008442211,0.00009512422,0.00024233553,0.9955918,0.00001468331],"about_ca_topic_score_codex":0.53588176,"about_ca_topic_score_gemma":0.8243214,"teacher_disagreement_score":0.46411824,"about_ca_system_score_codex":0.013824731,"about_ca_system_score_gemma":0.037545037,"threshold_uncertainty_score":0.93370306},"labels":[],"label_agreement":null},{"id":"W4402899379","doi":"10.1007/s40264-024-01483-9","title":"Safeguarding Patients in the AI Era: Ethics at the Forefront of Pharmacovigilance","year":2024,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Pharmacovigilance; Safeguarding; Engineering ethics; Pharmacology; Drug; Nursing","score_opus":0.08335957136492661,"score_gpt":0.45565188133373374,"score_spread":0.37229230996880713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402899379","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002714728,0.0074345786,0.006705651,0.9698629,0.0021448587,0.00003204074,0.000019986286,0.00004986529,0.011035398],"genre_scores_gemma":[0.2701685,0.023792984,0.0229164,0.65233785,0.024045462,0.00022398368,0.00007617144,0.00022507914,0.0062135924],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8900764,0.08068033,0.0050735865,0.0029613874,0.01768325,0.0035250883],"domain_scores_gemma":[0.6304953,0.24852583,0.01946016,0.015604118,0.034348037,0.05156653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09246118,0.0005193041,0.001420834,0.0013901852,0.0061075,0.016217366,0.003250104,0.017192002,0.0039352207],"category_scores_gemma":[0.21734093,0.00054309657,0.000795811,0.0012887961,0.018271368,0.010418003,0.009388416,0.04127199,0.0018279003],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022092665,0.00051371,0.012853644,0.00091938674,0.00024388716,0.0028113748,0.019110113,0.0010107782,0.0017190375,0.34897077,0.36352348,0.24810292],"study_design_scores_gemma":[0.00008932026,0.00021571742,0.004359894,0.0032284365,0.0000717562,0.0033122378,0.009950687,0.0016231916,0.0008879492,0.46998492,0.50612044,0.000155495],"about_ca_topic_score_codex":0.0040374487,"about_ca_topic_score_gemma":0.003933303,"teacher_disagreement_score":0.09246118,"about_ca_system_score_codex":0.005223509,"about_ca_system_score_gemma":0.041078802,"threshold_uncertainty_score":0.48898733},"labels":[],"label_agreement":null},{"id":"W4405509487","doi":"10.1007/s40264-024-01507-4","title":"Advances in Drug Safety: Highlights from the 23rd Annual Meeting of the International Society of Pharmacovigilance","year":2024,"lang":"en","type":"editorial","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; Health Canada; BC Children's Hospital; Magna International (Canada)","funders":"","keywords":"Medicine; Pharmacovigilance; Drug; Pharmacology","score_opus":0.0228139303988318,"score_gpt":0.3798366206024882,"score_spread":0.3570226902036564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405509487","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002240037,0.015427026,0.0001150834,0.032741275,0.950836,0.000016263904,0.00005408484,0.00004685226,0.000741079],"genre_scores_gemma":[0.00018519878,0.007830527,0.000105420186,0.018730834,0.9705885,0.000016613933,0.000038794235,0.000023681987,0.0024804906],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98964345,0.0016181741,0.0013581634,0.0010299542,0.0057543586,0.00059592293],"domain_scores_gemma":[0.9588841,0.01441507,0.0035888809,0.0006834407,0.016585063,0.0058433786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013944678,0.0063435873,0.007182548,0.0060008503,0.0033065793,0.01280329,0.0055227582,0.024317425,0.010800105],"category_scores_gemma":[0.03195005,0.0018519263,0.0052949106,0.0032992614,0.0025264218,0.0061399597,0.0028086412,0.02660506,0.00949984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005350033,0.000016524074,0.000029026467,0.00031497612,0.00003947908,0.000071370145,0.0000073693313,0.000023549968,0.000043910615,0.00010700775,0.9945147,0.0047785915],"study_design_scores_gemma":[0.00029037395,0.00007772799,0.0007299116,0.0016671299,0.0002828821,0.0003939304,0.000056257584,0.00036954085,0.00014169225,0.0010921571,0.9948488,0.000049621205],"about_ca_topic_score_codex":0.0037120252,"about_ca_topic_score_gemma":0.011829937,"teacher_disagreement_score":0.024317425,"about_ca_system_score_codex":0.0048898584,"about_ca_system_score_gemma":0.006372948,"threshold_uncertainty_score":0.07374734},"labels":[],"label_agreement":null},{"id":"W4406241940","doi":"10.1007/s40264-024-01510-9","title":"Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference","year":2025,"lang":"en","type":"article","venue":"Drug Safety","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada); AstraZeneca (Canada)","funders":"World Health Organization","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Excellence; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Call to action; Stakeholder; Action (physics); Public relations; Virology; Marketing; Infectious disease (medical specialty); Outbreak; Business; Internal medicine","score_opus":0.054750837146620414,"score_gpt":0.33679440995394266,"score_spread":0.28204357280732223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406241940","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00085433305,0.0022874204,0.0009903237,0.98187476,0.01033466,0.00003904394,0.00003126889,0.00004861373,0.0035395639],"genre_scores_gemma":[0.07541706,0.008036385,0.010838173,0.8656762,0.020490048,0.00034930656,0.00019511084,0.00029452905,0.018703165],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9409006,0.037606888,0.0017525933,0.0027024653,0.010718309,0.006319154],"domain_scores_gemma":[0.85981476,0.05195674,0.0038109242,0.0036480888,0.026432265,0.054337204],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10402649,0.0013696313,0.0012772188,0.0015869727,0.015026197,0.022024903,0.0038301595,0.028961817,0.015477984],"category_scores_gemma":[0.0682205,0.0009131286,0.0023023786,0.0010026328,0.0084937,0.015659165,0.020043531,0.042677406,0.0038797946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000985611,0.00016818204,0.00092006824,0.00038301153,0.000054278415,0.0006089295,0.008139189,0.0002490664,0.0009872634,0.020607252,0.9241299,0.04365432],"study_design_scores_gemma":[0.000023657685,0.000077233744,0.0012115601,0.00094854785,0.000021406291,0.00017148099,0.012485257,0.000313677,0.00035937532,0.0144472085,0.9698617,0.000078947596],"about_ca_topic_score_codex":0.0074515175,"about_ca_topic_score_gemma":0.014901925,"teacher_disagreement_score":0.8959735,"about_ca_system_score_codex":0.013968197,"about_ca_system_score_gemma":0.059687287,"threshold_uncertainty_score":0.5501512},"labels":[],"label_agreement":null},{"id":"W4410254171","doi":"10.1007/s40264-025-01551-8","title":"Incretin-Based Drugs and the Incidence of Endometrial Cancer Among People with Type 2 Diabetes: Active Comparator New-User Design","year":2025,"lang":"en","type":"article","venue":"Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Type 2 diabetes; Incretin; Incidence (geometry); Endometrial cancer; Diabetes mellitus; Cancer; Oncology; Internal medicine; Pharmacology; Endocrinology","score_opus":0.008170111180421281,"score_gpt":0.2504481417911726,"score_spread":0.24227803061075132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410254171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906335,0.0019125111,0.0013594882,0.000118766984,0.00030376695,0.0030486765,0.0010538063,0.000026630616,0.0015429127],"genre_scores_gemma":[0.992949,0.0003026064,0.0011075101,0.00025905916,0.00022983874,0.002930198,0.0005795099,0.000011902012,0.0016303768],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.991433,0.00591489,0.0007248447,0.0008743859,0.0005035353,0.0005493573],"domain_scores_gemma":[0.99212986,0.0034260284,0.0016762303,0.0012441655,0.0007582926,0.0007654099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074181873,0.0014999469,0.0030924706,0.0016759329,0.0009969021,0.0018718686,0.0016916131,0.002610926,0.0084029315],"category_scores_gemma":[0.015097424,0.0010974753,0.0034162092,0.0008392744,0.0014264277,0.0018460591,0.0016748314,0.002204648,0.00078610476],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94602555,0.010605041,0.029073805,0.0005517454,0.0032860904,0.0001341604,0.00032243252,0.00033325586,0.0013902384,0.0003614939,0.00031604175,0.0076002013],"study_design_scores_gemma":[0.3817372,0.4451726,0.13811497,0.00023255142,0.015507738,0.00044746246,0.0010661922,0.0057808287,0.003314995,0.0027349012,0.0056279376,0.00026260258],"about_ca_topic_score_codex":0.0018171326,"about_ca_topic_score_gemma":0.0017802947,"teacher_disagreement_score":0.0084029315,"about_ca_system_score_codex":0.0011172248,"about_ca_system_score_gemma":0.00088835537,"threshold_uncertainty_score":0.0392316},"labels":[],"label_agreement":null},{"id":"W4411971539","doi":"10.1007/s40264-025-01574-1","title":"The Effect of Opioid Agonist Treatment on Injection-Related Sequelae: A Population-Based Observational Study","year":2025,"lang":"en","type":"article","venue":"Drug Safety","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre Hospitalier de l’Université de Montréal; McGill University; Université de Montréal; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Observational study; Opioid; Agonist; Pharmacoepidemiology; Population; Anesthesia; Pharmacology; Intensive care medicine; Internal medicine; Medical prescription; Receptor; Environmental health","score_opus":0.01629320130632624,"score_gpt":0.311642727307649,"score_spread":0.2953495260013228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411971539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982736,0.00066398806,0.000106314,0.00005396036,0.000016410087,0.00001908162,0.00051222363,0.0000030715953,0.00035131132],"genre_scores_gemma":[0.9988745,0.00023181728,0.000079123034,0.000081504826,0.000025487172,0.000017532018,0.00056810677,0.0000029513476,0.000119096694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759656,0.00087982474,0.00028874664,0.00058245496,0.0002989972,0.00035343316],"domain_scores_gemma":[0.99444723,0.0013114044,0.0024619198,0.00061255734,0.0004600487,0.00070689793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017531894,0.00055316475,0.0010228354,0.0009703314,0.0009333445,0.0014329794,0.00084159995,0.0018538358,0.001992921],"category_scores_gemma":[0.005960182,0.0008850224,0.0024313058,0.0020580962,0.0006579041,0.0014937347,0.0008783211,0.0021234632,0.00033548876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010078539,0.00037186735,0.99675936,0.000028282744,0.0008375331,0.00007354423,0.00007595233,0.000027029104,0.00013684765,0.000020072135,0.000093972594,0.00056776433],"study_design_scores_gemma":[0.00009450288,0.0006633948,0.9981172,0.000013356707,0.00037958802,0.00016922287,0.00021406998,0.00016194984,0.000026140917,0.00003279628,0.00011561753,0.0000121365565],"about_ca_topic_score_codex":0.0118054245,"about_ca_topic_score_gemma":0.012134502,"teacher_disagreement_score":0.0118054245,"about_ca_system_score_codex":0.0007091164,"about_ca_system_score_gemma":0.0008363592,"threshold_uncertainty_score":0.023473382},"labels":[],"label_agreement":null},{"id":"W4412882697","doi":"10.1007/s40264-025-01588-9","title":"How does the Content and Dissemination of Communications on the Risks of Medicines Affect Prescriber Awareness, Knowledge, and Behaviour: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; University of Sydney","keywords":"Medicine; Affect (linguistics); Knowledge management; Communication","score_opus":0.2535261208218467,"score_gpt":0.5237633475532911,"score_spread":0.2702372267314444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412882697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038184018,0.9935202,0.00036565456,0.00058526377,0.00016518959,0.0007453334,0.00034175662,0.000012458888,0.0004456724],"genre_scores_gemma":[0.043646064,0.95259386,0.001248418,0.0007782057,0.00013625431,0.001264166,0.00020279308,0.000011092487,0.00011911034],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96545225,0.016666649,0.010079521,0.0018451016,0.0053537902,0.0006026591],"domain_scores_gemma":[0.8643211,0.108651936,0.01771724,0.0016937454,0.0069844215,0.00063151994],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028709207,0.0014932454,0.010617836,0.008685604,0.00082060124,0.0041839145,0.0019533378,0.0028200545,0.0028433397],"category_scores_gemma":[0.13388081,0.0014786068,0.011894263,0.0103943655,0.00166512,0.0046322653,0.0019808372,0.0017572324,0.000295648],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028407198,0.00003125893,0.0013993678,0.9477962,0.018514164,0.000052772717,0.00055040274,0.00010095694,0.000102303755,0.00017447889,0.0005160452,0.03047791],"study_design_scores_gemma":[0.00035707268,0.00030019393,0.004954313,0.85594946,0.13005103,0.00017273774,0.0004696381,0.0001376303,0.00026694225,0.00034080725,0.0069495374,0.00005056607],"about_ca_topic_score_codex":0.010769302,"about_ca_topic_score_gemma":0.023800708,"teacher_disagreement_score":0.97129077,"about_ca_system_score_codex":0.0051416694,"about_ca_system_score_gemma":0.018421706,"threshold_uncertainty_score":0.15183061},"labels":[],"label_agreement":null},{"id":"W4412995518","doi":"10.1007/s40264-025-01581-2","title":"Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation Strategies","year":2025,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"U.S. Food and Drug Administration","keywords":"Medicine; Risk assessment; Risk analysis (engineering); Risk management; Intensive care medicine; Environmental health","score_opus":0.02694763373666597,"score_gpt":0.3327823307369928,"score_spread":0.30583469700032684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412995518","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16462511,0.0016586964,0.6833376,0.02501725,0.0005860714,0.03412195,0.0028429483,0.0015369663,0.08627337],"genre_scores_gemma":[0.20981622,0.00041627494,0.7794501,0.00089976116,0.000039624127,0.0070004743,0.0007290815,0.00007818978,0.0015701753],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.89398044,0.074409746,0.0129967285,0.00237495,0.013995245,0.0022429365],"domain_scores_gemma":[0.78591865,0.13721141,0.01469187,0.007127258,0.050899383,0.0041513997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12554957,0.0017566292,0.0012200554,0.009848312,0.0034381645,0.0067836414,0.0037214293,0.0034873476,0.0070475265],"category_scores_gemma":[0.18751349,0.0010126869,0.0028118894,0.004089872,0.0037696322,0.0071151606,0.011489521,0.0032657944,0.0013455977],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010177859,0.0012893089,0.034753397,0.018523429,0.0005533121,0.0015226898,0.106818035,0.027051006,0.015853813,0.122527294,0.049086332,0.6210036],"study_design_scores_gemma":[0.0008779114,0.002714345,0.052256737,0.0305732,0.0011970194,0.0021589298,0.13150923,0.16434065,0.0310129,0.23125325,0.35058403,0.0015218284],"about_ca_topic_score_codex":0.0045844754,"about_ca_topic_score_gemma":0.0073004207,"teacher_disagreement_score":0.12554957,"about_ca_system_score_codex":0.008328174,"about_ca_system_score_gemma":0.025000064,"threshold_uncertainty_score":0.6639775},"labels":[],"label_agreement":null},{"id":"W4413094417","doi":"10.1007/s40264-025-01596-9","title":"Pharmacovigilance in Cell and Gene Therapy: Evolving Challenges in Risk Management and Long-Term Follow-Up","year":2025,"lang":"en","type":"review","venue":"Drug Safety","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kootenay Association for Science & Technology","funders":"","keywords":"Pharmacovigilance; Medicine; Blueprint; Clinical trial; Risk analysis (engineering); Intensive care medicine; Bioinformatics; Adverse effect; Pharmacology; Pathology","score_opus":0.055418353736730035,"score_gpt":0.36289067018476684,"score_spread":0.3074723164480368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413094417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013367548,0.44140184,0.15870543,0.36020333,0.003991888,0.00040550117,0.0010223291,0.0011626516,0.019739527],"genre_scores_gemma":[0.2935682,0.459669,0.13767035,0.09094704,0.010290578,0.0011815366,0.0017169325,0.0004971654,0.004459149],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.95954454,0.024304545,0.0045816544,0.0025893927,0.008127076,0.00085283717],"domain_scores_gemma":[0.84505206,0.11029682,0.013321852,0.006778404,0.020949032,0.0036018395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05706175,0.00082314055,0.0025123705,0.002253026,0.0014438385,0.011576129,0.003715847,0.004453651,0.0028600025],"category_scores_gemma":[0.13005301,0.000488402,0.0018807361,0.002281267,0.0039602383,0.007868866,0.0064825607,0.008815487,0.0012354072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031380542,0.00014424417,0.014569966,0.0059490623,0.0009047051,0.0011782318,0.0024475458,0.0055424795,0.0009180017,0.09155925,0.059364453,0.8171082],"study_design_scores_gemma":[0.00018256396,0.00085523754,0.007922836,0.025135508,0.0012816897,0.003954113,0.003433773,0.012881299,0.0033561864,0.28707,0.6535908,0.00033591627],"about_ca_topic_score_codex":0.0047544236,"about_ca_topic_score_gemma":0.0042032497,"teacher_disagreement_score":0.05706175,"about_ca_system_score_codex":0.0052005267,"about_ca_system_score_gemma":0.016059643,"threshold_uncertainty_score":0.30177498},"labels":[],"label_agreement":null},{"id":"W4413113797","doi":"10.1007/s40264-025-01597-8","title":"The Extent and Magnitude of Bias in Case-Crossover Studies of Real-World Non-transient Medications Patterns: A Simulation Study with Real-World Examples","year":2025,"lang":"en","type":"article","venue":"Drug Safety","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Crossover study; Statistics; Logistic regression; Magnitude (astronomy); Crossover; Cohort; Cohort study; Econometrics; Internal medicine; Mathematics; Computer science; Artificial intelligence; Pathology","score_opus":0.13412218584066074,"score_gpt":0.4441656779692209,"score_spread":0.3100434921285602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413113797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80145,0.0053798105,0.17902273,0.0010938679,0.00041533788,0.0075037396,0.0015463178,0.00024383087,0.00334441],"genre_scores_gemma":[0.9632041,0.00056843774,0.03197777,0.0002823728,0.00005264359,0.0029803899,0.00042431706,0.000015232368,0.00049473206],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.88011336,0.105217315,0.0046768677,0.005509864,0.003253717,0.001228856],"domain_scores_gemma":[0.455185,0.4923411,0.028030457,0.016353568,0.006959711,0.0011302237],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17684358,0.0013577285,0.0022731384,0.0013240038,0.00080300396,0.0023559986,0.0024240885,0.003844081,0.00363229],"category_scores_gemma":[0.25764236,0.0009810869,0.008212403,0.0012624689,0.002038759,0.002154322,0.001555844,0.0023913875,0.00027312365],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05656951,0.004968932,0.30725023,0.0044936305,0.025471428,0.0028841714,0.0023541672,0.5125593,0.003159334,0.02283212,0.0031860403,0.0542712],"study_design_scores_gemma":[0.019669168,0.03736456,0.07658758,0.0018893289,0.01816571,0.0018492746,0.0011812997,0.7978213,0.0055105467,0.032048196,0.0073182276,0.0005948763],"about_ca_topic_score_codex":0.004624474,"about_ca_topic_score_gemma":0.0022703314,"teacher_disagreement_score":0.8231564,"about_ca_system_score_codex":0.0023037854,"about_ca_system_score_gemma":0.002045539,"threshold_uncertainty_score":0.93524945},"labels":[],"label_agreement":null},{"id":"W4413358964","doi":"10.1007/s40264-025-01599-6","title":"Navigating Medical Device Safety: Current Status, Challenges, and Future Regulatory Directions","year":2025,"lang":"en","type":"review","venue":"Drug Safety","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Magna International (Canada)","funders":"","keywords":"Medicine; Current (fluid); Intensive care medicine; Risk analysis (engineering); Pharmacology","score_opus":0.12516063445094774,"score_gpt":0.4706423516385607,"score_spread":0.345481717187613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413358964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008668074,0.9979102,0.00019473114,0.0008425272,0.00013544486,0.000004894261,0.0000144559135,0.0000082710185,0.00080273114],"genre_scores_gemma":[0.00065098883,0.9982035,0.0002822039,0.00049807364,0.00012709062,0.0000059978906,0.000018225155,0.0000013437764,0.00021253998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995338,0.00011580349,0.000059540584,0.00007083889,0.00016611513,0.000053919866],"domain_scores_gemma":[0.9973322,0.0017358772,0.00028756144,0.000043824748,0.0004719353,0.00012857725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002232216,0.0008350755,0.0020221071,0.0017040207,0.0003211633,0.0024997497,0.0013950067,0.0024837377,0.0049136286],"category_scores_gemma":[0.002629772,0.0002954829,0.00077264017,0.002036736,0.0010143573,0.002935616,0.0010779481,0.0031760416,0.0016355609],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061401995,0.00008473743,0.00015882391,0.018263256,0.000073848634,0.000052367872,0.00006363741,0.00042315573,0.00053761393,0.0073621087,0.014543178,0.95837593],"study_design_scores_gemma":[0.000051242503,0.00022303309,0.00093239656,0.026646528,0.00028784532,0.00056862214,0.0002730098,0.00044094422,0.00046306525,0.010308457,0.9597596,0.00004538462],"about_ca_topic_score_codex":0.0022599697,"about_ca_topic_score_gemma":0.0050663254,"teacher_disagreement_score":0.0049136286,"about_ca_system_score_codex":0.0008906679,"about_ca_system_score_gemma":0.003609542,"threshold_uncertainty_score":0.01643771},"labels":[],"label_agreement":null},{"id":"W4414110520","doi":"10.1007/s40264-025-01612-y","title":"Drugs Withdrawn from the Canadian Market for Safety and Effectiveness Reasons, 1990–2024: A Cross-Sectional Study","year":2025,"lang":"en","type":"article","venue":"Drug Safety","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University; University of Toronto","funders":"","keywords":"Drug; Drug approval; Drug industry; MEDLINE; Pharmacovigilance; Patient safety","score_opus":0.01999037520374037,"score_gpt":0.356391062792379,"score_spread":0.3364006875886386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414110520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98632544,0.0009785694,0.00008011972,0.00021767025,0.00001539192,0.00012687586,0.009223316,0.0000100127445,0.0030226097],"genre_scores_gemma":[0.9911193,0.00096137985,0.0001620987,0.0003940084,0.000023345716,0.00007262823,0.00577171,0.000008042796,0.0014875636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979874,0.00015791482,0.00021003158,0.00024990103,0.00079131924,0.00060349156],"domain_scores_gemma":[0.99364763,0.0003949587,0.0026650564,0.00020762467,0.0020662271,0.0010184288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014407041,0.000645796,0.0006138006,0.00300218,0.0026303327,0.0020685212,0.0016893196,0.0015125752,0.003407397],"category_scores_gemma":[0.0043928935,0.0010548603,0.0013362487,0.007776201,0.0009584662,0.0010572723,0.0011968788,0.0020583165,0.0007505475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001609166,0.0000866549,0.9979724,0.000025016565,0.00008474359,0.00004919901,0.00029098723,0.000023794695,0.000050937175,0.000019766494,0.0004517934,0.00078365736],"study_design_scores_gemma":[0.000007654461,0.00003842866,0.99910223,0.000010591654,0.00003096178,0.00004411851,0.00035340717,0.00003639429,0.000019362622,0.0000033544184,0.0003470671,0.000006435372],"about_ca_topic_score_codex":0.9551286,"about_ca_topic_score_gemma":0.96583074,"teacher_disagreement_score":0.9836794,"about_ca_system_score_codex":0.01632061,"about_ca_system_score_gemma":0.015641028,"threshold_uncertainty_score":0.11841488},"labels":[],"label_agreement":null},{"id":"W4414161699","doi":"10.1007/s40264-025-01606-w","title":"Algorithms to Identify Major Congenital Malformations in Routinely Collected Healthcare Data: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Congenital malformations; Systematic review; MEDLINE; Pregnancy; Healthcare system","score_opus":0.07139971195216459,"score_gpt":0.44381818758230945,"score_spread":0.37241847563014485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414161699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017097538,0.9915489,0.0016283379,0.0007121566,0.00016738266,0.002285,0.0013858947,0.00004337365,0.000519176],"genre_scores_gemma":[0.03717209,0.9394447,0.015416715,0.0010523353,0.00013506679,0.0051803906,0.0014420616,0.00003282915,0.0001238769],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.90915406,0.038530856,0.03677413,0.0041538067,0.010588223,0.0007989107],"domain_scores_gemma":[0.6586164,0.28142652,0.03622497,0.004248532,0.018655393,0.0008282443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06817186,0.0023732677,0.010801397,0.029829811,0.0010245153,0.005528347,0.0040815813,0.0025996072,0.0039005855],"category_scores_gemma":[0.29038754,0.002057489,0.013167309,0.024137536,0.0018883691,0.0061228015,0.0032392517,0.0020512443,0.00046540023],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016605061,0.000017378297,0.0020853183,0.93156815,0.010527918,0.000043495264,0.0002519348,0.00028637177,0.00004899879,0.00046125305,0.0012783482,0.05326474],"study_design_scores_gemma":[0.0003204696,0.00015857529,0.0030864442,0.9444218,0.04134355,0.00015608256,0.00025345816,0.00027831466,0.00014438828,0.00052354357,0.009262424,0.00005084182],"about_ca_topic_score_codex":0.014294908,"about_ca_topic_score_gemma":0.029860165,"teacher_disagreement_score":0.06817186,"about_ca_system_score_codex":0.009028552,"about_ca_system_score_gemma":0.030329626,"threshold_uncertainty_score":0.36053157},"labels":[],"label_agreement":null},{"id":"W4415418769","doi":"10.1007/s40264-025-01623-9","title":"Incretin-Based Drugs and the Risk of Dementia Among Patients with Type 2 Diabetes","year":2025,"lang":"en","type":"article","venue":"Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Dementia; Type 2 diabetes; Diabetes mellitus; MEDLINE; Alzheimer's disease; Drug","score_opus":0.001622384739918409,"score_gpt":0.18268560671466258,"score_spread":0.18106322197474417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415418769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98718715,0.007738561,0.00011768771,0.00054294814,0.00005754554,0.0000103653365,0.0005003214,0.00000744869,0.003837998],"genre_scores_gemma":[0.9977653,0.0014616579,0.000091440954,0.00015932872,0.000077629586,0.0000029514913,0.00020347303,0.0000014283316,0.00023679085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994295,0.00015097237,0.000107890555,0.000063879466,0.00017600266,0.00007167546],"domain_scores_gemma":[0.99669844,0.0007988497,0.0018040879,0.00012949952,0.0002930554,0.00027606462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007772564,0.00019581486,0.0004482284,0.0010308439,0.0004226227,0.0010700455,0.00025811567,0.0006996025,0.0010950565],"category_scores_gemma":[0.004917055,0.000216093,0.0009100847,0.0013618122,0.00020129282,0.0005427436,0.00034625063,0.0013185819,0.00010771625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004099179,0.00012355327,0.99426717,0.0000427196,0.0002566128,0.00011685802,0.0000503968,0.000044078104,0.00006406248,0.000039743096,0.00014440916,0.0044405833],"study_design_scores_gemma":[0.000017766168,0.00013550525,0.9984446,0.00003270866,0.0002048671,0.00035658432,0.00012036672,0.00023150147,0.000039371225,0.00012328626,0.00028670026,0.000006842665],"about_ca_topic_score_codex":0.006340207,"about_ca_topic_score_gemma":0.0070953607,"teacher_disagreement_score":0.006340207,"about_ca_system_score_codex":0.00036741106,"about_ca_system_score_gemma":0.0003842604,"threshold_uncertainty_score":0.012606621},"labels":[],"label_agreement":null},{"id":"W60025275","doi":"10.2165/00002018-200730050-00007","title":"An Evaluation of the Cardiovascular Safety Profile of Duloxetine","year":2007,"lang":"en","type":"review","venue":"Drug Safety","topic":"Treatment of Major Depression","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Duloxetine; Medicine; Duloxetine Hydrochloride; Adverse effect; Clinical trial; Fibromyalgia; Major depressive disorder; QT interval; Internal medicine; Intensive care medicine; Psychiatry; Mood","score_opus":0.06706246941513194,"score_gpt":0.37751342052893105,"score_spread":0.3104509511137991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W60025275","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006175174,0.9987178,0.000088982095,0.0000907513,0.00004762205,0.000009195788,0.000029211504,0.0000043647865,0.00039461302],"genre_scores_gemma":[0.0034476907,0.9956456,0.0003076617,0.00023813988,0.000052306652,0.000008319646,0.0000498287,0.0000012757592,0.00024923097],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997662,0.000049877654,0.000048910366,0.000030232974,0.00008883804,0.000016078815],"domain_scores_gemma":[0.99927825,0.00041238367,0.0001329712,0.000014369109,0.00013557804,0.000026554375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011444914,0.0007396526,0.0023619595,0.0015478794,0.00017725905,0.000631189,0.0009871052,0.00070040004,0.0022344007],"category_scores_gemma":[0.0011251196,0.00022706804,0.0012048337,0.001502782,0.00022736593,0.00057682116,0.00030106923,0.0009954097,0.00032911473],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006513179,0.00009947559,0.0003585846,0.0379156,0.0008533941,0.00021267956,0.00005285583,0.00025308982,0.0017805233,0.00053491304,0.007366581,0.949921],"study_design_scores_gemma":[0.0018161734,0.004184339,0.019431148,0.042421285,0.0174778,0.0053871926,0.00034537268,0.0011057127,0.0070461063,0.0023138372,0.8983127,0.00015842124],"about_ca_topic_score_codex":0.0022099507,"about_ca_topic_score_gemma":0.0061778096,"teacher_disagreement_score":0.0023619595,"about_ca_system_score_codex":0.00048455733,"about_ca_system_score_gemma":0.00096619944,"threshold_uncertainty_score":0.0074748397},"labels":[],"label_agreement":null},{"id":"W787584711","doi":"10.1007/s40264-015-0308-6","title":"Accidents and Incidents Related to Intravenous Drug Administration: A Pre–Post Study Following Implementation of Smart Pumps in a Teaching Hospital","year":2015,"lang":"en","type":"article","venue":"Drug Safety","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Technician; Pharmacist; Pharmacy; Medical emergency; Patient safety; Officer; Clinical pharmacy; Pharmacy technician; Emergency medicine; Nursing; Health care","score_opus":0.026077544236014712,"score_gpt":0.4178141142902625,"score_spread":0.3917365700542478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W787584711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99950624,0.000021741263,0.000029319302,0.00007178235,0.000009698613,0.000036070276,0.000061750194,0.0000017793548,0.00026163357],"genre_scores_gemma":[0.99875665,0.00010044513,0.00008481333,0.00013710564,0.000021214113,0.000050670296,0.00012988455,0.0000026917708,0.0007166168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868876,0.0002854089,0.00019204622,0.0001282613,0.0002412526,0.00046437333],"domain_scores_gemma":[0.9932,0.0008347146,0.0019088777,0.00023744667,0.001483463,0.002335555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012667105,0.00044291117,0.0005396123,0.0020058183,0.0034501464,0.0012235863,0.0007642898,0.0014998842,0.0024340623],"category_scores_gemma":[0.0052094026,0.0010174958,0.001140426,0.0015805555,0.0012891269,0.001816197,0.0019724173,0.003123794,0.0006599995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005971508,0.0025692114,0.97820914,0.00004614725,0.000049565228,0.0012148179,0.012596439,0.00005646347,0.0007434381,0.00003908705,0.00020191344,0.0036766718],"study_design_scores_gemma":[0.0000113680535,0.0032681036,0.96146435,0.00001632139,0.000024160547,0.00029255025,0.034289874,0.00006564374,0.00023701611,0.00001835641,0.0002803497,0.000031963995],"about_ca_topic_score_codex":0.0447135,"about_ca_topic_score_gemma":0.07197055,"teacher_disagreement_score":0.0447135,"about_ca_system_score_codex":0.0026527846,"about_ca_system_score_gemma":0.0029374408,"threshold_uncertainty_score":0.08890647},"labels":[],"label_agreement":null},{"id":"W81216262","doi":"10.2165/11592780-000000000-00000","title":"Drug-Induced Photosensitivity","year":2011,"lang":"en","type":"review","venue":"Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Dermatology; Photosensitivity; Onycholysis; Drug; Rash; Ultraviolet radiation; Sunburn; Ultraviolet a; Pharmacology; Psoriasis","score_opus":0.07216491679120139,"score_gpt":0.34108831485469365,"score_spread":0.26892339806349225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W81216262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041146952,0.9951166,0.0003472249,0.00015862807,0.0001828844,0.000020836127,0.00004829207,0.000022713266,0.0036912514],"genre_scores_gemma":[0.004725655,0.9917064,0.00042963677,0.00042898863,0.00024062119,0.000014974094,0.00008402546,0.000004229111,0.0023655954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963963,0.00007414866,0.000071743736,0.00005227319,0.00013666526,0.000025543284],"domain_scores_gemma":[0.99938667,0.00024137652,0.00023665505,0.000024621319,0.000082048915,0.000028592025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050811196,0.0009916509,0.0013168914,0.0020771548,0.00019324505,0.0007096146,0.000577883,0.0006961948,0.0073975855],"category_scores_gemma":[0.00086797774,0.00024207609,0.000834508,0.0014630145,0.0003076976,0.0007950227,0.000658218,0.0010780961,0.0015668805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008424526,0.00009784978,0.00030356494,0.01685851,0.00015512995,0.00036186213,0.000021700858,0.00020402731,0.0019099955,0.00062352646,0.016978407,0.9624013],"study_design_scores_gemma":[0.000113863185,0.0005129095,0.0037436858,0.008993883,0.0009839102,0.009348047,0.000069208545,0.0003255182,0.0034069165,0.0014472395,0.9710208,0.000033932618],"about_ca_topic_score_codex":0.0005730139,"about_ca_topic_score_gemma":0.0016848857,"teacher_disagreement_score":0.0073975855,"about_ca_system_score_codex":0.0003597025,"about_ca_system_score_gemma":0.000519776,"threshold_uncertainty_score":0.024747431},"labels":[],"label_agreement":null},{"id":"W98970232","doi":"10.2165/00002018-200831010-00002","title":"Benefits and Risks of Antipsychotic Polypharmacy","year":2008,"lang":"en","type":"review","venue":"Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Louis-H Lafontaine","funders":"","keywords":"Polypharmacy; Medicine; Antipsychotic; Risperidone; Clozapine; Medical prescription; Psychiatry; Schizophrenia (object-oriented programming); Intensive care medicine; Pharmacology","score_opus":0.13994866495431282,"score_gpt":0.42378017582283767,"score_spread":0.28383151086852487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W98970232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014077287,0.99929905,0.000036552254,0.00012604859,0.000040320992,0.0000023737634,0.000016267864,0.0000017194492,0.00033682492],"genre_scores_gemma":[0.0013816954,0.99815696,0.000105759485,0.00012942287,0.00006663466,0.0000030418887,0.000013972672,4.4136874e-7,0.00014202317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996339,0.00008360612,0.00006654501,0.00004100564,0.00015945364,0.000015551954],"domain_scores_gemma":[0.9989555,0.00070039555,0.00022095638,0.00001694166,0.00008322143,0.000023048062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080982415,0.0007566113,0.0018395729,0.001816204,0.00017423737,0.00077785767,0.00067133637,0.00102557,0.003213732],"category_scores_gemma":[0.0019232589,0.00027478195,0.0009769199,0.0019205477,0.00039265965,0.0007620738,0.0004821474,0.0011432839,0.00047035274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030777766,0.000044851546,0.00046192636,0.04027934,0.0007685315,0.00021715871,0.000040635856,0.00027417525,0.0005427144,0.0013683946,0.009755517,0.9459391],"study_design_scores_gemma":[0.00040128536,0.00042467692,0.012231022,0.06067014,0.007315987,0.004884173,0.00027427234,0.0003587014,0.0011387521,0.0081572505,0.9040559,0.00008777881],"about_ca_topic_score_codex":0.0019145949,"about_ca_topic_score_gemma":0.0055294903,"teacher_disagreement_score":0.003213732,"about_ca_system_score_codex":0.00064627256,"about_ca_system_score_gemma":0.0009839559,"threshold_uncertainty_score":0.010751009},"labels":[],"label_agreement":null}]}